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SUMMARY
Following the general introduction, chapter one, the thesis is divided into four
chapters, covering literature review, materials and methods, results and discussion and
conclusion.
Fasciolosis is a liver fluke disease, caused by Fasciola hepatica in temperate
regions and high altitude areas of the tropics and subtropics and by Fasciola gigantica,
which is restricted to the tropics and subtropics. Liver flukes have a wide range of
definitive hosts, including man and in particular domestic ruminants, but the various
hosts are known to differ greatly in their resistance to infection with these parasites. For
example sheep are considered susceptible to challenge infection while cattle develop
resistance.
F. hepatica secretes the enzyme cathepsin-Ll protease (Fh-cathepsin) which has
a molecular weight (MWt) of 27 kDa. It is considered to have a functional role in
parasite evasion of the host immune response, through cleavage of host
immunoglobulin. The enzyme, glutathione s-transferase (GST) is of 27.8-29 kDa MWt,
is also secreted by F. hepatica (Fh-GST) and is thought to be involved in the
detoxification of exogenous (xenobiotic) and endogenous derived toxic compounds.
Both enzymes form part of the fluke excretory/secretory (E/S) products and are of
interest as they are considered as vaccine candidates against fasciolosis.
This study investigated the immunoglobulin isotype responses of sheep and
cattle, chronically infected with F. hepatica and F. gigantica, to defined the fluke
antigens (F. hepatica E/S products (Fh-E/S) or F. gigantica E/S products (Fg-E/S), Fh-
xii
cathepsin and Fh-GST). It was decided to study the immune response in chronically
infected animals since immunity is considered to play a potentially more important role
in chronic infection, than in acute infection, which is characterised by the death of the
animal through anaemia and blood loss caused by the migrating flukes. Serum and
faecal samples were collected weekly while the severity of the infections were defined
using clinical, parasitological, haematological, biochemical and pathological
parameters.
Serum and faecal antibody (total Ig, IgGb IgM, IgG2 and IgA) responses to 24-
48 hour Fh-E/S and Fg-E/S, adult Fh-cathepsin and adult Fh-GST were determined by
indirect Enzyme-linked Immunosorbent Assay (ELISA). The antigen recognition profile
of the Fasciola spp. infected sheep and cattle to Fh-E/S and Fg-E/S was examined by
sequential Western blotting.
The general clinical and pathological pattern, combined with the parasitological,
biochemical and haematological data confirmed that, in the main, the sheep and cattle
were suffering from chronic fasciolosis. Lesions were most severe in sheep culled 11 to
20 weeks post infection (wpi) and calves with single infection, but culled 12 wpi, and
those calves with challenge infection. Overall, the calves had very light infection and as
a result they displayed a less severe chronic fasciolosis than that observed in sheep.
A reduction in serum glucose levels was detected in F. hepatica and F. gigantica
infected sheep from 3 wpi, especially in severely infected sheep. In contrast, there was
an increase in serum P-hydroxybutyrate (P-HOB) levels in infected sheep, from about 6
to 15 wpi. And the extent of the rise in P-HOB levels was associated with the severity of
the infection There was no serum glucose or P-HOB changes observed in infected
calves. This was considered to be due to the very light fluke infection. Thus, it would
appear from the serum glucose and P-HOB levels, that fasciolosis leads to energy
deficiency (low glucose) and ketosis (increased b-HOB) especially noticeable in more
heavily infected animals.
There was an early (2-3 wpi) total Ig response to Fh-E/S and Fg-E/S, Fh-
cathepsin and Fh-GST in both F. hepatica infected sheep and cattle. Although there was
an early (2-3 wpi) total Ig response to Fh-E/S and Fg-E/S, and Fh-GST by F. gigantica
infected animals, there was a slight delay (7 wpi) noted in the response to Fh-cathepsin.
The pattern of the IgGj response of cattle and sheep to these defined fluke antigens was
similar to that of total Ig. In fact the serum isotype response was predominantly IgG].
The IgM response to Fh-E/S and Fg-E/S, Fh-cathepsin and Fh-GST was early in both
species. In cattle the IgG2 and IgA responses to Fh-E/S and Fg-E/S were late and more
pronounced (11 wpi and 19 wpi respectively) in contrast to sheep (2 wpi for both
isotypes). The serum IgG2 and IgA isotype responses to Fh-cathepsin and Fh-GST
followed the same pattern in cattle, however in sheep, responses to Fh-cathepsin was
much less marked and a response to Fh-GST was not detected. A rise in total Ig and
IgG, responses to Fh-E/S and Fg-E/S and Fh-cathepsin were detected following
challenge infection in calves, but there was no increase in the response to Fh-GST. The
dominance of the IgGj response in Fasciola spp. infected sheep and cattle suggests an
associated Th2 response in both species. The late IgG2 response in cattle may suggest
late Th, involvement in bovine cellular responses to Fh-E/S and Fg-E/S products.
The detection of serum antibody responses to Fh-cathepsin and Fh-GST in F.
gigantica infected sheep and cattle confirmed antigenic cross-reactivity. However this
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cross-reactivity may be only partial, as suggested by the late total Ig and IgG, response
to Fh-cathepsin by F. gigantica infected sheep and cattle. Comparison of the isotype
responses to Fh-E/S and Fg-E/S products, Fh-cathepsin and Fh-GST suggest that there
is very little difference between the response to Fh-E/S, Fg-E/S and Fh-cathepsin,
however, there was a relatively poor response to Fh-GST in both sheep and cattle.
Western blot analysis ofF. hepatica infected sheep serum identified antigens of
14 kDa from 2 wpi and 54, 79 and 134 kDa MW recognised later. In F. gigantica
infected sheep antigens of 14, 88 and 152 kDa were identified from 7-9 wpi. There was
a clear shift, at patency, in the antigen recognition pattern of cattle from higher (134
kDa for F. gigantica infection and 142 kDa for F. hepatica infection) to lower (60 kDa
for both parasite species) but there was no clear antigenic shift observed in sheep. None
of these antigenic molecules represented Fh-cathepsin (27 kDa MWt) or Fh-GST (27.9-
29 kDa MWt) used as antigens in the ELISA assay. The lower protein concentration of
the E/S products used in this assay is, one possible reason for failure to detect these
molecules.
There was no faecal antibody response detected in cattle to any of the three
defined antigens. This might have been due either to the light infections observed in
cattle or to the larger volume of faecal material produced by cattle (i.e. dilution). There
was an early (2 wpi) faecal total Ig response to Fh-E/S and Fg-E/S, Fh-cathepsin and
Fh-GST in F. hepatica and F. gigantica infected sheep. In fact there was no difference
in faecal antibody responses to the different antigens by either F. hepatica or F.
gigantica infected sheep. The isotype response was mainly IgA while a slight IgG2
response could be detected in F. hepatica infected sheep. The total Ig and IgA responses
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to all three defined antigens in F. hepatica sheep was biphasic, in F. gigantica infection
however the phases were less defined. The 1st phase (about 2-10 wpi) is considered a
response to juvenile flukes antigens after oral infection and the second peak (13-17 wpi)
is considered to be in response to antigens released by adult flukes in the bile duct.
This study indicates that in serum, IgG( isotype responses predominate and in
faeces IgA isotype responses to the three defined antigens predominate, suggesting
preferentially stimulation of the Th2 T-cell subset in sheep and cattle fasciolosis. The
late IgG2 response to F. hepatica and F. gigantica E/S and Fh-cathepsin in cattle may
indicate a delayed Th, stimulation.
In order to elucidate the different immune mechanisms operating in infected
sheep and cattle there is need for more work on the cellular responses to Fasciola spp.
as these may be related to resistance. There was antigenic shift in cattle at patency but
not in sheep. The 60 kDa molecule being recognised by cattle after the antigenic shift. It
is possible that this factor may be related to acquisition of resistance by cattle to
secondary Fasciola spp. infection
Finally the findings relating to the glucose and b- HOB levels in infected sheep
may prove helpful in experiments involved in the interaction between fasciolosis and






Fasciolosis, also known as liver fluke disease, is caused by several species of
digenic trematodes belonging to the genera Fasciola and Fascioloides. The two most
important species, are Fasciola hepatica and Fasciola gigantica. F. hepatica is more
commonly found in temperate areas and at high altitude in the tropics and subtropics,
while F. gigantica, which is more pathogenic, is found in tropical regions (Urquhart,
Armour, Duncan, Dunn and Jennings, 1996).
The major definitive hosts of these parasites are domestic ruminants (cattle,
sheep, goats and buffaloes) while equines (horses, donkeys, mules) are less
susceptible. Pigs are considered naturally resistant to Fasciola infection (Boray,
1969 and Soulsby, 1982). Wild mammals may also be infected with Fasciola spp.
and this plays an important epidemiological role (Hammond, 1972). Fasciolosis is
one of the most economically important helminth diseases, hampering the productivity
of domestic ruminants in endemic areas. It is also of zoonotic importance as man can
be infected with adult flukes.
There are clear differences observed in acquired immunity among the various
species of definitive host ofFasciola spp. For example, sheep show little resistance to
reinfection in comparison to cattle (Boray, 1967 and Losos, 1986). Haroun and Hillyer
(1986), in a review, classified cattle, rats and goats as having significant resistance to
Fasciola spp. reinfection and sheep and rabbits as having no resistance.
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Chapter One: Introduction
During their migration in the definitive host, liver flukes excrete and/or secrete
(E/S) many proteins including Cathepsin cystein proteases (Dalton and Heffernan,
1989) and Glutathione S-Transferase (Creaney, Wijffels, Sexton, Sandaman, Spithill
and Parsons, 1995). One of these proteases, cathepsin-Ll protease, has been isolated
from adult F. hepatica (Fh-cathepsin) and is of 27 kDa molecular weight (Smith,
Dowd, McGonigle, Keegan, Brennan, Trudget and Dalton, 1993). Fh-cathepsin is
thought to play an immunological role assisting the parasite in penetrating the gut
wall and liver of its mammalian host before taking up residence in the bile ducts
(Smith, Dowd, Heffernan, Robertson and Dalton, 1993). Adult F. hepatica
Glutathione S-Transferase (Fh-GST) has also been isolated and is of 28-27.8 kDa
molecular weight (Hillyer, Soler Der Galanes and Battisti, 1992). Helminth GST's
are known to conjugate with other endogenous substances such as lipid
hydroperoxides thereby protecting the parasite from host toxins and are also thought
play a role in protecting parasite against radicals produced by the host (Brophy and
Barrett, 1990).
The major immunoglobulins of cattle and sheep, IgM, IgG1; IgG2, IgA and IgE
have been well documented as far as their structure and antigenic properties are
concerned (Butler, Winter and Wagner, 1971; Tizard, 1992), but much less is known
about their specific activities against pathogens, especially helminths parasites
(Butler, Winter and Wagner, 1971; Tizard, 1992). Thus the involvement of the
various immunoglobulin isotypes in the response of cattle and sheep to Fasciola spp.
infection have not yet been fully elucidated. The available information, concerning
isotype responses in cattle and sheep fasciolosis covers mainly F. hepatica infections
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and responses to relatively undefined antigens such as E/S (Oldham, 1985; Chauvin,
Bouvet and Boulard, 1995) or whole fluke extracts (Brown, Davis, Dobbeleare and
Rice-Ficht, 1994; Clery, Torgerson, and Mulcahy, 1996). Relatively little is known
about isotype responses of cattle and sheep in F. gigantica infection to E/S antigen or
to Fh-cathepsin and Fh-GST.
A knowledge of serum and faecal isotype responses to E/S, Fh-cathepsin and
Fh-GST in cattle and sheep may help in the understanding of related cellular
responses and hence protective immune mechanisms. For example IgG! responses
are associated with stimulation of Th2 lymphocytes as has been reported in murine
schistosomiasis (Mountford, Fisher and Wilson, 1994) and inF. hepatica chronically
infected cattle (Clery, Torgerson and Mulcahy, 1996). Of the many domestic
ruminants, which are infected by fasciolosis, sheep and cattle were selected for this
study because of their importance as domestic animals and also because they differ in
both their response and resistance to fasciolosis.
These experiments were therefore designed to study sera and faecal
immunoglobulin isotype responses of F. hepatica and F. gigantica infections in
cattle and sheep against Fasciola spp. E/S, Fh-cathepsin and Fh-GST.
Chronic experimental infections in sheep and cattle were established and the
severity of these infections defined by clinical, parasitological, pathological,
haematological and biochemical indicators. It was decided to study the immune
response in chronically infected animals since immunity was considered to play
potentially a more important role in chronic infection than in acute infection, where
the primary cause of death is anaemia and blood loss caused by migrating flukes.
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The objectives of this study were:
1. To standardise indirect Enzyme-Linked Immunosorbent Assays (ELISA)
designed to detect total Ig, IgM, IgGb IgG2 and IgA isotype responses in F.
hepatica and F. gigantica infected sheep and cattle to 24-48 hour adult Fasciola
spp. E/S, adult Fh-cathepsin and adult Fh-GST.
2. To sequentially monitor the serum and faecal immunoglobulin isotype
responses of sheep and cattle chronically infected with either F. hepatica or F.
gigantica to these defined antigens.
3.To examine the isotype responses in order to try to associate these with
possible T-cell involvement in the response to fasciolosis. By comparing sheep
(susceptible) and cattle (resistant) an understanding may be reached of the
immune mechanisms contributing to resistance in cattle.
4. To compare this serological pattern with the original infection dose, fluke
recovery, pathology and biochemistry including glucose and P-hydroxybutyrate
serum levels. These last parameters were studied in order to examine the effects
fasciolosis has on the metabolism of carbohydrates and volatile fatty acids and
their contribution to ketosis (ketone bodies accumulation) in sheep and cattle.
The liver, which stores glycogen, the major source of glucose, is severely
affected during fasciolosis in ruminants.
4





Hepatic fasciolosis or liver fluke disease are terms commonly used to
describe the disease caused by flukes belonging to the genus Fasciola (Malek, 1980;
Losos, 1986; Hammond and Sewell, 1990; Burger, 1992). However clinicians and
pathologists consider liver fluke disease as that caused by digenean trematodes of the
genera Fasciola, Fascioloides and Dicrocoelium (Jones and Hunt 1983; Urquhart,
Armour, Duncan, Dunn and Jennings, 1987; Blood and Radostits, 1989). The most
important species of these genera are Fasciola hepatica (the common liver fluke)
Fasciola gigantica (the large African liver fluke), Fascioloides magna (the large
liver fluke) and Dicrocoelium dendriticum and D. hospes (the lancet flukes)
respectively. But world wide it is F. hepatica and F. gigantica that cause major
production loss.
2.1.2 Taxonomy
The members of the Phylum Platyhelminthes were first described by
Rudolphi "the father of parasitology" in 1806. Ershov (1960) and Georgi (1985)
described them as soft-boded, flattened dorsoventrally and hermaphroditic. Liver
flukes are members of the Order Digenea because they undergo an indirect
development with sexual and asexual generations parasitizing alternate hosts (Ershov
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1960). Many authors, including Kendall and Parfitt (1959), believe that only two
species of the genus Fasciola find a world wide distribution namely the temperate
Fasciola hepatica and its tropical and subtropical relative Fasciola gigantica. Varma
(1953) proposed a new species Fasciola indica on the basis of apparent
morphological differences between fixed material from Africa and Asia and after
examining a small sample of eggs .
Watanabe (1962) supported Varma's proposal after studying some biological
and morphological aspects of liver flukes in Japan. Kendall and Parfitt (1959),
however, were unable to find any morphological or biological differences after
studying African and Pakistani liver flukes and eggs. Kendall (1965) considered F.
indica to be synonomous with F. gigantica any minor differences being minor intra
species variations. Blair and McManus (1989) after studying the rDNA restriction
map of the Japanese species concurred with Kendall's (1965) observations.
There appears to be very little disagreement about the Fasciola species
present on the Africa continent. Hammond (1972) stated that apart from F. hepatica
and F. gigantica there exists two other true fluke species. Fasciola tragelaphi
reported from Southern Rhodesia (now Zimbabwe) and Uganda found parasitising
Kudu and Bushbucks and from East and Southern Africa Fasciola nyanzae in
Hippopotamus.
Opinions on fluke classification in the Americas differ. Sinitzin (1933)
described Fasciola halli and Fasciola californica although they do not exibit many
morphological deferences to the two common liver flukes F. hepatica and F.
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gigantica. Price (1953) noted morphological variations in flukes collected from
different parts of the United States of America with some close to F. hepatica, those
from Texas and Florida identical with F. gigantica and most of the Gulf isolates were
morphologically intermediate forms between F. hepatica and F. gigantica.
Malek (1980) summarised the taxonomy of liver fluke and concluded that
although there are taxonomic disputes in various geographical areas there are only
two most important valid species namely F. hepatica and F. gigantica.
2.1.3 Life Cycle of F. hepatica and F. gigantica
Figure 2.1: The life cycle of Fasciola spp. (after Urquhart, Armour, Duncan,
Dunn and Jennings, 1996)
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The life cycle of liver flukes was not known until early 1880s when two
independent investigators, Leuckart and Thomas published the results of their work
(quoted by Reinhard, 1957).
Adult flukes lay their eggs in the bile ducts of the definitive hosts, typically
sheep, goats, cattle and buffaloes, and the eggs enter the duodenum with the bile,
together with the faeces leave the mammalian host and enter the environment
(Georgi, 1980; Soulsby, 1982; Blood and Radostits, 1989; Burger, 1992). Soulsby
(1982) stated that the further development of the egg depends on the moisture content
of the environment, importantly temperature and availability of the intermediate host.
The general life cycle of F. hepatica and F. gigantica is shown in Figure 2.1. F.
hepatica has a land based intermediate host and F. gigantica has an aquatic snail
host.
Malek (1980) reported that it takes 10 to 15 days at a temperature of 23 to
25°C to hatch F. hepatica while Soulsby (1982) estimated 10 to 12 days at 26°C.
Ogambo-Ongoma and Goodman (1973) and Dinnik and Dinnik (1959) showed that
F. gigantica requires a minimum of 17 days and a maximum of 111 days to hatch at
a constant temperature of 26°C.
The process of hatching releases the miracidia which actively attack the soft
foot of the snail and penetrate the snail tissue. A cycle of development, which is
temperature dependent (Dinnik and Dinnik, 1964; Gorgi. and Theodorides, 1980;
Soulsby, 1982), then follows with the parasite passing through sporocyst, rediae and
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daughter rediae stages. This cycle takes from 45 days to about 100 days in the snail
after which cercariae starts to release from the snail. Dawes (1960) reported that the
miracidium adheres by suction to the epithelial cells of the snail and breaks these
down probably by means of enzymes secreted by apical organs of the gut and cast off
the ciliated epithelium as it enters the snail as a young sporocyst. Dawes (1960),
Kendall (1965) and Malek (1980) considered that miracidia change to sporocysts
near the site but before penetration, the young sporocysts then penetrate the snails.
Roberts (1950), Soulsby (1982) and Burger (1992) on the other hand believe that the
sporocysts are formed after the miracidia have penetrated the snail.
F. hepatica sporocysts are usually found in the mantle edge, the kidney and
oesophageal area of the snail where mother rediae from after about 2 to 3 weeks
(Dawes, 1960; Malek, 1980; Soulsby, 1982). Most F. gigantica sporocysts are
localised along the tissue surrounding the respiratory cavity, the pre-oesophageal
region and the mantle of the snail (Dinnik and Dinnik, 1963; Kendall, 1965).
The rediae usually leave the sporocysts by rupturing the sporocyst wall and
then migrate towards the digestive gland or hepato-pancreas, of the snail. It is in this
digestive gland where, under favourable conditions, the rediae develop into tailed
infective larvae or cercariae. In the case of F. gigantica however if the factors are
not conducive daughter rediae develop before cercariae (Kendall, 1965).
Development from miracidium to cercariae in F. hepatica takes two months
(under favourable conditions) according to Burger (1992) or 56 to 86 day as reported
by Malek (1980) and 36 to 40 days for F. gigantica (Dinnik and Dinnik, 1963).
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The infective stage of Fasciola species, metacercariae are normally found as
small white cysts on the grass or herbage on low lying damp ground. These white
cysts encysts from the free swimming tailed larval stages, cercariae, shed by the
intermediate host after actively reaching the herbage (Hughes, 1985; Georgi, 1985).
F. gigantica also encyst after attaching themselves to any object in shallow waters
especially floating leaves and plants (Cheruiyot and Wamae, 1990).
The definitive host becomes infected after ingestion of the plants harbouring
metacercariae (Hughes, 1985; Losos 1986; Malek, 1980; Sewell and Hammond,
1974; Hammond and Sewell, 1990; Burger, 1992). At the time Schumacher (1938 )
started his series of experiments there were three possible routes by which the fluke
was thought to reach the bile duct in the liver of their definitive hosts and these were:
(a) Via the duodenum and against the bile stream into the bile ducts
(b) Via the blood stream by way of portal vein and
(c) Through the abdominal cavity and the liver parenchyma to the bile ducts .
Schumacher (1938) concluded that the fluke's route of invasion in a definitive
host is through the abdominal cavity. He then carried out the same experiments in
sheep where he demonstrated the presence of young flukes in the abdominal cavity,
the liver parenchyma and after only eight weeks in the bile duct (Schumacher, 1938).
It is now an established fact that the migration of F. hepatica and F. gigantica
in the mammalian host starts with penetration of the duodenum by the young fluke or
Marita (Georgi 1985). This marita passes though the peritoneal cavity until it finds
the liver capsule. After crossing the capsule the young fluke passes through the liver
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parenchyma causing tissue damage before entering the bile ducts. The maturation of
the marita to an adult fluke takes place in the bile ducts (Reinhard, 1957; Boray,
1969; Malek, 1980; Georgi, 1985; Burger, 1992) .
From infection to a mature fluke, F. hepatica, in the bile ducts takes a
minimum period of 8 weeks (Schumancher, 1938; Burger, 1992) and at least 11
weeks forF. gigantica (Hammond, 1974).
2.1.4 Morphology of the Different Life Cycle Stages
The adult fluke (F. hepatica and F. gigantica)
The two major economically important Fasciola spp, F. hepatica and F.
gigantica, like most members of the Phylum Platyhelminthes are soft boded, flatted
dorsoventrally and hermaphroditic (Georgi, 1985; Burger, 1992). Jeffrey and Leach
(1966), Malek (1980) and Soulsby (1982) described the shape of these two flukes as
leaflike. Both species have two suckers, one surrounding the mouth and a slightly
larger suckers on the ventral side, close to each other in a cone-like anterior extension
of the body. The posterior end of the fluke is usually pointed.
Fluke internal organs are branched (Jeffrey and Leach, 1966; Malek, 1980).
The intestinal caecae reach to the posterior end, numerous branches of the testes fill
the middle half, and the single ovary is situated on the right side in front of the
anterior branches of testes. Also vitellaria are dorsal and ventral to the caecae
covering the whole lateral hindbody of the fluke (Malek, 1980; Soulsby, 1982; Jones
and Hunt, 1983). Soulsby (1982) clearly showed that F. gigantica though similar to
other Fasciola spp. differs in that it has more branched caecae, has a longer and more
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numerously branched ovary while that of F. gigantica has fewer club shaped
branches.
Malek (1980) gave a range from 20 to 50 mm in length and 6 to 12 mm in
width for F. hepatica and from 30 to 70 mm by 3 to 11 mm for F. gigantica.
Soulsby (1982) and Burger (1992) suggested that F. hepatica may reach 30 by 13
mm and that ofF. gigantica 70 by 12 mm.
Sahba, Arfaa, Farahmandian and Jalali (1972) examined the average length to
width ratios of the two species and concluded that for F. gigantica the ratio is 4.39-
5.20:1 and for F. hepatica 1.88-2.32:1. The size of adult flukes depends on several
factors, including the age of these parasites, the species of their definitive host and
the intensity of the infection (Kendall, 1965; Boray, 1969; Hammond, 1972).
The Ovum
Egg morphology has long been used to differentiate individual fluke species
(Taylor, 1964; Jeffrey and Leach, 1866; Malek 1980; Urquhart, Armour, Duncan,
Dunn and Jennings, 1987; Burger, 1992). Ogambo-Ongoma and Goodman (1973)
and Malek (1980) described Fasciola spp. eggs as yellowish brown, ovoid,
unembryonated, operculated with a clear nuclear area near the opercular. The eggs
contents was described as dark aggregations with uneven masses surrounding the
clear nuclear area. F. gigantica ova are larger than that of its temperate sister species,
F. hepatica.
Kendall and Parfitt (1959) and Jeffrey and Leak (1966) stated that F. hepatica
eggs are 130 to 150 microns long and 63 to 90 microns wide while F. gigantica eggs
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160 to 190 microns long 70 to 90 microns wide. Malek (1980) reported that the
average size of F. gigantica eggs collected from the Sudanese cattle to be 152 by 92
microns and 136 by 80 microns for eggs from cattle from Louisiana USA.
Soulsby (1982) noted the length of eggs as 130 to 150 microns and the width
range of 63 to 90 microns where as F. gigantica eggs measurements range from 156
to 197 microns for length and 90 to 104 microns for width. Care needs to be taken if
the size and shape of these eggs are measured after storage because according to
Hammond (1972) eggs may change in shape and size after storage.
The Miracidium
Troncy and Vasseau-Martin (1974) defined the miracidium of F. hepatica as
a mobile larva characterised by a ciliated locomotion system, an anterior papilla and
cephalic glands permitting the penetration of the host's tissue, two paired eye spots,
two excretory vibratile flame cells and germinal cells. Ogambo-Ongoma and
Goodman (1973) observed that the larvae ofF. hepatica which hatch from fluke eggs
are tiny, densely ciliated organisms and measure 156 by 58 microns. Malek (1980)
gave the size of miracidium as being 130 by 28 micron and that it has a ciliated
epithelium with 21 polygonal cells arranged in five rings of six, six, three, four and
two cell. He also pointed out that under the epithelial layer is syncytium with two
layers of muscle fibres, circular and longitudinal and beneath these muscle layers are
large vesiculated cells of about 10 microns in diameter. Little is known about F.
gigantica it is assumed however that it is similar to F. hepatica.
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The Sporocyst
The next stage of the development of flukes in the snail host is a sporocyst
which is an example of "regressive metamorphosis" and is distinguished by the
absence of a locomotion system, the variation of its shape, the regression of the
internal composition present in the miracidium and the presence of genital cells
(Troncy and Vasseau-Martin 1974). The sporocysts first appear as an elliptical
shaped sack measuring 0.15 mm they then grow to 0.5 mm after fifteen days. Three
weeks after initial infection of the snail the sporocyst start to produce rediae (Malek,
1980).
The Rediae
The rediae are characterised by (a) the presence of a locomotion system and a
structure made up of anterior, muscular collar and two posterior appendices which
become turgescent when the collar contracts (b) a sack-like, functional alimentary
tube (oesophagus) with a typical, muscular pharynx, an excretory system consisting
of two vibratile flame cells (selected location within the hepatopancreas and large
number of germinal cells) which develop into new forms of rediae and cercariae
(Dinnik and Dinnik, 1959; Troncy and Vasseau-Martin, 1974). Malek (1980)
suggested that the rediae when fully grown can measure as much as 0.78 mm taking
a cylindrical shape with a raised collar near the anterior end and two projections in
the posterior third of the body.
According to Ollerenshaw and Graham (1986) one can differentiate the rediae
of F. hepatica from that of F. gigantica simply by comparing their blind intestines.
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The blind intestines of F. hepatica rediae are short and globose commonly one sixth
but can be up to a third of the length of the body while these of F. gigantica always
occupy more than a third and up to half of the body length.
The Cercariae
The cercariae develop from rediae and have a large almost round spone
shaped body of 280 to 320 microns long by 250 microns wide, with a long motile tail
measuring approximately 700 microns long (Malek, 1980). The cercariae have four
types of cytogenic cells, characterised by their position and histochemical properties
(Dixon, 1966). Georgi (1985) summarised the morphology of cercariae as a tadpole¬
like larvae with a discoidal body and a long tail for swimming. This larval stage
displays certain adult organs including oral and ventral suckers, mouth, pharynx,
forked intestines, excretory canals with flame cells and a premordia of the
reproductive organs.
The Metacercariae
After the cercariae attach to the herbage and encyst they form the larval stage
usually referred to as metacercariae, the infective form ofFasciola for its mammalian
definitive host. This stage is non-sesile and it is surrounded by four layers of
protective cyst walls. It is within this protective cyst that the development takes
place. This development includes the continued formation of premordial reproductive
structures. The cyst containing a motile Fasciola embryo measures approximately
0.2-0.25 mm in diameter (Malek, 1980; Ershov, 1960). This embryonic stage has
very well-defined suckers, a branch of gut and an excretory bladder.
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2.1.5 Production ofMetacercariae in the Laboratory
All work with experimental infection of animals with Fasciola spp depends
upon the supply of viable metacercariae. The two most important intermediate host
groups are amphibic snails represented by Lymnaea spp and include Lymnaea
truncatula and aquatic group of Lymnaea spp. which including Lymnaea auricularia
(Kendall and Parfitt, 1965; Boray, 1969; Malek, 1980).
Laboratory maintenance and management of snails
Taylor and Mozley (1948), first developed ways for culturing L. truncatula
consisting essentially of simulating the natural habitat of the snail in unglazed
earthen- ware pans or shallow glass dishes. Each of these containers had a small
pool of water and a mud slope on which green algae (Oscillatoria brevis), the
principle food of the snail, grew. Kendall (1953) reported the production of many
uniform colonies of L. truncatula using this method.
Snails are kept at a temperature a little above 20°C, these temperatures are
usually controlled under laboratory conditions (Kendall and Parfitt, 1965). Kendall
(1953) reported that L. truncatula remain active at a temperature as low as 1.5°C and
that the optimum temperature for reproduction and growth ranges from 18° to 21°C,
mainly because at this range a vigorous growth of green algae is sustained. He,
however, warned that a constant temperature above 20°C may be regarded as
unfavourable while even occasional temperature above 25°C should be avoided.
Whitlock, Campbell, Chow, Rolfe, Porter and Kelly (1977) however managed to
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maintain Lymnaea tomentosa at a constant temperature above 20°C (approximately
23°C).
Kendall (1964) reported that when infected with F. hepatica, L. truncatula to
be maintained between 10°C and above 28°C. When snails are infected, the
temperature is to be taken into consideration and should be a balance between that
which suits development of the snails, of the Fasciola in the snails and the growth of
green algae in case of L. truncatula. Mahato (1993) maintained a constant
temperature of forced aerated aquaria at 25°C. L. natalensis and Lymnaea
auricularia kept in forced aerated aquaria have tolerated slightly higher temperatures
than their amphibic counterparts (Hammond, 1970; Mahato, 1993; Madsen and
Monrad, 1981).
The intermediate host of F. hepatica grow and thrive well with green algae
culture as feed and should be changed to fresh algae regularly (Kendall, 1953; Lee,
Kim and Lee, 1994; Urquhart Personal Communication, 1994). Kendall and Parfitt
(1965) mentioned the use of an artificial food i.e. modified calcium alginated gel. L.
natalensis can be fed on aquatic algae but can also be fed on lettuce and Tetramin®
(fish food) (Madsen and Monrad, 1981). Hammond (1970) kept L. natalensis in
aerated aquaria with aquatic plants which increased the surface area for algal growth
for the snails to feed on. Mahato (1993) maintained L. auricularia race referscens
collected from the field in glass sealed aquaria under fluorescent light to help the
algal growth. He also supplemented with fish food flakes (tropical fish food 'Vetra
Betta' Singapore) every other day.
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Collection and preparation of Fasciola spp. eggs for culture
Fasciola spp. eggs used for producing metacercariae can be collected from
the gall bladder after infected animals have been slaughtered (Schumacher, 1938;
Dinnik and Dinnik, 1959; Boray, 1969; Mahato, 1993). However eggs can also be
collected from the faeces of experimentally infected animals, as long as their egg
counts are high enough (Anon, 1977; Madsen and Monrad, 1981). Collecting eggs
from the bile involves washing the eggs, usually by repeated sedimentation in cold
water and carefully discarding the supernatant (Dinnik and Dinnik, 1959; Kendall,
1966; Sindou, Cabaret and Rondelaud, 1991). Faecal egg collection demands
removal of the debris by use of a sieve with a large enough mesh to let through the
eggs but retain most of the debris. This is followed by washing as described
previously (Madsen and Monrad, 1981).
The final wash removes further debris by use ofmultiple sieves with a large
meshed sieve first ending with small meshed sieve to trap the eggs. The number of
sieves used in this process varies from one (Boray, 1966) two (Mahato, 1993) to
three (Sindou, Cabaret and Rondelaud, 1991). Sindou, Cabaret and Rondelaud
(1991) sieved the eggs with gradual decreasing mesh sizes from 75 microns, 50
microns and 38 microns. The eggs trapped in the last sieve are then washed into a
beaker ready for incubation. Mahato (1993) used just two sieves one to trap debris,
150 mm mesh size, and 38 mm to trap the eggs. Although time consuming, Dinnik
and Dinnik (1959) and Ogambo-Ongoma (1971) washed the eggs by repeated
sedimentation in cold clean water.
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Culturing miracidia from fluke eggs
After cleaning the Fasciola spp. eggs are divided in small enough aliquots to
form a monolayer in an appropriate container for incubation (Kendall, 1966).
Kendall (1966), Roberts (1950) and Boray (1969) used Petri dishes. Dinnik and
Dinnik (1959) used glass beakers and Ajanusi (1993) and Urquhart (1994) personal
communication incubated the fluke eggs in amber coloured glass bottles. The eggs
are incubated in clean water either straight from the tap or any other clean water
source (Dinnik and Dinnik, 1959) or deionised water (Kendall, 1966; Boray, 1969).
The most important factor is the temperature under which the eggs are
incubated. Ollerenshaw (1959) and Rowcliffe and Ollerenshaw (1960) showed that
9.5-10°C is the minimum critical temperature for both eggs of F. hepatica and F.
gigantica to hatch viable miracidia. It took Boray (1969) 90 to 100 days to hatch F.
gigantica eggs maintained at 11°C but only 21 days at an average temperature of
15°C. Dinnik and Dinnik (1959) failed to notice any hatched eggs in winter when
the minimum water temperature was 5.5°C and 19.5°C as a maximum. Roberts
(1950) in his effort to examine factors affecting development and hatchability of
Fasciola spp. eggs found he was able to hatch the eggs in about 14 days at 25°C.
Incubation in the laboratory takes place in a lightproof environment (Kendall, 1966;
Boray, 1969; Ajanusi, 1994; Mahato, 1993). Light is important as a stimulating
factor at the time of hatching. When the miracidia are developed the eggs are placed
under a strong light and within minutes the eggs hatch (Roberts, 1950; Kendall,
1966; Boray, 1969; Ajanusi, 1994). Roberts (1950) reported that blue and violet
wavelengths do not induce hatching. The duration of incubation depends on many
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factors i.e. temperature, moisture and Fasciola species being the most important. It
takes longer for F. gigantica eggs to hatch than F. hepatica (Kendall, 1967).
Infecting snails with miracidia
Boray (1969) infected 4 to 6 weeks old L. tomentosa (4-6 mm) and placed
them in groups of ten in plastic dishes with deionised water. Instead of infecting the
snails with already hatched miracidia he put 20 eggs containing fully developed
miracidia for each snail in each group. Anon (1977) recommended that L truncatula
are infected when their shells are 2-3 mm long i.e. 2-3 week old. Ajanusi (1994)
infected L. truncatula when the shells were 2-5 mm long using flat-bottomed
polystyrene microwell plates (Gibco Ltd, (code 2-62162A). Sindou, Cabaret and
Rondelaud (1991) and Whitlock, Campbell, Chow, Rolfe, Porter and Kelly (1977)
infected in groups of 25 snails in Petri dishes.
Three to six hours contact is required for the infection to take place (Ajanusi,
1994; Sindou, Cabaret and Rondelaud, 1991; Mahato, 1993). It is important that the
water in which the infection takes place and temperature corresponds to that which
snails tolerate i.e. for L. natalensis aquarium water and for amphibic snails deionised
water (Boray, 1969; Sindou, Cabaret and Rondelaud, 1991).
Shedding of cercariae by snails
Schumacher (1938) realised that keeping snails harbouring mature (6 weeks
or more post infection) F. hepatica rediae at 10°C then bringing the temperature up
to room level induces shedding of rediae by the snails. The use of the 'Cold shock'
method is the current method of choice ofmany researchers (Ajanusi, 1994; Mahato,
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1993; Kendall, 1964). In contrast Taylor (1964) reported that direct sunlight or 60
watt light bulb stimulates cercariae shedding. Kendall and McCullough (1951) and
Kendall (1965) were of the opinion however that light doesn't stimulate shedding of
cercariae by the snail.
According to Standen (1963) however, this cold shock method does not work
as well for L. natalensis (F. gigantica) as it does for L. truncatula (F. hepatica). He
also found that the cercariae shedding is more frequent at night than during then day
for F. gigantica. Hammond (1970) reported an increased shedding of F. gigantica
cercariae shortly after removing the snails from a light to a dark environment.
Moving snails to fresh water also induces shedding, Boray (1969) reported that
flushing stagnant snail habitats and particularly watering the snail habitat induced
massive shedding of cercariae. After the snails shed the cercariae (4-5 hours) they
are returned to the aquarium or algae tray. The cercariae are left to stand at room
temperature overnight (Anon, 1977) or 16 hours (Boray, 1969) in order for the
metacercariae to form.
The container into which the shedding takes place should be convenient for
collection of the metacercariae especially to avoid physical damage (Urquhart
Personal Communication, 1994).
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2.2 Epizootiology
2.2.1 Geographical Distribution of F. hepatica and F. gigantica
The two species, F. hepatica and F. gigantica, have world-wide distribution
with the former species having a wider range than it's tropical relative (Malek, 1980;
Losos, 1986; Over, 1982).
Fasciolosis caused by F. gigantica is widespread throughout Africa, Asia and
the Pacific (Losos, 1986; Malek, 1980; Soulsby, 1982). According to Malek (1980)
the flukes that Prince (1952) described in Southern United States of America (USA)
may belong to the species F. gigantica. Blood and Radostits (1989) reported that F.
gigantica is also found in the Southern USA. F. hepatica on the other is found in
North America, Europe, Northern Asia, Northern Africa and Australia. It has also
been reported in the highlands of Kenya, South Africa and in Central and South
America and on many of islands including Japan, New Zealand, Cyprus, New Guinea
and Iceland (Malek, 1980; Over, 1982)
In some parts of the world, the geographical distribution of F. hepatica
overlaps that of F. gigantica. Kendall (1954) found F. gigantica mostly in the
lowlands and F. hepatica in the highlands of Pakistan but recorded mixed infection
in an intermediate zone. Although Magzout and Kasim (1978) reported the presence
of the two Fasciola spp. in animals slaughtered at abattoirs in Saudi Arabia, it is
clear that animals were imported into the country and that the species found were in
line with the country of origin i.e., the Sudan and Eastern Europe.
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Since the incidence of fasciolosis is often measured simply by abattoir liver
condemnations, the countries with a developed abattoir infrastructure give more
accurate figures than those with poor infrastructure. However, prevalence differs
from region to region within the same country due to numerous factors for example
agroecological zones and intermediate host habitation (Over, 1982).
Table.2.1: The prevalence of fasciolosis (F. hepatica and F. gigantica ) as it stands
in some of the most recent reports in some countries in the World. The
majority countries are on the African continent.
Country Species Prevalence References
Cameroon F. gigantica 45 Malek (1980)
Ethiopia F. gigantica 30-90 Malek (1980)
Kenya F. gigantica 19.8 Cheruiyot (1987)
Mozambique F. gigantica 70.0 Alves(1970)
Nigeria F. gigantica 65.0 Schillhorn Van Veen (1980).,
Nepal F. gigantica 18.5 Mahato (1993)
Pakistan F. gigantica 70.0 Kendall (1954)
Tanzania F. gigantica 41-50 Hammond (1965)
Zambia F. gigantica 89.6 Silangwa 1973)
Zimbabwe F. gigantica 50.0 Chambers (1987)
The Republic of Ireland F. hepatica 38.0 Dargie (1989)
The UK F. hepatica 6.0 Dargie (1989)
The USA F. hepatica 4.4 Malone et a/. (1982).
2.2.2 Transmission of Fasciolosis
Transmission depends on several factors related to the biology of the vector,
the biology of the parasite and stock management (Troncy, 1989). In many tropical
and subtropical regions, feed and water scarcity forces herdsmen to move long
distances with their livestock. Inevitably this leads to crowding at waterholes or
grazing areas. This in turn exposes the animals to high levels of infestation by
metacercariae (Hammond and Sewell, 1990; Losos, 1986). In Australia, where the
conditions are dry and hot, infections are usually due to recent contamination of the
environment (Meek and Morris, 1979), while in temperate region such as the United
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Kingdom and most of Europe, massive levels of metacercariae can accumulate over a
period of time (Ross, Dow and Todd, 1967).
The transmission of Fasciola spp. is complicated by involvement of two
species of Lymnaea one amphibic Lymnaea i.e. L. truncatula with world-wide
distribution (Urquhart, Armour, Duncan, Dunn and Jennings 1987) and the other
aquatic found in tropical countries Hammond and Sewell (1990) and Losos (1986).
Although the two species appear to be specific in their intermediate hosts, Boray
(1969) was able to show that L. tomentosa is a capable vector for F. gigantica.
Table 2.2 Some of snail subspecies responsible for the transmission of Fasciola
spp. in respective countries or regions
F. hepatica
Snail species Country (ies) References
Lymnaea truncatula Europe and West Asia Kendall, (1965)
Lymnaea. mweruensis Kenya Dinnik and Dinnik (1963)
Lymnaea. humilis Canada and part ofUSA Malek (1980)
Lymnaea. viatrix South America Malek (1980)
Lymnaea tomentosa Australia Boray (1969)
Fossaria modicella North America Malek (1980)
Fossaria. bulimoides Gulf of Mexico States Malek (1980)
F. gigantica
Fossaria. auricularia India and Pakistan Mahato (1993)
Lymnaea natalensis Most of Africa Burger (1992)
Lymnaea rufescens Pakistan Kendall (1965)
Lymnaea rubiginosa Malaysia Hammond and Sewell (1990)
Lymnaea gedrosiana Iran Malek (1980)
2.3 Pathogenesis of Fasciolosis
2.3.1 Clinical Signs
Ross and Todd ( 1968) reported that the severity of the clinical symptoms is
approximately related to the level of fluke infestation in the liver, however they also
reported evidence of resistance in some animals. According to Schillhorn van Veen,
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(1980), Blood and Radostits (1989), Malek (1980), Losos (1986) and Urquhart,
Armour, Duncan, Dunn and Jennings (1987), three partially overlapping clinical
syndromes are observed in cattle and small ruminants and include:
• The acute disease caused by immature worms migrating through the liver
parenchyma;
• The subacute form, characterised by anaemia and caused by the young adult
flukes emerging from the liver parenchyma into the bile ducts; and
• The chronic form which is a wasting disease with presence of flukes in the bile
ducts.
Acute syndrome
Acute fasciolosis occurs during invasion of the liver by recently ingested
metacercariae (Georgie, 1985; Burger, 1992; Malek, 1980; Soulsby, 1982; Losos,
1986). Soulsby (1982) further reported that in acute cases, especially in sheep, the
animal dies suddenly with blood stained foamy exudate appearing on the nostrils and
blood is discharged from the anus (as in the case of anthrax). When observed, the
clinical signs in sheep consist of apathy, lack of appetite, pallor and oedema of
mucosae and conjunctivae, and pain when pressure is exerted over the area of the
liver (Blood and Radostits, 1989). Losos (1986) reported in addition an occasional
appearance ofjaundice. Outbreaks are very rare but may appear in young animals. A
complication of the acute condition is black disease caused by anaerobic bacteria
(iClostridium novyi type B) which proliferates in the necrotic lesions produced by
immature flukes (Soulsby, 1982; Hammond and Sewell, 1990).
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Acute fasciolosis is common in small ruminants, goats and sheep and usually
results in death without other apparent clinical symptoms (Ross, Dow and Todd,
1967). Hammond and Sewell (1990) also suggested that acute fasciolosis is common
in small ruminants especially if infected with F. gigantica. Soulsby (1982) however,
pointed out that, in the field, acute fasciolosis is less common than the chronic
fasciolosis in both small and large ruminants. Schillhorn van Veen (1980) pointed
out that although acute fasciolosis is a rare form of the disease in cattle but it causes
great damage when it does occur.
Subacute syndrome
The subacute syndrome has a longer course than acute fasciolosis and is
usually associated with the emergence of young flukes in the bile ducts and ingestion
of large amounts of metacercariae over a long period (Blood, 1994; Urquhart,
Armour, Duncan, Dunn and Jennings, 1996). The prominent clinical symptoms are
pallor of the mucosae and some oedema in the submandibular area. Pain on pressure
over the liver is a common observation (Blood, 1994; Burger, 1992). Boray, (1969)
mentioned that in subacute fasciolosis sheep do not die earlier than seven to eight
weeks in agreement with Fraser (1991) the survival duration in subacute fasciolosis
is 7 to 10 weeks. Death does occur due to haemorrhages and anaemia.
Chronic syndrome
Chronic fasciolosis occurs when small numbers of metacercariae have been
ingested over a long period (Blood and Radostits, 1989). According to Soulsby
(1982) the syndrome is the most common form of fasciolosis in sheep, cattle and
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other hosts including man. In tropical countries this syndrome is mainly observed at
the end of the dry season (Schillhorn van Veen, 1980) The main symptoms in sheep
are loss of body weight, pallor of the mucosae over a period of weeks and
submandibular oedema (Blood and Radostits, 1989). Losos (1986) reported that in
F. gigantica infection subcutaneous oedema may also develop on the face and lower
regions of the abdomen and thorax. Dairy cattle also lose weight and suffer a
reduction in milk production (Blood, 1994). Eckert (1992) reported chronic
diarrhoea due to fasciolosis, but Urquhart, Armour, Duncan, Dunn and Jennings
(1996) emphasised that diarrhoea is not a clinical feature of bovine fasciolosis unless
complicated by Ostertagia spp infection. Development of acute clinical disease has
been observed in animals with chronic fasciolosis in under nourished animals
especially at the end of dry season (Graber, 1979).
2.3.3 Clinical Pathology
Anaemia
Anaemia is perhaps the most mentioned symptom of subacute and chronic
fasciolosis. The results obtained after analysing blood samples from animals
suffering from either F. hepatica or F. gigantica infection for 10 weeks or over
always show a decrease in red blood cells, packed cell volume and haemoglobin
concentration (Blood, 1994). There have been reports (Ogunrinade, 1984) of
terminal macrocytic anaemia in animals which died of acute fasciolosis. Sinclair
(1964) found a totally different type of anaemia, macrocytic hypochromic anaemia or
classical iron deficiency, seen as a late result of blood loss. This is in agreement with
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Ross, Dow and Todd (1967) who reported the macrocyotosis with erythroblastosis in
F. hepatica infection. Although Burger (1992) observed a macrocytotic and
hypocromic anaemia in fasciolosis, the majority of authors are of the opinion that
Fasciola spp. infection causes a normocytic and normochromic anaemia (Boray,
1967; Roberts 1968; Burger, 1992; Blood, 1994). As in the clinical syndrome the
severity of anaemia depends on the fluke burden, the nutritional status of the host and
the stage, as well as the duration, of the infection. Anaemia is not only the most
common clinical symptom of subacute and chronic fasciolosis but probably the most
characteristic of these two syndromes (Sewell, 1967).
Boray (1967) reported that all sheep infected with 200 to 700 Fasciola
hepatica metacercariae showed chronic progressive anaemia from about 12 weeks
after infection. Severe anaemia developed from about the fifth week after infection in
all sheep harbouring approximately 100 or more flukes. Kadhim (1976) working
with F. gigantica also recorded a progressive anaemia beginning 12 weeks post
infection, with the lowest values occurring in the 14 weeks post infection, in all
except for one sheep infected with 200 metacercariae.
Ogunrinade (1984b) compared F. gigantica infection in sheep and goats and
reported that anaemia was pronounced in both species of animal, in the eighth week
post infection with onset of anaemia as early as in the sixth week. Roberts (1968)
found that the onset anaemia in acute F. hepatica fasciolosis in sheep occurred as
early as three weeks after infection in groups of sheep, one receiving single infection
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of 5000 metacercaria and the other multiple infection of 1000 metacercariae given
every third day for five days. The severe anaemia lasted for 6 weeks post infection.
Hammond (1970) reported a reduction in packed cell volume, haemoglobin
concentration and red blood cell counts in sheep 2-4 weeks after infection with F.
hepatica metacercariae. In contrast Sewell (1966) experimentally infected a Zebu
steer with 2000 metacercariae of F. gigantica and observed anaemia about 8 weeks
later.
Conflicting ideas have been forwarded by researchers regarding the cause of
anaemia in fasciolosis, Jennings, Mulligan and Urquhart (1956) were able to
quantitatively measure the blood loss using 32P labelled red blood cells and recorded
a 0.2 ml blood loss per fluke per day. This was an underestimation according to
Holmes, Dargie, MacLean and Mulligan (1968a) who used 51Cr and 59Fe labelled
cells and found the red blood cell loss to be nearly 0.5 ml per fluke per day. This
phenomena, of blood loss due to haemorrhage caused by migrating Flukes and fluke
feedingon blood is supported by many other reports (Todd and Ross, 1966;
Hammond, 1970; Boray, 1967, 1969 and Burger, 1992). Contrary to this aetiogical
hypothesis, Dawes and Hughes (1964) reported evidence that flukes fed on
hyperplastic epithelium in the bile duct of a mouse. They suggested therefore that
anaemia may not be due to blood sucking. Sinclair (1965) supported this conclusion
and stated that sheep he bled daily had a higher rate of iron utilisation by erythrocytes
than F. hepatica infected sheep. He suggested therefore that the anaemia was due to
a secondary disorder of the reticuloendothelial system. On the other hand Symons
29
Chapter Two: Literature Review
and Boray (1967) were able to show that when intact flukes are removed from their
attachment sites the bile duct mucosa was missing and the region was occupied by a
blood clot containing erythrocytes. Symons and Boray (1967) further argued that the
results of their experiments showed clearly that the transfer of 59Fe to the bone
marrow and from thence to erythrocytes was so rapid that the rate of erythropoiesis
was greatly increased.
Cameron (1951); Ershov (1960) and Lapage (1968) suggested involvement of
pathologic substances in the pathogenesis of fasciolosis. Isseroff, Spengler and
Charmock (1979) working with rats suggested that proline as a pathologic product
could also be involved in the aetiology of anaemia. When Ogunrinade and Makinde
(1988) tried to examine the effect of proline in rabbits they did not record any
significant effect in either erythrocytes or 59Fe clearance and utilisation. The role of
Proline (an amino acid) has been examined by Isseroff, Sawina and Re Reino (1977)
as a contributing factoir in the causes of hyperplasia of the bile duct of the Fasciola
spp. infected animals.
Boray (1967) and Sinclair (1967) suggested that the deficiency of vitamin B12
might not be the cause of anaemia after injecting anaemic sheep with vitamin B12
and found that there was no improvement.
Eosinophilia
Eosinophilia, localised and systematic, is a common feature in helminth
infection of domestic animals and this includes Fasciola spp. infection (Malek,
1980). Eosinophilia appears soon after infection, increases to a high level while the
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flukes are migrating, and subsides when the flukes have reached the bile ducts
(Malek 1980). Kadhim (1976) reported a sharp increase in eosinophil counts which
increased to 17.5% of all white blood cell counts in the second week of F. gigantica
infection in sheep. After 4 weeks the counts reached the peak (20%). Thereafter, it
fluctuated but remained consistently higher than that of the control group
Changes in serum total protein and albumin levels
The liver is the only source of albumin and damage will cause
hypoproteinaemia and hypoalbuminaemia. The hypoproteinaemia and
hypoalbuminaemia have been reported in F. gigantica infections of different hosts
(El-Samani, Mahmoud, Fawi, Gameel and Haroun, 1985; Wiedosari and Copeman,
1990; Mahato, 1993; Wamae, 1996) and in F. hepatica infection of different hosts
(Boray, 1969; Urquhart, Armour, Duncan, Dunn and Jennings, 1996).
Serum total protein is almost always considered in the context of general
pathogensis or when anaemia is being examined as well as the effects of the disease
on the nutritional status of the animal (Roberts, 1968; Sewell, 1966; Burger, 1992).
Early in infection, during fluke paraenchymal migration, hyperproteinaemia,
hyperglobulinaemia and hypoalbuminaemia occur (Burger, 1992). The
hyperproteinemia has been attributed to mobilisation of body protein to maintain
labile protein levels, needed to replace blood cells, as well as other protein losses
caused by the infection as a result of leakage of blood constituents into bile caused by
the blood sucking activities of the liver flukes as well as direct leakage through the
bile duct epithelium (Soulsby, 1982). Wamae, (1996) reported total serum proteins
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remained low from 0-14 wpi. in both the uninfected and infected Friesians and Boran
cattle, thereafter the serum proteins rose between 14 - 17 wpi. after which no
differences were found between the infected and control groups of cattle. Thus the
infected Friesians showed a 2% increase over their uninfected controls whilst the
infected Borans had a 3% increase over their uninfected controls. There were no
significant differences in the total serum proteins between both the control groups.
Kadhim (1976) and Wamae, (1996) reported significant changes in serum protein
levels in sheep infected with F. gigantica occurring at the stage when other blood
parameters also changed.
Roberts (1968) reported, a progressive rise in gamma-globulin from the first
week up to the third week post infection in F. hepatica infection in sheep and a fall in
albumin levels resulting in a drop in the albumin/gamma-globulin ratio. After
treatment of these infected sheep a temporary rise of gamma-globulin occurred
accompanied by somewhat slower but continuous recovery of albumin. The
hypoalbuminaemia is associated with general expansion in plasma volume and
reduction in albumin synthesis following severe liver damage by migrating flukes
(Berry and Dargie 1978; Burger, 1992). Synthesis of albumin depends on availability
of dietary protein which is affected in turn by feed intake. Increased albumin
synthesis apparently diverts amino acids from anabolistic activity including building
muscle and milk production with consequential lowered productivity (Berry and
Dargie, 1978). According to the above authors the infected Borans were able to
maintain superior albumin levels despite suffering more severe liver damage but did
32
Chapter Two: Literature Review
lose more weight. Sheep, that catabolised the most albumin, also synthesised the
most and survived longest.
Changes in serum enzyme concentrations
Liver function enzymes glutamate dehydrogenase (GLDH) and gamma-
glutamyl transferase (y-GT) are found in high concentrations in the mitochondria of
hepatocytes and bile duct epithelium respectively (Doxey, 1983). Any damage to the
hepatocytes causes release of the enzyme from cell mitochondria into the blood
stream and are thus ideal for use in following the pathogenesis of fasciolosis.
The earlier rise of GLDH activity coincided with the migration of juvenile
liver flukes in the liver parenchyma. This results in damage to the hepatocytes
causing release of the enzyme from cell mitochondria into the blood stream. Thus
later rise of y-GT activity signals entry of the liver flukes into the bile ducts and
trauma of bile duct epithelium due to their feeding activities. It has been reported
that the intensity of these changes is indicative of intensity of infection and host
susceptibility (Reid, Armour, Urquhart and Jennings, 1970), a fact that may be of use
in serological and epidemiological studies.
The advantages in measuring plasma enzymes in ruminant fasciolosis are that
the onset and the course of the disease can be demonstrated and the effect of therapy
monitored (Hughes, Treacher and Harness, 1973). Thorpe and Ford (1969), after
studying the changes in plasma activity of the enzyme glutamate dehydrogenase
(GLDH), sorbitol dehydrogenase (SDH) and glutamic oxaloacetic transaminase
(GOT) in sheep with both single and multiple infection, found that as flukes migrate
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through the liver parenchyma SDH and GLDH increase, indicating parenchymal cell
damage. GOT activities in the plasma were found to increase earlier than the other
two enzymes and remained elevated for a long time. Simesen, Nielsen and Nansen
(1973) compared the activities of GOT and y-GT and concluded that the y-GT
estimation may be a more useful parameter than GOT for the evaluation of the
hepato-biliary damage caused by fasciolosis in cattle. Sewell (1967) reported that
GLDH was the best indicator of hepatic disturbance in ruminants infected with F.
hepatica and further suggested that because GLDH was less affected with haemolysis
than GOT, would find wider use in the diagnosis of fasciolosis.
Sykes, Coop and Robinson (1980) compared the activities of serum GLDH,
y-GT and aspartate amino-transferase (AST) and suggested that GLDH and y-GT
activities are more sensitive indicators of liver cell damage in chronic subclinical
ovine fasciolosis than AST activities and that y-GT may be more suitable as a
diagnostic aid due to its greater stability. This view is shared by Rowlands and
Clampitt (1979) who further showed that GLDH plasma activity indicates passage of
immature flukes through the parenchyma and y-GT indicate their migration into the
bile ducts.
For the above reasons liver enzymes, GLDH and y-GT, are a good method for
the detection of early or late fasciolosis respectively in experimentally infected
animals. Ferre, Barrio, Gonzalez-Gallego and Rojo-Vazquez (1994) reported an
increase in serum GLDH activity in sheep after forty days of F. hepatica infection,
the next was AST 80 days and although serum y-GT activities increased as early 80
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days it took 120 days to peak in some sheep. Wamae, (1996) reported that in
infected Friesian cattle, serum GLDH activities first increase 4 wpi., while in infected
Boran cattle, enzyme activities increased in the 4 wpi. Peak activities of the enzyme
occurred at 13-14 wpi. in the infected Friesians and Borans respectively. The activity
of serum y-GT increased from the twelfth week of infection in both infected groups
reaching peak activities at 16 wpi. between 13 and 16 wpi. the infected Borans had
significantly higher levels than the infected Friesian cattle (p<0.05).
2.3.4 Pathology
The reviews by Dawes and Hughes (1964), Taylor (1964), Boray (1969),
Jones and Hunt (1983) and Losos (1986) summarise the findings reported over the
years. The lesions produced by F. hepatica, as well as F. gigantica are most
constant and important in the liver although occasionally the parasite may reach the
lungs or other tissues where they are usually found within abscesses (Jones and Hunt
1983). Sinclair (1967) however, is of the opinion that lack of information on the
changes in other organs especially intestine, is responsible for the biased view that
the most important pathological changes take place in the liver.
Gross pathology
Gross pathological lesions depend on the stage and severity of the infection
(Taylor, 1964; Simesen, Eriksen, Nansen, Andersen and Nielsen, 1968; Losos, 1986;
Burger, 1992). Simesen, Eriksen, Nansen, Andersen and Nielsen (1968) reported an
enlargement of the liver with a mottled appearance especially on the visceral surface
in chronic fasciolosis. The bile ducts are prominent and thickened although
35
Chapter Two: Literature Review
calcification was not seen in the infected sheep. Peritoneal adhesions were common
and on incision all livers exhibited defined pseudolobulation due to increased
amounts of connective tissue. Dow, Ross and Todd (1967) confirmed these findings
in calves followed from 3 wpi. and they also recorded liver haemorrhages due to
fluke migration up to the 23 wpi in some cases. At 23 wpi. all the examined infected
calves clearly showed calcification of the bile duct walls, the bile ducts were either
dilated or stenosed. Taylor (1964) emphasised that calcification is usually seen in
cattle and not in sheep. However in both hosts species the hyperplasia of the bile
duct begins long before the flukes arrive (Simesen, Eriksen, Nansen, Andersen and
Nielsen, 1968; Taylor, 1964; Burger, 1992; Boray, 1969).
Boray (1969) gave the most comprehensive review of gross pathological
changes in relation to numbers of flukes in the liver and weeks after infection. He
found, for example that liver haemorrhage, rupture and haematoma, blood stained
fluid in the peritoneum and oedematous lymph nodes were prominent only in fluke
burdens of above 1000 per sheep and between the 4-13 wpi. On the other hand in
light infections the typical haemorrhagic tracks were found mainly in the left lobe of
the liver 4-5 wpi. Uzoukwu and Ikeme (1978) studied 6887 livers of Fulani Zebu
cattle slaughtered at the Nsukka abattoir in Nigeria between 1975 and 1977 and of
these, 15 were totally and 60 partially condemned. Gross lesions were described as
contracted livers with prominent bile ducts containing the liver flukes. Also seen in
one liver were kidney shaped firm and fleshy adenomatous growths.
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Mahato (1993) observed after examining buffalo livers from the abattoir that
two types of haemorrhages i.e petechiae and echimosis were common in livers
harbouring F. gigantica and liver abscesses were also seen in most of these livers.
Lapage (1968) included in the main pathological changes of chronic fasciolosis,
anaemia, ascites, hydrothorax and hydropericardia.
Carcasses of buffaloes infected with F. gigantica were cachectic (little or no
fat deposits), and there was severe peritonitis with serosanguinous ascitis in a calf
which died 15 weeks post infection (Mahato, 1993). Although the gross pathology
confined to the livers, all the visceral organs were pale. There was serous atrophy of
mesenteric fat and enlarged hepatic lymph nodes. Most larger bile ducts were
markedly dilated, the bile duct walls were thick and fibrotic, however were not
calcified (Mahato, 1993). Ajanusi, (1994) observed no changes in rats infected with
F. hepatica after day one, by day 14, however the livers were enlarged, friable and
peritonitis was common. At day 56 all the livers were fibrotic.
Histology
Ross, Dow and Todd (1967) carried out a comprehensive histological
comparison of the lesions of fasciolosis in pigs and other hosts from 1-10 weeks after
infection. Pigs show milder lesions than in cattle, sheep and goats.
Singh and Parihar (1988) examined pathologically fluke infection in livers of
sheep and goats. In advanced lesions, there was development of granulomas around
the fluke eggs in the bile ducts and their products with calcification and foreign body
reaction. The formation of granulomas around eggs and parasites products was also
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reported by Simesen, Eriksen, Nansen, Andersen and Nielsen (1968) and Mahato
(1993). Histologically, the flukes are seen surrounded by a layer of compressed
parenchyma cells, some of which are necrotic. In the later stages, the core of the
older lesions is reduced in size and is gradually replaced by macrophages and
fibroblasts. Patches of the black pigment appear due to the haematin discharged by
the fluke (Sinclair, 1964; Bitakaramire and Bwangamoi, 1969). Uzoukwu and Ikeme
(1978) studied 6887 livers of Fulani Zebu cattle slaughtered at the Nsukka abattoir in
Nigeria between 1975 and 1977. Of these, 15 were totally and 60 partially condemned.
Histopathology revealed numerous micro-abscesses containing Fasciola larvae or eggs
with accompanying cellular reactions and calcification. There was interlobular fibrosis,
proliferation of bile ducts and peribiliary fibrosis in the absence of parasites and
nodular hyperplastic growths of bile ductiles with complete absence of secretory
ability.
Bitakaramire and Bwangamoi (1969) administered various numbers of
metacercariae to 8 month old calves. Hepatic fibrosis was found in some but ascites
was present in 5 calves given 10,000 metacercariae. An increase in connective tissue
in portal triads coupled with slight lymphocytic infiltration was apparent in
histological examination. Much of the parenchyma was replaced by fibrous tissue
while bile ducts were hyperplastic. Bile ducts with flukes had denuded epithelium or
showed capillary proliferation. The smooth muscle of the bile ducts was necrotic and
infiltrated by mononuclear phagocytes and eosinophils
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Mahato (1993) reported a mild periportal fibrosis with some mild biliary
hyperplasia. The periportal inflammation comprised both mononuclear cells and
eosinophils. There were haemosiderin deposits in a periportal areas in two of the
twelve goats.
2.4 The economic importance of fasciolosis
Fasciolosis is an important parasitic disease with a cosmopolitan distribution.
Although more a problem of young stock, the disease is also a problem in older
animals (Armour and Urquhart, 1974). It is one of the most economically important
helminth diseases hampering productivity in cattle, sheep and goats in endemic areas.
The disease reportedly occurs in 300 million cattle and 250 million sheep world-wide
(Maurice, 1994). Besides mortality, the disease causes lowered live weight gains,
poor carcass quality due to its effect on carcass composition, liver condemnations,
lowered milk production, and abortions. Additional costs occur from implementation
of control measures including the cost of purchasing fasciolicides.
The economic importance of fasciolosis in the livestock industry ranges from
the devastating losses it causes from sudden death in the acute disease caused by
migrating, immature flukes, mainly seen in sheep (Ollerenshaw, 1971) to the less
spectacular effects of chronic disease seen in many hosts. Clinical disease, which is
most frequently seen in cattle under two years old, is characterised by weight loss
anaemia, eosinophilia and hypoalbuminaemia due to the haematophagic activities of
the adult fluke in the bile ducts (Sewell, 1966; Armour, 1975).
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In the USA, economic losses were first documented in the 1950s when the
Department of Agriculture reported losses of several million $ US due to liver
condemnations at abattoirs (Emment, 1956).
The measurement and evaluation of economic effects of diseases were
considered by Morris and Meek (1980). They pointed out that evaluation of diseases
in economic terms, and using this as the sole basis for deciding the economic
importance and institution of control measures is misleading, since this gives the
impression that the losses are recoverable by treatment. However control measures
themselves cost money, thus evaluation of economic benefits of control is a more
useful measure. This emphasises the monetary advantages of controlling the disease
rather than the costs of no control. Such evaluations can be very expensive and the
authors recommended that such undertakings should be few and provide as much
information as possible. An alternative to this approach is the use of computer
models in which variables can be computed within certain limits in order to predict
possible outcomes (Morris and Meek, 1980).
2.4.1 Mortality in the Definitive Host
Fasciolosis is often considered as a chronic 'production' disease and referred
to as 'production disease' with the economic impact solely measured by liver
condemnations (Losos, 1986; Malone, Loyacano, Amstrong and Archbold, 1982).
Acute and subacute fasciolosis due to F. gigantica can be caused even by a very light
infection resulting in very high mortality especially in goats and sheep (Hammond
and Sewell, 1990).
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The severity and mortality depends on the level of infection, the species of
the definitive host and parasite and most of all the nutritional condition the host is in
(Hammond, 1965; Sewell, 1966; Boray, 1969; Hammond and Sewell, 1975; Chick,
Coverdale and Jackson, 1980; Ogunrinade, 1984a; Vassilev and Jooste, 1991;
Ngategize, Bekele and Tilahun, 1993).
There is very little information reported to be able to conduct a concise
evaluation of the enormity of the losses caused by mortality as a result of liver fluke
infection especially in developing countries (Dargie, 1986). There is, however,
enough information to appreciate that mortality occurred by fasciolosis is a
significant problem especially if the host is infected with F. gigantica (Hammond,
1965; Ogunrinade, 1984a; Vassilev and Jooste, 1991).
In Nigeria, Ogunrinade and Ogunrinade (1980) estimated an annual financial
loss of US$1.03 million as a direct result of mortality due to fasciolosis. In
Zimbabwe, Vassilev and Jooste (1991) reported that 30 Zimbabwean dollars (Z$30)
per head of cattle are lost because of deaths caused by F. gigantica and in Ethiopia
Ngategize, Bekele and Tilahun (1993) estimated a loss of US$10.9 million on
account of small ruminants mortality after being infected with Fasciola gigantica.
Small ruminant mortality due to fasciolosis is bound to be higher in developing
countries but is not fully understood.
2.4.2 Liver Condemnations
Liver fluke damages the liver of it's definitive host making it both visually
unpleasant and unpalatable to eat thus leading to condemnation. Abattoir liver
41
Chapter Two: Literature Review
inspection has long been used to estimate fasciolosis prevalence in an area or
country.
Since fasciolosis is world-wide problem economic losses are a global
problem. Although Dargie (1986) reported a ten year (up to 1987) reduction, from
35% to 6% and 75% to 38% in the United Kingdom and Republic of Ireland
respectively, a report by Malone, Loyacano, Amstrong and Archbold (1982) shows
however that the gulf coast states had about 1.4 million livers condemned due to liver
fluke in 1981 alone. This was 22.4% of all condemned livers amounting to a
financial loss ofUS$7.2 million.
The situation is even worse on the African continent. For instance Schillhorn
van Veen, Usman and Ishaya (1980) were able to show that 65% of cattle 40.8% of
sheep and 17.6% of goat livers were condemned because of fluke infection in their
two year study in a rural abattoir in Nigeria. In Kenya an annual average of 11.5% in
cattle 2.5% in sheep and 2.7% in goats of all the livers from slaughtered animals
were rejected due to flukes (Anon, 1986). In the Ethiopian highlands about 51% of
all liver condemnations were due to Fasciola spp. (Ngategize, Bekele and Tilahun,
1993). In Southern Africa the situation resembles very much that of East Africa, for
instance in Zambia reported liver condemnations of between 80% and 90%
(Silangwa, 1973), in Zimbabwe 43.3% of all rejected livers in 1989 were caused by
F. gigantica according to Vassilev and Jooste (1991) and Alves (1970) in
Mozambique reported 50% of all slaughtered animals harboured liver flukes in their
livers .
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Surveys have been conducted in many developing countries i.e. Arabian
countries (Magzoub and Kasim, 1978), in the Indian Subcontinent and the South
Pacific (Losos, 1986). Most recently Mahato (1993) reported that 347 buffaloes out
of 408 (85%) and 14 goats out of 39 (35.9%) had their livers condemned because of
liver fluke.
2.4.3 Influence of Fasciolosis in Growth and Liveweight
Liveweight gain depression and impairment of growth is a major effect of
fasciolosis although, researchers have yet to establish the level of fluke burden
enough to significantly depress weight gain and retard growth .
In sheep a burden as few as 45 adult F. hepatica showed a significant
reduction of live weight gain (Hawkins and Morris, 1978). Boray (1969), Sinclair
(1962) and Berry and Dargie (1978) suggested that a burden above 350 F. hepatica
seriously reduced live weight-gain.
In cattle Hope-Cowdery, Strickland, Conway and Crowe (1977), Oakley,
Owen and Knapp (1979), Chick, Caverdale and Jackson (1980), Malone, Loyacano,
Armstrong and Archbald (1982), Hope-Cowdery (1984) and Mahato (1993) reported
that even a very low burden (37 F. hepatica) is capable of impairing growth and
depress weight gain. Mahato (1993) worked with both F. hepatica and F. gigantica
reported similar results.
In both small and large ruminants live weight gain and growth are indirectly
proportionate to F. gigantica or F. hepatica burden however other factors are also
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important and including importantly the nutritional status of the definitive host
(Berry and Dargie, 1976; Chick, 1980; Hope-Cowdery, 1984; Losos, 1986 ).
Studying the effects of treatment against fasciolosis Sewell (1966), Horchner,
Hennings, Verspohl, Averbeck and Boch (1970) and Malone, Loyacano, Amstrong,
and Archbold (1982) showed indirectly the importance of fasciolosis by comparing
weight gain and production of treated and untreated herds.
There is very little information about financial loss due to depression of
growth and live weight gain, however Ogunrinade and Ogunrinade, (1980), Malone,
Loyacano, Amstrong, and Archbold (1982) and Vassilev and Jooste,(1991) and
Ngategize, Bekele and Tilahun, (1993) were able to include this aspect in their
calculation to estimate total loss incurred by fasciolosis and were able to show that it
accounts for a significant loss.
2.4.4 Wool Growth and Quality
Reduction in wool growth and quality are common features in helminth
infections. Reduction in wool growth is usually associated with adult Fasciola spp.
burden and with as low in number as 30 flukes (Dargie, 1986). As with suppression
of liveweight gain there is a correlation between adult liver fluke burden and the
wool quality. Edward, Al-saigh, Williams and Hope-Cowdery (1969) and Reid
(1978) showed that treatment of infected ewes results in improvement of both quality
and quantity of fleeces. It is generally agreed that if the treatment is effective and the
nutrition correct, one should be able to restore the pre-infection wool growth level
but the gross losses remain until next shearing (Hope-Cowdery, 1984). Mean wool
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quality which is measured by determining fibre diameter length and tensile strength
remains poor, resulting in low grade fleece and financial losses (Hope-Cowdery,
1984; Dargie, 1987).
2.4.5 Milk Production
The dairy industry is under developed in most tropical and sub-tropical
countries but regardless of the location any suppression ofmilk production will affect
production.
Hope-Cowdery (1984) showed that Fasciola infection reduces milk
production. Ross (1970), Horchner, Henmings, Versopohl, Averbeck and Bock
(1970), Randell and Bradley (1980) proved that treating infected cows with
Oxoclozanide greatly improved milk total solids thereby increasing milk quality
leading to financial benefit for the farmer.
There are severe implications to new-born stock in milk quality or quantity
reduction (Sinclair, 1972; Crossland, Johnstone, Beaumont and Bennett, 1977; Reid
and Armour, 1978; Hope-Cowdery, 1984) who reported poor live weight gain of
lambs from ewes infected with Fasciola spp.
2.4.6 Reproduction Effects
The effect of liver fluke infection on reproductive capacity of livestock may
be the least researched aspect of this disease. Hope-Cowdery (1971) suggested that
fasciolosis reduces performance in ewes when the invasive stage of parasitism
coincides with mating and establishment of the foetus. However a number of authors
45
Chapter Two: Literature Review
have reported that infection with liver fluke does have a significant effect on the
fertility in food animals (Oakley, Owen and Knapp, 1979; Hope-Cowdery; 1984;
Dargie 1986; Kurma and Sharma, 1991; Vassilev and Jooste, 1991; Ngategize,
Bekele and Tilahun, 1993).
Kurma and Sharma (1991) in their survey found that only 36% anoestrus
were observed in uninfected cows but 50% anoestrus in cows with chronic
fasciolosis. Heavy Fasciola infection in sheep has been associated with abortions,
stillbirths and lambs of low birthweight followed by reduction in liveweight gains
(Sinclair, 1972; Dargie, 1986). It has also been reported that calves may be born
infected (Rees, Sykes and Rickard, 1975).
2.4.7 Feed Utilisation
A reduction in voluntary feed intake is a common feature in most
helminthosis including fasciolosis. The magnitude of the effect is related to the
severity and duration of the infection and the level of protein intake (Boray, 1969;
Berry and Dargie, 1976). There is very little data backing these facts especially
because of inaccuracies in feed intake measurements and the bias arising from intake
differences between infected and non-infected animals (Hope-Cowdery, Strickland,
Conway and Crowe 1977; Oakley, Owen and Knapp, 1979; Dargie, 1989). Sykes,
Coop and Rushton, (1980) reported a 15% drop in feed intake in an infected group as
compared with the uninfected control.
Changes in the efficiency in production results from reduction in feed intake,
digestibility and of nutrients. Weight loss leads to reduction of nitrogen retention as
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assessed by measurements of body composition (Sykes, Coop and Rushton, 1980) or
nitrogen balance (Dargie, Berry and Parkins, 1979). Sykes, Coop and Rushton
(1980) found that in sheep this occurs with a burden of more than 230 adult F.
hepatica. However, an adult fluke burden of 87 did reduce body fat deposition,
protein content and gross efficiency ofmetabolisable energy used for growth.
2.5 Chemotherapuetic treatments for fasciolosis
The efficiency of a fasciolicide should ideally be measured against its ability
to cure most important Fasciola species from immature to mature stages. At the
same time these drugs should not be toxic to most host animals and their form should
enable easy application to large numbers of animals in the field. It is the continuous
demand for drugs with these qualities that has given rise to the number of
anthelmintics now found on the market.
The earliest fasciolicides used were mainly chlorinated hydrocarbons
especially carbon tetrachloride, hexachlorethene and hexachlorophene (Gibson, 1969
and Losos, 1986). These fasciolicides are however no longer widely used.
There are now a wide range of fasciolicides some more commonly used than
others, and differ from region to region (Troncy, 1989). Berger (1971) compared the
therapeutic activities of five fasciolicides against immature and mature F. gigantica
in experimentally infected 2Vi to 5 month old calves. He was able to register high
efficiency of hexachlorophene, nitroxynil and bilevon-R at doses of 15, 10 and 3
mg/kg respectively. Oxyclozanide (Zanil®) at the recommended dose of 10 mg/kg
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given orally showed little effect. It however was effective against four week old
flukes at 20 mg/kg. At the maximum dose nitroxynil (40 mg/kg) and carbon
tetrachloride (0.4 mg/kg) were unable to cure four week old F. gigantica infection in
cattle. Roy and Reddy (1969) in India recorded 100% efficacy against six week old
flukes when they used 10 mg/kg nitroxynil in cattle, water buffalo and sheep.
Rafoxanide is another commonly used fasciolicide (Troncy, 1989; Losos,
1986). The therapeutic efficacy of rafoxanide against F. gigantica infection in cattle
has been carried out by Snijders, Horak and Louw (1971) who found it effective at
3.75 mg/kg against all adult flukes and Snijder, Louw and Errano (1971) concluded
that a 2.5 mg/kg to 20 mg/kg range is not only effective against adult flukes but also
non-toxic in cattle.
Boray, Crowfoot, Strong, Allison, Schellenbaum, Von Orelli and Sarasin
(1983) found that triclabendazole given at a dose of 2.5 mg/kg was only 53%
effective against four week old flukes but 5 mg/kg cleared 92% of the four week old
infection. This dose is in fact half the recommended therapeutic dose. Maes,
Vanparijs, Lauwers and Deckers (1990) tried to compare the viability of fluke eggs
shed by animals treated with closantel or triclabendazole (10 mg/kg) in sheep.
Although the trichlabendazole was 94.2% effective and closantel 83% against
fasciolosis, the eggs from closantel treated animals had only 37% embryonated eggs
while triclabendazole group had 71% much closer to 82% found in a non-treated
group. Many authors believe that triclabendazole is the most effective broad
spectrum fasciolicides (Richards, Bowen, Essenwein, Steiger and Biicher, 1990;
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Losos, 1986; Troncy, 1989; Hammond and Sewell, 1990; Burger, 1992). Waruiru,
Wada and Munyua (1994) reported that a single dose of 12 mg/kg of triclabendazole
and 13.5 mg/kg of oxyclozanide reduced egg shedding by more than 91% but both
flukecides were less effective against immature flukes. The current fasciolicides are
shown in table 2.3.
In Australia the first comprehensive case of drug resistance was reported by
Boray and De Boso (1989) involving mainly salicylanilide, rafoxanid and closantel
but failed to find resistance against triclabendazole and the sulphonamide, clorsulon.
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2.6 Current control methods for fasciolosis
The rationale of fasciolosis control measures depends very much on the
understanding of its epizootiology (Hiepe, Buchwalder and Ribbeck, 1981; Burger,
1992). Over (1982) stated it that the knowledge of the ecology of the parasites holds
the key to the success of the control measures. This knowledge unfortunately is
lacking in many developing countries, mostly tropical and sub-tropical countries
where the disease is endemic. The other main factor according to Hammond and
Sewell (1990) is the economic feasibility of the measures being considered.
There are numerous ways in which control measures have been classified by
different authors (Taylor, 1964; Malek, 1980; Burger, 1992), but they can be divided
into two categories according to their aim. The first class includes those measures
targeted at the definitive host with an aim of either reducing the adult fluke burden
hence pasture fluke egg contamination or reduce the new infection becoming a
clinical syndrome (Hiepe, Buchwalder and Ribbeck, 1981; Blood, 1994; Urquhart,
Armour, Duncan, Dunn and Jennings, 1996). The second group of measures is
directed towards the intermediate host, the amphibic or aquatic snail, leading to
reduction in metecercariae available to infect the host.
2.6.1 Strategic Use of Anthelmintics
One of the comprehensive reviews of this subject was by Taylor (1964) and
already at that time the importance of anthelmintics for control of fasciolosis was
underlined. The determining factor of using anthelminthics for control is the
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understanding of the local disease dynamics. This helps to determine the times that
dosing can take place in order to produce maximum effect. Whitelaw and Fawcett
(1977), Burger (1992) and the report by Urquhart, Armour, Duncan, Dunn and
Jennings (1996) suggested that the best time for strategic control of F. hepatica in
sheep and calves in UK are as detailed below:
1) April to early May, treatment of adult sheep with any fasciolicide effective
against adult parasites to reduce pasture fluke eggs contamination.
2) Early October, dose the whole flock with a drug effective against liver
parenchyma migratory stages such as triclabendazole.
3) January, treat with any anthelminthic effective against adult liver flukes.
4) If the year is extra wet, one or two more doses can be given with one 6 weeks
after the April/May and another one 4 weeks after the early October dose.
Control of fasciolosis caused by F. gigantica is mostly adapted from the
measures developed for fasciolosis caused by F. hepatica. In Thailand according to
Muagyai (1989) buffaloes older than 8 months are treated in early September to
prevent snail contamination with those in poor conditions getting a second dose in
April or May especially in highly endemic areas. In West Africa it is generally
advised to treat cattle either with Nitroxynil or Rafoxanide at the beginning of the dry
season for exposed animals. A repeat dose at the end of the dry season or beginning
of the wet season to reduce pasture contamination (Troncy, 1989).
In general prophylactic treatment is directed towards reducing fluke burden at
the time when the parasite is susceptible to available drugs and when the nutritional
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status of the animals is at its lowest (Burger, 1988; Troncy, 1989; Urquhart, Armour,
Duncan, Dunn, and Jennings, 1996).
2.6.2 Chemical Control ofVector Snails
Molluscicides are effective in controlling snails, but the high cost and
environmental impact renders them unsuitable for use in many countries, for example
in the USA their use is unwelcome in most circumstances (Simpson, Kunkle,
Courtney and Shearer, 1985; Westcott and Foreyt, 1986).
There are many molluscicides, which although not in common use, are
effective and might be employed in the future, i.e. insoluble copper compounds such
as copper pentachlorophenate, copper carbonate and cuprous oxide, Yurimin (P-99) a
Japanese product (Harada, 1974).
The efficacy of individual molluscicides may differ from one snail species to
another. Boray (1969) for example, using adults and their eggs found that L.
tomentosa required a higher concentration of Sodium Pentachlorophenate (NaPCP)
compared to Niclosamide, N-tritylmorpholine (Frescon) and copper sulphate.
The efficacy of four molluscicides NaPCP, (Frescon), copper sulphate,
(R)
Bayluscide and Yurimin on L. ollula was tested and it was found that Bayluscide
(Niclosamide) the most effective of them all (Harada, 1974).
The application of molluscicides according to the European experience
should be targeted to kill the snails prior to the commencement of breeding in May or
in Summer (July/August) to kill infected snails. The spring treatment may become
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difficult because of limitation in pasture growth making vehicular access difficult
(Hiepe, Buchwalder and Ribbeck, 1981; Urquhart, Armour, Duncan, Dunn, and
Jennings, 1987). The same strategy of killing snails shortly before shedding the
cercariae can be adapted for aquatic snails but application of molluscicides in water
is environmentally unacceptable therefore not a practical alternative (Hammond and
Sewell, 1990).
2.6.3 Use of Molluscicides Extracted from Plants
There is evidence that some plants or their products are toxic to the snail
vectors of trematodes and could be used as molluscicides (Kloos and McCullough,
1981) and Hammond (1970) reported that it was difficult to find L. natalensis in
Kenya in areas where Eucalyptus trees grow. No experimental observations were
made however and this prompted studies to determine the effect of Eucalyptus leaves
on aquatic snails in Kenya. Leaves of Eucalyptus globulus, a widely distributed
species in Kenya, killed 100% of L. natalensis, Biomphalaria spp. and Bulinus spp.
at 1.5 g/1 in 24-72 hours. Other species with molluscicidal properties were
Eucalyptus alba, Eucalyptus robusta, Eucalyptus microcorys and Eucalyptus
melliodora but these are of limited distribution in the country (Cheruiyot and
Wamae, 1988).
Hammond, Fielding and Nuru (1994) observed that the use of plant
molluscicides is a labour intensive undertaking and would require skilled labour.
They suggested a solution would be to identify plant species with a 'self-delivery
system' such as Eucalyptus spp. Such plants could be planted along the habitats so
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that their leaves will fall in the water and kill the snails. Thus providing a self-
sustaining snail control and by implication control against fasciolosis.
Another plant with molluscicidal properties is Phytolacca dodecandra
(Lemma, 1970). Phytolacca dodecandra (L'Herit), is commonly known as soap
berry and its dried berries (endod) are widely used in Ethiopia as a soap substitute.
In natural bodies of water where 'endod' was used high snail mortalities were seen
(Lemma, 1970) and testing of various plant parts indicated that the berries were the
most potent source of the molluscicide. The activity of 'endod' was preserved over a
wide range of water pH, temperature, under ultraviolet radiation and also in the
presence of river bed mud. It had an LC90 of 20 ppm in its crude form and thus
offers an alternative and natural method for snail control.
2.6.4 Biological Control
Environmental considerations have to be taken into account when
formulating snail control measures. Usually molluscicides are applied in water
bodies without due consideration to other aquatic fauna. This means that non-target
organisms might be exposed to harmful effects by the molluscicides, thereby
upsetting the balance of nature. Copper sulphate, for example, is toxic to both
livestock and fish when applied as a molluscicide at 0.1-0.2 ppm (Soulsby, 1982).
Even if no immediate deleterious effects might be apparent, repeated applications
might have such effects. Draining of marsh lands can also be used to control snails
but with an obvious detrimental effect on the balance of the marsh land ecosystem.
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There have been more reports on the biological control of Schistosoma-
bearing snails than the Fasciola-bearing ones. It is found that most biological control
methods recommended experimentally have failed to succeed in field trials (Boray,
1969; Malek, 1980).
Berg (1969) attempted to use fly larvae, Dichaetophora biroi, as a killer of
the snails, but the field trials failed. The use of other snail predators such as birds
(ducks), frogs and fish have been reported (Hammond and Sewell, 1990; Blood,
1994). Boray (1964) considered the use of larvae of trematodes which live as true
parasites of the snails thereby helping to kill the snail, however, further investigation
disclosed that the death of the snails takes place after the life-cycle of flukes in the
snail is completed i.e. shedding of metacercariae. Overall very little progress has
been made in the use of biological methods as a control measure for fluke-bearing
snails.
2.6.5 Control by Environmental Manipulation
Control by farm management and environmental manipulation of the snail
environment is arguably the cheapest method of avoiding fluke infection in areas
where the eco-system permits. The following physical control measures have been
recommended by Taylor (1964), Boray (1969), Soulsby (1982), Hammond and
Sewell (1990) and Burger (1992). These recommendations however are not practical
in regions such as Bangladesh where flooding leaves vast areas of suitable areas.
• Drainage poses a solution but cost is a major constraint and this method is only
suitable for the control of amphibic snails.
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• Fencing snail infected areas. This is mostly not practical if the infested area is the
only water hole in the area. The cost of fencing these areas has to be considered.
• Clearing plants and building concrete or stone platform to avoid animals grazing
in and around the water source.
• Adequately maintained troughs where water is provided by pipes from the source,
boreholes, deep wells or mobile water sites does prevent host-parasite contact (if
there are no snails in the troughs).
• Pasture rotation is only possible under commercial production systems or when
there is adequate pasture.
2.7 IMMUNOCHEMISTRY OF FASCIOLA SPP
2.7.1 Cross-reactivity of Fasciola spp. Antigens
Immunodiagnosis in helminthosis including fasciolosis has been hampered by
lack of species and/or stage-specificity in the reagents used manifested through cross-
reactivities with other helminths (Kagan, 1979; Hillyer and De Aleca, 1980, Fagbemi
and Obarisiagboni, 1991; Rodriguez-Perez and Hillyer, 1995).
Cross-reactions occur between Schistosoma spp. and Fasciola spp. in farm
animals (Christensen, Monrad, Nansen and Frandsen, 1980; Hillyer, 1985; Haroun
and Hillyer, 1988). Rodriguez-Perez and Hillyer (1995) reported Fasciola spp
extracts that cross-react with S. mansoni but not the reverse. Hillyer (1979)
immunised mice with crude extracts resulting in 28-58% reduction in S. mansoni
burden following challenge infection. After purifying these extracts by
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immunosorbent chromatography in immunised mice he managed to reduce the S.
mansoni burden. Chapbell, Kelly, Townsen and Dineen (1977) showed that a
primary infection with Taenia hydatigena cysticerci, for 12 weeks in sheep generated
a 95% protection against challenge with F. hepatica. This was confirmed by Dineen,
Kelly and Capbell (1978). Michel and Amour (1981) reported that neither N.
braziliansis nor T. hydatigena cysticerci induced resistance to a challenge with F.
hepatica. Hughes, Harness and Doy (1978) also failed to demonstrate resistance to F.
hepatica challenge infection in sheep, goats and cattle after a primary infection with
T. hydatigena cysticerci.
Cross-reactions of Fasciola spp. with other helminths like Schistosoma, Clonorchis,
Paragonimus and Paramphistomum have been reported in humans (Hillyer and
Capron, 1976). Partial purification of this antigen using Sephadex G-200 was
however able to eliminate most of this cross-reactivitiy. Hillyer and Capron (1976)
using crude F. hepatica extracts found an extensive cross-reaction with hydatidosis,
trichinosis, cysticercosis and amoebic hepatitis patients. However, after partially
purifying the extracts with Sephadex G-200 chromatography cross-reactions were
reduced without diminishing the sensitivity.
Choi and Lee (1979) found that despite the fact that the three protein peaks
from a Sephadex G-200 chromatography purified adult fluke extracts contained
specific proteins the other fractions cross-reacted with sera from paragonimus,
paramphistomum and clonorchis infected hosts. A comparison by Fagbemi and
Oberisiagbon (1991) of whole crude and Sephacryl S-300 column chromatography
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semi-purified parasite extracts from three trematodes, F. gigantica, S. bovis and D.
hospes identified cross-reactivity in both crude and semi-purified extracts confirming
the findings by Hillyer and Serano (1986) who reported common antigens in S.
mansoni and Paragonimus westermani adult worm extracts.
2.7.2 Characterisation of Fasciola spp. Antigens
Because of the problems of cross-reactivity associated with the use of crude
parasite extracts in the immunodiagnosis of fasciolosis, many studies have been
conducted with the aim of identifying and characterising potentially F. hepatica-
specific excretory and secretory products (E/S), surface or somatic antigens and to a
lesser extent F. gigantica. Methods employed include column chromatography,
radio-immunoprecipitation assays, Immunoelectrophoresis, western blotting and
Enzyme-linked Immunosorbent Assay (ELISA) (Hillyer and Santiago 1977,
Zimmermann and Clarke 1986, Pantelouris, 1965; El.Bahi, Malone, Todd and
Schnoor, 1992).).
There are methods of value in immunodiagnosis such as Western blotting techniques
and the high sensitivity of immunological methods like ELISA. The Western
blotting techniques provide a unique tool to simultaneously compare parasite-specific
and cross-reacting antigens (Tsang, Peralta and Simons, 1983).
Using Western blot, Marrero, Santiago and Hillyer (1988) analysed the
Sephadex G-75 polypeptides fraction and found that molecules ranging from 25-30
kDa could be used to diagnose F. hepatica infection in rabbits, cows and sheep.
Hillyer and Soler de Galanes (1988) were able to separate between two polypeptides,
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a specific 17 kDa and the one cross-reacting with S. mansoni and T. spiralis infection
(63 kDa) by using the Western blotting.
Western blotting or Enzyme-linked Immunoelectrotransfer Blot (EITB), as it
is also called, can improve the specificity of immunodiagnosis by comparing
reactions with other parasite infections (Santiago and Hillyer, 1986; Solano, Ridley
and Munocha, 1991; Poitou, Baeza and Boulard, 1992; Keegan and Trudgett, 1992).
In a study using Western blotting 3h ES of F. gigantica was characterised using
infected sheep sera and antigens of 43-75 kDa were detected by 2 weeks post
infection and more antigens were reportedly recognised with time. A 69 kDa antigen
was thought to be of diagnostic value since it was recognised 2 weeks post infection.
An 87 kDa antigen which was recognised by 12 wpi. and lost 2 weeks post-
chemotherapy was thought to be of value in assessing chemotherapeutic success
(Guobadia and Fagbemi, 1995).
Detection of circulating antigens has been reported and an 88 kDa antigen
derived from adult F. gigantica was used to diagnose experimental and natural
infections in cattle using a double polyclonal antibody ELISA. Although the antigen
was of some value, there were cross reactions with 18.8% of Paramphistomum
infected cattle. The assay gave negative absorbence values (below cut-off) three
weeks after oxyclozanide treatment while as might be expected antibody assays were
still positive 6 weeks after chemotherapy (Fagbemi, Obarisiagbon and Mbuh, 1995).
In a related study monoclonal antibodies were produced against a 28 kDa protease
purified from adult F. gigantica E/S which recognised the 28 kDa protease using a
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Falcon assay screening test-ELISA (FAST-ELISA), Western Blot and Immune
Precipitation (Fagbemi, 1995). Monoclonal antibodies had been produced against a
27 kE)a protease of a Fasciola spp. by Yamasaki, Aoki and Oya (1989) while Solano,
Ridley and Minocha, (1991) produced monoclonals against ES components of F.
hepatica.
Sephacryl S-200 column chromatography was used to separate adult F.
hepatica somatic extracts into four fractions. A 6 kDa fraction, showing no cross-
reactions with S. mansoni infected rabbits serum on Counter Immunoelectrophoresis
(CIEP) was used (Hillyer and Santiago, 1977). These authors, repeated their
experiments with Albino mice (Hillyer and Santiago, 1981). Sinclair and Wasall
(1988) were able to diagnose fasciolosis in cattle after fractionating the F. hepatica
extract on a column of Sephacryl S-300. After comparing Sephacryl S-200 and
Superose-6 (FPLC) column chromatography, Zimmerman and Clark (1986)
concluded that the FPLC system seemed to be faster and gave a higher resolution
separation of antigen. Santiago and Hillyer (1986) fractionated F. hepatica
homogenate on Sephacryl S-200 and with Western blot identified antigenic
polypeptides of which 18-23 kDa MW was recognised by infected cattle.
Lehner and Sewell (1980) using Sephadex G-200 to partially purify adult F.
hepatica E/S products showed that molecules in the range of 100-500 and 25-50 kDa
were recognised as immunogenic by infected sheep. Mansour, Youssef, Mikhail and
Boctor (1983) fractionated adult F. gigantica somatic extracts using the Sephadex G-
200.
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Irving and Howell (1982) precipitated three polypeptides of MW 24, 26 and
35
27 kDa from S-methionine radio-labelled juvenile F. hepatica E/S. After
35
biosynthetically ( S-methionine) radio-labelling, Dalton, Tom and Strand (1985)
noted that molecules ofbetween 25-30 kDa were reactive with sera from rabbits from
3 weeks after infection with F. hepatica . Santiago, Hillyer, Carcia-Rosa and
Morales (1986) identified, after co-precipatation of 35S-methionine radio labelling F.
hepatica E/S antigen, a 33 and 62 kDa components which reacted with sera from 3-5
weeks infected rabbits. In addition at least five other major polypeptides of 120, 84,
58, 52 and 39 kDa MW were recognised by the infected sera from 6 weeks post¬
infection. The 29-31 kDa MW range were identified by Sexton, Milner and
Campbell (1991) after biosynthetically radio-labelling of adult F. hepatica E/S
products as the most immunogenic and most likely to be successfully used in
speciation.
Studies on adult F. hepatica messenger RNA in vitro translation products,
using 4 weeks post-infection sheep sera, showed that the sera recognised
polypeptides in the 30-35 kDa range (Irving and Howell 1986).
2.7.3 Defined Fasciola spp. Antigen
Glycocalyx turnover or replacement in newly excysted juvenile (NEJ) F.
hepatica flukes has been suggested by Hanna (1980) as a possible mechanism for
protection against the host immune responses.
The rapid discard of the surface glycocalyx, and its continual replacement by
glycoproteins secreted within T1 and T2 granules, are believed to be due a
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mechanism by which F. hepatica discards bound antibody and thus avoid immune
attack (Hanna, 1980). The search for vaccine candidate or immunodiagnostically
stable antigen has for a long time directed the efforts of scientists towards proteolytic
enzymes (Howell, 1979)
Cathepsin L-like protease
During incubation in the presence of immune serum this glycocalyx is
continuously shed and replaced, and it has been postulated that the lack of in vitro
killing of F. hepatica NEJ's is due, in part, to the rapid turnover of this highly
antigenic layer (Duffus and Franks, 1981) preventing the attachment of both
antibodies and/or cells. After in vitro studies Chapman and Michell (1982) reported
that immature F. hepatica release a papain or Cathepsin-B-like proteolytic enzyme
which partially cleaves immunoglobulins in mouse, rat, rabbit and sheep this in turn
could render one of the host difference systems less affective. It has been shown that
the migratory liver fluke stage secretes a proteolytic enzyme which allows the
parasite to survive immune attack despite being in direct contact with the host fluids
(Chapman and Mitchell, 1982). This was found to be because this enzyme is capable
of cleaving host immunoglobulin G and M in the way Cathepsin B or papain does.
This secretion of proteolytic enzymes were initially studied by Locatelli and Paoletti
(1969). Rege, Herrera, Lopez and Dresde (1989) described one major cysteine
protease from adult worms, which, has been suggested to be involved in nutritional
and/or evasion of the immune response which they suggest is capable to digest
haemoglobin, collagen and IgG. Smith, Dowd, Heffernan, Robertson and Dalton,
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(1993) and Carmona, Dowd, Smith and Dalton (1993) demonstrated that a protease
secreted by F. hepatica plays an important role in immunoevasion by releasing the
Fc portion from IgG and thereby preventing host effector-cell attachment to newly
existed juvenile flukes (NEJs). In recent years Smith, Dowd, McConigle, Keegan,
Bennan, Trudgett and Dalton, (1993) reported the purification of a cysteine protease
secreted by adult F hepatica, the first Cathepsin-L like enzyme to be identified in
parasite trematodes. Later, Smith, Dowd, Heffernan, Robertson and Dalton, (1993)
demonstrated that this F hepatica Cathepsin-L like protease plays an important role
in immunoevasion by releasing the Fc portion from IgG and thereby preventing host
effector-cell attachment. From their results Carmona, Dowd, Smith and Dalton
(1993) suggested that Cathepsin-L cysteine protease is the major protease secreted by
newly excysted juveniles (NEJ) and demonstrated that this enzyme cleaves
immunoglobulin in the hinge region and prevents the in vitro antibody-mediated
attachment of eosinophils to the NEJ.
In recent years investigations, Smith, Dowd, McConigle, Keegan, Bennan,
Trudgett and Dalton, (1993), using gel filtration followed by ion exchange
chromatography, reported the purification of a cysteine protease from adult ES
products. By determining the N-terminal sequence, the purified protease was
characterised as a Cathepsin-L like enzyme. This Cathepsin-L like enzyme molecule
appears to have the molecular weight of 27 kDa, as determined by SDS-PAGE under
reducing conditions. This proteolytic enzyme was classified as a Cathepsin-L
cysteine protease based on many physico-chemical properties in common with
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mammalian Cathepsin-L proteases, whose role is the degradation of proteins in
lysosomes (Barrett and Kirschke, 1981).
Immuno-localisation studies at the electron microscope level reveal that this
Cathepsin-L cysteine is packaged in vesicles within the gut epithelial cells of the
parasite. If these vesicles are secretor granules, it is possible to presume that during
their migration through the host-liver, the flukes secrete the Cathepsin-L cysteine
protease into the host. The molecule could, therefore, protect the NEJ's from
immune attack, since the enzymes are capable of cleaving host immunoglobulins
(Smith, Dowd, Heffernan, Robertson and Dalton,. 1993), thus preventing antibody-
mediated attachment of eosinophils to the NEJ (Carmona, Dowd, Smith and Dalton,
1993).
Proteolytic enzymes are an important functional antigen of the parasitic
helminths. McKerrow, Brindley, Brown, Gam, Staunton and Neva (1990) for
example identified a protease produced by Strongyloses stercoralis when
penetrating the skin and migrating through the tissues of the host. A number of
proteases have been reported to induce immune responses which could be exploited
for vaccine development or immunodiagnosis (Zerda, Dreeds, Damian and Chappel,
1987; Chappel and Dresden, 1988 and Fagbemi and Hillyer, 1992).
Fagbemi and Hillyer (1991, 1992) purified and characterised a 28 kDa cysteine
protease of F. gigantica adult worm which enhanced the sensitivity of
immunodiagnosis of fasciolosis. However they do not have conclusive results as to
its stability.
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This enzyme is capable of cleaving host immunoglobulin G and M in a
Cathepsin B- or papain- like manner. Later, Dalton and Heffernan (1989),
demonstrated that in vitro, immature and mature F. hepatica release 11 distinct
proteolytic enzymes.
Glutathione S-Transferase
Glutathione S-transferases (GSTs; EC 2.5.1.18) are a group of
multifunctional proteins that assist the body in the detoxification of a large range of
exogenously derived compounds (xenobiotics) and endogenously derived toxic
compounds such as bilirubin and haem using enzymatic and binding activities
(Mannervick, 1985). They are capable of detoxifying these foreign substances by
conjugating reduced Glutathione to electrophilic centres of various molecules thus
protect parasites from membrane damage (Mitchell, 1989).
These enzymes are widely distributed in mammals but they have also been
found in abundance in tissues of adult F. hepatica i.e. in cytoplasm of parenchymal
cells, in the subtegument and tegument and on the lamellae of the intestinal
epithelium (Howell, Board and Boray, 1988 and Wijffels, Sexton, Salvatore, Pettitt,
Humphris, Panaccio and Spithill, 1992). GST as a vaccine candidate for ruminants
(Sexton, Milner, Panaccio, Weddington, Wijffels, Chandler, Thompson, Wilson,
Spithill, Mitchel and Campbell, 1990). In this trial, sheep were challenged with 500
metacercaria and after immunisation with GST an overall reduction in worm burden
of 57% was found. Thus, demonstrating a high level of protection in the vaccinated
sheep. This suggests that the target of the immune attack could be GST in the
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metacercariae and/or in the NEJ resulting in the subsequent damage and elimination
of the parasites.
The main role of mammalian just like parasite GST is to protect the cell
against immune-mediated lipid peroxidation. Thus inhibition of this enzyme offers
possibilities of combining immunotherapy and chemotherapy (Brophy and Barrett,
1990).
One of the latest purified antigenic GST is the F. hepatica glutatione-S-
transferase (FhGST) isolated from adult worms by glutathione agarose affinity
(Hillyer, Galances and Battisti, 1992). This enzyme, 28 kDa MWt, has been used to
evaluate whether different animals infected or immunised with F. hepatica or
Schistosoma mansoni developed antibodies to this affinity- purified FhGST. These
authors have found that sheep and rabbits infected with F. hepatica developed anti-
FhGST antibodies detectable by ELISA as early as 2 weeks of infection (thus called
responders) whereas neither mice nor calves equally infected with F. hepatica did
(thus they are called non-responders).
2.8 Diagnosis of Fasciolosis
2.8.1 Conventional Methods
Diagnosis of fasciolosis is still mainly dependant on the clinical observation
and detection of eggs in faeces. The most prominent clinical signs, especially in
small ruminants, include anaemia with submandibular oedema, lethargy, sometimes
jaundice, hyperalbuminaemia and eosinophilia. Acute fasciolosis may result in death
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especially in sheep (Sinclair, 1967; Boray, 1969; Sykes, Coop and Rushton, 1980;
Burger, 1992).
Coproscopic analysis is the routine method for diagnosis in patent fasciolosis.
Morel (1987), after comparing sedimentation and flotation techniques and their
modifications concluded that sedimentation as described by Hinaidy, Keferbock,
Pichler and Jahn (1988) was very efficient though laborious and time consuming. He
therefore recommended use of the differential flotation described by Hammond and
Sewell (1972) in field routine work. The worst results were recorded after using
flotation technique (without using saturated salt solution) as recommended by the
Anon (1977).
Although most commonly used, coproscopic methods have many
disadvantages. Diiwell and Rusenlecter (1984) in agreement with Boray (1969) could
not find any uniformity and consistency in low, medium and high worm burdens
after faecal egg counts. Fluctuations in faecal egg count per gramm (EPG) is
understandable considering the numerous pathophysiological changes including
peribiliary fibrosis, granulation or calcification of the liver which could easily lead to
obstruction of the egg passage (Boray, 1969; Malek, 1980; Urquhart, Armour,
Duncan, Dunn, and Jennings, 1996). Dorsman (1957, 1962) on the other hand
reported that there were relatively small variations from day to day and that the EPG
was consistently highest in the early afternoon.
Unfortunately, as a diagnostic method the faecal egg count can only detect
patent infections and yet most damage to the animal is done before patency by the
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migrating parenchymal forms ofFasciola spp. (Troncy, 1989). Another limitation to
the zinc sulphate or sedimentation methods of diagnosing this disease is that the
numbers of eggs detected does not reflect parasite burden in the animal. The egg
counts rise rapidly by 7-9 wpi. but become variable thereafter and may even be very
low for a heavily infected animal (Sewell, 1966). Although these tests, if successful,
when combined with epidemiological findings provide unequivocal evidence of
infection, they are limited, specially when applied to prepatent infections or low-level
infections (Losos, 1986; Burger, 1992).
Serum enzyme detection
One approach has been to measure liver function enzymes since damage to
the liver by the flukes causes increased seepage of these enzymes into the circulation.
It is clearly possible to suggest prepatent fasciolosis among other liver damaging
diseases by marked increase in serum activities of the liver enzyme, aspartate
aminotransferase (AST) and glutamate dehydrogenase (GLDH). This is associated
with liver parenchymal cell damage by invading young flukes. Increased serum
gamma-glutamyltransferase (y-GT) activities on the other hand is an indicator that
the flukes are penetrating or already are in the bile duct. This usually occurs from
about 80 days after F. hepatica infection (Berry and Dargie, 1976; Sykes, Coop and
Rushton, 1980; Ferre, Barrio, Gonzalez-Gallego and Rojo-Vazquez, 1987).
Reid, Urquhart and Jennings, (1970) reported that the intensity of these
changes is indicative of intensity of infection and host susceptibility a fact that may
be of use in epidemiological surveys.
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Simesen, Nielsen and Nansen (1973) also studied serum levels of y-GT in
cattle infected with F. hepatica and observed that the activities in serum increased
one month after infection and peaked at 5 months. In a similar study Anderson,
Berret, Brush, Herbert, Parfitt and Patterson (1977) performed serial enzyme assays
in cattle harbouring F. hepatica and concluded that the two enzymes, GLDH and y-
GT, were the best indicators of acute fasciolosis. Rowlands and Clampitt (1979) also
came to conclusion that the two enzymes, GLDH and y-GT, were the best indicators
of liver damage in cattle and sheep infected with F. hepatica.
Although earlier studies were confined to F. hepatica, F. gigantica infections
have also been examined. Kumar, Maru and Pachauri (1982) working with buffaloes
infected with F. gigantica, reported increased serum enzymes activities and an
increase in serum enzyme activities in F. gigantica infections was shown in
experimentally infected desert sheep 5 wpi. (El-Samani, Mahmoud, Fawi, Gameel
and Haroun, 1985). y-GT and 5-nucleotidase increased from week 8, while anaemia,
elevation of sorbitol dehydrogenase (SDH), and serum glutamate oxaloacetate
transferase (S-GOT) were reported in natural F. gigantica sheep infections by
Haroun, Gadir and Gameel (1986) and in buffaloes (Swarup, Pachauri, Sharma and
Bandhopadhyay 1987). In a phamacokinetic test Gatier, Coulet, Jean-Francois, Biro-
Sauveur and Alvinerie (1994) reported that serum GLDH activities substantally
increased in week four of infection while serum y-GT activities increased eight
weeks after infection
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Wamae, (1996) reported that F. gigantica infected Friesians serum GLDH
activities first increase 4 weeks after infection, F. gigantica infected Borans enzyme
activities increased in the fifth week post infection. Peak activities of the enzymes
occurred at weeks 13 and 14 weeks p.i. in the infected Friesians and Borans
respectively. The activities of serum y-GT increased from the twelfth week of
infection in both infected groups reaching peak activities at week 16 p.i
Sheep infected with both F. hepatica and F. gigantica showed a significant
increase in serum GLDF1 activities as early as two weeks after infection, by 3-5 wpi.
these activities reached the peak. Although there was a transient increase by 3-5
weeks p.i. in serum y-GT activities in these sheep a pronounced increase was first
noticed in 8 weeks of infection. F. gigantica infected goats differed in that GLDH
first increased in the fourth week of infection while y-GT activities rose in the
eleventh week after infection (Mahato, 1993)
2.8.1 Immunodiagnostic Techniques
The current conventional diagnostic methods are only effective after patency,
when the flukes are in bile ducts and laying eggs (Taylor, 1964; Sewell, 1966;
Burger, 1992), even then the efficiency of egg detection assay is very low. The
potential sensitivity and use in early helminths infections of immunodiagnostic
methods is undoubtedly very high, but generally lack of specificity of immunoassays
means that although they can be used in experimental infections they are of no value
under field conditions (Kagan, 1979; Fagbemi and Obarisiagboni, 1991; Rodriguez-
Perez and Hillyer, 1995).
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Immunodiagnostic methods have potential because these methods may also
find use detecting infection before patency therefore be able to assess the efficiency
of therapeutic or control measures before and after patency. Thus increasingly
epidemiological studies employ serological methods (Gaasenbeek, Over, Noorman
and De Leeuw, 1992) in addition to the monitoring of experimental infection.
Anti-parasite antibody detection in serum and faeces
Copro-antibodies were compared in Nippostrongylus braziliensis infected rats
following a primary infection (Wedrychowicz, MacLean and Holmes, 1983) and a 7-
fold, 3-fold and about a 50-fold increase was measured of IgA, IgG and IgM
respectively. Haemagglutinating antibodies appeared in the faeces on the third day
after infection and were detected using E/S and worm somatic extracts as antigen in
the assay.
El-Bahi Malone, Todd and Schorr (1992) using western blot techniques
detected antigens in the faeces of cattle experimentally infected with F. hepatica.
Wedrychowicz, Turner, Pfister, Holmes and Armour (1984) reported a high
IgGi and IgG2 in serum and IgM and IgA in bile from sheep with primary F.
hepatica infection but only slight increase in faecal IgA levels. Challenge infection
dramatically elevated IgA levels in the faeces. Youssef, Mansour and Aziz (1991) in
Egypt reported that Counterimmunoelectrophoresis (CIEP) was able to detect copro-
antigens in early as well as chronic human fasciolosis
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Parasite antigen detection in serum and faeces
An alternative method of diagnosis in parasite specific antibody detection
assay is the detection of circulating antigens. One advantage of this method is that
the assay can be designed to detect antigens produced by live parasites so that their
detection means presence of active infection. Excretory Products or immune
complexes in the tissues or excreta of the host suggests recent or active infection,
thus overcoming the problem of tests based on antibody detection which can not
distinguish between previous, current or re-infection. This method is thus potentially
superior to and more accurate than the detection of anti-parasite antibodies since
these remain in circulation some time after death of the parasite. Such a method was
developed for diagnosis of Taenia saginata cysticercosis in cattle by use of a double
antibody ELISA (Harrison, Joshua, Wright and Parkhouse, 1989).
Very few studies have been done on the detection of circulating antigens.
Fagbemi, Obarisiagbon and Mbuh (1995), detected circulating antigens in F.
gigantica experimentally or naturally infected cattle using antibodies against a
specific 88-kDa antigen of F. gigantica by a double antibody ELISA. They were
able to detect circulating antigens as early as the second and third week of infection.
However, this procedure has the apparent advantage over the antibody detection in
that it indicates current active infection, (Langley and Hillyer, 1989).
Using polyclonal sera in an antigen capture ELISA, Langley and Hillyer
(1989) detected antigens in the serum of F. hepatica infected rabbits by 6-8 weeks
post infection. The assay exhibited a better sensitivity than an antibody detection
74
Chapter Two: Literature Review
ELISA but specificity and cross-reactions were not studied. It is postulated that
sensitivity and specificity could be improved by the use ofmonoclonal antibodies.
Ellis, Gregory, Turnor, Kalkhoven and Wroth (1993) successfully developed
an antigen capture ELISA to identify Haemonchus contortus antigen in faeces in
naturally infected sheep.
Molecular biology
Recent advances in biotechnology have already been incorporated in the
diagnosis of fasciolosis. There are some situations where the difficulty to identify
differences between Fasciola spp. by morphological means has caused problems
(Taylor, 1964). Even in F. hepatica and F. gigantica it is not possible to decide from
the general body size to speciate some samples. In such situations, DNA probes
offer advantages. The major advantage of this methodology is that it potentially
permits detection of inter- and intra- specific genetic differences (Miller, 1990). In
fact, recombinant DNA technique probably represents the most powerful method of
diagnosis for many veterinary diseases.
Mahato (1993), when attempting to differentiate between F. hepatica and F.
gigantica, developed four DNA probes. Two of these are species-specific and two are
cross-reactive. The MHFh probe is specific to F. hepatica and the MHFg probe is
specific for F. gigantica. Thus if used in conjunction, probes can differentiate
between F. hepatica and F. gigantica.
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The advent of the polymerase chain reaction (PCR) has allowed the
amplification of very small amounts of parasite DNA (such as a single parasite egg)
facilitating its identification (Miller, 1990; Harrison, 1991).
Marin, Prioto, Martin, Casais, Boga and Parra (1992) identified and expressed
an F. hepatica gene encoding a gut antigen protein, 2fasl, bearing repetitive
sequences. This antigen when used diagnostically was able to detect five weeks post
infection.
The use of DNA probes in the epidemiological study of diseases has had
wider usage in protozoal diseases (trypanosomosis, theileriosis, leishmanosis and
malaria). This is because some protozoal species are morphologically similar but
differ in their vectors and definitive hosts, pathology in infected hosts and their
sensitivity to drugs. Identification of such organisms would help in the prediction of
potential outbreaks of a particular disease and allow formulation of suitable control
measures as well as evaluation of control measures (Majiwa, 1989). The advantages
of DNA probes include their potential sensitivity. The selection of repetitive DNA
sequence probes may help meet this requirement (Majiwa, 1989). Differentiation of
Fasciola spp. especially in areas where both occur and the occurrence of intermediate
forms has led to the utilisation ofDNA mapping in attempts to aid speciation.
Blair and McManus (1989) distinguished between the two Fasciola species
by restriction enzyme mapping of ribosomal DNA and found that each had two
unique recognition sites.
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2.9 Vaccination against fasciolosis
There have been many of attempts to immunise animals against Fasciola spp.
with crude antigen either in form of irradiated parasites (Boray, 1967),
excretory/secretory (Burden and Hammet, 1980), surface or somatic antigens
(Hughes, 1987) but generally there has been little progress made towards successful
vaccinations against animal helminth parasites in contrast to those against bacterial
and viral infections of veterinary importance.
The most promising vaccination studies to involve manipulation of a parasite
defence enzyme have been with schistosome glutathione s-transferase (GST). The
use of natural or recombinant GST candidate vaccine formulation to protect against
schistosomiasis was reviewed by Emery (1996). The response to GST is directed to
juvenile flukes reducing mean worm burdens by 78%. Schistosoma mansoni 28 kDa
Glutathione S-Transferase (Sm28GST) is recognised as a potential anti-morbidity
vaccine in human schistosomiasis as well as a diagnostic reagent in antigen
detection. There is also extension of GST vaccination studies to S. haematobium in
primates and S. bovis in ruminants (Hagen and Gryseels 1994). Another vaccine
candidate is a high molecular weight (480 kDa) glycosylated antigen of S. mansoni
found in soluble form in extracts of adult worms and eggs (Sm480); this proteolytic
enzyme is reported to induce protective immunity (22-30%) in rats (Curtis, Fallon
and Deonhoff, 1996). GST has also been used to vaccinate against F. hepatica
infection in sheep. The enzyme gives significant protection against F. hepatica in
sheep (mean reduction of 57% worm burden compared to control). However there
are reports of poor protection with this enzyme (Brophy and Pritchard, 1992).
77
Chapter Two: Literature Review
Sexton, Milner, Panaccio, Weddington, Wijffels, Chandler; Thompson, Wilson,
Spithill, Mitchell, and Campbell (1990) showed that adult F. hepatica glutathion s-
transferase (GST) can significantly protect sheep against liver fluke infection.
2.10 Immunology of fasciolosis
2.10.1 Host species differences in the response to fasciolosis.
The sheep and goats and murine rodents are most susceptible to Fasciola spp.
infection. Although they react severely to Fasciola spp, the immune response is
insufficient to damage or isolate the parasite. In less susceptible animals cattle,
humans, horses and guinea pigs, the response is usually to the late migratory stages
and adult flukes and involves fibrotic tissue reaction and calcification. The other
group of less susceptible animals are pigs, hamsters and carnivores. The tissue
reaction happens much earlier which kills most of the flukes (Taylor, 1964; Barriga,
1981; Tizard, 1992). Thus the immune response varies from species to species.
In mice and humans, helminth infections are generally characterised by
higher levels of IgE and eosinophils, induced by interleukin-4 (IL4) and interleukin-5
(IL5). These cytokines are produced by the helper T2 (Th2) subset of CD4+ T cells
(Finkelman, Pearce, Urban Jr and Sher, 1991).
2.10.2 Humoral Immune Responses to Fasciolosis
Duffus and Frank (1981) reported IgGl5 IgG2 and IgM responses against the
outer glycolyx antigen of juvenile flukes in cattle 2 weeks post infection and that
IgG) was tne dominant antibody isotype.
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Analysis of parasite-specific immunogloblin isotypes IgM, IgG,, IgG2 and
IgA by Clery, Togerson and Mulcahy (1996) showed IgG, to be the dominant isotype
in both chronically infected cattle and previously naive heifers. There is clearly an
involvement of humoral immunity even in the killing ofFasciola (Eckblad, Woodard
and Lang, 1981; Pfister, 1984).
Hanna (1980) studied antigenic changes to the production of antibodies
against To, Ti and T2 antibodies. He noted that the antibodies against To and T,
appear before 6 weeks post infection and T2 is associated with the second antibody
which appears after 6 weeks post infection. Hughes, Hanna and Symonds (1981)
found both IgG and IgA in bile and sera of F. hepatica infected calves. The IgA was
lower in serum and anti- T2 antibodies were absent in serum and bile. Ogunrinade
(1982) in agreement with Nansen (1974) found that F. gigantica infected cattle
recorded a high IgG, and low of IgG2, IgM and IgA isotype to E/S antigen. Burden,
Hughes and Hammet (1982) found that all immunoglobulins are involved in humoral
immune response in F. hepatica infected cattle but IgA and IgE might have a lesser
influence. Pfister (1984) suggested that antibody IgE is involved in Fasciola spp.
expulsion.
2.10,3 Cellular Immune Responses to Fasciolosis
A number of workers have reported on the possible damage to helminths by
involvement of various types of leukocytes particularly eosinophils (Hughes,
Anderson and Harness, 1976; Goose, 1978; Davis and Goose, 1981). Doy, Hughes
and Harness (1978) suggested that the eosinophilia which develops in the intestinal
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wall shortly after oral challenge with F. hepatica may be implicated in the rats'
resistance to reinfection. Encapsulation by host cells, including eosinophils has been
demonstrated when newly excysted flukes are injected in the peritoneal cavity of
sensitised rats and Davies and Goose (1981) confirmed that peritoneal eosinophils
play a vital role in killing of flukes.
Eosinophilia in cattle and sheep infected with Fasciola spp. appears at least
two to four weeks post infection and after subsiding fluctuates slightly above the
normal level. Several reports on the steps leading to the killing of helminths by
eosinophils indicate that first the eosinophils adhere to the surface of the parasite then
degranulate, releasing peroxidase directly onto the parasite or first in the cytoplasmic
vacuole and it is this enzyme that causes damage.
Doy and Hughes (1982) concluded that there are two different mechanisms
capable of inducing an eosinophilia in rats. One of these mechanisms is T-cells
dependant and the other T-cells-independent depending upon the stimulus, in their
case (the parasite). Oldham and Williams (1985) demonstrated the presence of
antigen sensitive T-cells (ASTC) in the peripheral blood of F. hepatica infected
calves by lymphocytes proliferation and lnterleukin-2 (IL-2) production tests. Zhu,
Lukas and Boros (1994) found after studying lymphocytes from liver granuloma of
S. mansoni infected mice that Th0- and Th2-type granuloma lymphocytes play a role
in parasite egg-induced granuloma formation.
One of the first results to describe the cytokines response of specific T cells
obtained from 36 and 40 weeks after F. hepatica infected cattle by Brown, Davis,
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Dobbelaere, and Rice-Ficht (1994) found that most T-Cell clones were Th2 (strong
IL4) as well as less restricted, IL2, IL4 and Interferon gamma (IFNy) or IL2 and IL4
or IL4 and IFNy, TH0 and very little or no Th, (IL2) cytokines profiles. After
lymphocyte proliferation there was no production of IFNy by lymphocytes
responding to adult fluke antigen suggesting strongly therefore that the response by
these two animal groups was not a TH! type response but that of a Th2 or Th0 cell
type (Clery, Togerson. and Mulcahy, 1996).
2.10.4 Mechanisms of Immunity
Glycocalyx turnover or replacement in newly excysted juvenile (NEJ) F.
hepatica flukes has been suggested by Hanna (1980) as a possible mechanism for
protection against the host immune responses. During incubation in the presence of
immune serum this glycocalyx is continuously shed and replaced, and it has been
postulated that the lack of in vitro killing of F. hepatica NEJ's is due, in part, to the
rapid turnover of this highly antigenic layer (Duffus and Franks, 1981) preventing the
attachment of both antibodies and/or cells
Traditionally it has been accepted that immunity to helminths involves
eosinophils, mast cells and IgE, and it is reasonable to assume that host immunity
against helminths might be dependant on Th2 cells (Finkelman, Pearce, Urban, and
Sher, 1991). Following infection with parasitic helminths, a clonal expansion of
antigen-specific T-cells occurs, and the subsequent and concerted immune response
is regulated by cytokines secreted differentially by subsets of helper T-cells,
currently designated TH, and TH2 cells. A good example would be the most
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thoroughly studied nematode Heligmosomoid polygarus in the mouse where it would
appear that immunity is mediated by a TH2-cell population through the production of
Interleukine 4 (IL-4) (Brophy and Pritchard, 1992)
The excretory and secretory products of helminths exert a wide range of
influences on the immune response of their mammalian host, from the induction of
host-protective immunity to providing mechanisms by which the parasites evade the
host immune response. Different immunosuppressive roles have been reported by
several workers. Goose (1978) suggested that F. hepatica E/S products were toxic to
rat leunphocytes and that these substances might protect the parasite from it's host
immune defence. Zimmerman, Kerkvliet, Braun and Carro (1983) reported an
immunesuppression of lymphoproliferation in sheep infected with F. hepatica and
suggested that this may explain the failure of sheep to develop resistance to Fasciola
spp. infection. Vieira, Gazzinelli, Kussel, De-Sousa and Colley (1986) demonstrated
that S. mansoni E/S products were able to decrease the proliferative response by mice
and human lymphocytes. In contrast Lightowlers and Richard (1988) observed a
stimulation of the lymphoproliferation in S. mansoni, as also Poitou, Baez and
Boulard (1992) reported for F. hepatica.
82




3.1.1 Commercial Source of F. hepatica (British strain) Metacercariae
The F. hepatica metacercariae used to infect the three sheep in
experiment 1, and in experiment 3 were purchased from the Compton Paddock
Laboratories, Newbury, Berks, England.
3.1.2 Fasciola gigantica (Kenyan strain) Metacercariae Source
The F. gigantica metacercariae used in experiment 4 were obtained from the
National Veterinary Research Centre, Muguga, Kenya. The F gigantica and those
used in experiment 6 were obtained from the Centre for Tropical Veterinary
Medicine (CTVM) laboratory Kenya isolate of the parasite (See section 2.1.3).
3.1.3 Laboratory Maintenance and Supply of Fasciola hepatica (Peruvian
strain) Metacercariae
F. hepatica (Peruvian strain) metacercariae for sheep 9 and 10 of
experiment 1 and experiment 5 were produced at CTVM Edinburgh by Mr. H.R.
Urquhart. These metacercariae were obtained from experimentally infected L.
viatrix.
Culture of green algae
The techniques used for culturing the green algae were those described by
Taylor and Mozley (1948) with some modifications. Top soil with as few stones as
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possible was collected. The soil was then passed through a 4 mm mesh sieve to
remove remaining stones and other debris. This fine soil was then autoclaved at 1
kg/ cm for 30 minutes. After cooling, the soil was mixed with 500 ml of mineral
solutions (See Appendix 1.) as described by Sewell (1973).
This mixture was smoothly spread at the bottom of 104 mm by 178 mm
plastic boxes (Stewart Plastic Products Ltd) to 15 mm in depth. The algae from a
previously prepared feeder culture were then transplanted into the middle of the box.
After gently spraying the soil with distilled water the boxes with algae were placed in
a warm room at 23°C, about 60 mm beneath a 38 Watt white fluorescent light bulb
(Gro-Lux, Sylvania, Germany). The algal cultures were gently sprayed with distilled
water every day.
Production of young snails
Egg masses from adult L. viatrix were placed onto a fresh algal culture
and maintained at 23°C to hatch. After hatching and eventual depletion of the algae,
the young snails were carefully collected using tissue forceps and transferred onto a
fresh algal culture.
Production of miracidia
F. hepatica eggs were imported from Peru. These eggs were put into 50
ml flasks (Nunclon, Gibco code 1-63371A) and incubated for five days at 23°C.
During this initial incubation the eggs were washed daily with distilled water. The
flasks were then wrapt in aluminium foil and kept in the dark for 9 days at 23°C.
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Miracidiae hatching was achieved by decanting the embryonated the eggs into a
petri-dish and exposing them to light at room temperature.
Infecting snails with miracidia
Infection of L. viatrix was carried out as described by Haroun (1979) for L.
truncatula. The snails were infected when they were 2 to 5 mm in length. Seven to
ten miracidia were pipetted into each well of a flat-bottomed 96 (317pl each) wells
polystyrene plate (Gibco, code 2-62162A). The snails were placed individually into
each of these wells and the plates covered and left for 4 hours at room temperature,
after which the infected snails were transferred onto a fresh algal culture. The
infected snails were maintained at 23 °C and transferred to fresh algal plates as
required. Five weeks after infection the snails were examined under a
stereomicroscope to determine if they contained F. hepatica rediae. Snails that did
not contain rediae were separated and re-examined after two weeks and those
showing no evidence of infection at that time were kept as egg-laying adults.
Harvesting metacercariae
Snails harbouring mature (6-week or more) F. hepatica infections were
placed in small (120 x 75 mm) polythene bags containing 40 ml of cold (4°C)
distilled water. The polythene bag was placed in a bottle and left at room
temperature. The cercariae were shed as the water warmed to room temperature.
The snails were removed from the water after approximately 4 hours and placed onto
a new agal plate. The bag containing the metacercariae was left at room temperature
for 3 days, after which the water was decanted, leaving a few drops in the bag. The
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bag was kept in the refrigerator at 4°C for a few days until needed. The discarded
water was autoclaved in order to kill any remaining metacercariae.
Precaution in handling Fasciola spp
Both F. hepatica and F. gigantica infect a wide range of animals including
man. The only stage infective to man is the metacercariae, and infection is by
ingestion.
According to the Scottish Advisory Committee on Dangerous Pathogens
Fasciola spp are level 2 containment pathogens and special guidelines exist for their
safe handling. Procedure involving infective material was carried out in accordance
with the code of practice for handling Fasciola spp. material in designated snail
rooms. Infected animals were handled in accordance with the regulations of the
Animal (Scientific Procedure) act of 1986 and specifically in accordance with the
protocols laid down in Project Licences PPL60/01582 and PPL60/1583.
Gloves were worn when handling metacercariae. The metacercariae were
removed from storage in the snail room only for the purpose of infecting animals.
During storage and transportation to the animal house the infective material was
contained in non-breakable screw topped containers. All such vessels were suitably
marked with biohazard tape. All materials used in this process were new and
equipment was sterilised before reuse.
3.2 Experimental Animals and Design
The experiment groups 1 and 2 monitoring was conducted by Mahato (1994)
in a pathogenesis experiment. Experiment 6 monitoring was conducted by M.
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Nyanzunda (1993). Sampling started 2 weeks prior to and continued weekly up to 22
weeks after the day of infection
3.2.1 Experiment 1: F. hepatica (British and Peruvian strains) Infection in
Sheep
Six sheep, four female Scottish Blackface sheep of about 11 months old, one
18 months old female Scottish Blackface sheep and one 18 months old Suffolk cross
sheep were purchased from the local farms within the Veterinary field Stations large
animal practitioners territorial unit. The sheep were injected with a single dose of a
1.0% weight per volume (W/V) Ivermectin (IVOMEC®. MSD AGVET Ltd.) to
eliminate intestinal nematodes.
The animals of this group were divided into three subgroups. As described in
the Table 3.1, five animals were infected with F. hepatica metacercariae. The
remaining one was left uninfected. Two of the animals from this group were infected
with 200 and the other three with 300 metacercariae of F. hepatica and one sheep in
this group was left trematode free and used as a control.
Table 3.1: Experiment 1: Experimental details of chronic F. hepatica (British and









Higher dose 5 Blackface F 300 75 33
6 Blackface F 300 150 50
7 Blackface F 300 172 73
Lower dose 9 Blackface F 200 - -
10 Suffolk S F 200 - -
Uninfected 8 BlackLce F 0 0 0
controls
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3.2.2 Experiment 2; F. hepatica (British strain) Infection in Sheep
Six sheep, 2 male and 1 female Scottish Blackface sheep, and 1 male and 2
female Suffolk crosses, all approximately 18 months old and raised under fluke-free
conditions, were obtained from the Firth Mains Farm ofMoredum Research Institute,
Edinburgh. The sheep were orally treated with a single dose of 5 mg/kg body weight
oxfendazole (Systamex, Wellcome Foundation Ltd., London) to eliminate intestinal
nematodes.
The animals of this group were divided into three pairs. As described in the
table 3.2, animals allocated in two of the three pairs were infected with F. hepatica
metacercariae. The remaining group was left uninfected. One pair of animals from
this group was infected with 150 and the other with 350 metacercariae of F. hepatica
and the other pair of sheep in this group were trematode free animals and used as
controls.
Table 3.2: Experiment 2: Experimental details of chronic F. hepatica (British strain)
infection in sheep
Experiment 2 Anima Breed Sex Metacercariae Fluke
1 given (No) recovery
No. (No) (%)
Lower dose 24 Suffolk X F 150 77 51.3
28 Suffolk X M 150 95 63.3
Higher dose 26 Blackface F 350 247 70.6
30 Blackface M 350 203 58.0
Uninfected 22 Suffolk S M 0 0 00
controls 32 Blackface F 0 0 0
3.2.3 Experiment 3: F. gigantica (Kenyan strain) Infection in Sheep
Nine sheep, all female Scottish Blackface, approximately 2 years old and
were purchased from the local farms within the Veterinary Field Station's large
animal practitioners territorial unit. The sheep were orally treated with a single dose
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of 1.0% w/v Ivermectin (IVOMEC*. MSD AGVET) subcutaneously to eliminate
intestinal nematodes. Although there were no fluke eggs in the initial faecal egg
count examination all the sheep were drenched with 5% w/v triclabendazole
(Fasinex® 5%. CIBA GEIGY) at a rate of 8 ml per 40 kg of sheep.
The animais of this sub-group were divided into two groups. As described in
Table 3.3, animals allocated in sub-group one were infected with 100 F. gigantica
metacercariae each and the sheep in the other group were trematode free animals and
used as controls.
Table 3.3: Experiment 3: Experimental detail of chronic F. gigantica (Kenyan
strain) infection in Scottish Blackface female sheep
Experiment 4 Animal Live Metacercariae Fluke
No. weight given (No) recovery
(No) %)
Infected 11 51 100 34 34
12 39 100 50 50
13 40 100 45 45
14 41 100 58 58
15 42 100 76 76
Uninfected 16 40 0 0 0
controls 17 41 0 0 0
18 43 0 0 0
19 47 0 0 0
3.2.4 Experiment 4: F. gigantica (Kenyan strain) Infection in Sheep
Six sheep, 2 male and 1 female Scottish Blackface sheep, and 1 male and 2
female Suffolk cross sheep, all approximately 18 months old and raised under fluke-
free conditions, were obtained from the Firth Mains Farm of Moredum Research
Institute, Edinburgh. The sheep were orally treated with a single dose of 5 mg/kg
body weight Oxfendazole (Systamex, Wellcome Foundation Ltd., London) to
eliminate intestinal nematodes.
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The animals of this group were divided into three pairs. As described in the
table 3.4, animals allocated in two of the three pairs were infected with F. gigantica
metacercariae. The remaining group was left uninfected. One pair of animals from
this group was infected with 150 and the other with 350 metacercariae of F.
gigantica and the other pair of sheep in this group were trematode free animals and
used as controls. Details of each animal including fluke recoveries are shown in
Table 3.4.
Table 3.4: Experiment 4: Experimental details of chronic F. gigantica (Kenyan strain)
infected sheep
Experiment Animal Breed Sex Metacercariae Fluke recovery
4 No. given (No) (No) (%)
Lower dose 23 Suffolk X F 150 80 53.3
27 Suffolk X M 150 83 55.3
Higher dose 25 Blackface F 350 181 51.7
29 Blackface M 350 34 9.7
Uninfected 21 Suffolk X F 0 0 0
Controls 31 Blackface M 0 0 0
3.2.5 Experiment 5: Chronic F. hepatica (Peruvian strain) Infection in Calves
Six calves, 5 male and 1 female, all Friesian between 10 to 12 weeks old and
raised under fluke-free conditions, were obtained from the Bush Farm, University of
Edinburgh..
As shown in the Table 3.5, 5 calves were infected with F. hepatica
metacercariae. One calf from this group was uninfected. Sampling started 2 weeks
prior to and continued weekly up to 27 weeks after the day of infection
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Table 3.5: Experimental detail of chronic F. hepatica (Peruvian strain) infection in
Friesian calves (wppi = Weeks post primary infection)
Calf Body Primary infection Challenge infection
Experiment 5 No./Sex weight metacercariae metacercariae
(Kg) given given/wppi
Single infection 14c/F 82 200
Infection/challenge 15c/m 91 200 100/15
Infection/challenge 23c/m 108 600 100/25
Single infection 34c/m 71 450
Single infection 45c/m 69 450
Uninfected control 26c/m 85 0
3.2.6 Experiment 6: Chronic F. gigantica (Kenyan strain) Infection in Calves
Four male Friesian calves of about 12 weeks of age were bought from Bush
Farm, University of Edinburgh. There were no helminths eggs at the initial faecal
egg count examination. Three calves (calves 22,23 and 24) were infected and one
(calf 26) was kept as uninfected control. The animals were monitored as an ongoing
research program at CTVM by Nyanzunda (1993).
As shown in the Table 3.6 below, 3 calves were infected with 400 F.
gigantica metacercariae, however weights were not taken. Sampling started 2 weeks
prior to and continued weekly up to 33 weeks after the day of infection
Table 3.6: Experiment 6: Experimental detail of chronic F. gigantica (Kenyan
strain) infection in Friesian male calves.
Experiment 6 Animal Metacercariae Fluke recovery
No. given (No) Fluke No. %
Infected calf 22 400 30 7.5
Infected calf 23 400 31 7.75
Infected calf 24 400 10 2.5
Uninfected calf 26 0 0 0
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3.3 Maintenance of experimental animals
Sheep were housed in concrete pens and provided with wood shavings as
bedding. They were fed a daily ration of 300g cubes Sheep Food® (dry matter 88%;
protein 18%, 021 2.5%, Fibre 10% and ash 8% of the dry matter) per head. Water and
hay were provided ad libitum. Calves were housed in concrete pens and provided
with straw for bedding. They were fed ad libitum a hay diet. The water was provided
ad libitum.
3.4 Infection of experimental animals
The polythene bag containing metacercariae was opened with scissors and cut
into manageable pieces. The metacercariae were examined for viability under a
stereomicroscope at magnification of 50X. Those metacercariae having a
characteristic granular appearance were considered as viable (Hammond, 1970).
The required number ofmetacercariae for experiments 1, 2 and 6 were counted
and then scraped and washed off the polythene into a plastic petri dish using a
microscope glass slide as scraper. The water, containing metacercariae, was poured
onto a Whatman No. 4 filter paper in a glass funnel making sure that no
metacercariae were left in the petri dish. After the paper had drained, it was folded,
with the retained metacercariae inside, and administered orally to the animals using a
balling gun.
For experiments 3, 4 and 5, the required number of metacercariae were
counted under a stereo microscope while still on the polythene. The polythene was
cut into thin strips which were laid on a sheet of Whatman No. 4 filler paper. The
92
Chapter Three: Materials and Methods
filter paper was folded into a ball with the polythene containing the metacercariae to
the inside. The filter paper ball was then orally administered using the balling gun.
3.5 Monitoring of animal experiments
The experiments three and four was monitored by Mahato (1993) as part of
his PhD. research work. The Cattle in experiment six were monitored by the staff in
helminthology laboratory and Nyanzunda (1993) as part ofhis MSc. project.
3.5.1 Measurements ofWeights
A weighing crush (Weighbridge, Leslie P. Morris Lt, Salop) was used to
weigh the sheep in the experiments at CTVM. The calves were not weighed.
3.5.2 Sample Collection, Preparation and Storage
Blood and serum sample collection
The blood samples for haematological studies were taken from the jugular
vein into vacutainers containing disodium or dipotassium ethylenediamine tetra-
acetic acid (EDTA) as an anticoagulant. The blood samples for biochemistry and
serology were obtained from the jugular vein into plain vacutainers (Becton,
Dickinson and Co Ltd, UK) and allowed to clot in an incubator at 37°C for 1 hour,
then kept at 4°C overnight for the clot to retract. The serum was separated by
centrifugation at 2,000g for 30 minutes, dispensed into 2 ml aliquots and stored in
labelled eppendorf tubes frozen at -20°C until required.
93
Chapter Three: Materials and Methods
Faecal samples collection
About 3 grams of faecal material was used for coproscopic assays and two
grams to prepare supernatant for immunodiagnostic assays. The two grams for
immunodiagnostic assays was thoroughly homogenised and mixed with 3 ml of
sample Phosphatase Buffered Saline (PBS) pH 7.4 containing 0.02% v/v sodium
azide and 0.05% w/v Tween 20 . The suspension was then mixed and centrifuged at
2,000g at 4°C for an hour. The supernatant was collected in 2 ml vials and stored at -
20°C until use. In experiment 3 whole faecal samples were also collected and stored
in 4 ml vials at -20°C.
3.5.3 Faecal Egg Counts
A differential centrifugal flotation technique as described by Hammond and
Sewell (1972) was used to calculate the fluke egg counts. Faecal samples in zinc
sulphate solution were centrifuged until slight convex meniscus was formed. A
cover slip was placed over the meniscus, left to stand for about 3 minutes, and then
lifted off vertically, placed on a microscope slide and examined for the presence of
Fasciola spp. eggs.
Nematode eggs counts were estimated according to the method described in
the Technical Bulletin No. 18 (Anon, 1977) with minor modification. A 3g sample
of faeces was weighed and homogenised in 42 ml. ofwater. A 15 ml. centrifuge tube
was filled and centrifuged for 5 minutes at 1500 g. The supernatant was decanted
and the sediment resuspended in saturated sodium chloride to the 15 ml mark. After
thorough mixing two chambers of a McMaster slide were filled and eggs counted in
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both chambers. The total number of eggs counted was multiplied by the factor of 50
and results expressed in egg counts per gram of faeces (EPG).
3.5.4 Haematological Techniques
Total erythrocytes and leukocyte counts
These were determined by the method described in the Reference Manual for
the Coulter Counter Model ZM (Coulter Electronics, 1985), using an electronic cell
counter (Coulter Counter Model Z, Coulter Electronics Ltd, Luton). The dilution
used for the total leukocyte count was 1:500 and 1:25,000 for erythrocyte counts.
12
The red blood cells (erythrocytes) were expressed in real numbers xlO and the
white blood cells (leukocyte) were expressed in real numbers xlO9.
Haemoglobin estimation
Haemoglobin, converted to cyanmethaemoglobin with Zapoglobin (Coulter
Electronics Ltd, Luton) was measured in a Haemoglobinometer (Coulter Electronics
Ltd, Luton). The haemoglobin concentrations were expressed as grams per decilitre
(g/dl) (Archer, 1963).
Packed cell volume determination
Packed cell volume (PCV) was determined using a Hawksley micro-
haematocrit centrifuge and reader (Hawksley and Sons Ltd, Lancing, England). The
samples were centrifuged at 12000g for 7 minutes and the volumes were expressed as
percentage.
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Eosinophil counts
These were done by a modification of the method of Archer (1963) using a
modified Fuschs Rosenthal Chamber (Weber Scientific International Ltd, Lancing,
England). EDTA blood 20pl was added to 0.38 ml of Discombe's fluid (10ml eosin
(200g/l), 10ml acetone and 80ml distilled water) to give a 1 to 20 dilution. This was
mixed for not longer than 30 seconds before filling both Fuchs-Rosenthal counting
chambers. The eosinophils were counted in all ruled areas in the chambers.
The total volume in the chamber is 3.2pl. The above information provided a
formula to calculate the eosinophils counts per pi. The eosinophil count results were
expressed in 109/1.
Calculation: If N eosinophils are counted in 3.2pl then the total eosinophil
N x20(dilution) _
count per ml is equal to (=) 3.2 x 10 /litre = N x 6.25 x 10 /litre.
eosinophils counted were expressed in real numbers xlO9.
Differential leukocytes counts
Thin blood smears were made on clean microscope glass slides using EDTA
blood (Chance Propper Ltd, England) and air-dried. The slides were fixed for two
minutes in methanol and then stained for 30 minutes in Giemsa's (British Drug
House Ltd. (BDH) stain diluted 1:10 with distilled water. The slides were washed
with Giemsa's buffer (BDH) pH 7.2 and allowed to air-dry. Differential leukocyte
counts were performed on the stained slides by differentiating a total of 200 cells in
successive microscope fields using the x 1000 magnification on a Leitz Dialux 22
microscope (Leica UK). The proportions of different white blood cells were
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calculated as a percentage and these were converted to real numbers. Results were
expressed as real numbers xlO9.
3.5.5 Biochemical Techniques Conducted on Serum Samples
Total protein
Total serum protein was determined by the Biuret method as described in
total protein procedure Anon (1994), using Randox total protein reagent and protein
standard. The procedure is based on the principle that the copper ions in alkaline
Biuret reagent, react with the peptide bonds of serum proteins to form a purple colour
with an absorbance maximum at 540 nm. The intensity of colour is proportional to
the total protein concentration which was measured in optical density using a
spectrophotometer (PU 8600 UV/VIS, Pye Unicam Ltd, Cambridge). The reliability
of test results were monitored by routine use of control sera. Calculation: Since a
standard was used the Total Protein Concentration in gram per decilitre (g/dl).
A 540 nm (sample)
(g/dl) =- x 6
A 540 nm(standard)
Albumin
Serum albumin was estimated as described by Anon (1994). using Randox
albumin reagent and an albumin standard. The measurements of serum albumin is
based on its quantitative binding to the indicator 3,3',5,5'-tetrabrom-m cresol
sulphonphthalein (bromcresol green) to produce a blue green colour with an
absorbance maximum at 628 nm. The intensity of the colour produced is directly
proportional to albumin concentration in the sample and was measured using the Pye
Unicam PU 8600 UV.VIS spectrophotometer (Pye Unicam Ltd, Cambridge) at room
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temperature. The albumin concentration, expressed as gram per decilitre, in the
sample was calculated from the following formula: The results were expressed in
gram per litre (g/1).
A 628 nm (sample)
Albumin concentration (g/dl) = x Concentration of Standard
A 628 nm (standard)
Glutamate dehydrogenase (GLDH) estimation
The activity of GLDH (EC 1.4.1.3) in the serum was measured, without
determination of non-specific creep reaction, using a kit, Test-Combination GLDH
activated (Randox Ltd.). The activities of GLDH in the samples were expressed as
Unit per litre (U/L).
The test is based on the following principal:
a- Oxoglutarate + NADH + NH+4 —gldh ^ Glutamate + NAD + H20
Gamma glutamyltransferase (y-GT) estimation
The activity of y-GT (EC 2.3.2.2) in the serum was assayed using a kit, r-GT
(Randox) which is based on the following principal:
y-GT
L-g-Glutamyl-3-Carboxy-4-Nitroanilide + Glycylglycine 7 Glutamylglycygllycine + p-Nitroaniline
Spectrophotometry readings were taken at 25°C and 405nm. The calibrated
standards. The activities of y-GT in the samples were expressed as Unit per litre
(U/L).
Glucose and b-Hydroxyl-butyrate analysis
The glucose and P-Hydroxylbutyrate were analysed using an automatic
chemistry analysing machine (Opera Chemistry Systems, Bayer , Leverkusen,
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Post-mortem examinations were carried out on all animals soon after they
died or were humanely killed. The method used for recovery, counting and
measuring the flukes are describe by Nyanzunda (1993). A careful examination was
made of all internal organs for abnormalities, with particular attention to their colour
and appearance and any sign of ectopic flukes. The animal was eviscerated and the
liver with intact bile duct was placed on a clean white 370 mm x 300 mm enamel pan
and weighed. The bile ducts were cut open and the flukes in them collected using
forceps. In order to make sure that most fluke have been collected and counted, the
liver was then cut into small pieces of about 45 mm x 45 mm. The collected flukes
were counted and immediately put in sterilised plastic container with sterile warm
(37°C) PBS (code BR14a) pH 7.3 (Oxoid Ltd. Basingstoke, Hampshire, England).
Part of liver parenchyma, large bile ducts and hepatic lymph nodes lymph nodes
were stored in 10% v/v Formalin for histology.
Histopathology
Samples of liver and other tissues were fixed in 10% v/v buffered formalin-
saline. Histological slides stained with haematoxylin and eosin (H&E), Maritus
scarlet blue (MSB), carbolchromotrope (CC) and Prussian Blue Reaction (PBR) were
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prepared by staff at the Veterinary Field Station, Department of Pathology, Royal
(Dick) School of Veterinary Studies.
3.6 Preparation of Fasciola spp. extracts
The flukes collected at post-mortem examination were washed, i.e. until they
were free of any visible bile pigments, 6 times in warm (37°C), sterile PBS, then 6
times in sterile PBS containing penicillin (100 IU/ml), streptomycin (lOOpg/ml) and
fungizone (2pg/ml) and washed further 6 times in RPMI medium containing
penicillin (lOOIU/ml), streptomycin (100pg/ml) and fungizone (2pg/ml. Following
these washes, the treatment of the flukes varied depending on the type of extract to
be made. The adult fluke extracts prepared from both F. hepatica and F. gigantica
are as described in the table 3.7, however only excretory secretory extracts were used
in these studies.
Table 3.7 The adult Fluke Excretory-Secretory extracts prepared from both F.
hepatica and F. gigantica.






3.6.1 Adult Fluke Excretory and Secretory (E/S) Products
The washed flukes were placed into tissue culture flasks containing RPMI
1640 medium with penicillin (100 IU/ml), streptomycin (100pg/ml), fungizone
(2pg/ml), sodium pyruvate and L glutamate at 1 fluke per 5 mis of medium. The
flasks containing the flukes were incubated in a 6% (v/v) carbon dioxide in air
incubator at 37°C for 24 hours. Following 24 hours maintainance, the medium was
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collected and fresh medium added to the flasks. Medium collected from the 24 hours
culture was centrifuged at 2000g, for 30 minutes, at 4°C, the supernatant collected
and the protein content determined below, (see section 3.5.5). The same procedure
was followed for the medium collected 24-48 hours incubation and the 2 solutions
were designated 0-24 and 24-48 hours E/S respectively, aliquoted into 1ml volumes
and stored at -70°C.
3.6.2 Source ofOther Purified Antigens and Monoclonal Antibodies.
Cathepsin-L like cysteine protease, 27 kDa, from adult F. hepatica was
supplied by Professor John P. Dalton of the School of Biological Sciences, Dublin
City University, Ireland. This antigen was purified and characterised as described by
Smith, Dowd, McGonigle, Keegan, Brennan, Trudgett and Dalton (1993). Adult F.
hepatica Glutathione S-Transferase (FhGST) was supplied by Professor G. V.
Hillyer of University of Puerto Rico, School of Medicine, Puerto Rico. The FhGST
was purified directly from the parasite as described by Hillyer, Soler de Galanes and
Battisti (1992)
The rat monoclonal antibodies used in sheep were provided by Dr. J. Hopkins
of the department of Clinical studies, Royal (Dick) Vet. School, University of
Edinburgh, Scotland.
3.6.3 Estimation of Protein Content
The protein concentration of the E/S products was estimated by the method
described by Warburgh and Christian (1941).
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This technique depends on the phenylalanine, triptophan and tylosin content
in the sample and so does not necessarily measure total protein accurately. It is
however particularly useful because it is easy and quick to use. The extinction of an
appropriately diluted solution of sample was measured at both 260 nm and 280 nm
in a 0.2 mm light-path quartz cells (© Unicam Ltd. Cambridge) in a Unicam 8625
Series spectrophotometer (© Unicam Ltd. Cambridge). The E260 : E280 ratio was
calculated, using this ratio the proportion of nucleic acids in the protein sample and a
factor for calculating the protein content was read off from the standard table
(Warburgh and Christian, 1941). The protein concentration was calculated using the
formula:
1
Protein Concentration (mg/ml) = Extinction at 280 nm x Factor x —
d
where d is length of light-path in centimetres.
3.7 Indirect Enzyme linked immunosorbent assays (ELISA)
Two Enzyme Linked Immunosorbent Assay (ELISA) systems were employed
for detection of parasite specific antibody in serum and faecal samples; the first using
the polyclonal conjugate (total Ig and IgM) as described by Nyanzunda (1993) and
the other detection incorporating immunogloblin subclasses using rat monoclonal
antibodies to sheep IgGl, IgG2 and IgA. In the ELISA assays either 48 hours
F.hepetica and F. gigantica excretory/secretary products (Fh-E/S or Fg-E/S), adult F.
hepatica Cathepsin-Ll cysteine protease (Fh-Cathepsin) or adult F. hepatica
Glutathione S-Transferase (Fh-GST) were employed as antigen.
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3.7.1 Indirect ELISA Protocol
Polystyrene microtiter immunoassay plates (Dynatech laboratories, Inc.
London, UK.) arranged in a 96-well, flat-bottomed format, were coated with 50
pl/well of Fasciola. spp extracts, diluted in borate buffered saline pH 8.2 (BBS,
appendix 1). The plates then were covered with plastic film to prevent evaporation
and left overnight at 4 °C. The contents of all the wells were then shaken out and the
wells washed three times in a 0.9% (w/v) solution of sodium chloride containing
0.05% (v/v) Tween 20 (washing solution, appendix 1) allowing 3 minutes for each
wash. The plates were then well drained. Normal serum of the same species as the
conjugate, diluted to 4% (v/v) in PBS pH 7.3 (appendix 1) containing 0.05% (v/v)
Tween 20 (blocking solution, appendix 1) was added, at 100 pl/well to all wells, the
plates were incubated for 1 hour at room temperature and then the blocking buffer
was shaken out and the plates blotted by tapping on absorbent paper. Positive and
negative controls, all diluted in blocking solution, were added to appropriate wells at
50 pl/well. The plates were incubated for 1 hour at 37 °C. For every incubation
step, the plates were covered with plastic film to prevent evaporation, then after
incubation subjected to three washes of 3 minutes duration in washing solution. Anti¬
serum, conjugated to horse-radish peroxidase (HRP), and optimally diluted in
blocking solution, was added at 50 pl/well to all. The plates were again incubated
for 1 hour at 37 °C, washed, following which the peroxidase substrate, tetramethyl
benzidine (TMB, Kirkegaard & Perry Laboratories, Gaithersberg, USA. lot SG24)
was added to all wells. The reaction was allowed to develop for 10-30 minutes
(making sure the background remained acceptably low) at room temperature and then
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stopped by the addition of 50 pl/well of 0.2 Sulphuric Acid (appendix 1). The
optical density (OD) was measured at 450 nm in an automated ELISA reader
(Multiskan version 2.03. Labsystems. Basingstoke Hants, UK). ELISA plate layout
for the assay for sequential analysis is shown in Table 3.10.
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3.7.2 The Indirect ELISA with Polyclonal Antibody Detection System.
This assay was used to monitor the total immunoglobulin response to the
three antigens, E/S products, Fh-Cathepsin and Fh-GST and the IgM response.
Blocking serum and indicator details are shown in Table 3.8. The polyclonal
detection system followed a general protocol as detailed in Figure 3.1
Table 3.8 Reagent details for polyclonal antibody detection system in sheep and in
cattle. The conjugates were purchased from three different companies,
i.e. Bethyl Laboratories INC (Bethyl Lab. INC. USA), Kirkegaard and
Perry Laboratories INC (Kirkegaard Lab INC. Gaithersberg, USA) and
Nordic immunological Laboratories (Nordic Lab. Halland)
Sheep Assay Blocking indicator





IgM Normal rabbit Rab anti-sh IgM Kirkegaard Lab
serum (H) lot JJ 21-1 INC.,
Cattle
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O Coat the well with defined antigen (Fh-E/S,
Fg-E/S, Fh-cathepsin or Fh-GST)
< Block
© Incubate with Test sera or faecal sample
C Wash (3x3 minutes)
© Incubate with Antibody PO-conjugate
I <{ wash (3x3 minutes)
© Add TMB and observe colour change
Figure 3.1 The indirect ELISA with polyclonal antibody detection system used in
3.7.3 Indirect ELISA Protocol for Monoclonal Antibodies Detection System
The indirect ELISA was carried out by a modification of the general
(polyclonal) procedure described in section 3.7.1. The difference is that one more
step was incorporated between the test sera or faecal samples and the substrate as
summarised in Figure 3.2. Thus, after the addition of the serum or faecal samples, rat
monoclonal antibody with specificity for either IgM, IgGb IgG2 or IgA was added.
The monoclonal antibody responses were tested by using anti-rat Ig (H&L) The
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Table 3.9 Reagent details for monoclonal antibody detection system assays in
sheep and in cattle
Sheep Assay Blocking indicator
IgGl normal Rabbit serum Anti-rat Ig (H & L)
IgG2 normal Rabbit serum Anti-rat Ig (H & L)
IgA normal Rabbit serum Anti-rat Ig (H & L)
O Coat the well with defined antigen (Fh-E/S,
Fg-E/S, Fh-cathepsin or Fh-GST)
< Block
© Incubate with Test sera or faecal sample
C Wash (3x3 minutes)
© Incubate with McAb
K. wash (3x3 minutes)
0 Incubate with antibody PO-conjugate
{ wash (3x3 minutes)
© Add TMB and observe colour change
Figure 3.2: The indirect ELISA with monoclonal antibody detection system
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Table 3.10: ELISA plate layout for the assay for sequential analysis.
1 2 3 4 5 6 7 8 9 10 11 12









P = Positive control sera
N = Negative control sera
B = Diluent (serum blank)
T-2, TO, etc. = Weeks post infection with either F. hepatica or F. gigantica.
3.7.4 Titration
Before carrying out sequential ELISA's chequerboard titrations of antigens
test sera, monoclonal antibodies and conjugates were performed to determine the
optimum concentrations. During monoclonal antibody titrations a comparison was
made with Fh-E/S or Fg-E/S assays to monitor the assay and ascertain whether or not
the assay was working for the respective immunoglobulin subclasses involved.
Faecal samples were not titrated because they were in limited amount. The general
indirect ELISA procedure described in sections 3.7.2 and 3.7.3 were used in the
respective titrations.
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3.7.5 ELISA Correction Factor
A correction factor was used to adjust the results of sequential screening for
day to day and plate to plate variations. The correction factor always related back to




Po = Average results of the positive sera from plate 1, day 1
No = Average results of the negative sera from plate 1, day 1
Pt = Average results of the positive sera from test plate
Nt = Average results of the negative sera from test plate
3.8 Western blotting (WB)
3.8.1 Sodium Dodecyl Sulphate Polyacrylmide Gel Electrophoresis (SDS-
PAGE).
All the Western blotting studies were conducted using a discontinuous
polyacrylmide gels consisting of a resolving or separating gel (lower) and a stacking
(upper) gel buffer system (see appendix 1) as described by Laemmli (1970).
The samples were mixed with either reducing buffer or non reducing buffers
(Appendix 1) at the ratio of 2 : 1 and boiled for 5 minutes at about 100 C. These
samples were then cooled before being loaded in SDS-PAGE mini-gel (prepared
according to the manufacturers specifications ). 0.75 mm thick, mini-gels with 2
wells, small well for pre stained broad spectrum marker and the large well for
samples, were used. Biotinylated broad spectrum molecular weight markers (8 ml)
(Biorad Laboratories, code, 161-0319) were added to the marker well of the 2 wells
and reduced or non reduced samples (300pl) were added to the larger well. The
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samples together with the broad spectrum prestained markers were electrophoresis
for 45 minutes at 200 Volts using 200/0.2 power supply (Bio-Rad®).
3.8.2 Electrophoretic Transfer Blotting
After electrophoresis, gels were electroblotted onto nitro-cellulose (NC)
paper, Schleichler and Schuel) in a semi-dry blotter (Biorad Laboratories Homel
Hempstead, UK). For each gel rectangular pieces of NC paper and filter paper
(Whatman International Ltd.. Maidstone, Kent UK) were cut to a size slightly larger
than the mini-gels and immersed in Bjerrum and Schaffer-Nielsen transfer buffer for
30 minutes (appendix 5). Three of the 6 wet filter papers were carefully placed on the
flat surface of the negative plate of the transblot cell and the NC paper placed on top
of the filter paper. The mini-gel was placed on top of the NC paper and then covered
with the second wet filter paper. Precautions were taken to prevent trapping air. Two
mini-gels prepared at one time. The cell was closed and electroblotting carried out
for 45 minutes at 10 volts and a current limit of 0.26 amps per mini-gel. After
transfer, the gel outline and the position of molecular weight markers on the gel
were marked on the NCP. A mark to show whether reduced or non-reduced sample
had been transferred onto the NCP was also placed on each mini blot.
3.8.3 Immunostaining
The sample arrangement of the sequential Western Blot is shown in Table
3.11. Following the protein transfer the mini-blots were washed 3 times in 0.05%
(g)
v/v PBS/Tween 20 , each wash lasting 15 minutes. This washing procedure was
used for all subsequent washing steps.
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The reaction of transblotted fluke extracts with test sera was carried out in a
mini PROTEAN II multiscreen apparatus (Biorad laboratories), which allows up to
20 serum samples on mini blots to be tested without having to cut the NC paper into
strips. Two mini-blots, one containing reduced and the other non reduced extract
were tested simultaneously. The mini-blots were aligned on the mini-PROTEAN II
apparatus (figure 3). The optimum dilutions of serum biotinylated rabbit anti-bovine
IgG, and streptavidin alkaline phosphatase were determined through titrations.
Free binding sites were blocked by 4% v/v normal goat serum (4% v/v
NGS/PBS/Tween20®) in case of cattle serum examination and 4% normal rabbit
serum (4% NRS/PBS/Tween20®) in case of sheep serum at 4°C overnight. After a
wash with 600 pi Tween20 per channel, test sera optimally diluted approprate
blocking buffer was added and incubated at 37°C for 1 hour. After the channels
were washed and 600 pi per channel of biotinylated anti-bovine Ig (Sigma
Chemicals, code B7140) diluted optimally in approprate blocking buffer was
incubated at 37 C for one hour. After washing both the reduced and non-reduced
mini blots were then removed from the mini-PROTEAN II apparatus, placed in
plastic dishes where an adequate volume of an optimal dilution of streptavidin
alkaline phosphatase conjugate (Amersham laborarories, code RPN 1234) was added
to completely cover each mini blot. The mini-blots were incubated for 30 minutes at
room temperature with gentle shaking and then washed. Adequate volumes of 5-
bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium (BCIP/NPT) (Kirkegaard
laboratories, code 50-81-07) to cover each mini blot were added to the plastic dishes
and the dishes shaken gently on a shaker until bands appeared.
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The reaction was stopped by washing the mini blots with distilled water.
Blots were photographed using a Polaroid MP4 camera (no filter, fl 1, 1/8 seconds).
Table 3.11 The arrangement of channels of the mini-PROTEAN II apparatus and
the alignment of the mini-blots for reaction with test sera.
Mr 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
TO T1 T2 T3 T4 N D
Mr = The area of the mini-blot containing molecular weight markers.
1, 2, etc. (Top) = The channels of the mini-PROTEAN II gasket
T1 (Bottom) = week after infection from which the serum sample in that channel
was collected.
N (Bottom) = negative serum sample
D (Bottom) = serum diluent
3.8 Silver staining
Samples for silver staining were prepared and run on SDS-PAGE gels
(section 3.8.1) with some modifications. 1 mm thick, 10 well, ready made single
percentage (10%)-slab gels (Biorad Laboratories code, 161-0907) were used. Biorad
prestained broad range molecular weight markers (code, 161-0318) were added to
wells 1 at 5 pi per well, while 45 pi per well of parasite extract samples were added
to wells 2 to 10.
Following electrophoresis each gel was immersed for 30 minutes in a fixative
containing 50% v/v methanol and 12% v/v glacial,acetic acid and 38% v/v of
deionised distilled water. This solution was then replaced by one containing 10% v/v
methanol, 5% v/v acetic acid and 85% v/v deionised distilled water and left to shake
for 30 minutes. The gels were washed in distilled water for 20 minutes before being
placed in Silver Nitrate solution of 0.95% w/v containing 5 ml of 0.8 nM NOAH, 3.5
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ml of 35% v/v ammonium hydroxide and left on an orbital shaker for 20 minutes.
After this stage the gels were again washed in distilled water v/v/v this time for 15
minutes and placed in 500 ml solution of 0.006 acetic acid, 125 pi of 38%
formaldehyde and 50 ml ethanol. The gels were left on the shaker until the colour
development was optimum. The reaction was stopped by placing the gels in 5%v/v
acetic acid solution for one hour after which they were take for photographed, using a
Polaroid MP4 camera.
3.9.4 Molecular Weight Estimation.
The distance migrated on the mini-blot by each of the molecular weight
standards and the dye front of the detected antigens were measured and the relative
mobility (Rf) value of each calculated using the formula:
_ Distance migrated by molecular weight standard or antigen
iv I — ;
Distance migrated by the dye
The molecular weight (Logio) of the standard (vertical axis) and the relative
mobility of each standard (horizontal axis) were plotted (Fig. 3.3). The molecular
weight of the detected antigens were determined by reference to the graph in relation
to standard.
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Predicted Log 10 mol.wt
Figure 3.3 An example ofmolecular weight estimation by the Ferusons plot
3.10 DATA PROCESSING AND GRAPHICS
The collected data were processed and analysed by using a computer. The
main software used are Microsoft Word 6.0 and Microsoft Excel version 5.0.
Statistical analysis were done using Windows MINITAB version lOXtra (10.5).







4.1.1 Experiment 1: F. hepatica (British and Peruvian strains) infection in
sheep
Clinical Findings
All the sheep were clinically normal up to the 4 week post infection (wpi.), of
the three sheep (5, 6 and 7) infected with 300 metacercariae (British strain) sheep 5
lost appetite was anaemic and often found recumbent by 6 wpi., sheep 5 deteriorated
further by developing fever and dyspnoea by 8 wpi. and died at 11 wpi. Sheep 6 also
lost appetite and became anaemic by 8 wpi. However, sheep 7 remained clinically
healthy just as the uninfected control. The other two sheep, 9 and 10, infected with
200 Peruvian F. hepatica metacercariae showed no clinical abnormalities.
Live weight
The changes in live weight of individual sheep is shown in Figure 4.1a The
live weight depression in sheep infected with 300 metacercariae (British strain) was
between 6-11 wpi., thereafter it started to pick up. The infected sheep weight gain
was much slower than uninfected control. Sheep 6 lost 3 kg by 9 wpi. Sheep 9




At the start of experiment sheep 5, 6, 7 and 8 were infected with nematode
(Appendix Table 4.1) but the EPG values reduced sharply after deworming at -2 wpi.
The F. hepatica prepatent period ranged from 10-12 wpi. (Figure 4.1c) with
egg counts peaking by sixteen wpi. Sheep 5 died before infection reached patency.
Sheep (6 and 7) infected with 300 metacercariae had higher faecal egg count than
those infected with 200 metacercariae.
Sheep 9 and 10 were not sacrificed at the end of experiment and left as egg
donors for production of future infective materials. Thus only sheep 5 to 8 were
sacrificed. The flukes recovery rate (Table 4.1) ranged from 73% to 33%. A small
number of flukes in sheep 5 were still in the liver parenchyma the majority however
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Figure 4.1: Liveweight (a) Nematodes EPG (b) and F. hepatica faecal
EPG (c) Counts of sheep 5, 6 and 7 infected with 300 metacercariae,




Table 4.1: Experiment 1: Parasitological details of sheep infected with F. hepatica







5 British strain 300 t 75 33
6 300 11 Ln O un O
7 300 10 172 73
8 Uninfected 0 - -
9 Peruvian strain 200 10 ND
10 200 12 ND
t = Died before patency
ND = Fluke Egg donors, not culled
Pathology
Lesions attributed to F. hepatica were wide-spread in sheep 5 and 6. The
carcasses of these sheep exhibited pale membranes and loss of condition. The
peritoneal cavity of the infected animals (Sheep 5, 6 and 7) had large amounts of
serous fluid and the abdominal organs were adhered to the wall cavity (fibrinous
peritonitis). The livers of infected sheep were enlarged with the major bile ducts
extended. The left lobe was seriously affected leading to the development of
abscesses (Figures.4.2). The hepatic lymph nodes were also enlarged.
Pathohistology revealed a mild mononuclear cell infiltration (lymphocytes, plasma
cells and macrophages). There was also necrosis and deposition of pigment
substances as shown in Figure 4.3.
118
Chapter Four: Results
Figure 4.2: Liver of sheep 8 uninfected control (top left): Liver from sheep 7
infected with 300 metacercariae (top right) showing oedema of the
entire liver, enlargement of gall bladder and distended bile ducts and
liver (bottom) from sheep 6 also infected with 300 metacercariae










Figure 4.3: Photomicrographs of sections liver of sheep 5 infected with 300
metacercariae and died in 11 wpi. (top) showing severe necrosis of
hepatocytes (H&E stained) and bottom a section from sheep 7 showing




The sheep infected with 300 metacercariae exhibited anaemia, a reduction in
values for red blood cell (RBC) counts, PCVs and haemoglobin concentration (Hb)
compared to the uninfected controls while the two sheep infected with 200
metacercariae only showed reduced (RBCs). The values started a progressive decline
by 5-7 wpi. (Figures 4.4a-c and Appendix Tables 4.2). mean corpuscular volume
(MCV) and mean corpuscular haemoglobin (MCH) values indicated a clear
increment in sheep 9 and 10 with a slight increment in sheep 6 and there was little
changes in mean corpuscular haemoglobin concentration (MCHC) values (Figures
4.5a-c and Appendix Table 4.3) as a result of infection.
The total WBC and Eosinophil Counts increased in second wpi. and remained
higher than the uninfected control (sheep 8) throughout the experiment. The
differential white blood cell counts also a slight increase in neutrophils (Figures 4.6a-
c) in infected sheep but the rest of the leukocytes (Lymphocytes, Monocytes and
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Figure 4.4: Haemoglobin (a) Packed Cell Volume (b) and Red blood
cell (c) of 5, 6 and 7 sheep infected with 300 metacercariae, sheep 9 and






—X—SH. 5 —SH. 6 —•—SH. 7 -n-SH. 8 -»-Sh9 -A-sh.10
Figure 4.5: Mean Corpuscular Volume (MCV) (a), Mean Corpuscular
Heamoglobin (MCH) (b) and Mean Corpuscular Heamoglobin
Concentration (MCHC) (c) of sheep 5, 6 and 7 infected with 300
metacercariae sheep 9 and 10 infected with 200 metacercariae and as
uninfected control sheep 8.
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Figure 4.6: White blood cell counts (a), Eosinophil counts (b) and
neutrophils counts (c) (xl()9/l) of sheep, 5, 6 and 7 infected with 300
metacercariae, sheep 9 and 10 infected wtih 200 metacercariae and




A reduction in albumin values was first noted 9-10 wpi. The serum albumin
levels reduction was more severe in the more heavily infected sheep. There was no
marked changes in the total protein levels until 8-9 wpi. when the values in sheep 5,
6, and 7 increased before decreasing by 10-11 wpi. The values in sheep 9 and 10
also decreased by 14 wpi., however the reduction was slower than in other three
infected animals (Figure 4.7) and appendix table 4.7).
The values in uninfected control, sheep 6, remained consistently low
throughout the experiment. The serum GLDH levels in infected sheep rose sharply
by 3 wpi. with sheep 6 and 7 activities peaking by 4 wpi. Sheep 7 remained high up
to 9 wpi. Interestingly sheep 5 which died 11 wpi. had GLDH levels similar to sheep
9 and 10 (Figure 4.8a and Appendix table 4.7).
There was a small rise in serum y-GT activities in infected sheep from 3-6
wpi. in sheep 5 and 6 while sheep 7, 9 and 10 values rose by 9-10 wpi. These
activities reached the peak by week 12-14 of infection (Figure 4.8a-b. and Appendix
Table 4.7). The y-GT levels in all infected animals declined by 17 wpi.
There was little difference in glucose and P-Hydroxybutyrate levels between
sheep infected with 200 cysts and the uninfected control, however glucose levels fell
in sheep infected with 300 metacercariae significantly (P<0.05, Mann-Whitney test)
from 6 wpi. Serum p-Hydroxybutyrate levels were elevated significantly (P<0.05) in
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Figure 4.7: Albumin (a) and Total Protein estimates (b) of sheep 5, '6
and 7 infected with 300 metacercariae, sheep 9 and 10 infected with
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Figure 4.8: Glutamate Dehydrogenase (GLDH) (a) and Gamma
Glutamyltransferase (y-GT) (b) estimates of sheep 5, 6 and 7 infected
with 300 metacercariae, sheep 9 and 10 with 200 metacercariae, and
uninfected control sheep 8 .
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Figure 4.9: Glucose (a) and b-Hydroxyl-Butyrate (b) estimates of sheep
5, 6 and 7 infected with 300 metacercariae, 2 (9 and 10) sheep infected
with 200 metacercariae and uninfected control sheep 8.
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4.1.2 Experiment 2: F. hepatica (British strain) infection in sheep
This experiment was conducted by Mahato (1994). The monitoring included
haematology clinical, biochemistry (excluding glucose and P-Hydroxybutyrate ) and
pathology.
Clinical Findings
All the sheep were clinically normal until 10 wpi. when sheep 26 (given 350
metacercariae) showed loss of appetite. None of the other sheep showed clinical
signs (Mahato, 1993).
Live Weight
The infected sheep lost weight between 8 and 11 wpi. and grew at a slower
rate thereafter. However the infected sheep gained weight over the experimental
period, although less than the uninfected control sheep (Mahato, 1993).
Parasitology
The recovery of flukes from F. hepatica infected sheep ranged from 51.3-
70.6% (Table 4.2). All of them were adults when recovered from the livers of
infected sheep at 20 wpi., except for sheep 26 in which a few flukes were still
migrating in the liver parenchyma (Mahato, 1993).
Table 4.2: Experiment 2: Some parasitological details of sheep infected with F.
hepatica (British strains) (From Mahato, 1993).
Procedure Sheep Prepatent Fluke Recovered
No. (Weeks) Numbers %
Infected with 150 24 10 77 51.3
metacercariae 28 10 95 63.3
Infected with 26 12 247 70.6
350 metacercariae 30 10 203 58.0
Uninfected 22 - - -




The remaining sheep showed typical lesions of chronic fasciolosis with
enlarged livers and bile ducts distended with flukes (Mahato, 1993).
Haematology
The infected sheep exhibited a reduction in RBCs counts, PCVs and
Haemoglobin values compared to the uninfected controls. There were no changes in
MCHC values as a result of infection
The total WBC and Eosinophil Counts increased in second wpi. and remained
higher than the uninfected control (sheep 22 and 32) throughout the experiment
(Mahato, 1993).
Clinical Biochemistry
The serum albumin and total protein were carried out by Mahato, 1993.
The values of GLDH in uninfected control, sheep 22 and 32, remained
consistently low throughout the experiment. The serum GLDH levels in infected
sheep rose sharply by 2 wpi. peaking by 3-4 wpi. for sheep 26 and 30, 10 wpi. for
sheep 24 and 9 wpi. for sheep 28 (Mahato, 1993).
Although there was a transient rise in serum Gamma Glutamyltransferase (y-
GT) levels in infected sheep, this was not pronounced until 8-10 wpi. (Data not
shown).
Slight changes were observed in serum Glucose and P-Hydroxybutyrate
levels in sheep infected with F. hepatica. Infected sheep had slight reduction in
serum Glucose levels from about 5 wpi. The serum P-Hydroxybutyrate
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measurements were erratic however there was a clear increase in p-Hydroxybutyrate
levels between 9 and 12 wpi. in sheep 24, 26, and 28 as shown in (figure 4.10).
Details are in appendix table 4.9.
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Figure 4.10: Glucose (a) and |3-Hydroxyl-Butyrate (b) values in sheep
24, 26, 28 and 30 infected with F. hepatica and uninfected
controls sheep 22 and 32 .
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4.1.3 Experiment 3: F. gigantica (Kenyan strain) infection in sheep
Clinical Findings
All the nine sheep (Table 4.3) in this group were clinically normal until 13
wpi. when sheep 13 lost appetite, was anaemic and developed a temperature. The
condition of this sheep did not improve and it was culled at 15 wpi. The condition of
sheep 11 and 15 was considered poor from 6-7 wpi. but they recovered before the
end of the experiment. Sheep 14 and 12 were least affected. The uninfected control
sheep showed no clinical abnormalities.
Live Weight
A slight depression in mean live weight gain in infected sheep was first noted
5 wpi. but the condition improved by 12 wpi. This continued with minor fluctuations
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Figure 4.1 : Mean ±SEM Liveweight (a) and faecal egg counts (b) values of five





The sheep were dewormed at week -3 of the experiment and cleared of
nematode infection. Patency was reached by 13-18 wpi. (Table 4.3) but sheep 13
however was culled before reaching patency and sheep 11 with the lightest fluke
burden was the latest (18 wpi.) to shed parasite eggs and had the lowest peak EPG
(Appendix Table 4.10).
Table 4.3: Some parasitological details of sheep infected with 100 metacercariae of
F. gigantica (Kenyan strains)
Experiment Sheep Prepatent Period Flukes Recovered
4 No. Weeks Post Infection Post Number %
Infected 11 18 34 34
12 15 50 50
13 culled before patency 45 45
14 14 58 58
15 13 76 76
Uninfected 16 - - -
control 17 - - -
18 - - -
19 - - -
Pathology
Lesions attributed to fasciolosis were most severe in sheep 12 and 13. The
carcasses of these sheep exhibited pallor and emaciation. The peritoneal cavity of the
infected Sheep 11 and 13 had large amounts of serous fluid. Sheep 15 organs were
adhered to the abdominal wall displaying a classical fibrinous peritonitis (Figure
4.12). In sheep 12 the internal organs including the liver showed signs of adhesive
peritonitis and liver fluke in the main bile duct (Figure 4.13). All the livers of
infected sheep were enlarged with major bile ducts extended and hyperplastic lymph
nodes. In sheep 11 the liver developed abscesses (Figure 4.14). The hepatic lymph
nodes were also enlarged.
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Pathohistology examination revealed a mononuclear cell infiltration as shown
in Figure 4.16 (lymphocytes, plasma cells and macrophages). There was also
infiltration of pigmentation in the liver parenchyma as shown in Figure 4.16. There
was necrosis as shown in Figure 4.16 in a section through a minor bileduct of the
liver from sheep 13 with a parasite eggs in it.
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Figure 4.12: The internal organs with signs of adhesions (arrows) (top)




Figure 4.14: The infected liver with abscesses and necrosis on the surface (arrows).
Figure 4.15: Photomicrographs of the sections of liver from infected sheep 13:




' U'' ' Iff ' f( i W '
- ■ y I ■' f-Ui t I 'H 7 * ' kV. <; <f' fit f •'
. I u i f < A i | t ' 4 ,i v <' '
/ - ,/i j' J - I .*/.
. If £ if *
> \ if ; -v. -m ■ \ fy 'i-.v™ r\ £ " ■
< wv <v . y t i ? .#•'/ / • s «gM
'/' h, *>/> ' ' / n
'
. S • #, <}; •* 4 ''
f /■' , * -> ! £lf; ,
Figure 4.16: Photomicrographs of the sections of liver from infected sheep: showing
large parenchyma necrosis with mass inflammatory cells infiltration
(H&E stained x260 magnification) and bottom a section from sheep 15




As judged by the RBC counts, Hb levels and PVC levels infected sheep
developed an anaemia from 11 wpi. onwards. There was some variation between
animals in the extent of the anaemia that developed but this did not relate to the
parasite burden (Figure 4.17a-c and Appendix 4.12-14) for example sheep 11 with
the lightest parasite burden had the greatest reduction in PVC.
The mean MCV and MCH values were elevated in the infected sheep but
MCHC was apparently not affected (Figure 4.18 and Appendix table 4.4.15-17), this
suggests that the animals developed normocytic normochromic anaemia.
The mean total white blood cell and eosinophil counts rose 2 wpi. and
remaining higher throughout the experiment (Figure 4.19a-b). Mann-Whitney test
confirmed that there already was significance (p < 0.01) in eosinophil response 2
wpi. between infected sheep and uninfected sheep. Although there was a slight
increase in neutrophils (Figure 4.19c.) in infected sheep the rest of the leukocytes
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Figure 4.17: Mean ±SEM Red Blood Cells (a), Haemoglobin (b) and Packed Cell
Volume (c) values of five sheep infected with 100 F. gigantica metacercariae (Kenyan
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Figure 4.18: Mean + SEM Mean Capscular Volume (MCV) (a), Mean
Capscular Haemoglobin (MCH) (b) and Mean Capscular Haemoglobin
concentration (MCHC) (c) of five Sheep infected with 100 F. gigantica
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Figure 4.19: Mean +SEMWhite Blood Cells (a), Eosinophils (b) and Neutrophils (c)
values of five sheep infected with 100 F. gigantica metacercariae (Kenyan strain) and




The serum total protein and albumin values are presented in Appendix Tables
4.25 & 4.26 and Figures 4.20a & b respectively. A reduction in mean serum albumin
in infected animals was first observed by 4 wpi. but became marked by 11 wpi. There
was a slight decrease in mean serum total protein levels in infected animals by 4 wpi.
and became marked by 11 wpi. The mean serum protein levels in these infected
sheep started to decline sharply by 17 wpi. reaching the minimum by 24 wpi.
A rise in mean serum GLDH activity levels in infected sheep was first noted
at +2 wpi. peaking at 5 wpi. and remaining elevated until the end of the experiment.
Mann-Whitney test confirmed this significant increse (p < 0.05) in serum GLDH
activities by 2 wpi. in infected sheep compared to uninfected control sheep.
There was a slight transient rise in mean serum y-GT activities in infected
sheep from 5-8 wpi. The y-GT levels peaked at 11-14 wpi. before declining slowly
thereafter, and reaching the levels of uninfected control sheep by end of the
experiment. In contrast to GLDH activities Mann-Whitney test showed that y-GT
activities were significant (p < 0.05) 2 wpi. in infected sheep compared to uninfected
control sheep (Figure 4.21 and Appendix tables 4.27 & 4.28).
A reduction in glucose levels in infected sheep was apparent from 6-13 wpi.
i.e. around the time of patancy but the levels became closer to normal sheep by 15
wpi. onwards. Mann-Whitney test confirmed that there was significant difference (p
< 0.05) in glucose levels between 8 and 11 wpi. between infected sheep and
uninfected sheep. The serum P-Hydroxybutyrate levels were elevated in infected
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sheep from 7-17 weeks i.e. again around the time of patency (Figure 4.22 and
appendix table 4.29 & 4.30). There was significant difference (p < 0.05) p-
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Figure 4.20: Mean ±SEM Albumin (a) and Total Protein (b) values of five sheep
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Figure 4.21: Mean ±SEM Glutamate Dehydrogenase (GLDH) (a) and Gamma
Glutamyltranferase (y-GT) (b) values of five sheep infected with 100 F. gigantica
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Figure 4.22: Mean ±SEM Glucose (a) and P-Hydroxybutyrate (b) values of five




4.1.4 Experiment 4: F. Gigantica (Kenyan strain) infection in sheep
This experimental group were monitored by Mahato (1993). The monitoring
included haematology, clinical biochemistry (excluding glucose and (3-
Hydroxybutyrate) and pathology.
Clinical Findings
All the sheep were clinically normal until 11 wpi. Thereafter, sheep 23, 27
(given 150 metacercariae) and sheep 25 (given 350 metacercariae) had loss of
appetite, abdominal distension and showed signs of anaemia. Sheep 23 died 14 wpi.
and sheep 25 was culled 15 wpi. (Mahato, 1993).
Live weight
The infected sheep lost weight between 8 and 11 wpi. and grew at a slower
rate thereafter. However the infected sheep gained weight over the experimental
period, although less than the uninfected control sheep, except for sheep 27 (given
150 metacercariae) which lost 2.5 Kg (Mahato, 1993).
Parasitology
The recovery of flukes from F. gigantica infected sheep ranged from 9.7-
55.3%, the lowest percentage being recovery from sheep 29 which had been given a
higher infective dose of 350 metacercariae (Table 4.4). In sheep 23 and 25, more
than 60% of the flukes were recovered from the liver parenchyma. Some ectopic
flukes from sheep 25; 4 from the peritoneal cavity, 3 from the intestinal wall and 1
from the lungs were also recovered. In sheep 27 which was slaughtered at 2014 wpi.,
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about 90% of the flukes were found in the bile ducts while 10% were still in the liver
parenchyma. All the flukes recovered from sheep 29 were adults and located in the
bile ducts. No flukes were recovered from the livers of any uninfected controls
(Mahato, 1993).
Table 4.4: Experiment 4: Some parasitological details of sheep infected with F.
gigantica (Kenyan strain) (Mahato, 1993).
Procedure Sheep Prepatent Flukes
No. (Weeks) Number %
Infected with 1500 23 13 80 53.3
metacercariae 25 13 83 55.3
Infected with 27 14 181 51.7
350 metacercariae 29 13 34 9.7
Uninfected 21 - - -
control 31 - - -
Pathological Findings
Lesions were widespread in sheep 23 and 25. The carcasses of these sheep
were pale; the peritoneal cavity contained large quantities of blood-stained fluid and
blood clots; the small and large intestines were filled with blood. The livers were
enlarged with prominent haemorragic tracts and with areas of fibrinous peritonitis on
the surface. The gall bladders were enlarged and filled with clotted blood. The liver
of sheep 23 was pale in colour than that of sheep 25 and there was a large blood clot
between the liver capsule and the parenchyma. The lungs of sheep 25 showed large
areas of congestion, these areas contained typical haemorragic tracts due to a
migrating fluke which was found in the subpleura, also subpleural oedema was
prominent.
The remaining sheep showed typical lesions of chronic fasciolosis with




As judged by the RBC counts, Hb levels and PVC levels infected sheep
developed an anaemia from 5-7 wpi. onwards. There was some variation between
animals in the extend of the anaemia that developed but this did not relate to the
parasite burden.
The mean MCV and MCH values were elevated in the infected sheep but
MCHC was apparently not affected and this suggests that the animals developed
normocytic normochromic anaemia.
The mean total white blood cell and eosinophil counts rose 2 wpi. and
remaining higher throughout the experiment. Although there was a slight increase in
infected sheep the rest of the leukocytes counts (lymphocytes, monocytes and
basophils) were not elevated (Mahato, 1993).
Clinical Biochemistry
The serum albumin and total protein were done by Mahato, 1993. The values
in uninfected control, sheep 21 and 31, remained consistently low throughout the
experiment. The serum GLDH levels in infected sheep rose sharply by 2 wpi.
peaking by 3-4 wpi. (Mahato, 1993).
Although there was a transient rise in serum Gamma Glutamyltransferase (y-
GT) levels in infected sheep, This was not pronounced until 11-12 wpi. (Mahato,
1993).
Slight changes were observed in serum glucose and (3-Hydroxyl-butyrate
levels in sheep infected with F. gigantica. Infected sheep had slight reduction in
serum glucose levels from about 10 wpi. (Figure 4.23). There was an increase in P-
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Hydroxyl-Butyrate levels however with a lot of variation within the infected sheep
(Figure 4.23). Details are in appendix 4.31.
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Figure 4.23: Glucose (a) and b-Hydroxyl-Butyrate (b) values in
sheep 23, 25, 27 and 31 infected with F. gigantica and uninfected
controls sheep 21 and 31.
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4.1.5 Experiment 5: F. hepatica (Peruvian strains) infection in Cattle
Clinical Findings
Infected cattle displayed few clinical symptoms of fasciolosis. Calf 15 did
show a mild loss of condition after challenge infection and calf 34c developed
diarrhoea at 8 wpi. This diarrhoea seen in calf 34c lasted for two days and was not
attributed to fasciolosis (Table 4.5).
Parasitology
Infected calves reached patency 8-11 wpi following primary infection
(Figure.4.24). The EPG of infected and challenged calf 15c dropped to 0 by 8 weeks
post challenge infection while eggs could still be detected in the faeces of the other
infected calves. The fluke recoveries were very low (Table.4.5) with calves 14c with
only primary infection and culled 38 wpi having the lowest flukes. The fluke
recoveries in the challenge control calves 34c and 45c, were rather low at <7%.
Table 4.5: Experiment 5: Some parasitological details of calves infected with
metacercariae ofF. hepatica (Peruvian strain)
Procedure Calf Number of metacercariae Prepatent Flukes recoveries
administered at week No. Period
No. -25 -15 0 (Weeks) No %
Infection 14c 200 - - 9 3 (2 dead) 1.5
Infection & challenge 15c 200 100 - 11 7 2.3
Infection & challenge 23c - 600 100 9 15 2.1
Challenge control 34c - - 450 8 20 4.4
Challenge control 45c - - 450 8 30 6.7




—■— 14C —15C —•—23C -a—26C —A—34C -*— 45C
Figure 4.24: Eggs per gram (EPG) values in calves 14c, 34c and 45c with single F.
hepatica (Peruvian strain) infection, calves 15c and 23c with challenge infection and
calf26c uninfected control.




In all infected calves lesions were restricted to the livers. There was very
little difference in appearance between calf 14c liver with a single infection and the
uninfected calf 26c liver. This was consistent with light infection of calf 14c and the
fact that post-mortem was done 38 wpi when the liver had almost fully regenerated.
The liver of infected and challenged calf 23c on the other hand showed most severe
congestion and calcification (Figure 4.25,). This is consistent with this calf having
received the highest infection dose and challenge infection only 13 wpi before post¬
mortem.
After histology examination the sections from the challenge and infected
calves 15c and 23c showed severe calcium deposits extending into the parenchyma.
The sections from calf 15c also revealed strong fibrosis (Figure 4.26). Bile duct
thickening and fluke eggs were most apparent in calf 23c (Figure 4.27). There was
mononuclear cell infiltration (lymphocytes, plasma cells and macrophages) in the
livers of infection and challenge calves 15c and 23c and challenge control calves 34c
and 45c. This again is consistent with these calves having received light infection.
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Figure 4.25: Photomicrograph of the section of liver from infected calf 23c: showing
large calcification deposits in the bile duct (Arrow) (H&E stained x52
magnification)
Figure 4.26: Photomicrograph of the section of liver from infected calf 15c: showing
extensive fibrosis (Arrow) (H&E stained x52 magnification)
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Figure 4.27: Photomicrographs of sections liver of calf 23c showing trapped fluke
egg in the small bile ducts and severe necrosis with inflammatory
cells infiltration (arrow) (H&E stained, x52 magnification) above, at
the bottom is section of calf 23c liver showing trapped eggs in bile duct




Generally haematological evidence from the infected calves was consistent
with light chronic infection . Calf 23c had a transient reduced packed cell volume
(Figure 4.28) and also a decreased haemoglobin (Figure 4.28). There was no changes
in MCV, MCH or values in any of the infected calves. (Figure 4.29 and Appendix
Table 4.32 & 4.34).
White blood cell counts were very variable in infected calves but remained
above that of the uninfected control calf 26c. Eosinophil values were highest in
infected and challenged calf 23c (Figure 4.30. and Appendix Tables 4.35-4.37).
Clinical Biochemistry
The serum total protein and albumin values are presented in Appendix Table
4.38 and Figures 4.31 There was no apparent change in serum total protein and
albumin values of all the animals.
The serum GLDH values in uninfected control calf 26 remained consistently
low throughout the experiment (Figure 4.32a). However values of GLDH of infected
cattle rose sharply by 2 wpi. peaking at 7 wpi. with values falling thereafter and
reaching normal. There was a steady rise in serum Gamma Glutamyltransferase (y-
GT) activities in infected calves from 4 wpi., this reached the peak by 11 wpi. and
fell thereafter to reach almost that of uninfected control calf by 21 wpi. (Figure
4.32b. and Appendix Table 4.4.39).
There was also no change in serum Glucose and P-Hydroxyl-Butyrate levels.
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Figure 4.28: Pact Cell Volume (a) Haemoglobin (b) and red blood cell counts (c)
in calves 14c, 34c and 45c with single F. hepatica (peruvian strain) infection,
calves 15c and 23c with challenge infection and calf 26c uninfected control.
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Figure 4.29: Mean Corpuscular Volume (MCV) (a) Mean Corpuscular
Haemoglobin (MCH) (b) and Mean Corpuscular Haemoglobin Concentration
(MCHC) (c) in calves 14c, 34c and 45c withsingle F. hepatica (peruvian strain)
infection, calves 15c and 23c with challenge infection and uninfected control calf 26
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Figure 4.30: White Blood Cells (a) and Eosinophil counts (b) in Calves 14c, 34c
and 45c with single F. hepatica (peruvian strain) infection Calves 15c and 23c
with challenge infection and Calf 26c uninfected control.
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Figure 4.31: Albumin (a) and total Protein (b) values in calvesl4c, 34c and 45c
with single F. hepatica (peruvian strain) infection, calves 15c and 23c with challengi
infection and calf 26c as uninfected control
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Figure 4.32: Glutamate dehydrogenase (GLDH) (a) and Gamma
Glutamyltransferase (y-GT) (b) values in calves 14c, 34cand 45c with single
F. hepatica (peruvian strain) infection Calves 15c and 23c with challenge
infection and Calf 26c uninfected control
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Figure 4.33: Glucose (a) and b-Hydroxyl-Butyrate (b) values in calves 14c, 34c
and 45c with single F. hepatica (peruvian strain) infection calves 15c and 23c with
challenge infection and uninfected control calf 26c
Primary infection Challenge infection
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4.1.6 Experiment 6: F. Gigantica (Kenyan strain) infection in Cattle
The general monitoring including clinical examination, parasitology and
pathology, of this group was carried out by Nyanzunda (1993).
Parasitology
As judged by faecal egg counts, none of the cattle were infected with
nematodes at any point in the monitoring period. Infected calves reached patency 14
wpi. (Table 4.6). The fluke recoveries were very low (Table.4.7) with calf 24 having
the lowest. The fluke recoveries in all the infected calves were rather low at <8%.
Table 4.6: Experiment 6: Faecal egg count details of calves infected with 400 F.
gigantica (Kenyan strain) from Nyanzunda (1993).
Weeks Post Infection Calf 22 Calf 23 Calf 24 Calf 26
10 0 0 0 0
11 0 0 0 0
12 0 0 0 0
13 0 0 0 0
14 6 7 5 0
17 6 37 10 0
24 8 29 13 0
Table 4.7: Experiment 6: Some parasitological details of Calves infected with 400
F. gigantica (Kenyan strain) from Nyanzunda (1993).
Procedure Calf Prepatency Flukes
No. (Weeks) No %
Infection 22 9 30 7.5
23 11 31 7.75
24 9 10 2.5




No abnormalities in the size or consistency of the 3 calves' livers were
observed. Major lesions were in the biliary system. The bile ducts were thickened
and the epithelium of the common bileduct and gall bladder showed areas of
haemorrhage and inflammation. The hepatic lymph nodes were hypertrophied.
Upon subjective comparison of the extent of the lesions calf 23 had most
pathological changes followed by calf 22 and calf 24 had the least pathological
changes. This is consistent with the fluke recoveries, calf 23 had the highest fluke
burden and calf 24 had the least as shown in section.
Haematology
Very few haematological factors were evident in the infected cattle, which
was consistent with a mild chronic F. gigantica infection. Although there was no
change in RBC and PVC levels (Figure 4.34), there was a noticeable drop in
haemoglobin levels 7-18 wpi. (Figure 4.35a). There were no apparent changes in
MCV, MCH or MCHC (Figure 4.35c & 36).
Although the results were very mild, there was a clear rise in WBC and
eosinophil counts in the infected cattle. Although lymphocyte count in the infected
cattle was raised (Figure 4.37) there were no apparent changes in any other cells in




There was no severe change in serum total protein and albumin values of all
the animals. The results of Glucose and (3-Hydroxybutyrate are shown in Appendix
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■Calf 22
Weeks post Infection
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Figure 4.34: Red Blood Cell Counts (a) and Packed Cell Volume (b) of calves 22. 23
and 24 infected with 400 F. gigantica metacercariae (Kenyan strain)
and uninfected control calf 26.
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Figure 4.35: Haemoglobin (a) and MCV (b) of calves 22, 23 and 24
infected with 400 F. gigantica metacercariae (Kenyan strain) and
uninfected control calf 26.
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Weeks post infection
•Calf 22 Calf 23 Calf 24 -<>-Calf26
Figure 4.36: MCH (a) and MCHC (b) of calves 22, 23 and 24 infected
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Figure 4.37: White Blood Cell Counts (a)and Eosinophils Counts (b) and
Lymphocytes (c)Counts (x 109/1) of calves 22, 23 and 24 infected with 400
F. gigantica metacercariae (Kenyan strain) and uninfected control calf 26.
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0 3 6 9 12 15 18 21 24 27 30 33
Weeks Post Infection
-■-22 —•—23 —•— 24 -<>-26
Figure 4.38: Glucose (a) and b-Hydroxyl-Butyrate (b) of calves 22,
23 and 24 infected with 400 F. gigantica metacercariae (Kenyan strain)
and uninfected control calf 26.
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4.2 Serum Antibody responses of sheep and cattle to
Excretory/Secretory products of Fasciola spp
4.2.1 Determination ofOptimum Assay Conditions by Titration
The optimum assay conditions i.e. those which optimised the signal to the
background ratios, were determined by titration of antigen i.e. either F. hepatica (Fh-
E/S) or F. gigantica (Fg-E/S) E/S products), serum and conjugate for the polyclonal
detection system or antigen (Fh-E/S or Fg-E/S), serum, monoclonal antibody and
conjugate for the monoclonal antibody based detection systems. Figures 4.39-4.46
show the titration's for total Ig and IgGj in both F. hepatica and F. gigantica infected
sheep and cattle representing the polyclonal total Ig and the monoclonal antibody
(IgG,) based detection systems.
Chequerboard titration for serum, monoclonal antibodies and conjugate were
carried out by diluting these systems in blocking buffer using doubling serial dilution
ranging from 20-0.313 pg/ml (antigen), 1:50-1:1600 (serum), 1:20-1:320
(monoclonal antibody) and 1:1000-1:32,000 (conjugate). Titrations were run in
duplicate and the mean values calculated. The chosen antigen concentration, serum,
monoclonal antibody and conjugate dilution were used in all subsequent sequential
screenings. The two positive sera PI and P2 were taken from F. hepatica or F.
gigantica infected animals and corresponded to 8, 9 or 10 wpi (PI) and 21, 22 or 23
wpi (P2) for sheep and 7 wpi (PI) and 32 wpi (P2) for calves. These times post
infection were chosen to assess responses at the middle and at the end of the
experimental period. The selected concentrations for all the assays, total Ig, IgGj,
IgG2, IgM and IgA for sheep and cattle are in Table 4.8-4.10. See Appendix Table
4.46-4.55 for full details.
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Table 4.8: Sheep infected with either F. hepatica or F. gigantica: Optimal dilution
of antigen (//g/ml), serum and conjugate for polyclonal antibody system
using Excretory/Secretory products from F. hepatica and F. gigantica as
antigen (Fh-E/S and Fg-E/S)











Table 4.9 Sheep infected with F. hepatica or F. gigantica: optimal dilution of
antigen (jug/ml), serum, monoclonal antibody (McAb)and conjugate for
monoclonal antibody system using excretory/secretory products from F.
hepatica and F. gigantica as antigen (Fh-E/S and Fg-E/S)
Assay F. hepatica F. gigantica
Fh-E/S Serum McAb Conj.
(pg/ml)





1.25 1:400 1:40 1:4000
5 1:50 1:20 1:1000
5 1:50 1:20 1:1000
1.25 200 1:40 1:4000
5 1:50 1:20 1:1000
5 1:50 1:20 1:1000
Table 4.10: Cattle infected with F. hepatica or F. gigantica: Optimal dilution of
antigen (//g/ml), serum and conjugate for polyclonal antibody detection
systems using Excretory/Secretory products from F. hepatica and F.
gigantica (Fh-E/S and Fg-E/S) as antigen.
Assay F. hepatica F. gigantica
Fh-E/S Serum Conj. Fg-E/S Serum Conj.
(pg/ml) (pg/ml)
Total Ig 1.25 1:200 1:4000 1.25 1:200 1:4000
IgG, 1.25 1:200 1:4000 1.25 1:200 1:4000
IgM 2.5 1:200 1:2000 2.5 1:200 1:4000
IgG2 2.5 1:50 1:1000 2.5 1:50 1:1000
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1000 2000 4000 8000 16000 32000
Reciprocal conjugate serial dilution
□ B BN BP1 IP2
Figure 4.39: Antigen (Fh-E/S) (a), serum (b), and conjugate (c)
titrations for total Ig for F. hepatica infected and uninfected control
sheep showing the mean ELISA OD (450 nm) values obtained for
diluent (B) negative (N) positive (PI) and positive (P2)
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Reciprocal conjugate serial dilution
■N ■ PI
32000
□ B B BP2
Figure 4.40: Antigen (Fg-E/S) (a), serum (b), and conjugate (c)
total Ig for F. gigantica infected and uninfected control sheep showing
titrations for the mean ELISA OD (450 nm) values obtained for
diluent (B), negative (N), positive (PI) and positive (P2)
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1000 2000 4000 8000 16000 32000
Reciprocal conjugate serial dilution
□ B BN BP 1 BP 2
Figure 4.41: Antigen (Fh-E/S) (a), serum (b), monoclonal (c) and
conjugate (d) titrations for IgGj for F. hepatica infected and uninfected
control sheep showing the mean ELISA (450 nm) values obtained for
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Figure 4.42: Antigen (Fg-E/S) (a), serum (b), monoclonal (c) and
conjugate (d) titrations for IgG] for F. gigantica infected and uninfected
control sheep showing the mean ELISA (450 nm) values obtained for
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Figure 4.43: Antigen (Fh-E/S) (a), serum (b), and conjugate (c) titrations
for total Ig for F. hepatica infected calves and uninfected control calves
showing the mean ELISA (450nm) values obtained for diluent (B),
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Figure 4.44: Antigen (Fg-E/S) (a), serum (b), and conjugate (c) titrations
for total Ig for F. gigantica infected calves and uninfected control calves
showing the mean ELISA (450 nmjvalues obtained for diluent (B),
negative (N), positive (PI) and positive (P2)
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Reciprocal conjugate serial dilutions
□ B BIN BP1 BP 2
Figure 4.45 Antigen (Fh-E/S) (a), serum (b), and conjugate (c)
titrations for IgGj for F. hepatica infected calves and uninfected control
calves showing the mean ELISA (450 nm) values obtained for diluent (B),
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Figure 4.46: Antigen (Fg-E/S) (a), serum (b), and conjugate (c)
titrations for IgG, for F. gigantica infected calves and uninfected
control calves showing the mean ELISA (450 nm) values obtained for
diluent (B), negative (N), positive (PI) and positive (P2)
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4.2.2 Experiment 1: F. hepatica (Peruvian and British strain) Infection in
Sheep
Following primary infection, total Ig, IgGl5 IgM, IgG2 and IgA antibody
responses to Fh-E/S were easily detected in the infected sheep but IgG2 responses
were relatively poor hence the Y-axis scale is different from the rest of the figures
(Figures 4.47a-4.48b)
All the infected sheep showed an increase in total Ig levels from 2 week post
infection (wpi.) and peak OD values in sheep 9 and 10 were obtained at 10 wpi.
These levels were high throughout experimental period. However the antibody
response by sheep 5 began to fall by 10 wpi. and it died at 12 wpi.
IgG, isotype responses to Fh-E/S were strongest in sheep 9 and 10 from 1-17
wpi. The IgG! antibody response was first detected in the rest of the infected sheep
+2 wpi. (Figures 4.47b). IgM levels were clearly noticeable in all the infected sheep.
Responses were recorded from 2 wpi. peaking 6 wpi. but declining by 14 wpi. One
of the F. hepatica infected sheep (7) showed low IgM responses than the rest of
infected in this group (Figures 4.47c). IgG2 levels in infected sheep particularly in
sheep 6 and 7 infected with 300 F. hepatica metacercariae were clearly higher than
the uninfected control (Figures 4.48a). IgA response to Fh-E/S appeared biphasic a
sharp increase in IgA response to Fh-E/S was noticed in all the F. hepatica infected
sheep by +2 wpi. dropping by +4 wpi. IgA levels started to rise very slightly in all
the infected sheep 14 wpi., this was however less so in sheep 10 (Figures 4.48b). The












-2-10 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Weeks Post Infection
■ SH5 —♦— SH6 —•- SH7 -O— SH8 —A— SH9 —X— SH10
Figure 4.47: The adjusted ELISA OD (450 nm) for total Ig (a), IgGl (b)
of F. hepatica infected and IgM (c) responses sheep (5, 6, 7, 9 and 10)





—■— SH5 —SH6 —SH7 —O— SH8 —A— SH9 —X— SH10
Figure 4.48: The adjusted ELISA OD (450 nm) values of IgG2 (a) and
IgA (b) responses of F. hepatica infected sheep (5, 6, 7, 9 and 10) and
uninfected control sheep (8) to FhESP
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4.2.3 Experiment 2: F. hepatica (British strain) Infection in Sheep
These sheep developed more pronounced antibody response than those in
experiment 1 (Figures 49a-50b). The adjusted data for each sheep are presented in
Appendix Tables 4.59-61.
Antibody to Fh-E/S were easily detected in F. hepatica infected sheep. The
total Ig IgG, and IgM responses were more pronounced while IgG2 and IgA were the
lowest.
The infected sheep showed increased total Ig levels +4 wpi. peaking at 10-15
wpi. Although the levels remained high throughout the experiment there was a clear
reduction in response by +22 wpi. (Figure 4.49a). IgG, isotype responses were first
detected by +6 wpi. peaking at 12-16 wpi. and remained high up to the end of
experiment (Figure 4.49b). IgM responses were first detected by +2 wpi. peaking at
4-8 wpi., showing a progressive decrease thereafter. (Figure 4.49c).
IgG2 levels increased sharply starting from 2 wpi. Sheep 24 showed the
strongest response peaking at 8 wpi. (Figure 4.50a) and decrease by 11-12 wpi.
Apart from Sheep 24 IgG2 levels in infected sheep remained slightly above
uninfected animals up to 22 wpi.
A sharp increase in IgA response to Fh-E/S was noticed in all the F. hepatica
infected animals. IgA showed a clear biphasic response at +2-8 wpi. and 16-22 wpi.
As with the previous experiment the second phase was very short so that by the end
of the experiment (22 wpi.) the ODs had reduced to just above those of the
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Weeks Post Infection
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Figure 4.49: The adjusted ELISA OD (450 nm) for total Ig (a),
IgGl (b) and IgM (c) responses ofF. hepatica infected sheep (24, 26,





-SH. 24 —SH. 26 —•— SH. 28 —•— SH. 30 —O— SH. 22 -O— SH. 32
Figure 4.50: The adjusted ELISA OD (450 nm) values of IgG2 (a)
and IgA (b) responses of F. hepatica infected sheep (24, 26,
28 and 30) and uninfectedcontrol sheep (22 and 32) to FhESP
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4.2.4 Experiment 3: F. gigantica (Kenyan strain) Infection in Sheep
The antibody response to Fg-E/S was easily detected in the sera of F. gigantica
infected animals for total Ig and IgGb but IgM, IgG2 and IgA values were lower.
The infected sheep showed an increase in total Ig levels from 2 wpi. with a
peak at 13 wpi. The mean OD levels remained high throughout the 22 weeks of
infection (Figure 4.51a). The IgG! isotype responses to Fg-E/S were strongest in the
infected sheep after 2 wpi. with peak at 10 wpi. Although the infected sheep
response started to decease by 13 wpi. the OD values remained higher than
uninfected sheep until the end of experiment (Figure 4.51b).
The IgM response to Fg-E/S in infected sheep was first detected at 2 wpi.
remaining elevated until the end of experiment (Figure 4.51c).
Slight IgG2 responses to Fg-E/S were first detected at 2 wpi. remained above
the uninfected up to the end of experiment 22 wpi. (Figure 4.52a).T-test analysis
showed that the F. gigantica infected sheep IgG2 response to Fh-E/S was
significantly higher than the non infected sheep by 4 wpi.
IgA response to Fg-E/S was detected by 4 wpi. but was back to the levels of
the uninfected sheep by 8 wpi. to the end of infection. The mean OD values F.
gigantica infected animal appear to be above that of uninfected sub-group only
weeks 4 to 6 of infection. The rest of the weeks analysed seem to indicate no
difference between the uninfected and the infected sheep (Figure 4.52b). The data is
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• Mean (+) —O—Mean (-)
Figure 4.51: The adjusted mean + SEM ELISA OD (450 nm) values of
total Ig (a), IgGi (b) and IgM (c) responses ofF. gigantica infected
sheep (Mean (+)) and uninfected control sheep (Mean (-) to FgESP
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Figure 4.52: The adjusted Mean + SEM ELISA OD (450 nm) values
of IgG2 (a) and IgA (b) responses ofF. gigantica infected sheep
(Mean (+) and uninfected control sheep (Mean (-) to FgESP
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4.2.5 Experiment 4: F. gigantica (Kenyan strain) Infection in Sheep
The antibody response to Fg-E/S was easily detected in the sera of F.
gigantica infected sheep for total IgG, IgGl IgM and IgG2 but IgA very poorly
detected.
The infected sheep showed an increase in total Ig levels first at 3 wpi. for
sheep 23 and 29 and 4 wpi. for sheep 25 and 27. The response reached the peak at 9
wpi. and remained high up to culling for sheep 23 and 25 and up to the end of
experiment for sheep 27 and 29. in 13 wpi. (Figure 4.53a).
The mean IgG, isotype responses to Fg-E/S were detected in all the infected
sheep from +4 wpi. peaking at +6 wpi. (Figure 4.53b) and declined +10-12 wpi.
continued to reduce to near background levels by the end of the experiment.
The IgM response to Fg-E/S in infected sheep (Figure 4.53c) started 2 wpi.
for sheep 27 and 29 and 4 wpi. for the rest of infected sheep reducing to the
background levels by the end of experiment.
Clear IgG2 response to Fg-E/S stardng from 6 wpi. The initial response fell
sharply and there was again a increase in response in all infected sheep 15 wpi.
remaining high up the end of experiment (Figure 4.54a).
IgA response to Fg-E/S was relatively poor displaying a biphasic response in
only two sheep (23 and 29), this was not related to either infective dose or fluke
recovery (Figure 4.54b).
The adjusted mean total Ig ELISA assay results and the isotype-specific
antibody responses to Fg-E/S of F. gigantica infected sheep 23, 25, 27, and 29 and
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—O— SH. 21 —SH. 23 —♦— SH. 25 —SH. 27 —A—SH. 29 —O— SH. 31
Figure 4.53: The adjusted ELISA OD (450 nm) values of Total IgG (a),
IgGl (b) and IgM (c) responses of F. gigantica infected sheep (23,
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Weeks Post Infection
•SH. 21 SH. 23 —SH. 25 —•—SH. 27 —A— SH. 29 -O— SH. 31
Figure 4.54: The adjusted ELISA OD (450 nm) values of IgG2 (a) and
IgA (b) responses ofF. hepatica infected (23, 25, 27 and 29) sheep
and uninfected control sheep (21 and 31) to FgESP
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4.2.6 Experiment 5: F. hepatica (Peru strain) infection in cattle
These cattle were either given primary infection as indicated or an infection
and a challenge (Calf 15c and 23c) (see Table 4.5 in section 4.1.5)
All the infected calves showed an increase in total Ig levels from +4 wpi.,
remaining high thereafter.
IgGj isotype responses to Fh-E/S were stronger in all the infected calves as
with total Ig, the IgG! response was detected 3-4 wpi. and remained unchanged
throughout the experimental period (Figure 4.55a-b). In calf 15c the circulating
IgG! antibody rose markedly after challenge infection but there was little change in
calf 23c (Figure 4.55a)
IgM responses were detected +2 wpi. peaking +3-5 wpi. and remained high
throughout the experiment (Figure 4.55c).
IgG2 levels rose slowly from +9 wpi. increasing gradually till the end of the
experiment. There was no marked change after challenge infection in calves 15c but
calves 23c may have shown a slight rise(Figure 4.56a).
A sharp increase in IgA response to Fh-E/S was noticed in calf 23c 5 wpi.
after the primary infection and 6 weeks after challenge infection. Calf 15c showed
an increased response after a challenge infection while unchallenged calf 14c only


















W 14c ♦ 15c • 23c —O—26c A 34c X 45c
Figure 4.55: The adjusted ELISA OD (450 nm) for total Ig (a),
IgGl (b) and IgM (c) responses ofF. hepatica infected calves (14, 15,
23, 34 and 45) and uninfected control calf (26) calves to FhESP
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Weeks Post Infection
-■-14c —•— 15c —♦—23c —O—26c -A-34c -*-45c
Figure 4.56: The adjusted ELISA OD (450 nm) values of IgG2 (a)
and IgA (b) responses of F. hepatica infected calves (14c, 15c, 23c,
34c and 45c) and uninfected control (calf 26c) to FhESP
—► Primary infection —^ Challenge infection
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4.2.7 Experiment 6: F. gigantica (Kenya strain) Infection in Cattle
Following infection, the Fh-E/S antibodies were easily detected in the sera of
F. gigantica infected calves for both total Ig and the four subclasses, IgGl, IgM,
IgG2 and IgA in varying degrees and time of infection (Figure 4.57-4.58).
All the infected calves showed an increase in total Ig levels from +3 wpi.
peaking +5-7 wpi. and remained high throughout the experiment (Figure 4.57a).
Serum IgG! responses rose sharply 3-4 wpi. and remained high up to 27 wpi.
apart from calf 24 whose response drooped to the level of the control sheep (Figure
4.58b).
IgM response to Fg-E/S rose by +2-3 wpi. and reached the peak in 5 wpi.
Calves 22 and 23 showed very strong fluctuation and declined to almost the levels of
the uninfected calf 26 by 26 wpi. Calf 24 on the other hand showed less fluctuation
and OD's remained high throughout the weeks experiment (Figure 4.57c).
Circulating IgG2 antibody response to Fg-E/S in calves 22 and 23 was
noticed from 5 wpi. but appeared very strong in calf 24 with a gradual increase until
the end ofmonitoring period (Figure 4.58a).
IgA response to Fg-E/S in infected calves appeared suddenly late at 22 wpi. it
fluctuated but with a clear increasing trend until the end of experiment (Figure
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Figure 4.57: The adjusted ELISA OD (450 nm) for total Ig (a), IgGl (b)
and IgM (c) responses of F. gigantica infected calves (22,23 and 24)
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• calf 24 —O— calf 26a •calf 23
Figure 4.58: The adjusted ELISA OD (450 nm) values for IgG2 (a)
and IgA (b) responses of F. gigantica infected calves (22, 23 and 24)
and uninfected control (calf26) to FgESP
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4.3 Serum antibody responses against f. hepatica Cathepsin-L1
cysteine protease (fh-cathepsin)
4.3.1 Determination ofOptimum Assay Conditions by Titration.
The results for titrations to determine optimum antigen serum, the
monoclonal antibody and the conjugate dilution are summarised in Tables 4. 11 -
4.13. The antigen concentration to be used in the ELISA assay for each of the
isotypes was determined by Fh-cathepsin titration at 4, 2 and 1 pg/ml. All titrations
were carried out in duplicate and the mean values calculated. The selected
concentration was 1 pg/ml for all of the isotypes in either F. hepatica or F. gigantica
infected sheep and cattle. Figures 4.59-4.66 are representative titrations for total Ig
and IgGl in F. hepatica and F. gigantica infected sheep and cattle for the two
polyclonal (total Ig) and the monoclonal antibody (IgG^ based detection systems.
Full data is represented in Appendix tables 4.75-4.84.
Chequerboard titration for serum, monoclonal antibodies and conjugate were
carried out by diluting these systems in blocking buffer using doubling serial dilution
ranging from l-4pg/ml (antigen), 1:50-1:1600 (serum), 1:20-1:320 (monoclonal
antibody) and 1:1000-1:32,000 (conjugate). The chosen antigen concentration,
serum, monoclonal antibody and conjugate dilution were used in all subsequent
sequential screenings. Dilutions were selected on the basis of optimising the signal to
background ratio. The two positive sera PI and P2 were taken from F. hepatica or F.
gigantica infected animals and corresponded to 8, 9 or 10 wpi (PI) and 21,22 or 23
wpi (P2) for sheep and to 7 wpi (PI) and 32 wpi (P2) for calves. These times post
infection were chosen to assess responses at the middle and at the end of the
experimental period and to optimise the signal to background ratio.
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Table 4.11: Sheep infected with F. hepatica or F. gigantica: Optimal dilutions of
serum and conjugate for polyclonal antibody system using Cathepsin-L
protease from F. hepatica as antigen. Antigen concentration of 1 pg/ml
in all the sheep assays.
Assay F. hepatica F. gigantica
Fh-Cathepsin Serum Conj. Fh-Cathepsin Serum Conj.
(pg/ml) (pg/ml)
Total Ig 1 1:400 1:4000 1 1:200 1:4000
IgM 1 1:200 1:2000 1 1:200 1:200
0
Table 4.12 Sheep infected with F. hepatica or F. gigantica: Optimal dilutions of
serum monoclonal antibody (McAb) and conjugate for monoclonal
antibody system using Cathepsin-L protease from adult F. hepatica as
antigen. Antigen concentration of 1 pg/ml in all the sheep assays.
Assay F. hepatica F. gigantica
Fh-Cathepsin Serum McAb Conj
(pg/ml)






1 1:200 1:400 4000
1 1:50 1:20 1000
1 1:50 1:20 1000
1 1:200 1:400 1:4000
1 1:50 1:20 1:1000
1 1:50 1:20 1:1000
Table 4.13 Cattle infected with F. hepatica or F. gigantica: Optimal dilutions of
serum and conjugate for polyclonal antibody system using Cathepsin-L
protease from F. hepatica as antigen. Antigen concentration of 1 pg/ml
in all the cattle assays.
Assay F. hepatica F. gigantica
Fh- Serum Conj. Fh-Cathepsin Serum Conj.
Cathepsin (pg/ml)
(pg/ml)
Total Ig 1 1:200 1:4000 1 1:200 1:4000
IgG, 1 1:200 1:4000 1 1:200 1:4000
IgM 1 1:200 1:2000 1 1:200 1:2000
IgG2 1 1:50 1:1000 1 1:50 1:1000
IgA 1 1:50 1:1000 1 1:50 1:1000
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Figure 4.59: Antigen (Fh-cathepsin) (a), serum (b) and conjugate (c)
titrations for total Ig for F. hepatica infected sheep showing the mean
ELISA (450 nm) obtained negative serum (N) and two positive
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Figure 4.60: Antigen (Fh-cathepsin) (a), serum (b) and conjugate (c)
titrations for total Ig for F. gigantica infected sheep showing the mean
ELISA (450 nm) negative serum (N) and two for diluent (B), positive














50 100 200 400










20 40 80 160






1000 2000 4000 8000 16000
Reciprocal serial conjugate dilutions
32000
□ B IN IP1 IP2
Figure 4.61 Antigen (Fh-cathepsin) (a), serum (b), monoclonal (c) and
conjugate(d) titrations for IgG] for F. hepatica infected sheep showing the
mean ELISA (450 nm) values obtained for diluent (B), negative serum (N)
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Figure 4.62: Antigen (Fh-cathepsin) (a), serum (b), monoclonal (c) and
conjugate (d) titrations for IgG, for F. gigantica infected sheep showing
the mean ELISA (450 nm) values obtained for diluent (B), negative serum
























1000 2000 4000 8000 16000 32000
Reciprocal conjugate serial dilutions
□ B UN ■ PI ■ P2
Figure 4.63: Antigen (Fh-cathepsin) (a), serum (b) and conjugate (c)
titration for total Ig for F. hepatica infected cattle and uninfected control
cattle showing the mean ELISA (450 nm) values obtained for diluent (B)
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Figure 4.64: Antigen (Fh-Cathepsin) (a), serum (b) and conjugate (c)
titration for total Ig for F. gigantica infected cattle and uninfected control
cattle showing mean ELISA (450 nm) values obtained for diluent (B)
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Figure 4.65: Antigen (Fh-cathepsin) (a), serum (b) and conjugate (c)
titrations for IgG, for F. hepatica infected and uninfected control cattle
showing the mean ELISA (450 nm) values obtained for diluent (B)
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Figure 4.66: Antigen (Fh-Cathepsin) (a), serum (b) and conjugate (c)
titrations for IgG, for F. gigantica infected cattle and uninfected control
cattle showing the mean ELISA (450 nm) values obtained for diluent (B)
negative (N) positive (PI) and positive (P2)
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4.3.2 Experiment 1: F. hepatica (Peru And British Strain) Infection in Sheep
Antibodies response to Fh-Cathepsin were detected in the infected sheep.
However there was a very poor IgG2 and IgA (Figures 4.67-4.68)
All the infected sheep showed an increase in total Ig levels from 2 wpi. with
peaked OD values at week 3-7 wpi. and remained throughout experimental period,
although antibody response of sheep 6 began to drop by week 12 wpi.
IgG! isotype responses were stronger in sheep 6 and 7 from week 2-11 wpi.
IgM levels were clearly noticeable in all infected sheep. Responses were
apparent from 2 wpi. peaking 7 wpi. Sheep 6 and 7 showed strongest IgM responses.
IgG2 responses were poor with only sheep 10 infected with 200 F. hepatica
metacercariae showing some clear responses (Figure 4.68a).
IgA response was almost non existent but a response was noticed by 2 wpi. in
sheep 5 and 6 then all the sheep 8 wpi., suggesting a biphasic response. The details
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Figure 4.67: The ELISA OD (450 nm) for total Ig (a), IgGi (b) and IgM (c)
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Figure 4.68: The ELISA OD (450 nm) for IgG2 (a) and IgA (b) responses
of F. gigantica infected sheep (5, 6, 7, 9 and 10) and uninfected control
sheep (8) to Fh-cathepsin
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4.3.3 Experiment 2: F. Hepatica (British Strain) Infection in Sheep
Antibody to Cathepsin-L protease were easily detected in F. hepatica infected
sheep. The total Ig and IgGl responses were most marked while IgM, IgG2 and IgA
were relatively poor (Figures 4.69-4.70).
The infected sheep showed increased total Ig levels +2 wpi. peaking at 8 wpi.
remaining high throughout the experiment.
IgG] isotype responses to Cathepsin-L protease were first detected by +8-10
wpi. peaking at 10-20 wpi. and dropped by the end of experiment.
IgM responses was very poor although sheep 24 developed a distinct but
variable IgM responses than the others showing peaks of activity at different wpi.
(Figure 4.69c).
IgG2 responses were poor in all infected sheep of this group (Figure 4.70a)..
An assay was carried out to assess whether this poor response was due to the assay.
It was established there was very clear response to Fh-E/S (Figure 4.50a) but not to
Fh-cathepsin (Figure 4.70a).
Only a slight increase in IgA response was noted in particular in sheep 26,
which displayed an early response from 2-13 wpi. (Figure 4.70b). The adjusted data
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Figure 4.69: The ELISA OD (450 nm) for total Ig (a), IgGi (b) and IgM (c)
responses of F. gigantica infected (24, 26, 28 and 30) sheep and uninfected
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Figure 4.70. The ELISA OD (450 nm) for IgG2 (a) and IgA (b) responses




4.3.4 Experiment 3: F. Gigantica (Kenyan Strain) Infection in Sheep
The antibody response to Fh-Cathepsin was easily detected in the sera of F.
gigantica infected animals for total Ig and IgG,. The subclasses IgM, IgG2 and IgA
recorded however lower values.
The infected sheep showed an increase in total Ig levels from 2 wpi. peaking
at 11 wpi. Levels repressively fell thereafter but were still elevated by the end of
experiment. (Figure 4.71a).
The IgG, isotype responses development were slowly peaked at 12-13 then
started to reduce but by 21 wpi. however the infected sheep mean OD values were
still raised (Figure 4.71b). T-Test analysis showed, however, that Fasciola gigantica
infected sheep IgGl response to Fh-cathepsin was significantly higher (p < 0.005)
than the non infected sheep by 8 wpi., this is four weeks later than the IgG, response
to Fg-E/S (Figure 4.51b).
The IgM response to Cathepsin-L protease in infected sheep was relatively
poor, showed two peaks at 6 wpi. and the other at 20 wpi. (Figure 4.71c).
IgG2 response to appeared biphasic starting from 2 wpi. with peak from 8-11
wpi. and a second peak occurring 16-17 wpi. (Figure 4.72a).
IgA responses were very poor and hardly visible at all (Figure 4.72b). The
mean OD values F. gigantica infected animals appear to be above that of uninfected
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Figure 4.71. The ELISA ODs (450 nm) for mean + SEM total Ig (a),
IgGi (b) and IgM (c) responses ofF. gigantica infected sheep
(Mean (+) and uninfected control sheep (Mean (-) to Fh-cathepsin
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Figure 4.72: The ELISA OD (450 nm) for Mean ± SEM IgG2 (a), IgA (b)
responses ofF. giganiica infected sheep (Mean (+)) and uninfected
control sheep (Mean (-)) to Fh-cathepsin
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4.3.5 Experiment 4: F. Gigantica (Kenyan Strain) Infection in Sheep
The antibody response to the Fh-cathepsin of the adult F. hepatica was easily
detected in the sera of F. gigantica infected animals for total Ig, IgGl IgM and IgG2.
IgA recorded however was very low.
The infected sheep showed a clear increase in total Ig levels by 8 wpi. The
response peaked at 12 wpi. and remained high up to culling for sheep 23 and 25 and
up to 20 wpi. for sheep 27 and 29 (Figure 4.73a).
The IgG, isotype responses to Cathepsin-L protease of infected sheep were
not as strong as in F. hepatica and F. gigantica infected sheep in experiment four,
however the OD's were markedly higher than the uninfected sheep 21 and 31 (Figure
4.73b).
The IgM response to Cathepsin-L protease in infected sheep was moderate
(Figure 4.73c). The antibodies were present from 2 wpi. for all the infected sheep.
Only sheep 27 showed a clear IgG2 response to Cathepsin-L protease (Figure
4.74a).
IgA responses were very poor and hardly visible at all. (Figure 4.74b).
The adjusted mean total Ig ELISA assay results and the isotype-specific
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Figure. 4.73 The ELISA OD (450 nm) for total Ig (a), IgG( (b) and Ig M (c)
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Figure 4.74: The ELISA OD (450 nm) for IgG2 (a) and IgA (b) responses




4.3.6 Experiment 5: F. Hepatica (Peruvian Strain) Infection in Cattle
These cattle were either given primary infection as indicated or an infection
and a challenge (Table 4.5 in section 4.1.5).
All the infected calves showed an increase in total Ig levels from +6-8 wpi.
peaking by 9-10 wpi. and then gradually reducing. Antibody levels rose in calf 15c
showed a second rise 5 weeks post challenge infection. This was not seen in calf 23c
however the antibody remained higher until the end of the experiment (Figure 4.75a).
IgG, isotype responses were very pronounced. As with total Ig, the IgGl
response were detected 6-8 wpi. peaking by 9-10 wpi. The response following
receiving challenge was also similar to that of total Ig (Figure 4.75b).
IgM levels followed an erratic pattern during the course of infection with a
response first detected 4 wpi. and remained high throughout the experiment (Figure
4.75c).
Serum IgG2 levels rose slowly from 9 wpi. increasing gradually however
reduced in all the calves by the end of the experiment. The challenged infection did
not appear to affect IgG2 levels at all (Figure 4.76a).
IgA responses could be detected by 3-6 wpi. one animal, Calf 23c with a
primary infection dose of 600 metacercariae had a particularly strong response.
There was noticeable rise in IgA following secondary infection (Figure 4.76b).






■ 14c 15c ♦ 23c —(>— 26c • 34c x 45c
Figure 4.75: The ELISA OD (450 nm) for Total Ig (a), IgGj (b) and IgM (c)
responses of F. hepatica infected calves 14, 15, 23, 34 and 45) and uninfecte
control calves (26) to Fh-Cathepsin
►Primary infection 2s-Challenge infection
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■•—14c A 15c ♦ 23c —<>— 26c ■ 34c x 45c
Figure 4.76: The ELISA OD (450 nm) for IgG2 (a) and IgA (b) responses of
F. hepatica infected calves (14c, 15c, 23c, 34c and 45c) and uninfected contr
calf (26c) to Fh-Cathepsin. ►Primary infection ► Challenge infection
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4.3.7 Experiment 6: F. Gigantica (Kenyan Strain) Infection in Cattle
The polyclonal ELISA assay system was used to detect the total Ig and the
isotype-specific antibody responses to Fh-Cathepsin by F. gigantica infected calves.
Following infec^on, the antibodies were easily detected in the sera of infected calves
for both total Ig and the four subclasses, IgGl, IgM, IgG2 and IgA. However the
kinetic of the antibody responses varied considerably (Figures 4.77a-4.78b).
Infected calves showed an increase in total Ig levels to Fh-Cathepsin from +7-
9 wpi. peaking +15 wpi. and remaining high throughout the experiment. Although
Calf 22 showed the poorest response (Figure 4.77a).
The kinetic of serum IgG, responses to Cathepsin-L protease showed a near
similar pattern to those of total Ig but more stronger(Figure 4.77b).
IgM responses rose sharply by 3 wpi. with a much variable response
thereafter (Figure 4.77c).
Interestingly the circulating IgG2 antibody responses were very strong in all
the calves. Calf 22 was the first (3 wpi.) to respond in contrast to total and IgG,
responses (Figure 4.78a).
A gradual increases in IgA response was evident with increasing trend until
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Figure 4.77: The ELISA OD (450 nm) for Total Ig (a), IgGt (b) and IgM (c)
responses of F. gigantica infected calves (22, 23 and 24) and uninfected
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Figure 4.78: The ELISA OD (450 nm) for IgG2 (a) and IgA (b) responses




4.4 Serum antibody responses against F. hepatica Glutathione S-
Transferase (Fh-GST)
4.4.1 Determination ofOptimum Assay Condition by Titration.
The results for titrations to determine optimum antigen serum, monoclonal
antibody and the conjugate dilutions are summarised in Tables 4.14-4.16. The
antigen concentration to be used in the ELISA assay for each of the isotypes was
determined by Fh-GST titration at 4, 2 and 1 pg/ml. The selected concentration was
1 pg/ml for all of the isotypes in either F. hepatica or F. gigantica infected sheep
and cattle. Figures 4.79-4.86 are representative titrations for total Ig and IgG, in F.
hepatica and F. gigantica infected sheep and cattle for the two detection systems,
polyclonal antibody (Ig) and monoclonal antibody (IgG2) detection systems. Full
Data is represented in Appendix 4.104-113
Chequerboard titration for serum, monoclonal antibodies and conjugate were
carried out by diluting these systems in blocking buffer using doubling serial dilution
ranging from 4-lpg/ml (Antigen), 1:50-1:1600 (serum), 1:20-1:320 (monoclonal
antibody) and 1:1000-1:32,000 (conjugate). Titrations were run in duplicates and the
mean values calculated. The chosen antigen concentration, serum, monoclonal
antibody and conjugate dilution were used in all subsequent sequential screenings.
Dilution were selected on the basis of optimising the signal to background ratio. The
two positive sera PI and P2 were taken from F. hepatica or F. gigantica infected
animals and corresponded to 8, 9 or 10 wpi (PI) and 21, 22 or 23 wpi (P2) for sheep
and 7 wpi (PI) and 32 wpi (P2) for calves. These times post infection were chosen to
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assess responses at the middle and at the end of the experimental period and to
optimise the signal to background ratio..
Table 4.14 Sheep infected with F. hepatica or F. gigantica: Optimal dilutions of
serum and conjugate for polyclonal antibody system using
Glutathione S-Transferase from adult F. hepatica (Fh-GST) as
antigen. Antigen concentration of lpg/ml in all the sheep assays.











Table 4.15 Sheep infected with F. hepatica or F. gigantica: Optimal dilutions of
serum, Monoclonal antibodies (McAb) and conjugate for monoclonal
antibody system using Glutathione S-Transferase from adult F.
hepatica (Fh-GST) as antigen. Antigen concentration of 1 pg/ml in all
the sheep assays.
Assay F. hepatica F. gigantica
Fh-GST Serum McAb Conj.
(gg/ml)





1 1:200 1:40 1:4000
1 1:50 1:20 1:1000
1 1:50 1:20 1:1000
1 1:200 1:40 1:4000
1 1:50 1:20 1:1000
1 1:50 1:20 1:1000
Table 4.16 Cattle infected with F. hepatica or F. gigantica: Optimal dilutions of
serum and conjugate for polyclonal antibody system using
Glutathione S-Transferase from adult F. hepatica (Fh-GST) as
antigen. Antigen concentration of 1 pg/ml in all the cattle assays.
Assay F. hepatica F. gigantica
Assay Fh-GST Serum Conj. Fh-GST Serum Conj.
(pg/ml) (pg/ml)
Total Ig 1 1:200 1:4000 1 1:200 1:4000
IgG, 1 1:200 1:4000 1 1:200 1:4000
IgM 1 1:200 1:2000 1 1:200 1:2000
IgG2 1 1:50 1:1000 1 1:50 1:1000
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Figure 4.79: Antigen (FhGST) (a), Serum (b) and Conjugate (c) titration
for total Ig for F. hepatica infected and uninfected control sheep showing
the mean ELISA (450nm) values obtained for diluent (B), negative (N)
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Figure 4.80: Antigen (FhGST) (a), Serum (b) and Conjugate (c) titration
for total Ig for F. hepatica infected and uninfected control sheep showing
the mean ELISA (450 nm) values obtained for diluent (B), negative (N)
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Figure 4.81: Antigen (Fh-GST) (a) serum (b), monoclonal (c) and
conjugate (d) titration for total Ig for F. hepatica infected and uninfected
control sheep showing the mean ELISA values obtained for diluent (B)
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Figure 4.82: Antigen (Fh-GST) (a) Serum (b), Monoclonal (c) and
Conjugate (d) titration for total Ig for F. gigantica infected sheep and
uninfected control sheep showing mean ELISA (450 nm) values



















50 100 200 400 800
Reciprocal serum serial dilution











1000 2000 4000 8000 16000
Reciprocal conjugate serial dilution
32000
Figure 4.83: Antigen (Fh-GST) (a) serum (b) and conjugate (c) titration
for total Ig for F. hepatica infected cattle and uninfected control cattle
showing mean ELISA (450 nm) values obtained for diluent (B)
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Figure 4.84: Antigen (FhGST) (a), serum (b) and conjugate (c) titration
for total Ig for F. gigantica infected and uninfected cattle showing
mean ELISA (450 nm) values obtained for diluent (B) negative (N)
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Figure 4.85: Antigen (FhGST) (a), serum (b) and conjugate (c) titration
for IgG[ for F. hepatica infected and uninfected control cattle showing
the mean ELISA (450 nm) values obtained for diluent (B), negative (In)
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Figure 4.86: Antigen (FhGST) (a) serum (b) and conjugate (c) titrations
for IgGt for F. gigantica infected and uninfected control cattle showing
mean ELISA (450 nm) values obtained for diluent (B ) negative (N)
positive (PI) and positive (P2)
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4.4.2 Experiment 1: F. Hepatica (Peruvian And British Strain) Infection in
Sheep
Following primary infection, serum total Ig, IgGb IgM, IgG2 and IgA
antibodies responses to Fh-GST were detected in the F. hepatica infected sheep.
There was however a moderate IgG2 and IgA response.
All the infected sheep showed a late increase in total Ig levels with a clear
increase by 6 wpi. peaking at 11 wpi. Sheep 6 with ODs above 0.7 nm at peak
response (Figure 4.87a).
There were sharp and early, 2-3 wpi., IgGj isotype responses to Fh-GST by
sheep 7, 9 and 10. There was no response by sheep 5 and little in sheep 6. as shown
in Figure 4.87b.
A variable IgM response was clearly noticeable in sheep 6, 7, 9 and 10 but as
with IgGl sheep 5 did not respond (Figure 4.87c).
A delayed sera IgG2 response to Fh-GST was recorded by sheep 6 and 5. The
rest of infected sheep were no different to uninfected control sheep 6 (Figure 4.88a).
The only clear IgA response to Fh-GST was noticed in sheep 9 wpi., there is
however some mild response by the rest of the infected sheep of this group as shown
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Figure 4.87: The ELISA OD (450 nm) values for serum total Ig (a), IgG!
(b) and IgM (c) responses of F. hepatica infected sheep (5, 6, 7, 9
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Figure 4.88: The ELISA OD (450 nm) values for serum IgG2 (a) and
IgA (b) responses of F. hepatica infected sheep (5, 6, 7, 9 and 10)
and uninfected control sheep 8 to FhGST
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4.4.3 Experiment 2: F. hepatica (British strain) Infection in Sheep
Antibody response to Fh-GST was detected in these F. hepatica infected
sheep. The total Ig and IgM responses were greatest while IgG,, IgG2 and IgA were
questionable, Figure 4.89a-4.90b. The adjusted data to each sheep are presented in
Appendix Tables 4.117-119.
The infected sheep showed an early total Ig response to Fh-GST and the
levels remained high throughout the experiment. IgGj isotype responses were only
clear in sheep 26 and 30. The rest of the infected sheep did not show clear response.
The IgM responses was early and strong in all the infected sheep with peaks
at 8-11 wpi. By 12 wpi. the OD values started to drop. Sheep 30 recorded lower
values than the rest of the infected sheep. The IgG2 and IgA response to Fh-GST by
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Figure 4.89: The ELISA OD (450 nm) values for serum total Ig (a),
lgGt (b) and IgM (c) responses of F. hepatica infected sheep (24, 26,
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Figure 4.90: The ELISA OD (450 nm) values for serum IgG2 (a)
and IgA (b) responses of F. hepatica infected sheep 24, 26, 28 and 30
and uninfected control sheep 22 and 32 to FhGST
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4.4.4 Experiment 3: F. gigantica (Kenya Strain) Infection in Sheep
The total Ig, IgM and IgG, antibody response to Fh-GST was easily detected in
the sera of F. gigantica infected sheep. The IgG2 and IgA responses, however were
very poor. The mean antibody responses of F. gigantica infected sheep 11, 12, 13,
14, and 15 and uninfected control sheep 16, 17, 18 and 19 are presented in Figures
4.91a-4.92b
The infected sheep showed a very early (2 wpi.) total Ig response to Fh-GST.
The mean OD levels remained high throughout the 22 weeks of infection with slight
reduction (Figure 4.91a).
The IgG, isotype responses to Fh-GST was first noted in the F. gigantica
infected sheep of this group after 2 wpi. with peak occurring at 4-9 wpi. The
response slowly and steadily started to reduce but by 21 wpi. the infected sheep mean
OD values were still high higher than the control (Figures 4.91b)..
The IgM response to Fh-GST in infected sheep was early and rose sharply in
the first week of infection peaking at 10 wpi. The antibody response declined slowly
after 11 wpi. There was a lot of variation within the individual infected sheep
(Figures 4.91c)..
A mild IgG2 response was noted from 9 wpi. The mean OD values of
infected sheep were above the uninfected up to 17 wpi. (Figure 4.92a).
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The IgA response to Fh-GST was slight but the mean OD values F. gigantica
infected sheep were above that of uninfected controls between 4 wpi. and 17 wpi.
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Figure 4.91: The mean + Sem ELISA OD (450 nm) values for serum
total Ig (a), IgGi (b) and IgM (c) responses ofF. gigantica infected
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Figure 4.92: The mean + Sem ELISA OD (450 nm) values for serum
IgG2 (a) and IgM (b) responses ofF. gigantica infected sheep
(Mean (+)) and uninfected control sheep (Mean (-)) to FhGST
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4.4.5 Experiment 4: F. gigantica (Kenyan Strain) Infection in Sheep
The adjusted mean total Ig ELISA assay results and the isotype-specific
antibody responses to Fh-GST of F. gigantica infected sheep 23, 25, 27, and 29 and
uninfected control sheep 21 and 31 are presented in Figures 4.93a-4.94b and in
Appendix tables 4.125-127.
The antibody response to Fh-GST was easily detected in these sera of F.
gigantica infected animals for total Ig, IgGl IgM and IgG2. IgA recorded however
was very low.
The infected sheep showed an early (2 wpi.) and sharp total Ig response. The
response reached the peak at 2 wpi. for sheep 23 and 25 and 21 wpi. for sheep 27.
Sheep 27 also had a late response compared to the rest (Figures 4.93a).
The IgG, isotype responses to Fh-GST were stronger in all the F. gigantica
infected sheep of this group after 2 wpi. The peak IgG] responses was 8 wpi. The
response slowly and steadily started to reduce but by 21 wpi. however the infected
sheep mean OD values were still above the uninfected control sheep by the end of
experiment (Figures 4.93b)..
The IgM response to Fh-GST in infected sheep was moderate and late i.e. 6-8
wpi. peaking 10 wpi. before slowly reducing (Figures 4.93c).
There was only one sheep with a clear IgG2 response to Fh-GST from +8 wpi.
as shown in Figure 4.94a
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IgA response to Fh-GST was not convincing in this experiment. There was no
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Figure 4.93: The ELISA OD (450 nm) Values for serum total Ig (a),
IgGj (b) and IgM (c) responses of F. gigantica infected sheep (23, 25,
27 and 29) and uninfected control sheep (21 and 31) to (FhGST)
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Figure 4.94: The ELISA OD (450 nm) Values for Serum IgG2 (a) and
IgA (b) responses of F. gigantica infected sheep (23, 25, 27 and 29)
and uninfected control sheep (21 and 31) to Fh-GST
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4.4.6 Experiment 5: F. hepatica (Peruvian Strain) Infection in Cattle
The ELISA assay was used to detect the total Ig and the isotype-specific
antibody responses Fh-GST in F. hepatica infected calves. These cattle were either
given primary infection as indicated or an infection and a challenge (Calf 15c and
23c) as shown in Table 4.5 in section 4.1.5. The total Ig and the four subclass as are
presented in Figures 4.95a-4.96b and the adjusted data in appendix tables 4.128-4.32.
All the infected calves showed a late increase in total Ig levels. The response
was on the increase when the experiment was stopped (Figures 4.95a).
IgG] isotype responses to Fh-GST was detected in all infected calves of this
group. As in total Ig, the IgGi response increased slowly. Calves 15c and 23c in
response to the circulating IgG! antibody showed an increased after the challenge
infection. It is clear in this experiment that calves 23c, 34c and 45c with first
infection of 600 and 450 metacercariae respectively had a sharper and earlier
response than calves 14c and 15c with 200 matacercariae (Figures 4.95b).
Circulating IgM antibody response to Glutathione S-Transferase was much
stronger than IgG! Calves 15c and 23c showed an increase in response after
challenge infection (Figures 4.95c).
In this experiment infected calves serum IgG2 response was variable. The
response was late and calf 23c infected with 600 metacercariae another increase after
challenge infection. There was no difference between challenged, calf 23c and
unchallenged, calf 14c (Figures 4.96a).
253
Chapter Four: Results
There was a very late IgA response to Fh-GST noticed in calves 14c, 15c and
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Figure 4.95: The ELISA OD (450 nm) values for total Ig (a), IgGi (b)
and IgM (c) responses of F. hepatica infected calves (14c, 15c, 23c,
34c and 45) and uninfected control calf (26c) to FhGST
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Figure4.96: The ELISA OD (450 nm) values for IgG2 (a) and IgA (b)
responses of F. hepatica infected calves (14c, 15c, 23c, 34c and 45c)
and uninfected control calf (26c) to FhGST
► Primary infection > Challenge infection
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4.4.7 Experiment 6: F. gigantica (Kenya Strain) Infection in Cattle
The Polyclonal ELISA assay system was used to detect the total Ig and the
isotype-specific antibody responses Fh-GST of F. gigantica infected calves.
Following infection, the Fh-GST antibodies were easily detected in the sera of
infected calves for both total Ig and the four subclasses, IgG,, IgM, IgG2 and IgA in
varying degrees and time of infection. The adjusted total Ig ELISA assay results and
the isotype-specific antibody responses to Fh-GST by F. gigantica infected Calves
22, 23 and 24 and uninfected control calf 26 are presented in Figures 4.97a-4.98b and
adjusted data in appendix tables 4.128-4.32.
All the infected calves showed an increase in total Ig levels from 3 wpi.
peaking 3 and 21 wpi. with all calves remaining high throughout the experiment
(Figures 4.97a).
Serum IgG! responses to Fh-GST was delayed and strong in all the F.
gigantica infected calves. The values remained high throughout the experiment
(Figures 4.97b).
There was a sharp and early (2 wpi.) IgM response to Fh-GST by F. gigantica
infected calves 22 and 24 while calf recorded a late (11 wpi.) antibody response. The
OD values remained high throughout the experiment (Figures 4.97c).
Circulating IgG2 antibody response to Fh-GST was very poor in calves 22
and 24 while calf 23 response was clear (Figure 4.98a).
A gradual and late IgA response to Fh-GST by F. gigantica infected calves




—Calf22 —calf23 -•-calf24 -o-calf26
Figure 4.97: The ELISA OD (450 nm) values for total Ig (a), IgGj (b)
and IgM (c) responses of F. gigantica infected calves(22, 23 and 24)
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Figure 4.98: The ELISA OD (450 nm) values for lgG2 (a) and IgA (b)
responses of F. hepatica infected calves (22, 23 and 24) and uninfected
control calf (26 ) to Fh-GST
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4.5 Faecal Antibody responses to F. hepatica or F. gigantica
excretory/secretory products (Fh-E/S or Fg-E/S)
4.5.1 Determination ofOptimum Assay Condition by Titration
The optimum assay conditions i.e. those which optimised the signal to the
background ratio, were determined by titration of antigen (Fh-E/S or Fg-E/S) and
conjugate for the polyclonal detection system or antigen (Fh-E/S or Fg-E/S),
monoclonal antibody (McAb) and conjugate for the monoclonal antibody based
detection system. Figures 4.99-4.102 are representative titrations for total Ig and IgA
in F. hepatica and F. gigantica infected sheep and cattle for the two detection
systems, polyclonal antibody (Ig) and monoclonal antibody (IgA) detection systems
(Table 4.17-4.18). Full data is represented in Appendix Tables 4.133-4.137.
Chequerboard titration for monoclonal antibodies and conjugate were carried
out by diluting these systems in blocking buffer using doubling serial dilution
ranging from 20-1.25pg/ml for Fh-E/S or Fg-E/S, 1:10-1:40 (monoclonal antibody)
and 1:1000-1:4,000 (conjugate). Titration were run in triplicate and the mean values
calculated. The chosen antigen concentration, monoclonal antibody and conjugate
dilution were used in all subsequent sequential screenings. The faecal samples were
not titrated, dilution of 1:1 was chosen for both assays. The two positive faecal
samples P1 and P2 were taken from F. hepatica or F. gigantica infected sheep and
corresponded to week 8-10 (PI) and p2 week 17-22 (P2) post infection. These times




Table 4.17 Sheep Infected with F. hepatica or F. gigantica: optimal dilution of
antigen (ug/ml), faecal sample and conjugate for polyclonal antibody
system using F. hepatica or F. gigantica excretory/secretory products
(Fh-E/S or Fg-E/S).
Assay F. hepatica F. gigantica







Table 4.18 Sheep Infected with F. hepatica or F. gigantica: optimal dilution of
antigen (ug/ml), faecal sample, monoclonal antibody (McAb) and
conjugate for monoclonal antibody system using F. hepatica or F.
gigantica Excretory/secretory products (Fh-E/S or Fg-E/S).
Assay F. hepatica F. gigantica




5 1:1 40 1000
5 1:1 20 1000
5 1:1 20 1000
5 1:1 40 1000
5 1:1 20 1000
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□ B BEN ■ PI SP2
Figure 4.99: Antigen (FgESP) (a) and conjugate (b) titration for total Ig for
F. hepatica showing the mean ELISA (450 nm) values obtained infected
sheep and uninfected control sheep for diluent (B) negative (N)
positive (PI) and positive (P2)
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□ B 01N ■ PI BP2
Figure 4.100: Antigen (FgESP) (a) and conjugate (b) titration for total Ig
for F. gigantica showing the mean ELISA (450 nm) values obtained
from infected sheep and uninfected control sheep for diluent (B)
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4000
Figure 4.101: Antigen (FhESP) (a), monoclonal antibody (b) and conjugate
(c) titration for faecal IgA for F. hepatica infected and uninfected control
sheep showing the mean ELISA values obtained for diluent (B)
negative (N) positive (PI) and positive (P2)
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Figure 4.102: Antigen (FhESP) (A), monoclonal antibody (b) and conjugate
(c) titrations for faecal IgA for F. gigantica infected sheep and uninfected
control sheep showing the mean ELISA (450) values obtained for diluent
(B) negative (N) positive (PI) and positive (P2)
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4.5.2 Experiment 1: F. hepatica (Peru and British Strain) Infection in Sheep
Following primary infection, total faecal Ig, IgG2 and IgA antibodies
responses to Fh-E/S were easily detected in the faeces of infected sheep. Flowever
there was a slight faecal IgG2 response to Fh-E/S particularly in sheep 5 and 6
(Figures 4.104a) and faecal IgGb and IgM response were not detected (Figures
4.103b and 4.103c). Full data is represented in Appendix tables 4.138-4.140.
All the infected sheep showed an early increase in total Ig levels from 1-4
wpi. peaking 6-8 wpi. and OD values started to reduce by 8-9 wpi. There was very
big variation in response within the group with samples from sheep 5 recording the
highest values and from sheep 10 the lowest (Figures 4.103a).
F. hepatica infected sheep 5 and 6 faecal IgG2 levels were high in the earlier
part of infection, 2 wpi. The rest of the sheep recorded the same OD values as the
uninfected sheep (Figures 4.104a).
Faecal IgA response to Fh-E/S was the dominant isotype with biphasic
response in sheep 6 and 9, the first peak was at 2-3 wpi., before patency and the
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Figure 4.103: The adjusted ELISA OD (450 nm) faecal total Ig (a), IgGt (b)
IgM (c) responses of F. hepatica infected sheep 5, 6, 7, 9 and 10 and uninfect
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Figure 4.104: The adjusted ELISA ODs (450 nm) faecal IgG2(a) and TgA (a)
responses of F. hepatica infected sheep 5, 6, 7 and 9 and 10 uninfected
control sheep 8 to F. hepatica excretory and secretory products (Fh-E/S)
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4.5.3 Experiment 3: F. gigantica (Kenyan Strain) Infection in Sheep
Total faecal Ig and IgA response to Fg-E/S was detected in F. gigantica
infected sheep but the IgM, IgG] and IgG2 responses were low. The mean(±SEM)
antibody responses to Fg-E/S of F. gigantica infected sheep and uninfected control
sheep are presented in Figures 4.105-4.106.
The infected sheep showed an early increase in total Ig levels, 4 wpi. and
peaking at 14 wpi. The mean OD levels started slowly to drop from 15 wpi. By the
end of experiment however the mean OD values in infected sheep were significantly
higher (p < 0.01) than the uninfected controls.
In this experimentally F. gigantica infected sheep, there was poor faecal IgG2
response to Fg-E/S.
Faecal IgA response to Fg-E/S F. gigantica was biphasic with the first peak
4-8 wpi. followed by a sharp drop 9 wpi. and a second peak 19-21 wpi. The adjusted
data in Appendix tables 4.141-4.145
269
Chapter Four; Results
-O.tO 1 1 1 1 1—1—1——1—1—1—1—1—1—1—1—1—1—1
-20 2 4 6 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Weeks Post Infection
-2 0 2 4 6 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Weeks Post Infection
0.10 ;






0.00 !—1 '—L—1 ' L—1 1 1 1 1 1 1 1 1 ' ' 1
-2 0 2 4 6 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Weeks P:ost Infection
• Mean (+) —o—Mean (-)
Figure 4.105: The adjusted ELISA OD (450 nm) mean faecal total Ig (a), IgG
(b) and IgM (c) responses ofF. gigantica infected sheep (+) and uninfected
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Figure 4.106: The adjusted ELISA OD (450 nm) mean faecal IgG2 (a) and
IgA (b) responses ofF. gigcintica infected sheep (+) and uninfected
control sheep (-) to F. giganlica and secretory products (Fh-E/S)
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4.6 Faecal Antibody responses to Fh-Cathepsin.
4.6.1 Determination ofOptimum Assay Conditions by Titration.
The optimum assay conditions i.e. those which optimised the signal to the
background ratio, were determined by titration of antigen (Fh-Cathepsin) and
conjugate for the polyclonal detection system or antigen (Fh-Cathepsin), monoclonal
antibody and conjugate for the monoclonal antibody based detection system. Figures
4.107-4.110 are representative titrations for total Ig and IgA in F. hepatica and F.
gigantica infected sheep and cattle for the two detection systems, polyclonal
antibody (Ig) and monoclonal antibody (IgA) detection systems. The selected
concentrations for the assays IgM, IgG2 and IgA for sheep are in Table 4.19. and
4.20. Full data is represented in Appendix table 4.146-4.150.
Chequerboard titration for monoclonal antibodies and conjugate were carried
out by diluting these systems in blocking buffer using doubling serial dilution
ranging from 4-lpg/ml for antigen, 1:10-1:40 for monoclonal antibody and 1:1000-
1:4000 for conjugate. Titrations were run in triplicate and the mean values calculated.
The chosen antigen concentration, faecal samples (1:1), monoclonal antibody and
conjugate dilution were used in all subsequent sequential screenings. Dilutions were
selected on the basis of optimising the signal to background ratio except in faecal
samples where a 1:1 dilution was selected as the highest dilution without titration.
The two positive faecal samples PI and P2 were taken from F. hepatica or F.
gigantica infected sheep and corresponded to week 8-10 (PI) and week 21-22 (P2)
post infection. These times post infection were chosen to assess responses at the
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middle and at the end of the experimental period and to optimise the signal to
background ratio.
Table 4.19 Sheep infected with F. hepatica or F. gigantica: optimal dilution of
antigen i.e. Fh-Cathepsin fug/ml), faecal sample and conjugate for
polyclonal antibody system using F. hepatica Cathepsin L Protease
(Fh-Cathepsin)
Assay F. hepatica F. gigantica







Table 4.20 Sheep infected with F. hepatica or F. gigantica: optimal dilution of
antigen (ug/ml), Faecal Sample, monoclonal antibody (McAb) and
conjugate for monoclonal antibody system using F. hepatica Cathepsin
L Protease (Fh-Cathepsin)
Assay F. hepatica F. gigantica
Fh- Faeces McAb Conj.
Cathepsi
n
Fh- Faeces McAb Conj.
Cathepsi
n
IgG, 1 1:1 1:20 1:1000 1 1:1 1:20 1:1000
IgG2 1 1:1 1:20 1:1000 1 1:1 1:20 1:1000
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Figure 4.107: Antigen (Fh-cathepsin) (a) and conjugate (b) titrations for
total Ig for F. hepatica showing the mean ELISA (450 nm) values
obtained for infected and uninfected control sheep for diluent (B),
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DIN ■ PI BP2
Figure 4.108: Antigen (Fh-cathepsin) (a) and conjugate (b) titrations for
total Ig for F. hepatica showing the mean ELISA (450) values obtained
for infected and uninfected sheep for diluent (B), negative (N),













































Figure 4.109: Antigen (Fh-Cathepsin) (a), monoclonal antibody (b) and
titrations for faecal IgA for F. hepatica infected sheep and uninfected
sheep conjugate (c) showing mean ELISA (450 nm) values obtained for
























Figure 110: Antigen (Fh-cathepsin) (a), monoclonal antibody (b) and
conjugate (c) titrations for feacal IgA for F. gigantica infected sheep
and uninfected sheep showing mean ELISA (450 nm) values
obtained for diluent (B) negative (N) positive (PI) and positive (P2)
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4.6.2 Experiment 1: F. hepatica (Peruvian And British Strain) Infection in
Sheep
Following primary infection, only total faecal Ig and IgA antibody responses
to Fh-Cathepsin were detected in the infected sheep. There was a no significant
faecal IgGb IgM, and IgG2 response (Figures 4.111-112).
All the infected sheep showed an early increase in total faecal Ig levels from 2
wpi. peaking at 6-7 wpi. OD values then started to decrease by 8 wpi., with a peak
again at 12 wpi. There were variations in IgA response within the group.
Faecal IgA response to Fh-Cathepsin was similar to total Ig. Faecal IgA
response was clearly biphasic in all the infected sheep . The first phase was started 2
wpi. and started to fall by 8 wpi. and the second and shorter phase started 13 wpi. and
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Figure 4.111: The adjusted ELISA OD (450 nm) faecal total Ig (a), IgGj (b)
and IgM (c) responses of F. hepatica infected sheep 5, 6, 7, 9 and 10 and
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Figure 4.112: The adjusted ELISA OD (450 nm) faecal IgG2 (a) and IgA (b)
responses of F. hepatica infected sheep 5, 6, 7 and 9 and 10 uninfected contro
sheep 8 to Fh-cathepsin
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4.6.3 Experiment 3: F. gigantica (Kenyan Strain) Infection in Sheep
Only total faecal Ig and IgA antibody responses to Fh-Cathepsin were
detected in the samples from F. gigantica infected animals. IgM, IgG, and IgG2
responses were low to non existence (Figures 4.113-114)..
The infected sheep showed an early increase in total Ig levels, 4 wpi. and
peaked at 19 wpi. The mean OD levels started to drop from 22 wpi. By the end of
experiment however the mean OD values in infected sheep were almost at the same
level as that of uninfected control sub group.
There was an early, 4 wpi., sharp faecal IgA response to Cathepsin L Protease
F. gigantica infected sheep with two phases, the peak was 10 wpi. for the first phase
and 16 wpi. for the second phase. The second phase was more pronounced than the
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Figure 4.113: The adjusted ELISA OD (450 nm) mean + SEM faecal total
Ig (a), IgGi (b) and IgM (c) responses ofF. gigantica infected sheep 11-15
and uninfected control sheep 16-19 to Fh-Cathepsin
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Figure 4.114: The adjusted ELISA OD (450 nm) Mean + SEM faecal IgG2 (a)
and IgA (b) responses of F. gigantica infected sheep (+) and uninfected
control sheep (-) to F. hepatica Fh-Cathepsin
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4.7 Faecal Antibody responses to F. hepatica Glutathione S-
Transferase (Fh-GST)
4.7.1 Determination ofOptimum Assay Condition by Titration.
The optimum assay conditions, i.e. those which optimised the signal to the
background ratio, were determined by titration of antigen (Fh-GST) and conjugate
for the polyclonal detection system or antigen (Fh-GST), monoclonal antibody and
conjugate for the monoclonal antibody based detection system. Titrations were run in
duplicates and the mean values calculated. Figures 4.115-4.118: are representative
titrations for total Ig and IgA in F. hepatica and F. gigantica infected sheep and
cattle for the two detection systems, polyclonal antibody (Ig) and monoclonal
antibody (IgA) detection systems. The selected concentrations for the rest of the
assays IgM, IgG2 and IgA for sheep are in Table 4.21 and 4.22.
Chequerboard titration for monoclonal antibodies and conjugate were carried
out by diluting these systems in blocking buffer using doubling serial dilution
ranging from 2-0.5 pg/ml (Antigen), 1:10-1:40 (monoclonal antibody) and 1:1000-
1:4000 (conjugate). The chosen antigen concentration, monoclonal antibody and
conjugate dilution were used in all subsequent sequential screenings. The faecal
samples were used at a strongest possible dilution of 1:1. The two positive sera PI
and P2 were taken from F. hepatica or F. gigantica infected animals and
corresponded week 8-10 (PI) and week 21-22 (P2) post infection for sheep and week
7 (PI) and 32 (P2) for calves. These times post infection were chosen to assess
responses at the middle and at the end of the experimental period and to optimise the
signal to background ratio. Full data is represented in Appendix tables 4.159-4.163
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Table 4.21 Sheep infected with F. hepatica or F. gigantica: optimal dilution of
antigen (/^g/ml), faecal sample and conjugate for polyclonal antibody
system using F. hepatica Glutathione S-Transferase antigen (Fh-GST).
Assay F. hepatica F. gigantica







Table 4.22 Sheep infected with F. hepatica or F. gigantica-. optimal dilution of
antigen (/rg/ml), faecal sample, monoclonal antibody (McAb) and
conjugate for monoclonal antibody system using F. hepatica
Glutathione S-Transferase antigen (Fh-GST).
Assay F. hepatica F. gigantica
Fh- faeces McAb Conj.
GST
Fh- faece McAb Conj.
GST s
IgG, 1 1:1 1:20 1:1000 1 1:1 1 20 1:1000
IgG2 1 1:1 1:20 1:1000 1 1:1 1 20 1:1000





















Reciprocal conjugate serial dilutions
BEN BP1 SP2
Figure 4.115: Antigen (FhGST) (a) and conjugate (b) titrations for total
Ig for F. hepatica showing the mean ELISA (450 nm) values obtained
from infected sheep and uninfected control sheep for diluent (B), negative
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Figure 4.116: Antigen (FgGST) (a) and conjugate (b) titrations for
total Ig for F. gigantica showing the mean ELISA values obtained
from infected sheep and uninfected control sheep for diluent (B),




















Reciprocal conjugate serial dilution
DIN BP1 §P2
Figure 4.117: Antigen (FhGST) (a), monoclonal antibody (b) and conjugate
(c) titrations for faecal IgA for F. hepatica infected sheep and
uninfected control sheep showing the mean ELISA (450 nm) values
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Figure 4.118: Antigen (FgGST) (a), monoclonal antibody (b) and conjugate
(c) titration for faecal IgA for F. gigantica infected sheep and
uninfected sheep showing the mean ELISA (450 nm) values obtained
for diluent (B) negative (N) positive (PI) and positive (P2)
289
Chapter Four: Results
4.7.2 Experiment 1: F. hepatica (Peruvian and British strain) Infection in
Sheep
Only total faecal Ig and IgA antibody responses to F. hepatica Glutathione S-
Transferase antigen (Fh-GST) were detected in the infected sheep. There were no
noticeable faecal IgGb IgM, and IgG2 response in the infected sheep (Figures 4.119a-
4.120b. The adjusted data is shown in Appendix Tables 4.164-4.166
All the infected sheep showed an early (2 wpi.) increase in total faecal Ig
levels peaking 6-7 wpi. OD values then started to fall by 8 wpi. only to start rising
again 12 wpi. showing a clear biphasic IgA response to Fh-GST. The first peak was
higher than the second peak.
There was early, 2 wpi., faecal IgA response to Fh-GST by sheep 6 and 9.
There was late response by sheep 7 and 10. It is clear that IgA was the main Ig
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Figure 4.119: The adjusted ELISA OD (450 nm) faecal total Ig (a), IgGi (b)
and IgM (c) responses of F. hepatica infected sheep 5, 6, 7, 9 and 10 and
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Figure 4.120: The adjusted ELISA OD (450 nm) faecal IgG2 (a) and IgA (b)
responses of F. hepatica infected sheep 5, 6, 7 and 9 and 10 uninfected contro
sheep 8 to F. hepatica Glutathion S-Transferase (FhGST)
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4.7.3 Experiment 3: F. gigantica (Kenyan strain) Infection in Sheep
Only total faecal Ig and IgA antibodies response was detected to Fh-GST in the
samples from F. gigantica infected animals. The subclasses IgM, IgGj and IgG2
were negative (Figures 4.121a-4.122b.
The infected sheep showed an early increase in total Ig levels, 4 wpi. and
peaked at 19 wpi. The mean OD levels started to drop from 22 wpi. By the end of
experiment however the mean OD values in the infected sheep were almost at the
same level as that of uninfected control sub group. The response was by phasic.
There was an early, 4 wpi., sharp faecal IgA response to Fh-GST F. gigantica
infected sheep with the peak 16 wpi. followed by a drop 20 wpi.
The mean ELISA ODs of adjusted data are presented in Appendix Tables
4.167-4.170 and adjusted data for the responses by the faecal antibodies in cattle to
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Figure 4.121: The adjusted ELISA OD (450 nm) mean + SEM faecal
total Ig (a), IgGi (b) and IgM (c) responses ofF. gigantica infected








Figigure 4.122: The adjusted ELISA OD (450 nm) mean + SEM faecal
lgG2 (A) and IgA (b) responses ofF. gigantica infected sheep (+) and





4.8.1 The Protein Concentration of the Fasciola spp. Excretory/Secretory
products
The adult F. hepatica and F. gigantica E/S products protein concentration
measured according to Warburgh and Christian (1941) is shown in Table 4.23. In all
cases the E/S with highest protein concentration 462 pg/ml and 196 pg/ml were used
for Western Blotting. The adult F. hepatica and F. gigantica E/S products used
throughout these studies were produced by liver fluke from experimentally infected
sheep.
Table 4.23: The protein concentration of excretory/secretory products from F
hepatica (British strain) and F. gigantica (Kenya strain) collected from livers of
experimentally infected sheep.
Period Cultured (Hours) Protein Concentration
(pg/ml)
Fh-E/S Products 0-24 237
24-48 462
Fg-E/S Products 0-24 186
24-48 196
The silver stained protein profile of the E/S products of adult F. hepatica and
F. gigantica are presented in figure 4.123. The different batches synthesised similar
polypeptides. However, due to low concentration, more polypeptides were in the 0-
48 hours preparation of both Fh-E/S and Fg-E/S than in 0-24 hours E/S. In reduced
sample the 24 hours Fh-E/S contained proteins of molecular weights ranging from 17
to 181 kDa, 48 hours Fh-E/SP ranging from 15 to 205 kDa, 24 hours Fg-E/S from 17
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Figure 4.123 Silver stain of 0-24 hours F. hepatica E/S Products (track 2), 24-48
hours F. hepatica E/S Products (track 3) 0-24 hours F. gigantica
E/S Products (track 4) and 24-48 (track 3 and 5) hours and 24-48
hours F. gigantica E/S Products (track 5) following separation
using SDS-PAGE. Samples were all run under reduced conditions.
The protein of the molecular weight xlO markers are on the left.
4. 13.2 Experiment 1 & 2 F. hepatica Infected Sheep
Titration
The results to determine the optimum serum and biotinulated rabbit anti-
sheep conjugate dilutions for use in Western Blotting are shown in Figure 4.124. The
24-48 hours adult F. hepatica E/S was selected for the assay. The undiluted 24-48
hours Fh-E/S solutions concentration of 462 pg/ml was found to be sufficient for
assay. The test sera of 1/50 and 1/2000 biotinulated donkey anti-sheep IgG produced
the most clear reaction and therefore was used in all subsequent Western Blotting
assays in F. hepatica infected sheep. Streptavidin alkaline phosphatase was used as
recommended by the manufacturers (1/3000). The sera of infected sheep were able
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Figure 4.124 Titration to determine the optimum F. hepatica infected sheep serum
and biotin labelled anti-sheep conjugate dilutions for immunostaining
electroblotted 24-48 hours F. hepatica E/S products under reducing
conditions. The position of molecular weight markers (Mr) are
shown on the left and below are lane numbers.
Lanes 1 6, 11 and 16 4% NRS/PBS/Tween 20
Lanes 2-5 and 12-15 1:50 serum from infected sheep
Lanes 7-10 and 17-20 1:100 serum from infected sheep
Lanes 1-10 1:2000 Donkey anti-sheep conjugate




There was a common antigen recognition in all F. hepatica infected sheep
serum although the time and duration of the recognition of individual antigen
differed from sheep to sheep. By 3-5 wpi. antigens of 54 kDa and 79 kDa were
recognised by all the infected sheep serum. A 14 kDa molecule doublet was
recognised by all the infected sheep serum, (sheep 7, 9, 10, 24, 26, 28 and 30),
starting from 7-8 wpi. A high molecular weight of 134 kDa was recognised by serum
from sheep 7 infected with British F. hepatica and 10 infected with Peruvian F.
hepatica. The results for uninfected control sheep were negative so were the
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Figure 4.125 (a & b) The 24-48 hours Fh-E/S recognition by sera of F. hepatica
infected sheep 7 (a) and sheep 9 (b) under reducing
condition. The position of molecular weight markers (Mr)
pre-bleed (0) and diluent (d) and the numbers at the bottom
represent weeks post infection (wpi.) and the molecular
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Figure 4.126 (a & b) The 24-48 hours Fh-E/S recognition by sera of F. hepatica
infected sheep 10 (a) and 28 (b) under reducing condition.
The position ofmolecular weight markers (Mr) pre-bleed (-2)
and diluent (-1) and the numbers at the bottom represent
weeks post infection (wpi.) and the molecular weights are
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Figure 4.127 The 24-48 hours Fh-E/S recognition by sera of F. hepatica infected
sheep 30 under reducing condition. The position of molecular
weight markers (Mr) pre-bleed (-1 & -2) and diluent (d) and the
numbers at the bottom represent weeks post infection (wpi.) and
the molecular weights are shown on the left hand side of the
figures.
4. 8.3 Experiments 3 & 4: F. gigantica Infected Sheep
Titration
The results to determine the optimum, serum and biotinulated rabbit anti-
sheep conjugate, dilutions for use in immunostaining electroblotting are shown in
Figure 4.128. The 24-48 hours adult F. gigantica E/S was selected for the assay.
The undiluted 24-48 hours Fg-E/S solutions concentration of 196 pg/ml was found to
be sufficient for assay. The test sera of 1/50 and 1/2000 biotinulated rabbit anti-
sheep Ig produced most clear reaction and therefore was used in all subsequent
western blotting assays in F. gigantica infected sheep. Streptavidin alkaline
phosphatase was used as recommended by the manufacturers (1/3000). The sera of
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Figure 4.128 Titration to determine the optimum F. gigantica infected sheep serum and
biotin labelled anti-sheep conjugate dilutions for immunostaining electroblotted 24-48 hours
F. gigantica E/S products under reducing conditions. The position of molecular weight
markers (Mr) are shown on the left.
Lanes 1-, 6, 11 and 16 4% NRS/PBS/Tween 20
Lanes 2-5 and 12-15 1:50 serum from infected sheep
Lanes 7-10 and 17-20 1:100 serum from infected sheep
Lanes 1-10 1:2000 Donkey anti-sheep conjugate
Lanes 11-20 1:4000 Donkey anti-sheep conjugate
Western Blotting
There was a common antigen recognition in all F. gigantica infected sheep
serum although the time and duration of the recognition of individual antigens
differed from sheep to sheep. By 3-5 wpi., antigens of 14 kDa was recognised by all
the infected sheep sera. Other molecular weights recognised after patency by the F.
gigantica infected sheep include a 152 kDa as recognised by sheep 12, 25 and 29 and
88 kDa as recorded by sheep 14 and 29. The results of uninfected control were
similar to those of pre-bleeds of the infected experimental animals. The two Western
Blotting figures are a representative the antigen recognition pattern of all F. gigantica















MR. -1 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 34 35 .] _2
Figure 4.129 (a & b) The 24-48 hours Fg-E/S recognition by sera of F. gigantica
infected sheep 11 (a) and 12 (b) under reducing condition.
The position of molecular weight markers (Mr) pre-bleed (-1)
and diluent (d) and the numbers at the bottom represent
weeks post infection (wpi.) and the molecular weights are
shown on the left hand side of the figures.
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4. 8.4 Experiment 5: F. hepatica Infected Cattle
Titration
The results to determine the optimum serum and biotinulated goat anti-bovine
conjugate dilutions for use in immunostaining electroblotting are shown in Figure
4.130. The 24-48 hours adult F. gigantica E/S was selected for the assay. The
undiluted 24-48 hours Fh-E/S solutions concentration of 462 pg/ml was found to be
sufficient for assay. The test sera of 1/50 and 1/2000 biotinulated bovine anti-bovine
Ig produced most clear reaction and therefore was used in all subsequent western
blotting assays in F. hepatica infected sheep. Streptavidin alkaline phosphatase was
used as recommended by the manufacturers (1/3000). Titration results for F. hepatica
infected sheep showed 7 prominent molecules with the majority banding between 69
kDa and 40 kDa. The other two were one measuring 116 kDa and the other large
molecule 134 kDa as shown in Figures: 4.130 There were less than 8 visible antigens
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Figure 4.130 Titration to determine the optimum F. hepatica infected cattle serum
and biotin labelled anti-bovine conjugate dilutions for immunostaining
electroblotted 24-48 hours F. hepatica E/S products under reducing
conditions. The position ofmolecular weight markers (Mr) are shown
on the left.
Lanes 1-, 6, 11 and 16 4% NGS/PBS/Tween 20
Lanes 2-5 and 12-15 1:50 serum from infected sheep
Lanes 7-10 and 17-20 1:100 serum from infected sheep
Lanes 1-10 1:2000 Goat anti-sheep conjugate




The was a lot of variation in response to Fh-E/S in calves of these animals
(Figures: 4.131-4.132 ). Calf 14c first recognised 142 kDa 7 wpi., other molecules
included a 40 kDa 19 wpi. and 62 kDa after 20 wpi., Calf 15c on the other hand
recognised more molecules than calf 14c namely a 142 kDa doublet, 60 and 40 kDa
by 7 wpi. and 10 wpi. a 14 kDa was also recognised. Most of these antigens were
less prominent by 37 wpi. The antigen with 142 molecular weight was the most
interesting in this calf with challenge infection, after appearing 7 wpi. this molecule
faded away by 18 wpi. only to reappear three weeks after challenge infection. Calf
23c serum recognised all the molecules calf 15 did and after challenge similar
response to molecule 142 was shown. The results of uninfected control calf 26c were
similar to those of pre-bleeds of the infected experimental animals. Calves 34c and
45c clearly recognised a 14 kDa molecule by 6 wpi. Another less clear molecule
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Figure 4.131 (a & b) The 24-48 hours Fh-E/S recognition by sera of F. hepatica
infected calf 15c -1 to 17 wpi. (a) and 20 to 32 wpi.(b) under
reducing condition. The position of molecular weight markers
(Mr) pre-bleed (n) and diluent (d) and the numbers at the
bottom represent weeks post infection (wpi.) and the
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Figure 4.132 (a & b) The 24-48 hours Fh-E/S recognition by sera of F. hepatica
infected calf 23c, -1 to 17 wpi. (a) and 20 to 32 wpi.(b) under
reducing condition. The position ofmolecular weight markers
(Mr) pre-bleed (-1) and diluent (-2) and the numbers at the
bottom represent weeks post infection (wpi.) and the




4.8.5 Experiment 6: F. gigantica Infected Calves
Titration
The results to determine the optimum, serum and biotinulated goat anti-
bovine conjugate, dilutions for use in immunostaining electroblotting are shown in
Figure 4.133.
The 24-48 hours F. gigantica was selected for the assay because of it's clearer
banding results obtained by SDS-PAGE/Silverstain. The undiluted 24-48 hours Fg-
E/S solutions concentration of 196 pg/ml was found to be sufficient for assay for F.
gigantica infected calves. The test sera of 1/50 and 1/2000 biotinulated goat anti-
bovine Ig produced most prominent antigens therefore was used in all subsequent
western blotting assays. A one to three thousand parts (1/3000) dilution of
Streptavidin alkaline phosphatase was used as recommended by the manufacturers.
Titration results show recognition ofmore than ten molecules starting from 11 to 142
kDa molecular weight.
Western Blotting
There was clear change in the antigen recognition pattern of infected calves
throughout the course of infection. In the early stage antigens of doublet 134 kDa
was recognised first 4-5 wpi. A different set of antigens, doublet 14 and doublet 60
kDa Mwt were recognised 8-9 wpi. The results of the uninfected control were
similar to those of pre-bleeds of the infected experimental animals. The results of
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Figure 4.133 (a & b) Titration to determine the optimum F. gigantica infected
cattle serum and biotin labelled goat anti-bovine conjugate
dilutions for immunostaining electroblotted 24-48 hours F.
gigantica E/S products under unreducing (a) reducing (b)
conditions. The position of molecular weight markers (Mr)
are shown on the left and on the bottom is the number of
lanes.
4% NGS/PBS/Tween 20
1:50 serum from infected sheep
1:100 serum from infected sheep
1:2000 Donkey anti-sheep conjugate
1:4000 Donkey anti-sheep conjugate
Lanes 1-, 6, 11 and 16
Lanes 2-5 and 12-15
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Figure 4.134 (a & b) The 24-48 hours Fg-E/S recognition by sera of F. gigantica
infected calf 22 under reduced (a) and unreduced conditions
(b) under reducing condition. The position of molecular
weight markers (Mr) pre-bleed (-1) and diluent (-2) and the
numbers at the bottom represent weeks post infection (wpi.)
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Figure 4.135 (a & b) The 24-48 hours Fg-E/S recognition by sera of F. gigantica
infected calf 23 under reduced (a) and unreduced conditions
(b) under reducing condition. The position of molecular
weight markers (Mr) pre-bleed (-1) and diluent (-2) and the
numbers at the bottom represent weeks post infection (wpi.)
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Figure 4.136 (a & b) The 24-48 hours Fg-E/S recognition by sera of F. gigantica
infected calf 24 under reduced (a) and unreduced conditions
(b) under reducing condition. The position of molecular
weight markers (Mr) pre-bleed (-1) and diluent (-2) and the
numbers at the bottom represent weeks post infection (wpi.)






The discussion is divided into four main sections, first the clinical status and
disease pathogenesis of the Fasciola spp infected sheep and cattle used in this study,
secondly their serum glucose and P-HOB levels, thirdly their serum and faecal
antibody isotype responses to defined Fasciola spp. antigens and finally the general
conclusions.
Fasciolosis is an economically important disease caused by digenic
trematodes of the genus Fasciola. F. hepatica and F. gigantica are the two most
important species responsible for fasciolosis. Both species are transmitted by snails
of the family Lymnaesidae. F. hepatica prevails in temperate regions while F.
gigantica is predominant in tropical zones (Over, 1982).
Fasciola spp. invasive larvae, or metacercariae, escape from their protective
cyst in the duodenum or jejunum of the definitive host and penetrate the intestinal
wall to reach the peritoneal cavity. Flukes specifically target the liver causing liver
pathology and necrotic lesions, which result from the parasites' migration through
the liver parenchyma. Further damage is caused when they enter the bile ducts
causing haemorrhage (Malek, 1980). The second important factor is that flukes are
haemophageous and infection results in anaemia.
Sinclair (1967) reviewed the pathogenesis of Fasciola spp in different
definitive host species and concluded that there are broad similarities, but
considerable species variation, in the pathology of fasciolosis. Thus F. hepatica and
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F. gigantica, differ in their pathogenicity and related production loss with F.
gigantica being more pathogenic and causing more production loss than F. hepatica
(Hammond and Sewell, 1990; Mahato, 1993).
It is also established that there are host species differences in resistance to
infection/reinfection with fasciolosis (Boray, 1969; Haroun and Hillyer, 1986;
Burger, 1992). Cattle, rats and goats develop strong resistance to challenge infection
with F. hepatica and F. gigantica following primary infection or drug-abbreviated
infection (Haroun and Hillyer, 1986) but accumulated evidence indicates that mice
and the majority of sheep breeds do not develop such resistance (Boray, 1969).
However, breed variation does occur as a small number of sheep breeds such as the
Red Maasai sheep (Wamae, 1996) and Indonesian thin tailed sheep (Roberts,
Estuningsil, Wijayanti, Wiedosari, Partoutomo and Spithill, 1997) are relatively
resistant to Fasciola spp. infection/reinfection.
From the above information, it is clear that, in the study of cattle and sheep
responses following infection either with F. hepatica or F. gigantica, we have a
useful system in which to investigate the basis of species differences in
susceptibility/resistance to parasite infection. Furthermore we can take advantage
from employing two parasites which differ in the severity of the pathology they cause
in definitive hosts.
The primary aim of this study was to examine whether the observed host
species differences in resistance and susceptibility is related to species difference in
the immune response following infection. This was done by examining the serum
and faecal antibody isotype responses of experimentally infected sheep and cattle to
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defined adult Fasciola spp. antigen (E/S, Cathepsin and GST) with the intention of
relating these findings to what is currently known about helper T-cell responses.
The second aspect of the study was to examine the effects of fasciolosis on
the serum glucose and (3-HOB levels in sheep and cattle. In ruminants, the liver is
the main store for glycogen and glycogen, which is a glucose reservoir, may
constitute as much as 8% of the liver compared to 1% or less in the skeletal muscles
(Breazile, 1971). The migrating flukes damage the liver resulting in severe liver
pathology and death of hepatocytes, which may potentially reduce liver glycogen
reservoirs (Berry and Dargie 1976; Ferre, Barrio, Gonzalez-Gallego and Rojo-
Vazquez, 1994). A reduction in available liver glycogen will lead to a reduction in
serum glucose levels and a corresponding increased mobilisation of free fatty acids,
resulting in increased serum ketone bodies of which the (3-HOB accounts for 80%
(Doxey, 1983; Fraser, 1991; Sanchez, Alvareg and Lunusse, 1996). The aim
therefore was to examine changes in glucose and P-HOB levels in infected sheep and
cattle considering this in relation to the severity of infection. The rationale being that
the potential interruption or disruption of carbohydrate metabolism may at least in
part be responsible for serious impairment of the animal productivity and growth, a
characteristic of fasciolosis.
5.1 Pathogenesis and clinical status of experimental animals
This study mainly investigated the immunoglobulin isotype responses of
sheep and cattle, chronically infected with F. hepatica and F. gigantica, to defined
the fluke antigens (F. hepatica E/S products (Fh-E/S) or F. gigantica E/S products
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(Fg-E/S), Fh-cathepsin and Fh-GST). Chronic infection was established because
immunity is considered to play a potentially more important role in chronic
fasciolosis than in acute infection. Acute fasciolosis is normally characterised by the
early death of the animal through severe liver pathology caused by migrating flukes
resulting in anaemia and haemorrhages caused by the flukes entering the bile ducts.
In order to determine the severity of the disease in infected sheep and cattle, clinical
findings, haematological, parasitologial, clinical biochemical and pathological
parameters were recorded and analysed. All the infected animals developed a
chronic fasciolosis with sheep showing a consistently more severe syndrome than
cattle.
5.1.1 Clinical Findings
The direct relation in sheep between clinical signs and the level of
metacercaria infection observed in this study is in agreement with Losos (1986) and
Burger (1992). For example sheep infected with 300-350 F. hepatica metacercariae
displayed appetite depression and reduction in live weight gain, while the two sheep
infected with 200 metacercariae showed no clinical signs, except for slight live
weight gain reduction. However, the F. hepatica metacercariae infection doses used
in all sheep were enough to cause chronic fasciolosis.
The infective doses of F. gigantica metacercariae in sheep were generally
lower than that of F. hepatica but the overall clinical signs were more severe in F.
gigantica infected sheep. The disease was so severe in sheep 13 infected with 100
F. gigantica metacercariae (45 flukes recovered) that it had to be culled 15 wpi. The
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same problem lead to the premature culling of sheep 23 infected with 150
metacercariae (80 flukes recovered) and sheep 25 infected with 350 F. gigantica
metacercariae (181 fluke recovered). The reasons for these differences in severity in
clinical signs between F. hepatica and F. gigantica are considered to be due to the
relative larger size of F. gigantica and the fact that F. gigantica spends a longer
period in the liver parenchyma than F. hepatica (Ogunrinade, 1984a and Mahato,
1993).
The absence of clinical signs in some sheep and in all the cattle infections
was considered due to the light infective dose which is in agreement with Hammond
(1973), Wiedosari and Copeman (1990) and Radostits, Blood, and Gay, (1994). The
lack of clinical signs in cattle was not surprising considering that the infective dose
was low with the fluke burden per Kg live weight below 0.15. This is also in
agreement with Bitakaramire and Bwangamoi (1969) who reported 500 F. gigantica
metacercariae to cause clinical signs in calves.
In conclusion the sheep had a clear chronic fasciolosis with some sheep more
severely affected but cattle displayed a chronic fasciolosis with few clinical signs.
5.1.2 Parasitology
There was significant difference between prepatent period of F. hepatica
infected sheep and F. gigantica infected sheep (t = 6.60 p<0.001) suggesting that F.
hepatica has a shorter prepatent period than F. gigantica in both sheep and cattle
which is in agreement with Hammond (1970), Soulsby (1982) and Mahato (1994).
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As reported by Mahato (1993) there was great variation in eggs counted in
individual animals which had no apparent relationship with the worm burden.
5.1.3 Pathology
There were variable gross pathological changes in both sheep and cattle
infected with both Fasciola spp. In general the lesions observed in this study are
comparable to those reported by Hammond (1970), Ogunrinade (1984a), Ajanusi,
Ogunsusi, Njoku, and Cryang, (1988) and Mahato (1993). As was expected the
lesion were most severe in culled sheep and calves with single infection but culled
earlier (11-16 wpi.) in the infection and those calves with challenge infection.
The lesions observed in sheep culled early in the experiments included
enlarged livers with prominent haemorrhagic tracks and fibrous peritonitis. Some of
the sheep had blood stained fluid in the peritoneal cavity. Ajanusi, Ogunsusi, Njoku
and Cryang (1988) reported similar lesions in sheep infected with F. gigantica and
Ogunrinade (1983) in cattle infected with F. gigantica. Mahato (1993) observed
similar changes in water buffaloes. Only slight pathological lesions were observed in
the majority of sheep livers, enlarged bile ducts being the most common.
Bitakaramire and Bwangamoi (1969) were able to show that the liver lesions
are most severe during prepatent period of F. gigantica infection due to flukes
migration. This explains why severe lesions were found only in animals culled in the
early stages of infection in these studies. Calves showed severe calcification
especially in those animals with challenge infection. This was in accordance with
Bitakaramire and Bwangamoi (1969) and Jones and Hunt (1983) who reported that
320
Chapter Five: Discussion
calcification is part of the pathology of fasciolosis in cattle. Calcification was not
observed in sheep as also reported by Mahato (1993).
One other prominent gross lesion was the presence of hepatic abscesses in
sheep with more severe pathological changes. This is in agreement with O'Sullivan
(1995) who after two years analysis of liver lesions from abattoirs in UK found that
abscesses due to F. hepatica infections were common.
Histopathological lesions found in these experiments ranged from peripheral
fibrosis, infiltration of mononuclear inflammatory cells in periportal areas, fibrosis
and hyperplasia of the bile ducts. This in agreement with Mahato (1993). There
were also eggs trapped in bile ductiles of livers of sheep 13 culled after 15 wpi. and
in calf 23c challenged by 15 wpi. and culled 12 weeks post challenge.
5.1.4 Haematology.
The onset of anaemia was earlier in F. hepatica infected sheep than in those
infected with F. gigantica and the anaemia was more pronounced in F. hepatica
infected sheep with high infective dose per kg than in those infected with F.
gigantica. The elevation in MCV, and lack of changes in the MCHC indicate that
sheep infected with 200 F. hepatica metacercariae developed macrocytic
normochromic anaemia while those infected with 300 F. hepatica metacercariae, had
an elevated MCV and reduced MCHC suggesting a normocytic hypochronic
anaemia. The other F. hepatica and F. gigantica infected sheep also displayed a
macrocytic normochromic anaemia in agreement with Mahato (1993) who observed
a macrocytic normochromic anaemia in his sheep fasciolosis experiments. The F.
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gigantica infected sheep on the other hand had a predominantly normocytic
normochromic anaemia in agreement with Sewell (1966), Hammond (1970) and
Wiedosari and Copeman (1990). The absence of anaemia in the cattle experiments
was considered to be due to the light infection.
Differential white blood cell counts agreed with Hammond's (1970)
conclusions that the only clearly defined change occurring in fasciolosis in sheep and
cattle is a consistently high eosinophilia with slight elevation in number of
lymphocytes and neutrophils but monocytes and basophils fluctuate within a normal
range.
5.1.5 Clinical biochemistry
There was an initial rise in serum total protein levels in all the infected sheep
but less so in cattle. The rise was followed by a fall by 10-12 wpi. Hammond (1970)
and Mahato (1993) findings agree with the above observations. Hammond (1970)
was able to show that much of the initial increase in serum globulin fraction of the
total protein concentration was due to y-globulin fraction, he however also noticed an
increase in the a- and P-fractions.
There appears to be a positive relationship between higher infective dose and
severity of hypoproteinemia and hypoalbuminaemia in F. hepatica infected sheep.
Hypoproteinaemia was more severe in sheep infected with F. gigantica which have
lost more lost more protein than those infected with F. hepatica confirming that F.
gigantica is more pathogenic than F. gigantica (Burger, 1992).
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Hypoalbuminaemia followed the same pattern as serum total protein except
that there was no initial increase. Mahato, (1993) and Wamae (1996) found the same
pattern in serum total protein and albumin in sheep and goats. Holmes, Dargie,
MacLean and Mulligan (1968b) associated hypoproteinaemia in chronic ovine
fasciolosis with hypercatabolism of albumin and globulin due to loss of protein into
the bite ducts of the infected animals.
GLDH activities in both F. hepatica and F. gigantica infected sheep
increased significantly in the third week of infection confirming the findings by
Mahato (1993) and Wamae (1996). The increase in this serum enzyme activity was
greater in infected sheep with high infective dose per kg live weight. The decline in
serum GLDH by 11 wpi. in both F. hepatica and F. gigantica sheep is due to
reduction of damage to the liver parenchyma because most flukes have reached the
bile ducts and the parenchyma has started to regenerate (Wamae, 1996). The results
agree with Hughes, Teacher and Harness (1974) who suggested that in F. hepatica
infected goats, GLDH levels reach a peak at the period of maximum fluke activity in
the liver parenchyma before they enter the bile ducts. In heavy infections the tissue
damage is greater and the peak is very heavy activities the peak may be reached by 3
wpi.
Serum GLDH in cattle followed a similar pattern except the levels were lower
possibly due to low infective doses used. In the F. gigantica infected calves
however the decline in GLDH levels was later at 14 wpi. This may be explained by




There appeared to be to no increase in GLDH after challenge infection in
calves. Fernandez (1984) reported increased serum GLDH activities both after initial
and challenge infection. This difference is perhaps because our challenge infective
dose was only 100 F. hepatica metacercariae per calf while Fernandez (1984) used
1000 metacercariae per animal for both initial and challenge infection.
Other authors (Rowlands and Clampitt, 1979; Wamae, 1996) also found that
in some animals there was a second small serum GLDH activity elevation. Wamae
(1996) suggested that it could be due to late migration. This reasoning is similar to
Rowlands and Clampitt (1979) who found that flukes were still in the migratory
stage when the majority were in already in the bile ducts. It is also suggested that
fibrosis of the liver parenchyma could lead to cell degeneration hence GLDH
elevation in the serum (Wamae, 1996). Hughes, Teacher and Harness (1973)
suggested after planting immature flukes in the biliary system of goats and recording
elevated GLDH that this may be due to diffusion of toxic product or an auto-immune
response.
The serum y-GT activities in cattle on the other hand rose much later at 12
wpi. There was however, an earlier (4-5 wpi.) increase y-GT serum activities in
cattle which could be as a result of damage of small bile ducts as the flukes migrate
to the main bile ducts as suggested by Burger (1992).
Changes in serum GLDH and y-GT levels during the course of
experimentally induced infection with both F. hepatica and F. gigantica are in
accordance with previous studies, which indicate that serum activities of liver
enzymes are sensitive indicators of liver damage in sheep and cattle (Sykes, Coop
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and Robinson, 1980; Mahato, 1993; Wamae, 1996; Ferre, Ortega-Mora and Rojo-
Vazquez, 1997). Increased GLDH serum levels are related to migration of juvenile
flukes through the liver parenchyma and are associated with inflammation and tissue
destruction. On the other hand, the increase in serum y-GT activities coincides with
the entrance of adult flukes into the biliary system and is associated with hyperplastic
cholangitis (Blood, 1994)
5.1.6 Glucose and (3-hydroxybutyrate
The results in these experiments show reduction in glucose levels in infected
sheep from as early as 3 wpi. This continued till the end of infection in both F.
hepatica and F. gigantica infected sheep. There were no significant differences
between calves infected with either fluke species and the uninfected control calves in
serum glucose levels. The sheep results are in agreement with Ferre, Barrio,
Gonzalez-Gallego and Rojo-Vazquez (1994) who reported decreased glucose values
from 40 days post infection in lambs infected with F. hepatica while the controls
showed no decrease. It is possible that the plasma glucose values were lower than
normal due to the hepatic glycogenic pathways being depressed. Another factor to
be considered for the reduction of glucose is the reduction of voluntary feed intake
by the infected sheep. Kouider and Kolb (1994) also reported reduction of glucose in
F. hepatica infected sheep prior to injecting them with ascorbic acid. However there
is generally lack of research on the effect of fasciolosis on glyconeogenesis.
In ruminants food deprivation induces breakdown of body tissue and causes a
shift in the main energy producing pathway, trichloroacetic acid cycle (TCA-cycle)
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towards increased formation of ketone bodies (P-OHB and acetoacetate) as a result of
insufficient supply of acetoacetate precursors (Wensvoort, Kyle, Rskov and Bourke,
1996). Thus in sheep and cattle infected with Fasciola spp, the migratory flukes
damaging the hepatic glycogenic pathways and poor appetite may lead to increased
production of ketone bodies. The poor nutrition status due to reduction in voluntary
feed intake in sheep was corroborated by the high serum P-OHB in this study. This
in agreement with Sanchez; Alvarez and Lanusse (1996) who reported that feed
restriction in sheep does lead to increased P-OHB serum concentration. Wensvoort,
Kyle, Rskov and Bourke, (1996) after starving sheep, cattle, camels and llama for 5
consecutive days with 6 weeks in between found that sheep and cattle recorded
decreased serum glucose and increased serum P-OHB similar to the sheep results in
this study.
5.2. Serum antibody responses to defined Fasciola spp antigens
This part of the study investigated the immunoglobulin isotype responses of
sheep and cattle, chronically infected with F. hepatica and F. gigantica, to defined
fluke antigens Fh-E/S, Fg-E/S, Fh-cathepsin and Fh-GST).
There was an early (2-3 wpi.) total Ig response to Fh-E/S and Fg-E/S, Fh-
cathepsin and Fh-GST in both F. hepatica infected sheep and cattle. Although there
was an early (2-3 wpi.) total Ig response to Fh-E/S and Fg-E/S, and Fh-GST by F.
gigantica infected animals, there was a slight delay (7 wpi.) in the response to Fh-
cathepsin. The pattern of the IgG) response of cattle and sheep to these defined fluke
antigens was similar to that of total Ig. In fact the serum isotype response was
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predominantly IgG). The IgM response to Fh-E/S and Fg-E/S, Fh-cathepsin and Fh-
GST was early in both species. In cattle the IgG2 and IgA responses to Fh-E/S and
Fg-E/S were late (11 wpi. and 19 wpi. respectively) in contrast to sheep (2 wpi. for
both isotypes). The isotype responses to individual antigens are discussed under
respective antigens below.
There was no relationship between the serum antibody levels to Fh-E/S, Fh-
E/S, Fh-Cathepsin and Fh-GST in indirect ELISA by individual animals and the
infective doses (100, 150, 300 and 350 in sheep or 200, 450, 600 in cattle), fluke
burden or pathological changes observed during post-mortem. This lack of influence
in the primary infective dose in the antibody response has previously been reported in
sheep with 250 and 500 metacercariae by Zimmerman, Farnsworth, Cerro and
Wescott (1982) and more recently by Martinez, Martinez-Cruz, Martinez, Gutierrez
and Hernandez (1996) in goats infected with 100 or 200 metacercariae. However,
this apparent lack of difference may be related to the sizes of the infective doses,
because Wyckoff and Bradley (1986) reported significant differences in cattle
infected with 3000 and 30 metacercariae but not with 3000 and 300 or with 300 and
30.
The lack of relationship between antibody levels and the number of flukes
recovered in this study agrees with Sandeman and Howell (1980). Dalton,
McGonigle, Ralph and Andrew (1996) also reported lack of correlation between total
Ig response, assessed by ELISA and immunoblot, and the levels of protection
obtained in cattle vaccinated with Cathepsin-Ll protease and those vaccinated with
Cathepsin-Ll protease Cathepsin-Ll protease and haemoglobin.
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Cathepsin LI protease is more immunogenic than Fh-GST however the current
attempts to use it as a vaccine candidate for Fasciola infection in ruminants and
humans (Dalton, McGonigle, Ralph and Andrew, 1996; Emery, 1996) appears to
suggest that the molecule is of limited value as a vaccine candidate and that in future
more molecules should be isolated from Fasciola spp. E/S products and examined
for immunogenicity and protective properties.
5.2.1 Fasciola spp. E/S products
The measurements of antibodies against certain Fasciola spp.
excretory/secretory products (E/S) in Fasciola spp infected animals may assist in the
diagnosis of fasciolosis and also demonstrate an antigen recognition pattern that
could be associated with immunity. Thus serving as a tool to investigate reasons
why cattle are more resistant to primary (Ross, 1967; Boray, 1967, 1969) and to
challenge infection (Doy, 1973; Fernandez, 1984) than sheep.
A number of studies have evaluated different antigens and test systems for the
serodiagnosis of fasciolosis, and numerous attempts have been made to detect
antibodies stimulated by Fasciola spp. infections (Nyanzunda, 1993; Wamae, 1996).
The use of excretory/secretory parasite products (E/S) rather than somatic antigens
afford a chance to study products actively produced by the living liver fluke. Somatic
F. hepatica antigens were shown to be inferior to 24 hours E/S products in diagnosing
experimental and natural infections (Sinclair and Wassail, 1988) using an ELISA
method. Such products have been used in Western Blot analysis as well as ELISA for
immunochemical analysis and diagnosis studies. Martinez-Moreno, Jemenez,
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Martinez-Cruz, Martinez-Moreno, Beccerra and Hernandes (1997) used F. hepatica
E/S products as antigen in an Enzyme-Linked Immunosorbent Assay (ELISA) to
asses drug efficacy in goats with experimental and natural infections.
This study has clearly demonstrated that F. hepatica and F. gigantica infected
sheep and calves develop clear total Ig responses to F. hepatica E/S (Fh-E/S) and F.
gigantica E/S (Fg-E/S) starting from 2 weeks post infection and reaching high levels
by 8 wpi. in sheep and 3-7 wpi. in cattle. This early response to adult Fasciola spp.
E/S antigen suggests an early exposure to the antigen presumably through the cross-
reacting E/S products of juvenile flukes. This does suggest that juvenile flukes
secrete enough antigenic E/S products to provoke a detectable antibody response.
These results are in agreement with those obtained by Wamae (1996), who reported
specific total Ig responses to Fg-E/S by 2 wpi in sheep and cattle with primary F.
gigantica infection. Also with Santiago and Hillyer (1988) who, assessing the
reactivity of sera from ruminants with F. hepatica using somatic and E/S antigens by
ELISA and Western Blot, found that major antigenic E/S polypeptides of 23-28 kDa
were detected by 4 weeks post infection. In addition Sinclair and Wassail (1988)
found that there was greater sensitivity and consistency in antigens prepared from
metabolic and secretory products compared with somatic antigens.
Few sequential immunoblot, Western Blot, analyses have been carried out to
monitor the total Ig response to Fh-E/S and Fg-E/S in the course of infection in both
sheep and cattle infected with F. hepatica and F. gigantica. The Western Blot results
in calves showed that all F. hepatica infected calves sera first recognised a 142 kDa
doublet by 7 wpi. and a 134 kDa molecule by all F. gigantica infected calves. A new
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prominent 60 kDa molecule in both groups of cattle replaced the higher one after
patency. Other prominent molecules recognised in the course of infection was a 14
kDa doublet in both F. hepatica and F. gigantica infections. There was a clear
consistent shift in antigen recognition by cattle from higher (134 kDa for F.
gigantica infection and 142 kDa for F. hepatica infection) to lower (60 kDa for both
parasite species) affirming the reports by Nyanzunda (1993) and Wamae (1996), who
examined F. gigantica infected cattle, but there was no clear shift in antigenic
recognition by sheep sera.
In F. hepatica infections in sheep Western Blot analysis identified 14, 54, 79
and 134 kDa proteins whereas F. gigantica infected sheep sera recognised products
of 14, 88 and 152 kDa. However comparison of molecular weights of
immunoreactive proteins with the published data was difficult due to differences in
methods used to calculate these weights. These results are close to those reported by
Chauvin, Bouvet and Boulard (1995) who observed in sheep infected with F.
hepatica 12 major antigenic proteins ranging from 9 to 156 kDa with those of 20,
24, 51 and 69 kDa described as specific for F. hepatica.
There were differences in recognition pattern between sheep and cattle as
well as within the same host species. These variations in recognition pattern of
antigenic molecules by different host animals during the course of infection was also
reported by Marrero, Santiago and Hillyer (1988) and Wamae (1996).
The present work clearly shows that there is a shift in antigen recognition in
cattle at or after the time of patency (i.e. eggs in faeces) but not in sheep. The
consequences of this difference is open to speculation but it could be that the lower
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Mwt antigens are involved in resistance in cattle fasciolosis which would imply a
protective role for the 60 kDa antigen. The role of a 14 kDa antigen is unclear
considering that it is detected by both sheep, the host considered susceptible, and
cattle the resistant host.
Antibody isotype analysis indicated that in infected sheep the antibody
response to Fh-E/S and Fg-E/S was predominated by IgG, while IgM, IgG2 and IgA
responses could also be detected. The results in cattle also indicated that the
response was predominantly IgG, from 3 wpi. however IgG2 response was equally
strong but late (19 wpi.) in F. hepatica infected cattle and there were clear detected
IgA responses in both F. hepatica and F. gigantica cattle. This is in agreement with
Movsesijan, Jovanovic, Aalund and Nansen (1975) who, after employing the indirect
fluorescence antibody technique in F. hepatica infected sheep found that IgG!
response was dominant to F. hepatica digestive tract antigens. Clery, Torgerson and
Mulcahy, (1996) working with cattle also reported a predominantly IgG, response to
adult F. hepatica somatic antigen in F. hepatica infection. The IgG, subclass
dominance in ruminant fasciolosis has also been detected by Poitou, Baeza and
Boulard (1993) IgM, IgG, and IgG2 antibody isotype response to adult fluke 0-24
hour E/S antigen in rats with primary F. hepatica infection. This isotype, IgG,
dominance is also reported in other helminth infections. For example McKeand,
Duncan, Urquhart and Kennedy (1996) reported an initial IgM response preceded
with IgG, and IgG2 in calves infected with or vaccinated against Dictyocaulus




Sheep exhibited an early but low IgA and IgG2 response to Fh-E/S and Fg-E/S,
Doucil, Green and Risdon (1994) also reported these isotype responses in sheep
infected with Trichostrongylus colubriformis and treated with Dexamethazone.
The comparison of the isotype responses between infected sheep and infected
cattle shows that cattle developed early total Ig, IgG1; IgM but late response IgG2 and
IgA, while in the infected sheep all the isotypes developed earlier. The sheep IgG2
and IgA responses were generally lower than in cattle and lasted for a shorter period
(ca. 3-4 weeks). In F. hepatica infected cattle the IgG2 response, though late, was
stronger than in F. gigantica infected cattle.
The differences in responses between host species is difficult to explain
considering that not all immunogenic components of Fasciola spp. E/S have been
isolated and their influence on individual immune response to Fasciola spp.
infection analysed.
This earlier detection of an antibody detection of an antibody response
indicates a similar antigenic pattern between juvenile and adult flukes with respect to
Fh-E/S and Fg-E/S. Juvenile flukes share antigens with both metacercariae and
adults (Sandeman and Howell, 1980).
After challenge, the two F. hepatica infected and challenged calves (15c and
23c) showed no increased IgM, IgG2 or IgA to E/S however in calf 15c total Ig and
IgGi response increased slightly. This increase suggests that juvenile flukes from
challenge infection releases sufficient antigenic materials to cause this increase in
antibody response. The increased levels of ELISA values after a second infection is
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in agreement with Fernandez (1984), who reported increased antibody levels after
challenge infection as compared to the primary infection in either bullocks or in rats.
5.2.2 Cathepsin-L protease from adult F. hepatica
The antigenicity of Fh-cathepsin was confirmed in that the sera of all infected
sheep and cattle reacted against this enzyme, and in general, the antibody profile
revealed an earlier detection of total antibody responses (total Ig) from two to four
weeks post infection. These results are in agreement to those obtained by Levieux,
Levieux, Mage and Venien (1992) in sera from calves using the specific antigen f2 of
F. hepatica in a passive haemagglutination test. The results obtained here reveal that
the total Ig and isotype IgGj responses began earlier in the infection, suggest that Fh-
cathepsin a proteolytic enzyme is also produced by juvenile flukes. Juvenile flukes
share antigens with both metacercariae and adults (Sandeman and Howell, 1980).
This corresponds to the findings of previous studies (Dalton and Heffernan, 1989)
which revealed that proteases are functional even in invasive flukes i.e. newly
exysted juveniles, therefore proteases are secreted by all stages of liver flukes that
exist in the mammalian host (Carmona, Dowd, Smith and Dalton, 1993).
This study has clearly demonstrated that F. hepatica and F. gigantica infected
sheep and cattle developed clear total Ig responses to Cathepsin-L 1 protease of adult
F. hepatica starting from 2 wpi. and reaching the peak from 8 to 22 in sheep and 3
wpi. to end of experiment in F. hepatica infected cattle and 8 wpi. in F. gigantica
infected cattle. The high levels of total Ig responses are in agreement with findings in
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humans and other animals with Schistosoma mansoni infection (Chappell, Dresden,
Gryseels and Deelder, 1990).
Antibody isotype analysis in F. hepatica and F. gigantica infected sheep
indicated that there was predominantly IgG] while IgG2 and IgA responses could be
detected in F. hepatica infection to some extent. IgG2 and IgA responses were less
marked in the F. gigantica infected sheep. In F. hepatica and F. gigantica infected
cattle there was predominately an IgG] response but unlike in sheep, late IgG2 and
IgA responses were clearly detected. IgM, though variable, in both hosts was more
pronounced in cattle. However, there was late (ca. 8 wpi.) total Ig and IgG, response
to Fh-cathepsin by F. gigantica infected cattle. This may suggest a partial cross-
reactivity between F. hepatica and F. gigantica.
These results can be compared with those reported in the related trematode like
Schistosoma spp. since little similar work has been done in Fasciola spp. The
antibody responses to purified Schistosoma spp. protease have been monitored in
different hosts, including man. The antibody isotypes results reported in this study,
especially in cattle, are similar to the findings by Bout, Rousseaux, Carlier and
Capron (1980) who found early IgG! and IgM antibodies responses and late IgA (80
days post infection) during Schistosoma mansoni murine infection. Chappell and
Dresden (1988) also reported that response to a SMw32, purified protease, primarily
involves IgM and IgG! antibodies. Later, sera from S. mansoni infected individuals
were tested for IgM and IgG cysteine protease antibodies (Chappell, Dresden,
Gryseels and Deelder, 1990).
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Mountford, Fisher and Wilson (1994) reported that S. mansoni cercariae
infected mice developed a serum IgG, response to soluble antigens from different
developmental parasite stages, including adult worms, between weeks five and seven,
whereas IgG2 responses were lower.
Kamata, Yamada, Uchikawa, Matsuda and Arizono (1995), examined the
allergenicity of a 16 kDa purified cysteine protease of the nematode, Nippostrongylus
brasiliensis, which stimulated high levels of IgG, and lower levels of IgE and
negligible levels of IgG2 in rats. Although anti-cysteine protease IgE was not
examined in the present work, the other isotype responses were very similar to this
experiment.
The total Ig and IgG! response in homologous infection was earlier, 2 wpi. for
sheep and 4 wpi. in cattle than in heterologous infection, 8 wpi. in sheep and +7 wpi.
in cattle. Therefore, Fh-cathepsin activity against heterologous infection (i.e. F.
gigantica) needs to be ascertained. Although the sera from sheep separately infected
with F. hepatica and F. gigantica recognised the Fh-cathepsin antigen, the level of
antibodies reacting with the purified enzyme was higher in F. hepatica infected
animals.
5.2.3 Glutathione S-Transferase of adult F. hepatica (Fh-GST)
This study has clearly demonstrated that F. hepatica and F. gigantica infected
sheep and cattle developed clear total Ig responses to Fh-GST of adult F. hepatica
starting from 2 wpi. Antibody isotype analysis indicated that the response was
predominately IgG, and IgM while IgG2 and IgA response was either non existent in
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some sheep or cattle or just barely detectable. IgG2 and IgA responses were more
marked in the cattle. All isotype responses were variable especially in sheep.
The total Ig responses to adult Fh-GST began early in the infection suggesting
that, as with Fh-cathepsin, Fh-GST could also be produced by juvenile flukes and
that they are capable of producing enough Fh-GST to provoke detectable humoral
immuneresponse. This is in agreement with previous studies by Hagan and Gryseels
(1994) who reported that Schistosoma mansoni GST (Sm28GST) are found in
different life cycle stages. Bal and Das (1996) on the other hand suggested that in S.
mansoni GSTs is most abundant on the surface of the adult fluke and in the eggs.
However there is no evidence to suggest that this abandance in GST in adult and eggs
has any influence on isotype pattern in ruminants.
The antigenicity of Fh-GST was confirmed in that the sera of all infected
animals reacted against this enzyme, and in general, the antibody profile revealed an
earlier detection of total antibody responses (total Ig) from two to four weeks post
infection. These results are in agreement to those obtained by Hillyer, Soler de
Galanes and Battisti (1992) who were able to detect anti-Fh-GST in sera from sheep
using the specific antigen Fh-GST of adult F. hepatica in an ELISA.
However the antibody responses to GST were poorer than that to Fasciola Fh-
E/S, Fg-E/S and Fh-cathepsin. Unlike the results to Fh-cathepsin there was no sharp
antibody response by infected sheep or cattle and there were variations in response in
all the isotypes analysed. This might explain why Hillyer, Soler de Galanes and
Battisti (1992) could not record any response in cattle and rats infected with F.
hepatica. These authors found that sheep and rabbits infected with F. hepatica
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clearly developed anti-Fh-GST antibodies but in contrast cattle and rats infected with
F. hepatica did not respond to Fh-GST. They further concluded that one can divide
the four host species into Fh-GST responders (sheep and rabbits) and non responders
(cattle and rats). The results in this study clearly are different. The Hillyer, Soler de
Galanes and Battisti (1992) findings especially those in cattle and rats may be due to
many factors including the assay itself. These results also differ to those reported by
Sexton, Milner, Panaccio, Weddington, Wijfells, Chandler, Thomson, Wilson,
Spithill, Mitchell and Campbell (1990) who could not demonstrate antibody response
to Fh-GST in sheep infected with F. hepatica by 6 wpi., however they did notice a
slight response by 12 wpi.
The anti- Fh-GST isotype response was mainly limited to IgG, and IgM in both
infected sheep and cattle but cattle showed slight IgG2 and IgA response. The GST
used as antigen in these studies was isolated from adult F. hepatica, there is clear
evidence therefore of cross-reactivity with F. gigantica. The anti-Fh-GST antibody
responses were observed in both F. hepatica and F. gigantica infected sheep and
cattle and this included all the isotypes tested in this study, i.e. IgG,, IgM, IgG2 and
IgA.
These results can be compared with those reported in the related trematode
Schistosoma spp. as similar work in Fasciola has not been well documented. The
antibody responses to purified Schistosoma GST has been monitored in different
hosts, including man. The antibody isotypes were also reported by Auriault, Gras-
Masse and Pierce (1990) who found increases in IgE, IgA and IgG4 antibodies during
schistosomiasis in humans. Generally there are very few reports confining IgG,
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and IgG2 responses to parasite GST even in well researched helminths like
Schistosoma spp. or N. brasiliensis.
The present results are similar with those of Bal and Das (1996), who reported
responses in human infected with Wuchereria bancrofti to GST. These authors
reported that GST illicits predominantly a IgGj and IgM response and low levels of
IgA. They also recorded high IgE responses in humans from endemic areas. As in
the cattle studies presented here, these authors found that IgM isotype responses were
higher than total Ig and IgGl earlier in infection but IgGl became the dominant
isotype in the late stages of infection.
In conclusion, these results indicate that the Fh-GST promotes a dominant
IgG) and IgM isotype response with the IgG! response being more persistent than the
IgM response.
The response in cattle was gradual and total Ig was lower than IgG, and IgM.
Helminth GST are known to conjugate with other endogenous substances such as
lipid hydroperoxides and are thought to have a role in protecting the parasite against
radicals produced by the host (Brophy and Barrett, 1990). Thus rats are known to
produce 30 times more radicals per animal than mice in response to F. hepatica
(Smith, Ovington and Boray, 1992). Rats and cattle are considered as more resistant
to Fasciola infection (Boray, 1969; Malek, 1980; Haroun and Hillyer, 1986) and this
might help explain the initial poor response to Fh-GST in cattle (resistant hosts
produce more radicals) as compared to sheep (susceptible host produce less radicals).
This is the first comparative study of serum isotype responses to F. hepatica
in sheep and cattle infected with either F. hepatica or F. gigantica and more
338
Chapter Five: Discussion
experiments need to be done in order to understand the influence of GST on
protection and its contribution to host resistance against fasciolosis. The relationship
of this isoenzyme to hydrogen radicals produced by the hosts need to be established.
In order to understand the individual Ig isotype response and T-cell subset response
experiments examining the cellular responses are necessary.
5.3 COPRO-ANTIBODIES TO FASCIOLA SPP. E/S PRODUCTS, CATHEPS1N-L1
CYSTEINE PROTEASE AND FH-GST
Since the parasite invades the host via the gut the response at gut level is of
importance in protection. The study of copro-antibody afforded a non invasive way
of looking this.
There was no faecal antibody response detected in cattle to any of the three
defined antigens. This might have been due either to the light infections observed in
cattle or to the larger volume of faecal material produced by cattle (i.e. dilution).
There was an early (2 wpi.) faecal total Ig response to Fh-E/S and Fg-E/S, Fh-
cathepsin and Fh-GST in F. hepatica and F. gigantica detected in infected sheep.
These results are in agreement to those obtained by Wedrychowicz, Turner, Pfister,
Holmes, and Armour, (1984) in antibody detection in faecal from Scottish blackface
sheep. The faecal antibody responses were in this study similar to the different
antigens by either F. hepatica or F. gigantica infected sheep.
The isotype response was mainly IgA while a slight IgG2 response could be
detected in F. hepatica infected sheep. The faecal IgA antibody isotypes reported
here are in accord with Ellis, Gregory, Tumor, Kalkhoven, and Wroth (1993) who
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reported significant increases (p<0.02) of F. hepatica IgA reactors in infected sheep
compared to uninfected sheep.
The total Ig and IgA responses to all three defined antigens in F. hepatica
infected sheep was biphasic, in F. gigantica infection however the phases were less
defined. This pattern may be due to the fact that the IgA stimulation after oral
infection reduces as the parasites migrate through the liver parenchyma then the adult
fluke antigens passing with bile in the digestive tract reinforces the antibody
stimulation leading to the second peak IgA. Thus the first phase (about 2-10 wpi.) is
consistent with a response to juvenile flukes antigens after oral infection and the
second peak (13-17 wpi.) a response to antigens released by adult flukes in the bile
duct.
Wedrychowicz, Maclean, and Holmes (1985) reported a seven fold increase of
IgA, a three to six fold IgG, and a fifty fold increase in IgM in primary
Nippostrongylus brasiliensis infected rats. As in our findings the authors above
reported an early total Ig and IgA. Ogunrinade (1983) reported an IgG, antibody in
bile which correlated with circulating (sera) IgG, and suggested that IgG, in the bile
is as a result of a leakage of serum IgG,.
There was no correlation in IgA response to faecal egg counts in these studies.
Gill, Gray, Watson and Husband (1993) on the other hand reported a negative
correlation between IgA and faecal egg counts and suggested that IgA may be
involved in host resistance.
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5.4. GENERAL DISCUSSION AND CONCLUSIONS
The differences in susceptibility/resistance between sheep and cattle to
Fasciola spp. infection is well documented (Haroun and Hillyer, 1986), but little is
known about the underlying protective mechanisms. A comparison of serum isotype
immune responses of these definitive hosts to primary Fasciola spp. infection will
help our understanding of protective immunity in resistant (cattle) as compared to
susceptible (sheep) hosts. The main objective of this study was to investigate the
faecal and serum immunoglobulin isotype (IgGb IgG2, IgM and IgA) responses of
sheep and cattle chronically infected with either F. hepatica or F. gigantica, to
defined fluke antigens (F. hepatica E/S products (Fh-E/S), F. gigantica E/S products
(Fg-E/S), Fh-cathepsin and Fh-GST).
The complexity of these trematode parasites is reflected in the variety of
molecules in their E/S compartment, which directly interacts with the host. Fluke
antigenic E/S products are of particular interest since the function of some of these
components is to either stimulate or modulate the host immune responses.. Two
important E/S components were selected for detailed study, firstly the secreted
enzyme Fh-cathepsin which has a MWt of 27 kDa. It is considered to have a
functional role in parasite evasion of the host immune response, through cleavage of
host immunoglobulin. The second enzyme, Fh-GST is also an E/S product and is of
27.8-29 kDa MWt. It is involved in the detoxification of exogenous (xenobiotic) and
endogenous derived toxic compounds. Both enzymes are of interest because they
have also been considered as vaccine candidates against fasciolosis (Hillyer, Soler de
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Galanes and Battisti, 1992; Dalton, McGonigle, Ralph and Andrew, 1996; Emery,
1996).
The first objective of this study was to determine whether there are host species
differences in the serum and faecal isotypes (IgGl5 IgG2, IgM and IgA) responses to
these defined antigens which may be related to host susceptibility/resistance and
whether any observed differences are associated with the degree of pathogenicity.
The possibility of host differences in the antigen (E/S) recognition patterns was
examined by Western Blotting.
The results clearly demonstrated that Fasciola spp. infection provokes a
dominant and rapid IgG] serum response to E/S, Fh-cathepsin and Fh-GST in both
sheep and cattle. However, the response is more marked, and of longer duration, in
cattle (resistant) compared to sheep (susceptible). Cattle exhibited a late IgG2 serum
antibody response to the defined antigen while sheep did not. Again unlike sheep,
infected cattle produced a strong IgGi and IgM response to Fh-GST which rose
throughout the infection. The implication of these findings are discussed in detail
(see sections 5.2) however, the indications are that the persistence of a IgG] isotype
response with a late IgG2 isotype response to the parasite, as seen in cattle, may be
associated with resistance.
Adult Fh-E/S, Fg-E/S and Fh-cathepsin evoked a stronger antibody response
than adult Fh-GST especially in cattle which may reflect the immunogenicity of the
two enzymes in sheep and cattle. The fact that antibody responses to adult Fh-
cathepsin and Fh-GST were also detected in F. gigantica sheep and cattle indicates
species cross-reactivity. Antigenic crossreactivity obviously exists between
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components of juvenile and adult flukes as indicated by the early detection of
antibody responses to adult fluke antigens. However, the relatively late detection of
serum IgG and IgG! antibody to Fh-cathepsin in F. gigantica infected sheep and
cattle may indicate that this cross-reactivity is only partial. Further isotype analysis
of the antibody responses to Fasciola spp. infection involving a larger number of
defined antigens, particularly those from juvenile and adult E/S products is clearly
required.
In faeces, IgA was the main isotype antibody directed against all three defined
antigens in both F. hepatica and F. gigantica infected sheep and this response was
biphasic. The lack of detectable anti-parasite IgA in cattle faeces may be due to light
infection or assay in sensitivity rather than absence of antibody isotype. It is
therefore considered inappropriate at this point to draw a final conclusion on the role
of intestinal IgA.
Unfortunately it was not possible to include an analysis of the IgE response of
sheep and cattle to Fasciola spp. infection. This is an obvious omission, but we have
since developed an assay to detect anti-parasite IgE in the sheep system and are in the
process of developing another assay for cattle (Harrison, Personal Communication).
In the present studies an eosinophilia was first detected at 2 wpi. and dropped
by 17 wpi. in sheep infections but remained high for up to 30 wpi in infected calves,
especially those calves infected with F. gigantica. The levels of eosinophilia,
particularly in cattle infected with F. hepatica, was generally lower than sheep. The
main reason for this was considered to be that sheep were given a higher infective
dose per kg live-weight than cattle. The persistence of an eosinophilia as found in
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cattle may be associated with resistance as is thought to be the case with other
helminths. For example, in Schistosoma mansoni infection, eosinophils are
important effector cells, killing invading juvenile parasites by antibody-dependant
cell-mediated cytotoxicity (Butterworth, Sturrock and Houba, 1975). It is known that
the eosinophil adherence to Fasciola spp. is antibody mediated (Butterworth, 1984).
In schistosomiasis, in vitro experiments demonstrated that eosinophils are involved
in antibody dependant cytotoxicity in association with IgE (Capron, Dessaint,
Caporn, Ouma and Butterworth, 1987). In rat fasciolosis, eosinophilia was also
observed to be correlated with an increase in IgE (Pfister, Turner, Currie, Hall and
Jarret, 1983; Poitou, Baeza and Boulard, 1993).
Western Blotting analysis using 48 hours adult fluke E/S products, clearly
showed that there is a shift in the antigen recognition pattern just after the time of
patency (i.e. eggs in faeces) in cattle but not in sheep. There was a clear consistent
shift in antigen recognition by cattle from higher (134 kDa MWt for F. gigantica
infection and 142 kDa MWt for F. hepatica infection) to lower molecule (60 kDa
MWt for both parasite species). The 60 kDa MWt doublet recognised by F. hepatica
and F. gigantica infected cattle after patency may stimulate a protective resistance.
However, due to the very small sample size examined in this investigation, these
results require confirmation. Also of interest would be a Western Blotting analysis
of the isotype responses of sheep and cattle to the 60 kDa MWt doublet discussed




In mice and man, normal helper T-cells are divided into two subgroups with
distinct functions, they are designated Thl-cells and Th2-cells. These subpopulations
respond in different ways to cytokines and produce different interleukins in response
to antigen stimulation. Thus in mice Thl-cells secrete characteristically cytokines
IFN-y and IL-2 while Th2-cells are characterised by the secretion of IL-4, IL-5, IL-6
and IL-10 (Finkelman, Pearce, Urban, and Sher, 1991; Tizard, 1995). This division
of T-cells into Thl-cells and Th2-cells was first done in mice and was found to be
applicable in human immune system, although with important differences such as the
ability of both Thl-cells and Th2-cells in human to express IL-10 (Delprete, Decarli,
Almerigogna, Giudizi, Biagiotti and Romagna, 1993). There is little information
about Thl-cells and Th2-cells response and their characteristic cytokines in sheep
and cattle, however, Brown, Hash and Rice-Ficht (1993) reported expression of IL-
10 by Tho, Thl-cells and Th2-cells in cattle. In helminth infected mice, Thl immune
response induces IFN-y hence IgG2a secretion, while Th2-cells immune response
induces IL-4 which stimulates IgE, IgG, and IgG3 secretion (Finkelman, Pearce,
Urban, and Sher, 1991; Tizard, 1995).
If similar events occurred in Fasciola spp. infected sheep and cattle, the
dominance of a serum IgG, response and faecal IgA response may be explained.
Results in the present study show that serum IgG, was the dominant isotype response
to all three antigens suggesting that these antigens may preferentially stimulate a Th2
T-cell subset response. The late IgG2 response to Fh-E/S, Fg-E/S and Fh-cathepsin
in cattle may indicate delayed Thl T-cell subset stimulation. In a limited study
Brown, Davis, Dobbelaere and Rice-Ficht (1994) reported that T-cells clones derived
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from cattle infected with F. hepatica produced cytokine profiles reflective of a Th2-
cell, involvement i.e. similar to the results reported in mice and man that helminth
antigens can induce Th2-cells.
Allen and Maizel (1997) concluded that the available evidence suggests that in
many infectious diseases, both T helper cell (Thl- and Th2-type) are involved
especially in the avoidance of severe immunopathology. Thus differences in
antibody isotype responses of sheep and cattle to fasciolosis may play an important
role in the "self cure" phenomenon and resistance against challenge infection
observed in Fasciola spp. infection in cattle but not sheep. Helminth infection is
universally associated with high levels of IgE, eosinophilia and a rise in mast cell
numbers (Malek, 1980). The Th2-cell class of helper T-cells is known to be involved
in eosinophil differentiation in man and mouse (Spry, Kay and Gleich, 1992) as they
produce IL-3, IL-4 and IL-5 (Mosman, 1991). IL-5 is known to be a growth factor
for eosinophils in mice, as injection of this cytokine alone stimulates eosinophilia
(Coffman, Seymour, Hudak, Jackson and Rennik, 1989). The demonstration that
eosinophils and IgE can kill helminth parasites in vitro has lead to the wide belief
that Th2-dependent responses are primarily responsible for the destruction of large
extracellular parasites (Tizard, 1992).
Thus if the eosinophil stimulation mechanism in ruminants is similar to that
observed in mice, the persistence of IgG, response with the implied Th2-cell driven
eosinophilia and IgE involvement may be of great importance to the resistance
observed in cattle as well as the late development of antibodies of IgG2 subclass with
the implied Thl-cell involvement. These observations plus the fact that cattle
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display a switch in their antigen recognition profile following patency may be
another critical factor in the IgGl/IgG2 profiles. This latter point further emphasises
the need for more detailed study in the antibody isotype responses to defined fluke
antigens importantly the 60 kDa Mwt doublet. Further cellular studies are therefore
recommended in order to help define the mechanism ofprotection in cattle.
The second part of the study dealt with serum glucose and P-HOB levels in
both sheep and cattle. Migrating flukes damage the liver (Mahato, 1993), this may
potentially reducing liver glycogen reservoirs. This could result in a reduction in
glucose levels and an associated increased mobilisation of free fatty acids detectable
through increased levels of serum ketone bodies. In ruminants P-HOB accounts for
80% of all ketone bodies (Doxey, 1983; Fraser, 1991; Sanchez, Alvareg and
Lunusse, 1996). Analysis of serum glucose and P-HOB levels in resistant and
susceptible hosts would therefore help the understanding of possible changes in
carbohydrate metabolism (i.e. energy source) in fasciolosis. The reduction in serum
glucose and increase in P-HOB levels observed in Fasciola spp. infected ruminants
in this study supports this hypothesis. While such direct comparative studies have
not previously been conducted, the available evidence on the changes in intermediate
carbohydrate metabolism in fasciolosis supports our findings (Berry and Dargie
1976; Ferre, Barrio, Gonzalez-Gallego and Rojo-Vazquez, 1994; Sanchez, Alvarez
and Lunusse, 1996).
In further support of this contention was the observation that changes in
intermediate carbohydrate metabolism tended to be more pronounced in sheep (the
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susceptible host) than in cattle and further they were more pronounced in F.
gigantica infection (the more pathogenic of the parasites).
These changes in intermediate carbohydrate metabolism could be expected to
be of importance to animal productivity particularly in young growing animals. Thus
the dietary supplementation of carbohydrate intake may be expected to ameliorate the
effects of fasciolosis. However, as this is one of the first studies of its kind, further
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To 250 ml of solution add 900 ml of distilled water followed by 1.0 ml of solution B
and 1.0 of solution C, and make up to 1 Litre (for 1 Kg of soil Preparation
2 COUNTING OF EOSINOPHILS
Equipment









8ml of 0.5% eosin Y solution (Sigma-AccustainTM)
Mix the above and make up to 100ml with distilled water


















Foetal calf serum 6ml
(sterile, heat inactivated)
Amphotericin B (no filtration) 1 OOpg
5 ELISA REAGENTS
Borate Buffered saline.
Bone acid 6.18 g
Di-sodium tetra borate 9.54 g
Sodium chloride 4.38 g
Distilled to 1 litre pH. 8.2
PBS Tween 20
Tween 20 (Sigma, 70H0171) 0.5 g
PBS 1000 ml
Blocking solution (4% Normal Rabbit Serum/PBS Tween 20)
Rabbit Serum (Sigma, 115H8812) 10ml
PBS Tween 20 240 ml
Washing solution (0.9% NaCl-Tween 20)
NaCl 9 g
Tween 20 0.5 g.
Distilled water 1 Litre





Stopping solution (0.2 M H2S04)
11 ml concentrated H2S04 (Merck 1M) to 1000 ml distilled water (0.2 M)
6 SDS-PAGE SOLUTIONS
Solution A
1 M HCL 96 ml
Tns 73.2g
TEMED 92 ul




Deionized distilled H20 to 500 ml
Stacking buffer
Tris 17.94 g
1 M HCL 144 ml







Deionized distilled water to 1 Litre.
Preparation of 10% separating gel
Deionized distilled H20 4.05
1.5 M Tris-HCL pH 8.8 2.50
10% w/v SDS 100 gil
30% w/v Acrylamide 3.30 ml
TEMED 5 pi
10% w/v Ammonium persulphate 50 ul
Preparation of 3% stacking gel
Deionized distilled water 6.10 ml
0.5 M Tris-HCL pH 6.8 2.50
10% w/v SDS 100 ul
30% w/v Acrylamide 10 pi
TEMED 10 ul
10% w/v Ammonium persulphate 100 ul
7 WESTERN BLOTTING





NP 40 1 ml
Bjerrum and Schafer-Nielsen Transfer buffer
Tris 5.82 g
Glycine 2.93 g
SDS 10% w/v 3.75 ml
Methanol 200ml
Deionized distilled water to 1 L.
Reducing sample loading buffer
Deionized distilled water 4.0 ml
0.5 M Tris HC1 pH6.8 1.0 ml
Glycerol 0.8 ml
10% w/v SDS 1.6 ml
B- mercaptoethanol 0.4 ml




Experiment 1: Sheep infected with F. hepatica (British and Peru strains)
Results of lite Nematode faecal egg counts per gram of faeces (EPG), Fluke faecal egg
counts per gram faeces (EPG) and Livewcight (Kg).
Nematodes EPG EPG Fluke Livcweight (Kg)
WIM Sll. 5 SI 1. ft SI (.7 Sll. 8 SI I 9 SM 10 Sll. 5 SH.6 SH.7 Sll. 8 SH9 Sll.10 Sll. 5 Sll. 6 sn. 7 Sll. 8 Sll 9 SH.10
-2 200.0 100 0 00 0 0 00 0 0 0.0 0 0 00 0.0 0.0 0.0 19.0 23.0 22.0 25.5 78.0 53 0
•1 200.0 100.0 0.0 0.0 00 0.0 0.0 0 0 00 0.0 00 0.0 19.0 23.0 22.0 25.5 79.0 S3.0
0 400.0 0.0 00 100 0 0.0 0 0 0.0 0 0 0.0 00 0.0 0.0 19 0 23.0 22.0 260 75.0 51.0
1 1 50 0 0.0 0.0 0.0 0 0 00 0.0 oo 00 00 00 0.0 19.0 23.0 22.0 26 0 800 54.0
2 150.0 100 0 200 0 100.0 0 0 0.0 0.0 00 0.0 0.0 0.0 0.0 20.0 23.0 22.0 26.0 79.0 56.0
3 300.0 100.0 200.0 200.0 00 0.0 0.0 oo 0.0 0.0 00 0.0 20.0 23.0 22.0 26.0 81.0 56.5
« 500.0 200.0 300.0 300.0 2000 300.0 0.0 oo 0.0 0.0 00 0.0 20.0 23.0 23.0 26.0 81.0 57.0
5 450.0 150.0 330.0 300.0 100 0 300.0 0.0 oo 0.0 0.0 04) 0.0 20.0 22.0 21.0 26.0 84 0 575
6 550.0 300.0 2SO.O 350.0 250.0 550.0 0.0 oo 0.0 0.0 0.0 0.0 21.0 23.0 23.0 30.0 83.0 56.5
7 150.0 0.0 150.0 100.0 00 0.0 0.0 oo 0.0 0.0 0.0 0.0 21.0 22.0 23.0 29.0 81.0 50.5
8 450.0 200.0 300.0 100.0 100.0 120 0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 22.0 23.0 29.0 82.0 53.0
9 500.0 200.0 350.0 150 0 0.0 100 0 0.0 oo 0.0 0.0 0.0 0.0 22.0 23.0 23.0 31.0 83.0 54.0
10 200.0 250.0 150.0 0.0 100 0 100.0 0.0 oo 2.0 0.0 0.0 0.0 22.0 21.0 21.0 32.0 84.0 54.0
11 200.0 350.0 400.0 500 0.0 200 0 0.0 2.0 3.0 0.0 0.0 2.0 21.0 23.0 23.0 34.0 81 5 52.0
12 150.0 300.0 3000 0.0 250.0 oo 5.0 0.0 1.0 3.0 22.5 24.0 35.5 81.0 54.0
13 150.0 350.0 100.0 100 0 235.0 no 590 0.0 37.0 4.0 23.0 245 38.0 80.0 51.0
14 250.0 150.0 150.0 0.0 100.0 790 67.0 0.0 69.0 2.0 23.0 25.0 39.0 82.5 53.0
IS 100.0 50.0 200.0 0.0 0.0 197.0 257.0 0.0 111.0 19.0 235 24.5 39.0 85.0 56.0
16 100.0 400 0 0.0 0.0 0.0 287.0 336.0 0.0 103J) 45.0 24.0 26.0 40.0 82.0 55.0
17 100.0 200.0 00 0.0 0.0 1370 231.0 0.0 113 0 39.0 25.0 26.5 41.0 83.0 55.0
Appendix Table 4.2
Results of Packed cell volume (PCV) (%), Haemoglobulin (Hb) (g/1) levels and
Red Blood Cell counts (xl012/l)
PCV Hb RBC
WP1 Sll. 5 SH.6 SH.7 Sll. 8 Sh 9 sh 10 SH . 5 SH 6 SH.7 SH 8 SH 9 SH.10 SH. 5 SH. 6 SH.7 SH. 8 SH 9 SH.10
■2 21 32 30 29 32 32 8.4 13.1 132 12.0 12.1 14.0 9.3 13.7 12.5 113 11.8 11.7
-1 22 31 28 30 34 31 9.1 138 125 122 118 135 8.7 11.4 122 12.8 10.8 122
0 22 31 28 30 33 32 8.9 135 12.0 122 125 12.9 8.7 115 122 13 0 108 132
1 20 29 33 31 32 32 8.6 123 13.9 13.4 11.7 13.4 92 10.8 12.8 13.6 10.9 13.7
2 21 33 31 31 32 31 10.0 13.1 12.0 13.6 143 13.8 9.5 12.1 9.6 13.7 10.4 11.4
3 21 27 30 29 33 29 8.9 125 11.9 13.1 135 132 9.6 10.7 115 12.4 10.6 115
4 21 28 30 29 29 31 9.8 11.0 112 13.4 13.1 122 113 10.0 125 12.4 113 10.8
5 21 26 29 29 30 33 9.7 11.0 11.6 12.4 13.1 133 11.7 12.7 13.4 122 12.6 12.1
6 25 24 27 31 29 29 9.8 9.6 10.7 12.9 13.0 132 13.1 12.7 12.0 12.4 12.6 12.0
7 21 23 28 29 28 29 9.0 92 10.6 12.9 12.7 13.0 9.5 92 10.7 12.1 9.794 10.7
8 20 20 23 32 27 32 ■8.5 8.1 9.3 13.1 12.1 12.1 10.8 8.4 83 125 9.141 8.3
9 19 17 22 28 28 31 7.9 6.8 8.9 123 12.9 15.0 7.4 6.3 8.4 123 7360 8.4
10 16 15 22 28 26 32 5.9 62 8.8 11.7 14.6 133 82 5.4 83 12.7 7.313 83
11 15 15 19 28 28 31 5.1 5 8 7.0 11.6 13.1 14.1 4.9 5.4 6.6 11.0 5.640 9.0
12 14 21 29 27 30 55 8.8 12.8 13.6 10 8 5.6 7.7 11.6 6.649 7.8
13 14 23 29 28 33 6.6 8.8 13.9 13.1 132 4.4 7.7 102 6.043 7.4
14 14 24 30 27 31 5.9 112 13.9 14.0 14.8 4.1 5.9 13.1 4.996 8.0
IS 14 23 29 27 35 68 10 6 14 0 12.7 14.5 45 8.4 11.0 6.481 83
16 14 21 30 27 30 6.6 8.7 13 8 119 12.7 3.8 8.4 112 6.130 8.4




Results of MCV (11), MCH (pg) and MCHC (g/dl)
MCV MCH MCHC
WPI SI 1. 5 SI 1. 6 SI 1.7 SI 1. 8 Sh 9 nh.10 SI 1.5 SI 1.6 SI 1.7 SI 1. 8 Sh 9 sli.10 SI 1. 5 SI 1.6 SH. 7 SH. 8 Sh 9 lh.10
-2 23.0 23.0 23.0 26.0 27.1 27 4 96 10.0 11.0 11.0 10 20 12.00 40 31 44 41 38 44
-1 25.0 27.0 23.0 23.0 31.5 25 5 106 12.0 10.0 10.0 10.90 1 1.10 41 45 45 41 35 44
0 25.0 27.0 23.0 23.0 30.6 24 2 106 120 10.0 9.0 11.60 980 40 45 43 41 38 40
1 22.0 27.0 26.0 23.0 29 2 23 4 96 116 11.0 106 10.70 980 43 42 42 43 37 42
2 22.0 27.0 320 23 J3 30.7 272 103 11.0 120 10.0 13.70 12.10 48 40 39 44 45 45
3 22.0 25.0 26.0 23.0 31.1 25 3 96 120 10.0 103 12.70 11.50 42 48 40 45 41 46
4 19.0 28.0 24.0 23.0 25.7 288 96 11.0 9.0 106 11 60 11.30 47 39 37 43 45 39
5 18.0 15.0 220 24.0 238 272 8.0 6.0 9.0 10.0 10.40 11.00 46 42 40 43 44 40
6 19.0 19.0 220 25.0 23 0 24 I 86 8.0 9.0 106 10.30 11.00 39 40 40 42 45 46
7 22.0 25.0 17.0 206 28.6 27 2 93 10.0 6.0 9.0 13.00 1220 43 40 38 44 45 45
8 16.0 24.0 28.0 253 29 5 383 76 10.0 11.0 103 13.20 14.60 43 41 10 41 45 38
9 26.0 271) 26.0 23.0 38 0 36 9 11.0 11.0 11.0 10.0 17.50 17.80 42 40 40 44 46 48
10 19.0 28.0 26.0 220 35.6 38 4 76 113 106 9.0 20.00 16.00 37 41 40 42 56 42
11 30.0 27.0 29.0 25.0 49.6 34 4 10.0 11.0 10.7 103 2320 15.70 34 39 37 41 47 45
12 25.0 27.0 25.0 40.6 38 6 10.0 113 116 20.50 13.90 39 42 44 50 36
13 320 20.0 28.0 463 443 15.0 8.0 146 21.70 1780 47 38 48 47 40
14 34.0 27 .0 20.0 54.0 38 7 143 123 9.0 28.00 18.50 42 47 46 52 48
15 31.0 27.0 26.0 41.7 42.1 15.0 123 136 19.60 17.50 49 46 48 47 41
16 36.5 327 276 44.0 35.7 17.0 14.0 120 19.40 15.10 47 41 46 44 42
17 29.5 39.0 26.0 34.9 384 1 120 16.0 113 16.30 15.70 41 42 44 47 41
Appendix Table 4.4
Results of total While Blood Cells and Eosinophils Counts (xl012/l).
White Blood Cells (WBC) Eosinophils Counts
WPI SH. 5 SH. 6 SH. 7 SH. 8 SH 9 SH.10 SH. 5 SH. 6 SH. 7 SH . 8 SH 9 SH.10
-2 4.412 8.621 7.121 4.781 5.400 4 850 0.013 0294 0.094 0 063 0.000 0.013
-1 5.012 7.600 6.800 5.600 5 400 5.10C 0.006 0.063 0.031 0.044 0.033 0.006
0 4.300 7.6(H) 6.600 5200 5252 5212 0.025 0.069 0.038 0.050 0.043 0.038
1 5.2(H) 8 500 6.000 5.700 5 500 6 50C 0.038 0.075 0.044 0.050 0244 1238
2 9.7(H) 9800 6200 5.100 7.700 7.600 0.684 0.825 0.569 0.044 1.875 1.425
3 10.000 10 4(H) 8.750 5.400 10310 7.440 1.962 2.175 2.856 0.019 4.169 1.913
4 9.900 9.300 10 100 5 400 9.950 10 64© 3.125 1.863 3281 0 031 1.388 J.419
5 10 500 8.300 9.960 5.300 13.040 11 65© 2 725 1.688 0.875 0 013 2.313 3238
6 9 960 9 670 11 980 5 720 13 761 9 627 2.563 1.938 2.156 0.006 7.062 1.344
7 8.490 9.190 14 080 6.300 15 633 9 957 1.450 2.756 3.025 0.019 7.181 2.494
8 8.750 10.730 13.870 5.880 13.745 8.432 2.069 1.350 2.125 0 043 5.388 2.137
9 9.710 8.920 13 870 5.900 15 438 10 825 2.963 2.844 3.669 0.013 7.738 2.069
10 9 293 9.979 15.507 6.098 15.721 8.980 2262 3250 5.419 0.006 8.306 2.65
11 14.000 8.987 15288 5.744 14.022 9.080 0.862 2.644 5.711 0 006 5.785 2.325
12 9.484 18.166 4.810 13211 9.747 2 906 5.575 0.006 6262 2.281
13 10.010 1 5.080 6.360 14.126 10 678 2.194 4.375 0.019 6.631 2.619
14 8.718 12.895 6.079 11 278 8280 2.681 5.881 0.044 1.880 1256
15 1 1.423 14.134 5.557 9 442 7.990 4.488 5.213 0013 1.388 1.188
16 9.415 10 633 6 027 10 017 7.883 3218 2.706 0 013 2.350 0.925




Results ol Dil'crcntial Neutrophils, Lymphocytes counts (xl()9/l) and Monocytes.
Neutrophil. Lymphocytcs. Monocytes.
W1M Sll 5 SI I . 6 SI I 7 SH.K SH9 533.10 SII 5 Sll. 6 Sll 7 Sll.8 Sll 9 Sll.10 SI 15 SH. 6 SII 7 SH.8 SH9 Sll.10
•2 2 200 0.602 3 053 1.728 2368 1 -504 2.1 56 7.310 3.763 2 928 2.700 2.862 0 044 0.172 0.142 0.096 0.108 0.194
-1 3.250 0.836 1.496 2.520 1 944 2.142 1 650 6 080 4.828 2.520 3.132 2.601 0.100 0.608 0.340 0.112 0.108 0.102
0 3.016 4.420 2.880 3 534 3 158 1 912 1.872 3.570 2.760 1.881 1.766 2.922 0208 0210 0300 0.171 0.107 0.053
1 1.978 0.456 1.452 1 768 2.365 1.885 2.193 6.156 4.620 2.964 2.145 3.575 0.129 0.988 0.462 0.416 0.110 0260
2 3.492 0392 0.868 1.581 3 696 3 396 4 074 8 330 4 402 3 111 2.772 3.724 0 388 0.392 0.124 0357 0308 0228
3 5.500 0 416 r. ; 3 2.322 4 327 1 .488 2.000 6.136 4.725 2 808 4.330 4.166 0.900 0.312 0.438 0270 0206 0321
4 3332 1.395 l.Mi 1.944 2 687 2 341 2.744 5.301 4.646 3.078 2.587 5214 0.686 0.558 0305 0378 0.697 0.000
5 4.410 1.162 1.693 1.325 2 869 2330 2.730 5.146 5.478 3 604 4 173 5.592 0.630 0.083 0.797 0371 0.782 0233
6 2.689 1.257 1318 2388 1.927 2399 2.789 5.995 7347 3.146 4.541 4.140 0.797 0.097 0240 0.172 0.688 0.096
7 3.396 0.735 2.675 1.764 2.189 2290 3366 4.779 6.054 3.906 6.722 4.680 0.425 0368 0.141 0367 0313 0.100
8 1.838 1 180 1.537 1.940 2.062 1.939 2 800 5.150 6.426 3.352 5.086 4.806 0263 0.751 0.699 0294 0275 0.169
9 3.395 1.068 1.664 1.534 2.933 2.815 1.940 3.115 5.825 3 953 6.484 5.521 0.679 0.623 0 000 0295 0.618 0.000
10 4.368 1 098 2.636 1.098 2358 2.604 1.859 5.588 6.668 4.574 5.974 3.592 0.651 0200 0.775 0244 0314 0.449
II 7.140 1.528 2.752 1.379 1342 2.542 5.180 3.954 3.516 4.193 5.609 3.814 0.840 0.270 0.764 0.172 0.000 0.091
12 1.233 6.176 1.580 1.453 2 729 4.837 5 631 5.170 5284 5.068 0.000 0.000 0287 0.132 0292
13 2.202 4 322 3.053 2.401 2.136 3203 5.127 3.116 6.357 6.941 0200 0.452 0.191 0.141 0214
,4 1.221 1.418 1.898 3 947 2.898 4.795 5287 4.74 5 6 090 4.968 0262 0.129 0.068 0226 0.994
15 1.143 1.696 1334 1.133 1.199 4 230 7.067 3.945 6.421 5.993 0.114 0.424 0.167 0.189 0.799
16 2.354 3.403 1.025 2 905 1377 4.331 5.104 3.918 5209 5.124 0.094 0319 1.085 0.100 0.473
17 0.856 1.519 1.750 1.143 1.155 5.395 5220 4251 6.478 5.773 0257 0380 0250 0.191 0.77
Appendix Table 4.6
Results of Diferential Eosinophil and Basophil counts in (xl09/l)
Eosinophil. Basophil.
WPI SH5 SH. 6 SH 7 SH.K SH 9 SH.10 SH 5 SH. 6 SH 7 SH.8 SH 9 SH.10
-2 0.000 0516 0.071 0.048 0.324 0343 0 000 0.000 0.071 0.000 0.000 0.049
-1 0.000 0.076 0.068 0.056 0.216 0304 0 000 0 000 0.068 0.056 0.000 0.051
0 0.052 0 000 0.060 0057 0321 0372 0.052 0.000 0 000 0.057 0.000 0.053
1 0 000 0000 0.000 0 052 0495 3105 0 000 0.000 0.066 0.000 0.055 0.065
3 1.600
0.980 0.806
3.536 2.975 0.000 1 547 3 365 0 000 0.000 0.000 0 000 0.000 O.OOO
5 2.730
2.046 3.737
1.909 1.992 0.000 5 086 3.379 0 000 0 000 0.000 0.000 0.130 0.117
6 3.685 2321 2.875 0 1 14 6 605 2.696 0 000 0 000 0.000 0.000 o.ooo 0.096
7 1.104 3.308 5.210 0.063 6353 2 888 0 000 0 000 0.000 0.000 0.156 0.000
R 3.763 3 541 5.169 0.294 6.185 1 433 0 088 0.107 0.140 0.000 0.137 0.084
9 3.5X9 3.827 6.242 0059 5.403 2490 0.097 0267 0.139 0.059 0 000 0.000
10 2.416 3 093 5427 0 183 7.074 2335 0 000 0.000 0.000 0 000 0.000 0.000
11 1.120 3 235 8.256 0.000 6.871 2.633 0 000 0 000 0 000 0.000 0.000 0.000
12 3.414 6.358 0 144 6.341 3.657 0.000 0.000 0.000 0.000 0.000
13 4 404 4.976 0.000 5 227 1 388 0.000 0.000 0 000 0 000 0.000
13 2.441 6.061 0 068 0 113 0 083 0.000 0 000 0.000 0.000 0.000
14 5.945 4.947 0 111 1.700 0 000 0 000 0.000 0 000 o.ooo 0.000
15 2.636 1.808 0 000 1.703 O 709 0.000 0.000 0.000 0.000 0.000




Results ol" scrum Albumin (g/1), Total Protein (g/dl) and Glucose (mmol/1)
Albumin Total Protein Glucose
wpi Sh.5 Sh. fr Sh. 7 Sh. 8 Sh . 9 Sh. 10 Sh.5 Sh. 6 Sh . 7 Sh. 8 Sh. 9 Sh. 10 Sh.5 Sh . 6 Sh. 7 Sh 8 Sh. 9 Sh 10
-2 31.00 37.00 40 00 38.00 36 1 48 2 5.30 7 JO 6.20 8.10 7.6 12 2.75 2.5 3.02 2.41 224 2.4
-i 24.00 40 (X) 32.00 37 00 37.1 35 8 6.40 7.30 6J0 6,60 8.0 8.0 2.12 2.1 238 232 235 2.7
0 30.00 36 00 30(H) 36(H) 37.6 34,9 6.60 620 7.90 8.40 8 0 12 1.64 2J 2.46 3 231 2.4
1 27(H) 36 00 31.00 36 00 34.0 18 6 6 90 6.00 7 JO 6.60 7.4 7.5 2.61 2.6 2.4 3.12 261 2.5
2 33.00 38.00 35.00 38 00 40.9 35.7 7.00 6.50 6.90 7.00 7.9 7.1 2.3 3 23 2.59 2J8 2
3 30.00 30.00 41.00 34.00 34.0 29.9 7.70 8.80 10.00 8.00 7.3 7.0 1.95 3 222 2.47 225 26
4 33.00 32 JO 30 00 38.00 38.5 35 8 7.40 6.80 8.40 8.60 8.0 7.5 1.75 2.8 1.85 23 2C.6 1.7
5 30.00 31 JO 32.00 35.00 31.1 38.0 7.70 8.60 8.80 8 00 7.4 7.6 2.18 1 J7 2.43 233 2_5 22
6 40.00 38.00 32.00 37.00 39.5 37.0 8.10 8.00 8J0 7.40 7.6 7.9 1.84 1.44 231 2.8 23 2.61
7 39.00 38 00 43.00 34 00 40.4 38J 6.60 7.40 7.40 8.90 8.3 7.7 2J5 1.13 1.66 2.61 22 2.18
X 43.00 35 00 33.60 40.00 35.7 33.4 8.40 8.90 7.30 8.40 7.8 7.7 1.85 1.03 1.74 2.75 26 225
9 35(H) 36 00 32 00 39.00 39 8 372 7.70 8.40 8 60 8 JO 7.9 8J 2.06 1.57 1.42 2.61 3 2.06
10 23.00 33 00 34.00 40.00 44.1 32 9 7.70 8 JO 8.90 7.4 7.4 7.7 0.83 1 J7 1.3 2.43 23 2.5
II 19.00 33 00 25(H) 3600 38.9 33.9 4.40 12.90 7.20 7.6 8.7 8J 1 J 1.44 1.43 231 2J 2.1
12 24.00 31 00 25 00 36 00 31.3 30.3 5.10 920 8.20 8.3 8.9 8.0 1.06 1.13 1.82 2.61 242 2 J
13 21 00 24.00 38.00 34 0 31.1 8.90 6.30 7.8 8.6 7.8 1.03 1.67 2.61 2.43 2.6
14 22 20 26 00 36.00 32.1 30 6 6.10 8.00 7.9 8.9 8.3 1.42 232 3 231 3
15 21 00 21.00 33.00 29.5 29.9 6.80 7.00 8.9 8 J 7.9 1.3 2.1 3.1 2.43 3
16 17.00 21.00 30.00 28.5 31.3 6.00 6.00 8.6 7.6 7.8 1.43 1.6 2.8 231 2.8
17 17 00 22 00 34 00 30.4 30.6 6.00 5 JO 8.9 7.6 73 1.6 1.89 2.9 232 2.42
Appendix Table 4.8
Results of Gamma Gluiamyltransferase (IU), Glutamate Dehydrogenase (IU)
and b-Hydroxyl-butyrate (mmol)
-vGT GLDH b-Hydroxyjjsbutyrate
WPI Sh.5 Sh. 6 Sh. 7 Sh.8 Sh 9 3). 10 Sh.5 Sh. 6 Sh. 7 Sh. 8 Sh. 9 Sh. 10 Sh.5 Sh . 6 Sh. 7 Sh. 8 Sh. 9 Sh. 10
-2 27.40 20 10 20 80 21 JO 24.7 26.6 OJO OJO OJO 3.90 1.4 8.7 0J1 0J9 0J5 035 035 039
-1 35.10 27.00 20 80 27.00 30.9 24.7 OJO 0.60 OJO 1.80 2J 3 0.43 0.43 0.4 0J1 029 032
0 41.00 21 JO 1850 24 00 37.4 29.7 0.60 2.60 0.60 0.90 0.4 5.9 0.48 0.46 0J8 0.32 036 036
3550 26J0 29 70 25.50 28.6 27 0.60 0.90 0.40 0.80 1 J 3 J 0.49 0.45 0.44 0.34 033 032
40.90 2930 3240 26.60 26J 25.1 3.70 4.90 31 JO 2.60 9J 4.10 0.45 0.46 0.42 OJ 0.41 039
38.60 39.00 3950 28.60 34.7 24.5 32.50 141.60 141 JO 1.80 120 126.10 0.58 0.52 0.41 039 029 038
37.40 46.70 39(H) 22 00 28 2 255 104.00 149.10 146.60 2.00 91.40 54.40 0.47 0.51 0J5 039 032 035
46 70 57 50 39 00 23 20 30.9 25.9 99.90 143 80 151.90 2.00 109 78.40 0.51 0.55 0J1 0.32 03* 034
57.00 63 70 41.70 25 50 35.1 33.9 110.70 138 50 141.60 3.30 113 J 91.40 0.42 0J1 0J1 0.36 022 031
40.50 56 30 42.80 23 50 30.5 40 52 00 126.10 147.60 6.10 98.8 88.30 0J9 021 0J5 032 026 037
8 44.40 55 20 40.50 24 70 36 38 54.40 88.30 144.60 3.70 97.9 65.60 0.49 0.33 0.36 0J9 039 031
9 55.60 50 00 4940 28 10 38 7 43 78.40 65 60 1 50.50 4.50 88J 80.00 0.42 0.43 0.41 039 024 03
10 63.70 51.70 66 40 32 00 40 59 91.40 80.00 131 JO 12.80 69.5 52.00 0J5 0.5 0.4 031 02" 032
1 1 77 20 75 70 65 20 34.70 44 56 7 79 JO 74.90 105.00 6.10 89.3 32.9 0.36 0.58 0.41 031 025 036
12 79.90 93 00 52.50 30 00 98 9 51.1 99.50 31.70 47.90 9.50 86 J 18.7 0.33 0.32 0.43 035 02 031
13 77 (X) 54 00 25 90 67.5 78.1 54 60 63.20 14.00 29.7 34.3 0.58 0.47 039 0.3 S 035
14 72 90 50.20 27.00 79.5 98 4 32.90 50.40 4.10 80.4 54 J 0.87 0.58 0.31 021 03
15 62 90 44.80 28.00 64 5 78.4 42.60 70.70 7.10 31 J 36.1 0.53 0.45 031 026 038
16 46 30 36 30. 26 60 93 X 45.9 43.70 36.80 7.50 42.4 36.8 0.68 0.48 0.25 02-4 032
17 33 60 37.80 28.50 61.8 38 2 49.30 37.00 0.60 10 37.8 0.7 0.55 03 03 031
379
Appendix Table 9:
Glucose and P-Hydroxyl-Bulyralc (mmol/ml) values in sheep 24, 26, 28
and 30 infected with F. hepatica (Britsh strain) and sheep 22 and 32 as
uninfected controls.






































































































































































































































































Experiment 3: Five sheep infected with 100 Cysts of F. gigantica
and four uninfected controls Sheep infected with
Appendix Table 4.10
Egg counts per gram (EPG) in live sheep infected
with 100 Cysts of F. gigantica and four uninfected controls
Infefecicd group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. U SH. 15 Mean(+) SH. 165H. 17 SH. 18 SH. 19 Mean(-)
31.03.94 -2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
07.04.94 -1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
14.04.94 0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
21.04.94 1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
28.04.94 2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
05.05.94 3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
12.05.94 4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
19.05.94 5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
26.05.94 6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
02.06.94. 7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
09.06.94 8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
16.06.94 9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
23.06.94 10 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
30.06.94 11 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
07.07.94 12 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
14.07.94 13 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0
21.07.94 14 0.0 0.0 0.0 1.0 21.0 4 4 0.0 0.0 0.0 0.0 0.0
28.07.94 15 0.0 1.0 0.0 8.0 67.0 15.2 0.0 0.0 0.0 0.0 0.0
04.08 94 16 0.0 5.0 43.0 96.0 36.0 0.0 0.0 0.0 0.0 0.0
11.08.94 17 0.0 23.0 70.0 92.0 46.3 0.0 0.0 0.0 0.0 0.0
18.08 94 18 2.0 22.0 92.0 141.0 64.3 0.0 0.0 0.0 0.0 0.0
25 08.94 19 3.0 54.0 50.0 32.0 34.8 0.0 0.0 0.0 0.0 0.0
01.09.94 20 2.0 100.0 173.0 160.0 108.0 0.0 0.0 0.0 0.0 0.0
08.09 94 21 16.0 195.0 181.0 188.0 145.0 0.0 0.0 0.0 0.0 0.0
15.09.94 22 21.0 74.0 81.0 16.0 48.0 0.0 0.0 0.0 0.0 0.0
22 09.94 23 67.0 192.0 280.0 206.0 186.3 0.0 0.0 0.0 0.0 0.0
29.09 94 24 90.0 175.0 236.0 4.1 126.3 0.0 0.0 0.0 0.0 0.0
06.10.94. 25 85.0 174.0 211.0 61.0 132.8 0.0 0.0 0.0 0.0 0.0
13.10 94 26 0.0 0.0 0.0 0.0 0.0
Appendix Table 4.11
Mean Liveweight of five sheep infected with 100 Cysts of F. gigantica
and four uninfected controls
Infefected group Uninfected control
Due WPI SH. 11 SH. 12 SH. 13 SH. 14 SH IS Mean (+) SH. 16 SH. 17 SH. 18 SH. 19 Mcm(-)
31.03.94 -2 51.0 39.0 43.0 41.0 42.0 43.2 400 41.0 43.0 47.0 42.8
14 04 .94 0 51.0 40.0 44.0 41.5 42.0 43.7 40.0 41.0 43.0 47.0 42.8
28 04.94 2 50.0 40.0 44 0 42.0 44.5 44.1 41D 42.0 44 D 49.0 44.0
12.05.94 4 51.0 40.0 45.0 41.0 45.0 44.4 42.0 43.0 45 0 495 44 9
26.05.94 6 51i 41.0 45.0 42.0 45.0 44.9 43.0 45.5 45.0 50.0 45.9
09.06 94 8 52.0 42.0 45.0 43.0 45.0 45.4 43.0 46.0 46.5 51.0 46.6
23.06.94 10 51.0 42.0 44.0 45.0 46.0 45.6 43.5 46.0 46.0 52.0 46.9
07.07.94 12 51.0 43 0 48.0 47.0 47.0 47.2 44.0 47.0 46.0 53.0 475
21.07.94 14 51 0 43.0 49.0 48.0 48.0 47.8 44.0 47.0 47.0 535 47.9
04 .08 94 16 52.0 43.5 455 45 0 46.5 45.0 48.0 47.5 54.0 48.6
18.08.94 18 53.0 44.0 46.0 46 0 47.3 46.0 49.0 48.0 55.0 495
01.09 94 20 51.0 43 0 47.0 45 5 46.6 47.0 50O 49.0 56.0 505
15 09 94 22 51.0 45.0 48.0 47.0 47 8 47.0 510 485 57.0 50.9




Tola! Red blood Cells levels (xI()"/!) in
Infected group Uninfected group
Wl'l SI 1.11 SII.I2 Slf .13 SH.14 SI 1.15 Mun (-) SllJev SliM SH.16 SH.17 SH.18 SH.19 M«o(.) SlDcv SEM
11 03 94 •2 14 OHO 1 1.440 13.430 11.410 10 070 12 086 1.637 0.732 10 770 9 610 9.150 11.130 10.165 0.937 0.469
07.04.94 1 1 1.330 1 1 540 15.5(H) 12.130 11.910 12.482 1.716 0.767 13 640 12.140 11.860 11 340 12295 0.930 0.465
14 04.94 0 10.240 9 770 13.450 13.320 10.460 11.448 1.786 0.799 14.100 12.950 10.140 12.790 12.495 1.675 0.837
21.04.94 1 10.370 12.170 14.0(H) 13.200 12.660 12.480 1361 0.609 11.330 12.480 9420 12.470 11.425 1.442 0.721
28.04.94 2 14.630 15.750 12.870 13.510 12.470 13.846 1 J42 0.600 11 5O0 12.650 14.050 12.500 12.675 1.049 0.525
05.05.94 3 13.100 14.740 13.150 16 160 12.380 13.906 1327 0.683 12.800 13.580 12380 13230 13.047 0.446 0223
12.05.94 4 12.540 1 1.190 12.570 14.430 11.790 12.504 1 220 0346 13.420 12.850 11.610 12 050 12.483 0X09 0.404
19 05.94 5 11.660 11 490 12.410 12.430 11.180 11.834 0362 0251 12360 12.150 10200 11.440 11387 1.034 0317
26.05.94 6 11.720 11.530 12.270 12.430 11.170 11.824 0322 0234 12.810 11.780 11.750 12.410 12.187 0315 0257
02.06.94. 7 12.590 11.850 1 2.220 11 670 9.150 11.496 1358 0 607 12.480 12.680 10.070 10.410 11.410 1361 0.680
09.06.94 8 12.930 9.540 12.620 13.230 9.770 11.618 1.807 0.808 13.470 14.120 10.810 11.640 12310 1345 0.772
16 06.94 9 12 080 8.850 10.890 13.580 10.440 11.168 1.777 0.795 12 300 10.580 11370 10.750 11250 0.778 0389
23.06.94 10 10.320 8.890 11.070 12.370 9.410 10.412 1.378 0.616 10.780 10.780 9.460 11.110 10332 0.732 0.366
30.06.94 11 10.320 8.740 10.610 12.170 8.850 10.138 1.414 0.632 11.480 11.000 9.720 10.440 10.660 0.757 0379
07.07.94 12 8.920 8.990 10.580 12.050 7.570 9622 1.726 0.772 11320 10.840 10340 10.140 10660 0329 0265
14.07.94 13 9.810 8.150 8.960 11.900 6.970 9.158 1856 0.830 10.410 10.120 9.650 10310 10.122 0337 0.169
21.07.94 14 8.880 8.430 9.000 10.430 7330 8.814 1.118 0300 10370 10.010 10210 10.490 10320 0258 0.129
28.07.94 15 9.750 6.980 7.670 8.440 8.050 8.178 1.031 0.461 11.650 10.650 10.400 10.420 10.780 0391 0295
04.08.94 16 9.810 6.870 6.830 7380 7.773 1.401 0.701 11.190 10320 10.010 10.170 10.422 0327 0264
11.08.94 17 9.430 7.170 7.500 6.880 7.745 1.152 0376 10X50 10370 10.150 11390 10.690 0351 0275
18.08.94 18 8.940 10.000 9.700 8.430 9267 0.715 0357 13X90 12.400 12.470 12.620 12.845 0.703 0351
25.08.94 19 8.660 8 000 9.430 7.500 8398 0.836 0.418 12.070 10.710 11220 11.430 11358 0363 0282
01.09 94 20 3.060 7.610 9.120 8.680 7.120 2.780 1390 11.860 10220 10250 11290 10.905 0.8O8 0.404
08.09.94 21 4.120 7 850 9 680 7230 7220 2310 1.160 10.650 9.660 10.020 10.850 10295 0352 0276
15.09.94 22 7.520 7.750 9290 7270 7.957 0.910 0.455 11.140 9.080 9270 11.170 10.165 1.146 0373
22.09.94 23 9420 7.640 9.560 6.510 8283 1.470 0.735 11210 8.970 9.860 10300 10.135 0.952 0.476
29.09 94 24 9.3(H) 6 620 9 520 7260 8.175 1.453 0.726 11260 9.470 10.160 10.710 10.400 0.766 0.383
06.10.94. 25 9.030 7.650 9.860 6290 8207 1370 0.785 11.650 9.830 10350 10.850 10.720 0.753 0.377
13 .10 94 26 11.110 6 090 8 600 3.550 2.510 10.320 10.470 10395 0.106 0.075
Appendix Table 4.13
Packed Cell Volume (PCV) (%)
Infected group Uninfected group
Date Wl'l SM. 11 SM. 12 SM. 13 SM. 14 SH. 15 Mean (♦) SlDcv SQ4 SH. 16 SH. 17 SH. 18 SH.19 Mcan(-) StDcv SEM
31.03.94 -2 34.0 33 0 40 0 34.0 28.0 33X 4J 1.9 35.0 31.0 29.0 36.0 32.8 33 1.7
07.04.94 -1 38.0 37.0 39.0 36.0 29.0 35X 4.0 1.8 37.0 29 0 29.0 34.0 323 4.0 2.0
14.04.94 0 39.0 32.0 38 0 350 25.0 33X 5.6 23 380 36.0 27.0 37.0 34.5 5.1 23
21.04.94 I 38.0 37.0 36.0 34.0 28.0 34.6 4.0 1.8 380 37.0 31.0 37.0 35.8 32 1.6
28.04.94 2 34 0 38.0 36.0 38.0 28.0 34.8 4.2 1.9 38.0 38.0 31.0 37.0 36.0 3.4 1.7
05.05.94 3 38.0 37.0 38.0 390 26.0 356 5.4 2.4 39a 38.0 30.0 36.0 35.8 4.0 2.0
12.05.94 4 36 0 34.0 34.0 38.0 26.0 33.6 4.6 2.0 380 37.0 28.0 36.0 34.8 4.6 23
19.05.94 5 350 390 33.0 36 0 29.0 34.4 3.7 1.7 400 39.0 28.0 380 363 5.6 2.8
26.05.94 6 38.0 360 34.0 350 30.0 34.6 3.0 13 39.0 38.0 32.0 380 36.8 32 1.6
02.06 94. 7 360 380 35.0 36.0 29.0 34 8 3.4 15 390 36.0 32.0 390 36.5 33 1.7
09.06.94 8 37.0 35 0 35 0 360 29.0 34.4 3.1 1.4 390 37.0 30.0 39.0 363 43 2.1
16.06.94 9 350 31.0 37.0 37.0 290 33 8 3.6 1.6 38.0 38.0 31.0 37.0 36.0 3.4 1.7
23.06.94 10 29.0 31.0 37.0 37.0 28.0 32.4 A3 1.9 38.0 38.0 30.0 370 35.8 3.9 1.9
30.06.94 11 310 30.0 37.0 39.0 26.0 32.6 53 2.4 41.0 38.0 32.0 35.0 363 3.9 1.9
07.07.94 12 30.0 33.0 36.0 33.0 260 31.6 3.8 1.7 39.0 38.0 31.0 37.0 363 3.6 1.8
14.07.94 13 26.0 29.0 29.0 37.0 23.0 28 8 52 23 37X 35.0 30.0 35.0 343 3.0 13
21.07.94 14 26 0 28 0 32.0 33.0 24.0 28 6 3.9 1.7 36.0 31.0 30.0 35.0 33.0 2.9 13
28.07.94 IS 27.0 260 25 0 26 0 27.0 262 0 8 0.4 36.0 37.0 31.0 35.0 34.8 2.6 13
04.08.94 16 27 0 26 0 25 0 26.0 26.0 0.8 0.4 38.0 35.0 32.0 33.0 34.5 2.7 1.3
1 1.08.94 17 27 0 27.0 26.0 23.0 258 1.9 0.9 370 36.0 31.0 38.0 353 3.1 1.6
18.08.94 IH 25.0 28 0 27 0 27.0 26 8 13 0.6 41.0 36.0 34.0 37.0 37.0 2.9 13
25.08 94 19 21 0 30 0 34 0 25 0 27.5 5.7 2.8 410 37.0 34.0 38.0 373 2.9 1.4
01.09.94 20 14 0 300 35.0 24.0 25.8 9.0 4.5 40.0 35.0 32.0 38.0 363 33 1.8
08.09.94 21 20 0 26.0 350 25 0 263 62 3.1 380 33.0 30.0 370 34.5 3.7 1.9
15.09 94 22 23 0 33 0 34 0 23.0 28J 6.1 3.0 400 32.0 29.0 350 34.0 4.7 2.4
22.09 94 23 290 33 0 350 24 0 30J3 4 9 2.4 400 32.0 30.0 37.0 34.8 4 6 2.3
29.09 94 24 24 0 29 0 350 260 285 4.8 2.4 400 32-0 31.0 350 34.5 4.0 2.0
06 10 94 25 30.0 32 0 34.0 23.0 29X 4 8 2.4 410 34.0 33.0 370 36.3 3.6 18




Haemoglobin (Hb) in g/dl.
Infected group Uninfected group
Dale WPI SI 111 SI1I2 SHI 3 Sif 14 SHI 5 Mem (♦-) SiDev SEM 1 SH.16 SI1.17 SH.18 SH 19 Mem (-) StDev SUM
31.03.9-1 2 14.9 14.3 16.0 13 0 10.5 13.7 2.1 0.9 142 12.8 9.6 133 125 2.0 1.0
07.04 *1 -1 16.2 15.1 17.0 142 11.7 14.8 2.1 0.9 15.7 13.6 10.4 15.4 13.8 2.4 12
14.04.94 0 12 4 14.2 16 8 15.4 10 7 13 9 2.4 1.1 163 152 11.0 15.7 14.6 2.4 12
21 04 94 1 15.0 15.8 16.7 1 5.3 12 3 15.0 1.7 0.7 15.7 16.4 13.1 15.0 15.1 1.4 0.7
28.04 94 2 15.2 154 16.3 15.5 11.3 14.7 0.9 16.7 16.2 123 15.7 152 2.0 1.0
05 05 94 3 16 5 16.7 17.1 13 8 11.7 15.2 1.0 17.0 17.3 12.4 15 0 15.4 23 1.1
12.05 94 1 3 2 12.8 12 9 12 9 94 122 0.7 143 13.4 9.9 125 125 1.9 0.9
19.05 94 5 17.7 16 0 16 7 15.9 13.7 16.0 1.5 0.7 17.5 17.1 13.1 14.7 15.6 2.1 1.0
26.05.94 6 15.4 15.7 15.7 15.4 122 14.9 1.5 0.7 17.5 16.5 12.8 162 15.8 2.0 1.0
02.06.94 7 13.2 16.8 17.7 15 9 13 6 15.4 0.9 17.9 15.3 13.4 14 9 15.4 1.9 0.9
09.06.94 8 14.9 14.9 16.3 13 5 12.6 14.4 1.4 0.6 16 1 16.3 13.8 16.7 15.7 13 0.7
16.06 94 9 13.7 13.8 16.5 16.0 132 14.6 15 0.7 17.1 16.4 132 17.1 16.0 1.9 0.9
23.06.94
'
10 13.7 14.9 17.3 16.9 12.8 15.1 0.9 17.0 17.0 13.8 17.4 163 1.7 0.8
30 06.94 1 1 14.0 15.2 16.3 17.1 12 a 15.1 1.7 0.8 18.0 15.9 132 16.1 15.8 2.0 1.0
07.07.94 12 13J 15.6 16.8 16.2 10.8 145 25 1.1 18.1 17.0 155 153 165 13 0.7
14.07.94 13 11.3 13.7 13.0 15.8 105 12.8 2.1 1.0 155 14.9 122 152 145 15 08
21.07.94 14 12.2 142 13.9 13.5 112 13.0 1J 0.6 15.0 15.9 14.7 168 15.6 0.9 05
28.07.94 15 12.3 12.1 12.1 11.8 12.4 12.1 02 0.1 16 8 162 14.9 17.0 162 0.9 05
04.08.94 16 10.7 12.8 11.0 112 11.4 0.9 05 15.4 15.0 12.9 153 14.7 12 0.6
11 08.94 17 11.9 11.7 12.9 11.8 12.1 0.6 03 16.8 15.8 13.0 152 152 1.6 08
18.08.94 18 11.0 10.1 12.5 11.7 113 1.0 0.5 132 15.4 143 15.1 145 ID 0.5
25.08 94 19 7.2 12.9 10.9 11.7 10.7 25 12 16.5 16.5 16.0 17.0 165 0.4 02
01.09 94 20 6.8 14.0 14.8 12.0 11.9 3.6 1.8 17.1 14.9 13.5 15.4 152 15 0.7
08 09.94 21 8.8 14.0 14.3 115 122 2.6 1.3 17.0 13.7 12.6 15.6 14.7 2.0 1.0
15 09.94 22 10.7 142 13.8 92 12.0 2.4 12 16.9 13.3 122 14.6 143 2.0 1.0
22.09.94 23 12.1 14.1 14.7 10.4 12.8 2.0 1.0 16.8 152 12.0 15.8 15.0 2.1 1.0
29.09.94 24 11.9 12.1 14.3 118 12.5 12 0.6 17.0 142 12.4 15.0 14.7 1.9 1.0
06.10 94. 25 13.3 12.9 14.1 9.6 12.5 2.0 1.0 172 15.1 13.0 158 153 18 0.9
13.10 94 26 0.0 132 9.1 7.4 6.8 1.9 135 15.1 143 1.1 0.8
Appendix Table 4.15
Mean corposcular volume (MCV) in fl
Infected group Uninfected group
l)aic W1M SH. ii SH. 12 SH. 13 SH. 14 SH. 15 Mem (+) StDev SEM SH 16 SH. 17 SH. 18 SH. 19 Mcm(-) SlDcv SEM
31 03 94 •2 24.1 28.8 298 29.8 26.0 27.7 2.S 1.1 32.3 323 31.7 323 325 05 05
07.04 94 -1 335 32 0 25.2 29.7 24.4 29 0 4.0 1.8 27.1 23.9 245 295 265 2.6 15
14.04 94 0 38.0 32 8 28 0 26.3 23.9 29.8 5.6 2.5 27.0 27.8 26.6 28.9 27.6 1.0 05
21.04 94 1 36.6 30.4 25 7 25.8 22.1 28.1 5.6 2.5 335 29.7 32.9 29.7 315 2.0 1.0
28.04 94 2 23 0 24.0 28 0 28.0 225 25.1 2.7 15 33.0 30.0 22.0 30.0 28.8 4.7 2.4
05.05 94 3 29 0 25.0 30.0 24 0 21.0 25.8 3.7 1.7 30.0 28.0 24.0 27.0 273 25 15
12.05.94 4 28.7 304 27.0 263 22.1 26.9 3 1 1.4 28.3 28.8 24.1 30.0 27.8 2.6 15
19.05 94 5 30.0 34.0 26.6 30.0 26.0 295 35 1.4 31.8 32.0 27.4 33.0 31.1 25 15
26.05 94 6 32.0 310 27.7 28.0 26 8 29 1 2.3 1.0 300 32.0 27.0 30.6 29.9 2.1 1.1
02 06.94. 7 28.6 32.0 28.6 30.8 31.7 30.3 1.6 0.7 31.0 28.4 31.8 375 325 3D 1.9
09.06.94 8 28 6 36.7 27.7 27 0 29.7 29.9 3.9 1.8 30.0 26.0 27.6 335 295 35 1.6
16.06.94 9 29.0 35 0 34 0 27.0 28 0 30.6 3.7 1.6 31.0 36.0 27.0 34.0 32.0 3.9 2.0
23.06 94 10 28.0 35 0 33 0 30 0 30.0 315 2.8 15 35.0 35.0 32.0 33.0 33.8 15 0.8
30.06 94 11 30.0 34.0 35 0 32.0 290 31.0 2.6 1.1 36.0 35.0 33.0 34.0 34.5 15 0.6
07.07.94 12 34 0 37.0 34.0 27.0 34.0 33.2 3.7 1.7 34.0 35.0 30.0 36.0 33.8 2.6 15
14.07.94 13 26.0 36.0 32 0 31.0 33.0 31.6 3.7 1.6 35.5 35.0 31.0 34.0 33.9 2.0 1.0
21.07 94 14 29.0 33.0 35 5 32.0 33 0 325 2.4 1.1 34.0 31.0 29.0 33.0 31.8 25 1.1
28 07.94 15 28 0 37.0 33 0 31.0 33.5 325 3.3 1.5 31.0 35.0 30.0 34.0 325 2.4 15
04.08 94 16 28.0 38.0 37.0 34.0 34.3 4.5 2.3 34.0 34.0 32.0 32.0 33.0 15 0.6
11.08 94 17 29.0 38 0 35.0 33 0 33.8 3 8 1.9 34.0 35.0 30.5 33.0 33.1 1.9 1.0
18.08 94 18 28 0 28 0 28 0 32 0 29.0 2.0 1.0 29.5 29.0 27.0 29.0 28.6 11 06
25.08 94 19 24.0 37.0 36 0 33.0 32.5 5.9 3.0 34.0 35.0 30.0 33.0 33.0 22 1.1
01.09.94 20 46.0 390 38 0 28.0 37.8 7.4 3.7 34.0 34.0 31.0 34.0 33J 15 0.8
08.09 94 21 49.0 33 0 36 0 35.0 38.3 7.3 3.6 37.0 34.0 30.0 34.0 33.8 25 1.4
15.09.94 22 31.0 43 0 37 0 32.0 35.8 5.5 2.8 36.0 35.0 32.0 32.0 33.8 2.1 1.0
22.09.94 23 310 43 0 360 37.0 36.8 4.9 2.5 36.0 36.0 30.0 35.0 345 2.9 1.4
29.09.94 24 26.0 44.0 37.0 36.0 35.8 7.4 3.7 355 34.0 30.5 33.0 335 2.1 1.1
06.10 94 25 33.0 410 34.0 36 0 36.0 3.6 1.8 35.0 34.6 31.0 34 0 33.7 1.8 0.9




Mean Corpuscular Haemoglobulin (MCH) in pg.
Infected group Uninfected group
Date Wl'l SI 1. 11 Sll. 12 SH. 13 S1L 14 Sli. 15 Mean (♦) SlDcv SEM SH. 16 SII. 17 SH. 18 Sll. 19 Me® (-) SlDcv SLM
31.03.94 2 10.0 12.5 12.9 11 4 10.4 114 13 0.6 132 13.3 103 11.9 122 13 0.7
07.04.«M -1 14.3 13.1 10.9 11.7 9.8 12.0 18 0.8 11.5 112 8.8 13J 112 1.8 0.9
14 04.94 0 12.1 14.5 12.0 11 6 102 12.1 16 0.7 15.6 11.7 10.8 123 12.6 2.1 1.1
21.04.94 1 14 5 13.0 11.9 1 I 6 9.7 12.1 1.8 0.8 13.9 13.2 13.9 12.0 133 0.9 0.4
28 04.94 2 10 0 9.8 12.7 113 9.0 10 6 1.5 0.7 14 5 12.8 9.0 12.6 122 23 12
05.05.94 3 12 6 11.5 13 0 85 9.5 11.0 2.0 0.9 13 3 12.7 10.0 113 11.8 1.5 0.7
12 05.94 4 10.5 11.4 10.3 9 O 8.0 9.8 1J 0.6 10 6 10.6 83 10.4 10.0 1.0 03
19 05.94 5 ISO 14.0 13.5 12JS 12.0 13.5 1.1 05 13.9 14.0 12.8 12.8 13.4 0.7 03
26 05 94 6 13.0 13.6 12.8 124 10.9 12.5 1.0 0.5 13.5 14.0 11.0 13.0 12.9 13 0.7
02 06.94. 7 10.5 14.0 14.5 136 14.9 13.5 1.7 0.8 14 0 12.0 13.0 14.0 133 1.0 0.5
09.06.94 8 11.5 15 6 13.0 10 0 13.0 12.6 2.1 0.9 12.0 113 12.8 14.0 12.6 1.1 03
1 6.06.94 9 11.0 16.0 15.0 12 O 13.0 13.4 2.1 0.9 14.0 16.0 12.0 16.0 143 1.9 1.0
23.06.94 10 13.0 17.0 17.0 14 jO 14.0 15.0 1.9 0.8 16 0 16.0 15.0 16 0 15.8 0.5 03
30.06.94 11 14.0 17.0 15.0 14 0 14.0 14.8 13 0.6 16.0 14.0 14.0 15.0 148 1.0 03
07 07.94 12 15.0 17.0 16.0 uo 14.0 14.6 2.3 1.0 17.0 16.0 15.0 15.0 15.8 1.0 03
14.07.94 13 11.5 17.0 14.5 130 15.0 142 2.1 0.9 15.0 15.0 13.0 15.0 14.5 1.0 03
21.07.94 14 14.0 17 0 15 0 13 O 15 0 14.8 1.5 0.7 15 0 16.0 14.0 16.0 153 1.0 0.5
2R 07 94 15 13.0 17.0 160 14 0 15.0 15.0 1.6 0.7 14.0 15.0 14.0 16.0 14.8 1.0 03
04 OX .94 16 11.0 19.0 16 O 14 0 15.0 3.4 1.7 14.0 14.5 13.0 15.0 14.1 0.9 0.4
11.08.94 17 13.0 16 0 170 17.0 15.8 1.9 0 9 15.0 15.0 13.0 13.0 14.0 12 0.6
18 OR 94 18 12 0 10 0 130 14.0 12.3 1.7 0.9 9.5 12.0 11.0 12.0 11.1 12 0.6
25.OX 94 19 8.3 16.0 12 0 16 0 13,1 3.7 1.9 14 0 15.0 14.0 15.0 143 0.6 03
01 09 94 20 22.0 18.0 ISO 14 0 17.3 3 6 1.8 14.0 15.0 13.0 14.0 14 0 0.8 0.4
08.09.94 21 21.0 18 0 150 16.0 17.5 2.7 1.3 16.0 14.0 13.0 14.0 143 1.3 0.6
15.09.94 22 14 0 18.0 150 13.0 15.0 22 1.1 15.0 15.0 13.0 13.0 14.0 12 0.6
22.09.94 23 13.0 18.0 ISO 16.0 15.5 2.1 1.0 15.0 17.0 12.0 15.0 14 8 2.1 1.0
29.09.94 24 13.0 18.0 ISO 16.0 153 2.1 1.0 15.0 15.0 12.0 14.0 14.0 1.4 0.7
06 10 94 25 14.0 17.0 1 4 O 15.0 15.0 1.4 0.7 14.8 15.0 12.0 15.0 142 13 0.7
13.10 94 26 11.9 15.0 133 22 1.6 13.0 14.0 133 0.7 03
Appendix Table 4.17
Infected group Uninfected group
Dale WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SiDcv SEM SH.16 SH. 17 SH. 18 SH. 19 Mean (-) SlDev SEM
31.03.94 -2 43.8 43.3 40 0 382 37.5 40.6 2.9 1.3 40.6 41.3 33.1 36.9 38 0 3.8 1.9
07.04.94 -1 42 6 40.1 43 6 39 4 40.0 41.1 1.8 0 8 42.4 46.9 35.9 45.0 42.6 4.8 2.4
14 04 .94 0 31.0 44.4 44 2 44 0 42 8 41.3 5.8 2.6 42.9 422 40.7 42.4 42.1 0.9 03
21.04.94 1 39.0 42.7 46.4 45 0 44.0 43.4 2.8 1.3 41.0 44.0 42.0 403 41.9 13 0.8
28.04.94 2 44.7 40.5 45.0 4! 0 40.0 422 2.4 1.1 43.9 42.8 39.7 42.4 422 1.8 0.9
05.05.94 3 43 4 45.0 57.0 35 4 45.0 452 7.7 3.5 43.6 45.5 413 41.7 43.0 1.9 1.0
12.05 94 4 36.6 37.7 38 0 34 0 36.0 36 5 1.6 0.7 37.6 36.0 35.4 34.7 359 12 0.6
19 05 94 5 50.6 41.0 50.6 44 0 47.0 46.6 42 1.9 43.8 43.8 46.8 38.7 433 3.4 1.7
26.05.94 6 40.5 43 6 46.0 44 0 40 7 43.0 23 1.1 44.5 43.4 40.0 42.6 42.6 1.9 1.0
02.06.94. 7 36.7 44 0 50.7 44 O 46.9 44.5 5.1 2J 45.9 42.5 41.9 38.0 42.1 32 1.6
09 06.94 8 40 0 42.6 46 6 375 43 4 42.0 3.5 1.5 41.0 44.0 46.0 42.8 433 2.1 1.1
16.06 94 9 39.0 44.5 45.0 43 C 45 5 43.4 2.6 12 45.0 43.0 43.0 46.0 44.3 13 0.8
23 06 94 10 47.0 48 0 47 0 46 0 46 0 46.8 0.8 0.4 45.0 45.0 46.0 47.0 45.8 1.0 03
30.06.94 11 45 0 50.0 44 0 44 0 49.0 46.4 2.9 1J 44.0 42.0 41.0 46.0 43 3 22 1.1
07.07.94 12 44.0 47 0 47.0 40 0 41.5 45.7 3.0 1.3 46.0 45.0 50.0 41.0 453 3.7 1.9
14.07.94 13 43.0 47.0 45 0 43 3 45 0 44.6 1.7 0.7 42.0 43.0 41.0 43.0 42.3 1.0 03
21.07 94 14 47 0 50.0 43 0 4 1 0 47.0 45.6 3.6 16 43 0 51.0 49.0 48.0 47.8 3.4 1.7
28 07.94 15 45 5 46.5 48 0 45 0 46 0 462 12 0.5 47.0 44.0 48.0 49.0 47.0 22 1.1
04,08.94 16 40.0 49.0 44 t 41 0 43 5 4.0 2.0 41.0 43 0 40.0 46.0 423 2.7 13
1 1 08 94 17 44 0 43.0 50 0 51.0 47.0 4.1 2.0 45.0 44.0 42.0 40.0 42.8 22 1.1
18 08 94 18 44.0 36 0 46 o 43 0 42.3 4.4 22 32.0 43.0 41.0 41.0 393 4.9 23
25 08 94 19 34.0 43 0 32 0 47.0 39.0 72 3.6 40.0 45.0 47.0 45.0 443 3.0 1.5
01.09.94 20 2.3 47.0 4 ; o 50 0 35.3 22.3 11.1 43.0 42.0 42.0 41.0 42.0 0.8 0.4
08 09.94 21 40.0 54 0 41 0 46.0 45.3 6.4 32 45.0 41.0 42.0 42.0 423 1.7 0.9
15.09 94 22 47.0 43.0 41 0 40 0 42.8 3.1 1.6 42.0 42.0 42.0 42.0 42.0 0.0 0.0
22 09 94 23 42 0 43 0 42 0 43.0 42.5 0.6 0.3 42.0 47.5 40.0 43.0 43.1 32 1.6
29.09.94 24 50.0 42.0 41 C 45.0 44.5 4.0 2.0 42.5 45.0 40.0 45.0 43.1 2.4 12
06 10.<>4. 25 44 0 40 0 41 0 41.0 41.5 1.7 0.9 42.0 44.0 39.0 43 0 42.0 22 1.1




Total White Blood cell counts (xl09/ml.)
Infcfcctcd group Unin footed control
Date VVPI SH 11 SH. 12 SH. 13 SH. 14 SH. 15 Mem (♦) StDcv sr-M SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) *Dcv SliM
31.03.94 -2 6 600 5.400 5.400 4.840 5.400 5.396 2.92 1.31 9.370 9.340 5.400 4.840 7.238 2.46 1.23
07.04.94 -1 6 220 4.640 6.440 5.040 4.640 5.528 1.695 0.758 7.520 6.060 4.640 5.040 5.815 1.284 0.642
14.04.94 0 5 950 6.600 4.680 6.440 5.040 5.396 1.529 0.684 5.100 6.430 4.680 4.770 5.245 0.81 0.405
21.04.94 1 6.440 12.341 6.337 8.605 11.251 5.742 2.74 1.23 7.584 5.077 4 285 6.349 5.824 3.5 1.75
28.04.94 2 11.811 9.858 9.079 9.810 11.199 8 995 1.119 0.5 5.840 5.794 6.054 4.254 5.486 0 829 0.414
05.05.94 3 16.840 9.002 13.230 15.015 13.748 10.351 2.91 1.3 5.983 7.329 6.425 4.570 6.077 1.15 0.575
12.05.94 4 13.900 11.900 15.200 22.100 11.700 13.567 4.25 1.9 6.800 6.800 7.200 6.700 6.875 0222 0.111
19 05.94 5 12.941 11.415 11.664 15.631 12.118 14.960 1.71 0.765 6.986 6.687 7.951 5.078 6.676 1.194 0.597
26.05.94 6 11.876 11.911 7.232 10.375 13.098 12.754 2.27 1.01 6.297 6.469 5.408 5.062 5.809 0.681 0.341
02.06.94 7 11.893 10.868 7.490 9.926 13.324 10.898 2.193 0.981 6.242 6.089 6.356 5.360 6.012 0.448 0.224
09.06.94 8 10 884 8.136 11.469 11.328 13.743 10.700 2 0.895 5.893 7.516 5.827 5.220 6.114 0.983 0.491
16.06.94 9 10.203 8.597 10.812 9.488 15.638 11.112 2.75 1.23 6 253 7.114 5.919 4.913 6.050 0.91 0.455
23.06.94 10 9.403 8 894 7.803 8.593 17.136 10.948 3.83 1.71 6.038 6.915 5 329 4.921 5.801 0.875 0.437
30.06.94 11 9.177 9.645 6.546 9.275 17.768 10.366 4.26 1.9 6.291 6.185 5.825 5.347 5.912 0.426 0.213
07.07.94 12 8.165 8 225 8.371 8.756 14.627 10.482 2.8 1.25 5.514 5.916 5.486 5.133 5.512 0.32 0.16
14.07.94 13 9.344 8.424 4.941 8.774 12.450 9.629 2.68 1.2 5.549 5.328 4.965 4.587 5.107 0.422 0.211
21.07.94 14 8.330 8.388 10.083 10.355 9.410 8.787 0.937 0.419 5.230 5.348 5.232 4.131 4.985 0.572 0.286
28.07.94 15 7.088 7.338 17.865 12.204 9.446 9.313 4 46 1.99 5.629 5.807 4.542 4.427 5.101 0.717 0.359
04.08.94 16 8.575 6.452 13.941 8.018 10.788 3.26 1.63 5.306 5.453 5.315 4.386 5.115 0.491 0.245
11.08.94 17 7.675 6.330 7.456 7.739 9.247 0.658 0.329 5.986 6.903 4.829 4.453 5.543 1.117 0.559
18.08.94 18 9.732 6.581 6.974 7.467 7.300 1.41 0.705 6.543 6.134 5.472 4.192 5.585 1.028 0.514
25.08.94 19 10.554 5.312 5.986 6.751 7.689 2.34 1.17 6.084 6.865 5.358 3.998 5.576 1219 0.609
01.09.94 20 12.287 5.310 5.922 6.232 7.151 3.26 1.63 5.915 5.286 5.641 4.541 5.346 0.595 0 298
08.09.94 21 4.789 4.167 5.166 6.350 7.438 0.919 0.459 5.633 5.370 4.896 4.610 5.127 0 46 0.23
1 5.09.94 22 4.779 4 741 5.496 6.122 5.118 0.658 0.329 5.543 6.259 4.575 4.220 5.149 0.927 0.464
22.09.94 23 5.465 4.099 5.204 5.294 5.285 0.621 0.31 5.696 5.493 4 643 4.012 4.961 0.78 0.39
29 09.94 24 5 856 3.638 5.233 5.295 5.016 0.954 0.477 5.282 5.417 4.131 3.738 4.642 0 834 0.417
06.10.94 25 5.754 4.382 5.620 10.772 5.006 2.83 1.41 5.675 5.404 4.721 3.931 4.933 0.779 0.39
13.10.94 26 5.802 4.944 6.632 0.607 0.429 4.540 3.795 4.168 0.527 0.372
Appendix Table 4.19
Eosinophil counts (xl09/ml.)
Infefectcd group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SlDcv SEM SH. 16 SH. 17 S1L 18 SH. 19 Mean (-) StDev SEM
31.03.94 -2 0381 0.119 0.075 0.081 0.025 0.136 0.141 0.063 0.013 0213 0.056 0.031 0.078 0292 0.046
07.04.94 1 0306 0.162 0.375 0.275 0206 0265 0.084 0.037 0.162 0.119 0219 0388 0222 0.118 0.059
14.04.94 1 0.350 0.500 0.338 0.069 0.094 0270 0.184 0.082 0.044 0.056 0.044 0294 0.110 0.123 0.062
21.04.94 2 1.756 1.056 1.556 0.663 1.144 1235 0.431 0.193 0.050 0313 0206 0.469 0260 0.177 0.088
28.04.94 3 6.363 2.825 4.863 2225 3.131 3.881 1.699 0.760 0.064 0300 0262 0.412 0260 0.145 0.073
05.05.94 4 6 625 4.713 9.350 7.125 3.156 6.190 2.370 1.060 0.144 0.188 0231 0.081 0.161 0064 0.032
12.05.94 5 7319 5.119 8.888 12.550 1.494 7.110 4.140 1.850 0.094 0.119 1213 0.419 0.461 0522 0261
19.05.94 6 7.106 5.850 6.456 7.156 1.581 5.630 2.330 1.040 0269 0.156 0.625 0331 0.345 0200 0.100
26.05.94 7 7362 7 206 3 694 3.338 3.225 4.945 2.097 0.938 0 106 0.063 0381 0.356 0227 0.165 0.083
02.06.94. 8 7.769 7.388 4.106 2.575 5.431 5.4 54 2.191 0.980 0.106 0.088 0.838 0.594 0.406 0371 0.186
09 06.94 9 6375 3.1 25 7.700 2238 4 906 4 849 2234 0.999 0.069 0.144 0.419 0.169 0200 0.152 0.076
16.06.94 10 5.263 2.875 6.038 1.794 7.056 4.605 2.202 0.985 0.113 0.200 0.600 0.088 0250 0238 0.119
23.06 94 1 1 5331 4 425 3.1 13 1.606 9 400 4 780 2.940 1320 0.0S6 0.169 0 444 0.194 0216 0.164 0.082
30.06.94 12 4 369 3.763 2.350 2.188 7.875 4.090 2.300 1.030 0213 0.131 0475 0.088 0227 0.173 0.087
07.07.94 13 4 539 3 056 2 339 2.450 6.162 3.709 1.627 0.728 0 075 0.056 0.400 0.038 0.142 0.173 0.086
14.07.94 14 4 569 3.381 0.006 2.744 5.656 3271 2.140 0.957 0.018 0.056 0244 0.088 0.102 0.099 0.050
21.07.94 15 3 675 3.356 0 000 4.750 1.819 2./20 1.847 0.826 0.006 0.088 0.169 0.056 0.080 0 068 0.034
28.07.94 16 3 506 3.688 0 044 5.081 0.988 2.661 2.078 0.929 0.081 0.088 0225 0.169 0.141 0 069 0.035
04 08.94 17 3.306 1.875 2.063 0.506 1.938 1.146 0.573 0.038 0.025 0.131 0.063 0.064 0047 0.024
11.08 94 18 2 913 1 244 0.356 0.306 1205 1218 0.609 0.162 0225 0.175 0.113 0.169 0 046 0.023
IK.08 94 19 3325 0 850 0 119 0.319 1.153 1.480 0.740 0 156 0.094 0.181 0.125 0.139 0.038 0.019
25.08 94 20 3 262 0 756 0 175 0 419 1.153 1.426 0.713 0 113 0.044 0.144 0.050 0.088 0.049 0.024
01.09.94 21 1 919 0.387 0.100 0.081 0622 0.876 0.438 0.131 0.075 0.319 0.081 0.152 0.115 0.057
(18 09 .94 22 0 700 0.275 0 144 0 312 0.358 0239 0 120 0.119 0.075 0.138 0.094 0.107 0.028 0.014
15.09 94 23 0.463 0238 0 150 0.113 0 241 0.157 0.079 0.100 0.081 0225 0.144 0.138 0 064 0.032
22.09.94 24 0 7KX 0 213 0.100 0.075 0.294 0.335 0.167 0 050 0.031 0.181 0.081 0.086 0.067 0.033
29.09.94 25 1 069 0 288 0.1 19 0.156 0.408 0.447 0223 0 069 0.019 0.194 0.113 0.099 0.074 0.037
06.10.94 26 1.106 0 375 0.119 0.069 0 417 0.478 0.239 0.119 0.000 0.075 0.056 0.063 0 049 0.025




Neulrcophils difcrcnlial counts (x109/ml.)
Infcfcclcd group Uninfected control
Dale WPI SH. 11 SH. 12 SH. 13 SH 14 SH. 15 Men (4) StJJcv SI-M SH. 16 SH. 17 SH. 18 SK 19 Men ( ) SiDcv SIM
31.03.94 •2 2 640 4.216 1.731 2.163 1.848 2.52 1.011 0.452 2 249 1.401 0.810 0 629 1.272 0.73 0.365
07.04.94 •1 1.057 1.865 1.128 1.718 0.278 1.209 0 63 0 282 1 504 0.545 0 974 0.4S* 0.869 0.48 0.24
14.04.94 0 1 785 1.378 1.172 2.295 1.332 1.592 0 453 0.203 0 561 0.836 0 889 0 620 0.7265 0.16 0.08
21.04.94 1 1.159 2.592 0.951 1.721 1.238 1.532 0 656 0.293 1.213 2.318 2.857 0 &&9 1.819 0.924 0.462
2K.04.94 2 1 772 2.070 1.453 1.373 1.008 1.535 0.404 0.181 1.226 1.564 1.453 0 553 1.199 0.453 0.227
05.0S.94 3 1 347 0.090 0.794 .0.450 2.337 1.004 0.878 0.392 1.376 1.099 1.478 0.594 1.137 0.396 0.198
12.05.94 4 1 390 1.666 2.128 2.210 0.936 1.666 0.529 0.236 1.564 1.360 1.152 0.558 1.253 0.269 0.135
19.05.94 5 3.235 1.484 1.750 2.032 0.242 1.749 1.076 0.481 1.327 0.736 4.373 1.117 1.888 1.674 0.837
26.05.94 6 1.663 1 072 0.651 1.141 2.227 1.351 0.608 0.272 0.882 1.747 1 298 0.810 1.184 0.432 0.216
02.06.94. 7 0.951 1.522 0.824 1.191 1.732 1.244 0.381 0.17 1.061 1.218 1.335 0.S90 1.051 0.327 0.164
09 06.94 8 1.197 1.627 1.262 1.812 1.374 1.454 0.259 0.116 1.179 1.954 2.389 1.357 1.72 0.556 0.278
16.06.94 9 1.530 2.149 1.081 1.423 1.720 1.581 0.394 0.176 1.126 0.996 1.184 0.533 1.0598 0.115 0.058
23.06.94 10 1.410 1.512 0.936 1.633 0.857 1.27 0.351 0.157 1.268 1.245 1.013 0.964 1.1275 0.15 0.075
30.06.94 11 1.744 2.025 0.851 1.855 3.554 2.006 0.978 0.437 1.384 1.794 1.456 1.123 1.439 0.276 0.138
07.07.94 12 1.143 1.316 1.088 1.751 3.803 1.82 1.139 0.509 0.937 1.183 1.152 0.975 1.0617 0.124 0.062
14.07.94 13 1.215 1.601 3.014 1.228 2.615 1.935 0.83 0.371 0.999 0.693 0.894 0.563 0.8873 0.137 0.068
21.07.94 14 1.083 1.426 5.949 2.071 1.035 2.313 2.074 0.928 1.046 0.909 1.046 0 289 0.822 0.361 0.181
2X.07.94 15 1.134 1.027 13.756 2.563 0.945 3.88 5.56 2.49 1.351 1.161 1.136 0.620 1.067 0.313 0.157
04.0X.94 16 1.801 1.548 6.134 0.481 2.49 2.5 1.25 1.061 0.491 1.222 1.C09 0.946 0.316 0.158
11 0X.94 17 1.305 1.266 1.939 0.619 1.282 0.539 0.27 1.676 1.174 1.207 0.6-46 1.226 0.342 0.171
1X.0X.94 18 2.920 0.790 1.813 0.373 1.474 1.138 0 569 1.047 1.104 1.149 1 258 1.1395 0.089 0.045
25.0X.94 19 4.433 0.903 0.898 0.338 1.643 1.879 0.939 1.156 1.098 1.072 0.720 1.0115 0.198 0.099
01.09.94 20 7.004 0.956 1.244 0.374 2.39 3.09 1.55 1.360 0.951 1.749 0.727 1.197 0.452 0.226
OX.09.94 21 0.814 1 083 1 240 0 953 1.0225 0.182 0.091 1.352 1.235 1.420 2.121 1.S32 0.4 0.2
1 5.09.94 22 1.051 1.327 1.429 1.041 1.212 0.196 0.098 0.887 1.440 1.281 1.055 1.166 0.244 0.122
22.09.94 23 1.148 1.271 1.145 0.741 1.076 0.231 0.116 1.538 1.318 1 486 0.4Z1 1.196 0.512 0.256
29.09.94 24 1.113 0.910 0 890 0.794 0.9268 0.134 0.067 1.056 1.138 1.239 0.635 1.017 0.265 0.133
06.10.94. 25 0.978 1.139 1.349 7.110 2.64 2.98 1.49 1.930 1.135 1.416 0.708 1.297 0.513 0.256
13.10.94 26 1.857 1.335 1.596 0.369 0.261 1.226 1.C2S 1.125 0.142 0.1
Appendix Table 4.21
Lymphocytes difcrential counts (xl09/ml.)
Infcfccted group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Men (+) SiDev SEM SH. 16 SH. 17 SH. 18 SHl 19 Men (-) StDcv SEM
31.03.94 -2 3.234 6.323 2.651 6.386 8.085 5.34 2.31 1.03 5.809 6.164 4.320 3.436 4.932 1.278 0.639
07.04.94 -1 4.478 4.817 5.320 8.270 8.250 6.227 1.88 0.841 5.715 5.090 3.202 3.780 4.447 1.157 0.579
14 04 .94 0 3.808 3.731 3.794 6.610 5.624 4.713 1.328 0.594 4.080 5.337 3.650 3 244 4.078 0.906 0.453
21-04.94 1 3.606 7.775 3.612 6.454 9.226 6.13 2.51 1.12 5.916 6.953 10.142 4.508 6.88 2.39 1.2
28.04.94 2 2.480 3.943 2.905 6.573 7.503 4.68 2.24 1 4.380 3.650 3.814 2.893 3.684 0.613 0.307
05.05.94 3 3.705 4.321 3.837 6.006 8.799 5.334 2.144 0.959 4.248 5.717 3.919 3 245 4.282 1.044 0.522
12.05.94 4 3.892 5.831 4.256 8.398 9.126 6.3 2.38 1.06 4.488 5.304 4.824 4.489 4.776 0.386 0.193
19.05.94 5 4.012 4.566 3.266 6.721 10.421 5.8 2.89 1.29 5.030 5.751 3.101 3.199 4.27 1.327 0.664
26.05.94 6 2.731 4.764 3.761 6.744 7.990 5.198 2.152 0.962 5.101 4.399 3.623 3.138 4.065 0.864 0.432
02.06.94. 7 4.876 3 478 3.595 6.948 8.394 5.458 2.155 0.964 4.806 4.445 4.322 4.074 4.412 0.305 0.152
09.06.94 8 3.809 3.824 3.555 7.250 7.834 5.254 2.101 0.94 4.361 5.111 2.564 3.445 3.87 1.106 0.553
16.06.94 9 3.775 3.697 4.865 6.262 8.757 5.471 2.11 0.944 4.877 5.264 4.321 3.438 4.488 0.771 0.385
23.06.94 10 3.761 3.113 3.902 5.500 9.768 5.21 2.7 1.21 4.468 5.463 4.050 3.691 4.418 0.766 0.383
30.06.94 11 2.661 4.147 3.011 4.916 4.442 3.835 0.961 0.43 4.592 4.206 4.078 3.689 4.141 0.372 0.186
07.07.94 12 3.184 3.455 3.767 5.166 5.997 4.314 1.212 0.542 4.301 4.260 3.785 3 952 4.075 0.248 0.124
14.07.94 13 3.831 3.454 1.828 4.913 6 350 4.075 1.686 0.754 4.162 4.316 3.624 3.257 3.84 0.489 0.244
21.07.94 14 3.082 2.013 3.327 4.038 6.305 3.753 1.601 0.716 3.975 4.171 3.872 3.635 3.913 0.223 0.112
28.07.94 15 3.119 2.495 2.858 4.515 6 990 3.995 1.841 0.823 4.109 4.355 3.270 3.536 3.83 0.492 0.246
04.0X.94 16 4.030 3.420 4 461 6.976 4.722 1.562 0.781 3.873 4.853 3.827 3.290 3.961 0.651 0.326
11 08.94 17 4.298 3.735 5 145 6.501 4.92 1.203 0.601 4.250 5.522 3.429 3.340 4.135 1.011 0.506
IX 0X.94 18 3.601 4.607 4 882 6.496 4 897 1.2 0.6 5.234 4.907 3.776 2.609 4.181 1.108 0.554
25 0X94 19 2 955 2 762 4 609 6.008 4.083 1.527 0.764 4.746 5.286 3.965 3.038 4.259 0.978 0.489
01.09.94 20 3 317 3.770 4 205 5.609 4,225 0.991 0.496 4.141 4.229 3.610 3.360 3.835 0.418 0.209
OX.09.94 21 2 682 2.709 3 668 5.144 3.551 1.157 0.578 4.112 3.598 3.182 2.351 3.311 0.744 0.372
1 5.09.94 22 3 011 3.034 3.627 4 836 3 627 0.855 0.427 4 324 4.694 2 791 3.C38 3.712 0.938 0.469
22.09.94 23 3 170 2.623 3 435 4 288 3.379 0.694 0 347 4 044 4.010 2.972 3.571 3.649 0.5 0.25
29.09.94 24 3 338 2.437 3.715 4 130 3 405 0.722 0.361 4.067 4.225 2.520 2.990 3.451 0.828 0.414
06.10.94. 25 3.395 2.804 4 046 3.662 3.379 0.522 0.261 3.405 3.837 3.021 3.105 3.342 0.369 0.184





Moncyles difcrcntial counls (xl09/ml.)
Infc footed group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (♦) SlDcv SLM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) SlDcv SEM
31 03 94 •2 0.264 0.117 0.108 0.515 0.578 0.3164 0 22 0.098 0.562 0.374 0.162 0.484 0.3955 0.174 0.087
07 04 94 • 1 0 062 0.155 0 484 0 107 0.371 0 2358 0.183 0.082 0.226 0.242 0.000 0.151 0.1547 0.111 0.055
14 04 94 0 0 060 0.115 0.335 0.184 0222 0.1832 0.105 0.047 0.255 0.129 0.047 0.143 0.1435 0.086 0.043
21 04 94 1 0.322 0 000 0.380 0 172 0.338 0 2424 0.157 0.07 0.152 0 403 0 429 0.063 0.2617 0 182 0.091
2H 04 94 2 0 4 72 0.197 0.182 0.000 0.448 0.2598 0.199 0.089 0.058 0 348 0.182 0.085 0.1682 0.131 0.066
05.05 94 3 0337 0.090 0.132 0.450 0.275 0 2568 0.148 0.066 0.120 0.147 0.257 0.091 0.1538 0.073 0.036
12 05.94 4 0.278 0.119 0.152 0.221 0.234 0.2008 0.064 0.029 0.476 0 068 0.144 0.268 0.239 0.178 0.089
19 05.94 5 0259 0.114 0233 0.469 0.485 0.312 0.16 0.072 0.349 0 134 0.080 0.051 0.1535 0.135 0.067
26.05 94 6 0.238 0.000 0.289 0.519 0.262 0.2616 0.184 0.083 0.063 0.259 0.108 0.101 0.1328 0.087 0.043
02 06 94 7 0.119 0.109 0.000 0.496 0.533 0.251 0.245 0.11 0.062 0.426 0.127 0.322 0.2342 0.169 0.085
09 06 .94 8 0.000 0.244 0.115 0.453 0.550 0.272 0.229 0.102 0.118 0.150 0.117 0.052 0.1093 0.041 0.021
16.06.94 9 0.102 0.086 0.216 0.095 0.313 0.1624 0.1 0.045 0.125 0 569 0.118 0.246 0.264 0.211 0.106
23.06.94 10 0.188 0.089 0.000 0.000 0.000 0.0554 0.084 0.037 0.181 0.000 0.000 0.049 0.0575 0.086 0.043
30.06.94 11 0.092 0.386 0.000 0.093 0.355 0.1852 0.174 0.078 0.126 0.124 0.058 0.053 0.0903 0.04 0.02
07.07.94 12 0.082 0.000 0.251 0 000 0.146 0.0958 0.106 0.048 0.110 0.237 0.219 0.103 0.1673 0.071 0.035
14.07.94 13 0.280 0.084 0.049 0.000 0.000 0.0826 0.116 0.052 0.055 0.266 0.099 0.000 0.105 0.115 0.057
21.07.94 14 0.000 0.084 0.706 0.104 0.094 0.198 0.287 0.128 0.105 0.267 0.052 0.041 0.1162 0.104 0.052
28.07.94 15 0.284 0.147 1.072 0.244 0.189 0.387 0.386 0.173 0.113 0.116 0.136 0.089 0.1135 0.019 0.01
04.08.94 16 0.000 0.000 0.836 0.160 0.249 0.399 0.199 0.212 0.109 0.159 0.000 0.12 0.09 0.045
11.08 94 17 0.077 0.063 0.075 0.387 0.1505 0.158 0.079 0.060 0.000 0.048 0.045 0.0382 0.026 0.013
18.08.94 18 0.292 0.132 0.139 0.224 0.1968 0.076 0.038 0.065 0.061 0.055 0.042 0.05575 0.01 0.005
25 08.94 19 0.106 0.053 0.120 0.135 0.1035 0.036 0.018 0.183 0.412 0.054 0.120 0.1922 0.156 0.078
01.09 94 20 0.246 0.212 0.178 0.187 0.2058 0.03 0.015 0.118 0 106 0.113 0.091 0.107 0.012 0.006
08.09.94 21 0 096 0.167 0.103 0.000 0.0915 0.069 0.034 0.169 0.483 0.098 0.046 0.199 0.196 0.098
15 09.94 22 0.287 0.047 0.220 0.245 0.1998 0.106 0.053 0.166 0.125 0.275 0.042 0.152 0.097 0.048
22.09.94 23 0.055 0.041 0.208 0.053 0.0892 0.079 0.04 0.000 0.110 0.046 0.000 0.039 0.052 0.026
29.09.94 24 0.000 0.036 0.262 0.106 0.101 0.116 0.058 0.106 0.000 0.207 0.037 0.0875 0.091 0.046
06.10 94. 25 0.115 0.000 0.056 0.000 0.0428 0.055 0.028 0.057 0.216 0.094 0.000 0.0918 0.091 0.046
13.10 94 26 0232 0.148 0.19 0.059 0.042 0.272 0.228 0.25 0.031 0.022
Appendix Table 4.23:
Eosinophil difcrential counts (xl()9/ml.)
Infefected group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SlDcv SEM SH. 16 SH. 17 SH. 18 SH. 19 Me*i (-) SlDcv SEM
31.03.94 •2 0 396 1.054 0.920 1.133 1.040 0.909 0.297 0.133 0.750 1.588 0.108 0.290 0.684 0.66 0.33
07.04.94 -1 0622 0.855 1.048 0 644 0.371 0.708 0.256 0.115 0.075 0.182 0.464 0.655 0.344 0.264 0.132
14.04.94 0 0 298 0.517 0 279 0.092 0.222 0.2816 0.154 0.069 0.204 0.129 0.094 0.763 0.298 0.314 0.157
21 04 94 1 1.352 1.975 1.394 0.258 0.450 1 086 0.715 0.32 0.303 0.403 0.857 0.889 0.613 0.303 0.152
2X.04.94 2 7.087 3.647 4.540 1 864 2.240 3.876 2.093 0.936 0.175 0.232 0.605 0.723 0.434 0.271 0.136
05.05.94 3 11.451 4.501 8.467 8.108 2.337 6.97 3.58 1.6 0.239 0.366 0.771 0.640 0.504 0.244 0.122
12.05 94 4 8 340 4.284 8.664 11.271 1.404 6.79 3.91 1.75 0.272 0 068 1.008 1.005 0.588 0.49 0.245
19.05.94 5 5.176 5.251 6.415 6.409 0.969 4.84 2.25 1.01 0.279 0.067 0.398 0.711 0.364 0.269 0.134
26.05 94 6 7.244 6.075 2.531 1.971 2.620 4 09 2.4 1.07 0.252 0.065 0.379 1.012 0.427 0.411 0.205
02.06.94. 7 5.828 5.760 3.071 1.290 2.665 3.723 2.003 0.896 0.312 0.000 0.572 0.375 0.315 0.237 0.119
09 06 94 8 5.877 2.441 6.308 1.812 3.985 4.085 2.002 0 895 0.236 0.301 0.758 0.365 0.415 0.235 0.117
16 06.94 9 4.795 2.665 4.541 1.708 4.848 3.711 1.437 0.643 0.125 0.285 0.296 0.246 0.238 0.078 0.039
23 06.94 10 4 043 4.180 2.809 1.461 6.683 3 835 1.934 0.865 0.121 0.207 0.266 0.197 0.1978 0.06 0.03
30.06.94 11 4.680 3.086 2.684 2.412 9.417 4.46 2.91 1.3 0.189 0.062 0.233 0.481 0.2412 0.176 0.088
07.07.94 12 3.674 3.455 3.265 1.839 4 681 3.383 1.021 0.457 0.165 0.237 0.274 0.103 0.1947 0.076 0.038
14.07.94 13 4.018 3.285 0 049 2.632 3.486 2.694 1.56 0.697 0.333 0.053 0.348 0.367 0.2752 0.149 0.074
21.07.94 14 4.165 4.781 0.101 3.935 1.976 2.992 1.927 0.862 0.105 0.000 0.209 0.165 0.1198 0.091 0.045
28.07.94 15 2.481 3.449 0 179 4 882 1.322 2.463 1.826 0.817 0.056 0.174 0.000 0.133 0.0908 0.078 0.039
04.08.94 16 2.744 1.484 2.509 0.401 1.785 1.072 0.536 0.159 0.000 0.106 0.088 0.0882 0.066 0.033
11.08 94 17 1.996 1.266 0.298 0.155 0.929 0.866 0.433 0.000 0.207 0.097 0.223 0.1318 0.104 0.052
18.08 94 18 2.920 1.053 0.139 0.373 1.121 1.26 0.63 0.196 0.061 0.492 0.084 0.2083 0.198 0.099
25 08.94 19 3.061 1 594 0.359 0.135 1.287 1.345 0.673 0.000 0.069 0.268 0.120 0.1143 0.114 0.057
01.09.94 20 1.720 0.372 0.296 0.062 0.613 0 75 0.375 0.296 0.000 0.169 0.363 0.207 0.16 0.08
08 09 .94 21 1.197 0 208 0.052 0.254 0 428 0.52 0.26 0.000 0.054 0 196 0.092 0.0855 0.083 0.041
15.09.94 22 0.430 0.332 0.220 0.000 0 2455 0.185 0.092 0.166 0.000 0.229 0.084 0.1198 0.1 0.05
22 09 94 23 1 093 0.164 0.416 0.212 0 471 0.429 0.214 0.114 0.055 0.139 0.000 0.077 0.062 0.031
29 09 94 24 1.405 0.255 0 366 0 265 0.573 0.557 0.279 0.053 0.054 0.165 0.075 0.0868 0.053 0.027
06 1 0 94 25 1 208 0 438 0.169 0.000 0 454 0.534 0.267 0.284 0 216 0.189 0.118 0.2018 0.069 0.034




Basophils difcrential counts (xl09/ml)
Infcfecled group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mem (+) SlDev SEM SH. 16 SH. 17 SH. 18 SH. 19 Mem(-) StDev SEM
31.03.94 -2 0.066 0.000 0.000 0.103 0.000 0.034 0.048 0.022 0.000 0.000 0.000 0.000 0.000 0.000 0.000
07.04.94 -1 0.000 0.000 0.081 0.000 0.000 0.016 0.036 0.016 0.000 0.000 0.000 0.000 0.000 0.000 0.000
14.04.94 0 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
21.04.94 1 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
28.04.94 2 0.000 0.000 0.000 0.000 0 000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
05.05.94 3 0 000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
12.05.94 4 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.072 0.000 0.018 0.036 0.018
19.05.94 5 0.259 0.000 0.000 0 000 0.000 0.052 0.116 0.052 0.000 0.000 0.000 0.000 0.000 0.000 0.000
26.05.94 6 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
02.06.94. 7 0.119 0.000 0.000 0.000 0.000 0.024 0.053 0.024 0.000 0.000 0.000 0.000 0.000 0.000 0.000
09.06.94 8 0.000 0.000 0.000 0 000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
16.06.94 9 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
23.06.94 10 0.000 0.000 0.156 0000 0 000 0.031 0.070 0.031 0.000 0.000 0.000 0.000 0.000 0.000 0.000
30.06.94 11 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
07.07.94 12 0.082 0.000 0.000 0.000 0.000 0.016 0.037 0.016 0.000 0.000 0.000 0.000 0.000 0.000 0.000
14.07.94 13 0.000 0.000 0.000 0 000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
21.07.94 14 0.000 0.084 0.000 0.207 0.000 0.058 0.091 0.041 0.000 0.000 0.052 0.000 0.013 0.026 0.013
28.07.94 15 0.071 0.000 0.000 0 000 0.000 0.014 0.032 0.014 0.000 0.000 0.000 0.000 0.000 0.000 0.000
04 08.94 16 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
11.08.94 17 0.000 0.000 0.000 0.077 0.019 0.039 0.019 0.000 0.000 0.048 0.000 0.012 0.024 0.012
18.08.94 18 0.000 0 000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
25.08.94 19 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
01.09.94 20 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
08.09.94 21 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
15.09.94 22 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
22.09.94 23 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
29.09.94 24 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
06.10.94. 25 0.058 0.000 0.000 0.000 0.015 0.029 0.015 0.000 0.000 0.000 0.000 0.000 0.000 0.000
13.10.94 26 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Appendix Table 4.25
Albumin (g/1) in sheep
Infcfcctcd group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mem (+) StDev SEM SH. 16 SH. 17 SH. 18 SH. 19 Mem (-) StDev SEM
31.03.94 2 48.2 46 5 48.7 36.1 40.6 44.02 5.48 2.45 39.6 39.6 342 322 36.4 3.78 1.89
07.04.94 1 35.8 413 34 9 37.1 46.4 39.1 4.76 2.13 36.1 37.6 34.0 40.7 37.1 2.82 1.41
14 04 94 0 34.9 38.1 41 7 37.6 41.0 38 66 2.75 1.23 29.9 38.5 33.1 35.9 34.35 3.7 1.85
21.04.94 1 38 6 38 2 419 34.0 306 3666 4.40 1.97 41.6 34.4 32.1 36.3 36.1 4.05 2.02
28 04 94 2 35.7 34 6 32.2 40.9 314 34.96 3.75 1.68 35.1 45.6 33.9 38.6 38.3 526 2.63
05 05.94 3 29 9 32 2 33 7 34.0 373 33.42 2.71 1.21 26.9 33.6 34.2 42.8 34.37 6.52 326
12 05.94 4 35 8 354 35 2 38.5 44 4 37.86 3.89 1.74 45.0 41.3 35.4 38.1 39.95 4.14 2.07
19.05.94 5 38 0 32 4 37 4 31.1 416 36.1 4.31 1.93 49.9 45.9 40.6 40.7 44.28 4.49 225
26.05.94 6 37.0 48 4 38.3 39.5 39 8 40.6 4.50 2.01 47.8 49.5 31.7 48.5 44.38 8.48 424
02.06.94. 7 38.3 40.9 38 0 40.4 39.3 39.38 127 0.57 49.3 44.4 43.1 39.7 44.13 3.98 1.99
09.06.94 8 33.4 33.3 33.4 35.7 38 0 34.76 2.07 0.93 39.7 37.3 39.4 36.4 382 1.61 0.80
16.06.94 9 37.2 310 34 8 39.8 36.0 35.76 3 24 1.45 38.4 39.5 34.4 40.3 38.15 2.62 1.31
23.06.94 10 32.9 35 2 33.9 44.1 33.9 36 4.60 2.06 43.5 38.0 32.1 41.3 38.72 4.96 2.48
30.06.94 I 1 33.9 31.5 40.5 38.9 33 8 35.72 3.80 1.70 41.6 38.8 37.3 41.7 39.85 2.17 1.08
07 07 94 12 30.3 30.6 35.4 31.3 35.2 32.56 2.53 1.13 43.8 41.4 41.0 37.5 40.92 2.60 1.30
14.07.94 13 31.1 30.1 31.8 34.0 31.0 31.6 1.47 0.66 37.5 34.8 36.3 38.7 36.825 1.67 0.83
21.07.94 14 30.6 30 9 23.0 32.1 28.4 29 3.61 1.61 41.3 37.4 36.3 40.1 38.78 2.32 1.16
28.07.94 15 29.9 28.1 23 6 29.5 29.6 28.14 2.63 1.18 38.7 39.1 35.8 40.3 38.475 1.91 0.95
04.08.94 16 31.3 28.1 28.5 31.6 29.875 1.83 0.92 392 38.9 35.6 39.6 38.325 1.84 0.92
11.08.94 17 30.6 28.4 30.4 29.4 29.7 1.01 0.51 392 37.0 36.7 39.3 38.05 1.39 0.70
18.08.94 18 27.3 296 27.6 32.1 29.15 2.22 1.11 37.4 56.8 35.3 39.8 42.33 9.82 4.91
25.08.94 19 24.9 27.9 33.8 29.3 28.97 3.70 1.85 39.4 392 37.9 41.4 39.475 1.45 0.72
01.09.94 20 26.1 28 3 29.0 32.0 28 85 2.44 1.22 38.7 36.8 33.3 35.7 36.12 225 1.13
08.09.94 21 27.2 31 8 32.4 31.8 30.8 2.42 1.21 61.8 31.4 34.5 39.6 41.83 13.74 6.87
1 5 09.94 22 24.4 32 0 32.2 29.0 29.4 3.64 1.82 35.3 34.1 38.5 35.6 35.875 1.87 0.93
22.09.94 23 22.0 217 24.1 25 8 23.4 1.92 0.96 30.0 26.9 29.1 34.4 30.1 3.15 1.57
29.09.94 24 24.1 26.0 31.2 30.0 27.83 3.33 1.67 32.8 30.0 32.8 33.4 3225 1.53 0.76
06.10.94 25 28.7 29.1 33.7 33.7 31.3 2.78 1.39 40.7 37.5 36.5 35.1 37.45 2.38 1.19




Total protein (g/1) in sheep
Infefected group Uninfected control
Date WPI SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) StDev Sf-M SH. 16 SH. 17 SH. 18 SH. 19 Mean () SiDev SEM
31.03.94 -2 10.0 9.1 8.5 7.6 12 8.48 1.13 0.505 7.5 9.3 7.1 72 7.8 7.8 1.0
07.04.94 -1 9.2 8.9 7.9 8.0 8.0 8.4 0.604 021 8.6 92 8.1 8.8 8.8 0.5
14.04.94 0 8.9 8.0 8.5 8.0 9.1 8.5 0.505 0226 6.8 8.8 6.4 7.3 13 1.063
21.04.94 1 9.5 8.1 7.3 7.4 7.5 7.96 0.915 0.409 12 10.0 7.3 7.9 7.9 1.384
28.04.94 2 8.6 7.9 8.1 7.9 7.1 7.92 0.54 0.242 6.9 10.9 7.8 8.6 8.6 1.723
05.05.94 3 9.1 7.7 8.4 7.3 7.0 7.9 0.851 0.381 7.4 8.2 8.3 8.0 8.0 0.403
12.05.94 4 7.1 7.5 8.5 8.0 7.5 7.72 0.54 0242 7.5 7.5 7.5 7.8 7.8 0.5
19.05.94 5 7.7 7.6 10.0 7.4 10.0 8.54 1.337 0.598 7.4 7.6 7.5 7.6 7.6 0263
26.05.94 6 8.5 8.3 9.5 7.6 9.2 8.62 0.753 0.337 7.3 6.9 82 7.9 7.9 0.981
02.06.94. 7 8.5 7.3 7.9 8.3 8.9 8.18 0.61 0.273 7.9 7.6 7.3 7.6 7.6 0245
09.06.94 8 7.5 7.4 8 0 7.8 9.5 8.04 0.85 0.38 6.9 7.8 72 7.6 7.6 0.75
16.06.94 9 8.2 10.0 8.6 7.9 8,6 8.66 0.805 0.36 7.9 7.8 7.4 8.0 8.0 0.638
23.06.94 10 8.5 92 8.7 7.4 9.1 8.58 0.719 0.322 7.7 8.9 72 8.7 8.1 8.1 0.81
30.06.94 11 8.2 8.3 8.4 8.7 10.0 8.72 0.74 0.331 7.6 8.0 8.6 7.8 7.8 0.714
07.07.94 12 11.8 7.6 8.9 9.2 9.1 1.643 0.735 7.6 8.5 12 7.9 7.8 7.8 0.548
14.07.94 13 10.0 11.0 7.6 8.6 7.8 9 1.463 0.654 7.4 8.0 7.9 8.3 7.9 7.9 0.374
21.07.94 14 9.4 8.5 7.3 8.9 8.3 8.48 0.782 0.35 7.4 91 7.8 8.1 8.1 8.1 0.726
28 07.94 15 9.3 12 8.3 7.9 0.76 0.34 6.9 7.6 7.5 82 7.6 7.6 0.532
04.08.94 16 9.2 7.6 7.8 0.719 0.359 7.4 8.0 7.4 7.7 7.6 7.6 0287
11.08.94 17 8.8 7,6 7.3 7.9 0.648 0.324 7.8 7.7 7.5 82 7.8 7.8 0294
18.08.94 18 10.0 7.0 8.0 1.3 0.65 7.4 7.9 7.5 8.2 7.8 7.75 0.37
25.08.94 19 10.9 7.7 6.6 1.954 0.977 8.6 7.7 8.6 8.1 8.125 0.55
01.09.94 20 7.9 8.0 7.7 6.6 0.645 0.323 8.9 7.8 7.7 8.4 8.2 82 0.56
08 09.94 21 7.1 7.1 7.5 5 0 1.132 0.57 7.9 8.7 7.8 8.1 8.075 0.419
15.09.94 22 6.4 5.6 5.8 4.9 5.7 0,618 0.31 8.5 8.9 9.2 8.6 8.55 0.695
22.09.94 23 6.7 5.2 2.8 5.5 5.1 1.634 0.82 8.3 8.6 9.1 8.3 825 0.896
29.09.94 24 4.5 4.4 4.5 4.6 4.5 0.1 0.0 8.4 8.9 7.4 8.5 8.45 0.759
06.10.94. 25 6.8 5.3 5.6 5.3 0.7 0.4 8.1 6.5 72 72 72 0,668
13 10.94 26 6.7 6.1 0.4 0.3 7.6 7.7 7.7 0.141
Appendix Table 4.27
Glutamate Dehydrogenase (IU/1) in sheep
Infcfcctcd group Uninfected control
Date WP I SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) StDev SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) StDev SEM
31.03 94 2 0.2 1.2 2.2 1.4 8.7 2.7 3.4 1.5 0.2 0.6 1.0 0.6 0.6 0.3 02
07.04.94 -1 2.0 0.2 2.4 2.2 11.6 3.7 4.5 2.0 0.4 32 3.5 3.5 2.7 1.5 0.8
14 04 .94 0 3.2 3.0 4.1 0.4 5.9 3.3 2.0 0.9 1.0 0.0 1.2 8.3 42 2.1
21.04.94 1 3.0 1.0 22.1 19.1 3.3 9.3 10.5 4.7 2.4 9.1 2.8 4.9 3.1 1.5
28.04.94 2 19 7 9.7 25 8 9.3 11.4 15.2 7.3 3.3 1.0 6.3 3.2 9.3 3.6 1.8
05.05.94 3 87.3 294 108.7 12.0 12 0 49 9 45.1 20.2 1.0 2.4 3.3 3.5 1.1 0.6
12.05.94 4 110.7 53.4 130.2 21.9 13,8 66.0 52.3 23.4 0.6 7.9 4.1 6.3 3.2 1.6
19.05.94 5 85 3 72.3 98.9 32.1 17.3 61.2 35.0 15.7 0.0 7.1 1.8 9.7 4.5 2.3
26.05.94 6 81 4 63.0 57.5 28.6 17.7 49.6 26.0 11.6 0.0 9.5 8.7 9.9 4.7 2.4
02.06.94. 7 80 2 61.9 57.3 45 3 44.9 57.9 14.5 6.5 0.0 4.1 3.9 9.9 4.1 2.0
09.06.94 8 72 7 37 4 61.3 24.4 22 9 43.7 22.3 10.0 6.3 2.2 6.5 4.1 2.0 1.0
16.06.94 9 52.4 26 8 40.8 24 4 26.4 34.2 12.1 5.4 6.1 12 5.7 1.8 2.6 1.3
23 06.94 10 43 5 29 3 16.7 11.0 18.1 23.7 12.9 5.8 6.5 6.1 6.3 8.7 12 0.6
30.06.94 11 35.1 38 6 24.8 20.3 32.9 30.3 7.6 3.4 8.0 3.0 5.5 3.9 5.1 22 1.1
07.07 94 12 23 8 21.5 18.7 52 0 18.7 26.9 14.2 6.3 7.9 6.1 12.0 6.5 2.7 1.4
14,07.94 13 33.9 25.0 8.5 29.7 34 3 26.3 10.6 4.8 2.6 15.4 152 6.3 6.4 32
21.07.94 14 36.1 73 9 24.4 80.4 54.2 53.8 23.9 10.7 2.8 1.3 0.4 7.5 32 1.6
28.07.94 15 24.8 39 2 8.5 31.5 36.1 28.0 12.2 5.5 7.7 7.2 6.7 3.0 2.1 1.1
04 08.94 16 19.7 26.6 42.4 36.8 31.4 10.2 5.1 6.1 3.3 7.3 9.7 2.7 1.3
1 1.08.94 17 64 2 38 0 10.0 37.8 37.5 22.1 11.1 2.6 4.1 12.2 9.3 7.1 4.5 22
18 08.94 18 92 8 12.4 9.2 17.9 33.1 40.0 200 2.8 22 8.1 9.4 3.7 1.8
25.08.94 19 73.7 15 6 1 1.6 34.5 33.8 28.4 14.2 6.7 1.2 6.3 8.2 3.1 1.5
01.09.94 20 143.0 112 7.1 43 9 51.3 63.3 31.7 7.9 6.5 2.8 7.7 2.4 12
08 09 94 21 24.6 13.4 11 2 42 7 23.0 14.4 7.2 7.1 6.9 3.5 9.3 2.4 12
15.09.94 22 45.1 32.1 16 4 45.3 34.7 13.7 6.8 9.5 3.0 11.8 3.0 4.5 2.3
22 09.94 23 28.8 60.3 46.5 40.6 44.1 13.1 6.6 4.1 2.6 7.9 9.3 3.1 1.6
29.09.94 24 63.8 31.5 20.0 68.4 459 23.8 11.9 22 10.4 13.0 9.7 4.6 2.3
06 10.94. 25 63.8 21.5 15 4 34.1 33.7 21.5 10.8 \2 12.6 7.7 12.4 5.4 2.7




Gamma Glutamyltransferase(IU/l) in sheep
Infefected group Uninfected control
Dale WPl SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SlDev SIM SH. 16 SH. 17 SH. 18 SH. 19 Men (-) StDev SEM
31.03.94 -2 13.9 17.0 19.3 24.7 26.6 20.3 5.3 2.4 22.4 27.0 32.0 19.7 253 5.4 2.7
07.04.94 •1 21.2 23.7 27.8 30.9 24.7 25.7 3.8 1.7 7.7 29.0 20.5 30.9 22.0 10.6 5.3
14.04.94 0 23.5 262 21.6 37.4 29.7 27.7 62 2.8 27.8 25.5 33.6 20.1 26.8 5.6 2.8
21.04.94 1 26.2 27.4 30.5 28.6 27.0 27.9 1.7 0.7 29.0 30.5 22.0 32.4 28.5 4.5 23
28.04.94 2 23 0 24.7 25.9 26.2 25.1 25.0 1.3 0.6 28.6 39.8 41.7 29.0 34.8 6.9 3.5
05.05.94 3 30.9 30.1 44.4 34.7 28.6 33.7 6.4 2.9 31.7 39.8 36.3 23.9 32.9 6.9 3.4
12.05.94 4 28.2 23.5 43.2 28.2 25.5 29.7 7.8 3.5 32.8 33.6 27.4 24.7 29.6 43 2.1
19.05.94 5 21.6 27.0 46.7 30.9 25.9 30.4 9.7 4.3 30.5 30.5 24.7 212 26.7 4.6 2.3
26.05.94 6 31.7 32.0 42.8 35.1 27.8 33.9 5.6 2.5 25.9 30.1 25.5 212 25.7 3.6 1.8
02.06.94. 7 44.0 34.0 47.9 30.5 30.5 37.4 8.1 3.6 26.6 33.2 26.6 21.6 27.0 4.8 2.4
09.06.94 8 42.8 30.9 42.5 32.8 33.6 36.5 5.7 2.5 27.8 34.7 25.1 24.3 28.0 4.7 2.4
16.06.94 9 36.3 22.8 31.7 25.1 32.1 29.6 5.5 2.5 22.4 27.4 24.3 212 23.8 2.7 1.4
23.06.94 10 43.6 28.6 36.3 29.3 34.4 34.4 6.1 2.7 25.9 28.9 262 22.0 25.8 2.8 1.4
30.06.94 11 42.1 30.5 41.7 27.8 56.7 39.8 11.5 5.1 29.3 32.4 27.8 193 272 5.6 2.8
07.07.94 12 44.8 29.0 35.9 106.0 51.1 53.4 30.6 13.7 38.2 36.4 29.0 21.6 31.3 7.6 3.8
14.07.94 13 40.1 31.3 32.4 43.6 131.6 55.8 42.7 19.1 30.5 31.7 31.7 25.9 30.0 2.8 1.4
21.07.94 14 43.6 61.0 29.0 79.5 98.4 62.3 27.7 12.4 29.3 31.7 32.4 23.9 29.3 3.9 1.9
28.07.94 15 42.8 92.6 32.8 64.5 78.4 62.2 24.7 11.0 27.0 30.9 31.3 232 28.1 3.8 1.9
04.08.94 16 28 6 84.5 93.8 45.9 63.2 31.0 15.5 23.9 26.6 27.0 20.0 24.4 32 1.6
11.08.94 17 49.0 65.2 61.8 38.2 53.6 12.4 62 27.0 26.2 30.9 18.1 25.6 5.4 2.7
18.08.94 18 66.0 52.1 52.9 369 52.0 11.9 6.0 24.7 26.6 282 20.1 24.9 3.5 1.8
25.08.94 19 90 3 48.3 42.8 31.3 53.2 25.7 12.9 25.5 27.8 29.0 20.1 25.6 3.9 2.0
01.09.94 20 95.7 36.3 39.0 39.8 52.7 28.7 14.4 27.0 28.6 30.9 19.3 26.5 5.0 2.5
08.09.94 21 64.1 29.3 33.6 39.0 41.5 15.6 7.8 25.9 28.6 29.3 20.5 26.1 4.0 2.0
15.09.94 22 59.1 35.1 31.3 33.2 39.7 13.0 6.5 26.6 29.3 31.7 21.6 27.3 4.3 22
22.09.94 23 51.3 35.9 27.8 34.0 37.3 10.0 5.0 29.0 30.9 31.7 20.8 28.1 5.0 2.5
29.09.94 24 47.0 43.2 42.8 50.2 45 8 3.5 1.8 28.2 30.1 30.9 20.5 27.4 4.8 2.4
06.10.94 25 46.3 34.7 23.5 37.1 35.4 9.4 4.7 26.6 29.7 30.5 20.1 26.7 4.7 2.4
13.10.94 26 27.0 29.3 28.2 1.6 1.2 31.3 22.8 27.1 6.0 4.3
Appendix Table 4.29
Scrum Glucose levels (mmol/1)
Infcfcctcd group Uninfected control
Date WPl SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) StDev SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) StDev SEM
31.03 2 2.80 2.80 2.90 2.70 2.25 2.69 0.26 0.11 1.80 2.60 2.40 2.84 2.41 0.45 022
07 04 .94 1 2 60 2.30 2 60 2 00 2.04 2.31 021 0.12 2.53 2.60 2.00 1.69 221 0.44 022
14.04.94 0 2.20 2.30 2.20 1.60 2 13 2.09 0.29 0.13 1.82 2.22 2.30 222 2.14 022 0.11
21.04.94 1 2 30 2.00 2.30 2.30 2.12 2.20 0.16 0.07 2.38 2.01 1.90 2.01 2.08 021 0.11
28.04.94 2 2.10 2.10 1.52 1.60 2.36 1.94 0.30 0.13 2.38 2.28 2.40 2.28 2.34 0.06 0.03
05.05.94 3 2 60 1.50 1.68 1.20 1.76 1.75 0.62 0.28 2.10 1.60 2.60 2.13 2.11 0.41 020
12.05.94 4 2.20 1.10 1.82 2 60 1.42 1.83 0.60 021 2.60 2.84 2.20 2.38 2.51 0.28 0.14
19.05.94 5 2.30 0 60 2.38 2 20 2 60 2.02 0.77 0.34 2.20 1.69 2.30 2.10 2.07 027 0.13
26.05.94 6 2.30 2.10 1.82 2 30 2 20 2.14 0.47 0.21 2.30 2.22 2.30 2.60 2.36 0.17 0.08
02.06 94. 7 1.90 1.77 0.40 1.85 2.30 1.64 0.63 0.28 2.38 2.01 1.50 220 2.02 0.38 0.19
09.06.94 8 1.50 1.90 1.82 1.50 1.67 1.68 0.18 0.08 2.10 2.28 1.90 2.30 2.15 0.19 0.09
16.06.94 9 1 80 2.10 1.20 1.90 1.20 1.64 0.42 0.19 2.60 2.13 1.60 1.69 2.01 0.46 0.23
23.06.94 10 1.10 1.90 1.40 1 60 1.40 1.48 0.30 0.13 2.20 1.26 1.90 2.09 1.86 0.42 021
30.06.94 11 1.40 1 50 1.30 1 50 2 30 1.60 0.17 0.07 2.30 2.60 1.80 2.12 2.21 0.34 0.17
07.07.94 12 2.30 1.80 1.20 1 90 2 38 1.92 0.40 0.18 2.04 220 2.00 2.14 2.10 0.09 0.05
14.07 94 13 2.38 2 30 0.50 1 90 2 10 1.84 0.68 0.30 2.38 2.30 2.40 2.13 2.30 0.12 0.06
21.07.94 14 2.10 2.00 0.70 2.10 2 60 1.90 0.48 0.21 2.10 2.30 1.40 1.86 1.92 0.39 0.19
28.07 94 15 2 60 2 00 0.50 2 60 2.20 1.98 0.68 0.31 2.60 2.73 2.00 2.15 2.37 0.35 0.18
04 08 94 16 2.20 2 30 2 80 2.30 2.40 0.57 0.29 2.20 2.03 1.90 2.04 2.04 0.12 0.06
II .08.94 17 2.30 2 38 2.10 2.04 2 21 0.45 0.22 2.30 2.63 2.40 2.61 2.49 0.16 0.08
18.08.94 18 2.04 2 10 2 60 2 41 2.29 0.53 0.27 2.38 2.46 2.38 2.49 2.43 0.06 0.03
25.08.94 19 2.60 2 60 2.80 2.60 2 65 0.33 0.17 2.10 2.73 2.10 1.54 2.12 0.49 0.24
01.09 94 20 2.20 2 20 2.20 2.20 2.20 0.10 0.05 2.60 2.03 2.60 1.81 226 0.40 0.20
08.09 94 21 2.30 2 30 2 30 2.30 2.30 0.27 0.14 220 2.63 2.20 1.98 2.25 027 0.14
15 09.94 22 2.80 2.38 2.30 2.93 2.60 0.18 0.09 2.30 2.46 2.30 2.73 2.45 020 0.10
22.09.94 23 2.30 2.10 2 38 2.30 2.27 0.22 0.11 2.21 2.61 2.10 2.03 224 026 0.13
29.09.94 24 2.30 2.60 2.10 2.38 2.35 0.36 0.18 1.91 2.49 2.60 2.63 2.41 0.34 0.17
06.10.94. 25 2.10 2.10 2.60 2.10 2.23 0.09 0.05 2.21 1.54 2.30 2.46 2.13 0.41 020




[Uhydroxy-buiyratc measurements of Sheep
Infefectcd group Uninfected control
Dale wpi SI I. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SlDcv SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) SlDev SEM
31 03.94 -2 0.21 0.25 0.25 0.23 0.20 023 0.02 0.01 0.26 0.14 0.17 025 021 0.06 0.03
07.04.94 1 0.14 0.17 0.19 0 20 0.18 0.18 0.02 0.01 0.14 0.16 023 0.16 0.17 0.04 0.02
14.04.94 0 0.16 0.23 0.23 0.17 0.15 0.19 0.04 0.02 0.19 0.16 0.24 0.27 022 0.05 0.02
21.04.94 1 0.16 0.24 0.17 0.26 0.27 022 0.05 0.02 0.19 0.19 0.19 027 021 0.04 0.02
28.04.94 2 0.19 0.19 0.21 0.20 0.15 0.19 0.02 0.01 0.19 020 0.15 0.30 021 0.06 0.03
05.05.94 3 0.20 0.15 0.23 0.25 0.24 021 0.04 0.02 022 0.18 0.16 0.31 022 0.07 0.03
12.05.94 4 0.18 0.16 0.27 0.24 0.11 0.19 0.06 0.03 020 025 0.15 0.25 021 0.05 0.02
19.05.94 5 0.25 0.15 0.22 0.21 0 29 022 0.05 0.02 0.19 0.26 0.16 0.31 023 0.07 0.03
26.05.94 6 0.26 0.16 0.25 0.22 0.28 023 0.05 0.02 0.18 023 0.19 023 021 0.03 0.01
02.06.94. 7 0.23 0.19 0.26 0.48 0.14 026 0.11 0.05 0.18 021 020 0.17 0.19 0.02 0.01
09.06.94 8 0.21 0.20 0.41 0.31 0.16 026 0.09 0.04 027 0.18 025 022 023 0 04 0.02
16.06.94 9 0.29 0.29 0.48 0.35 0.16 0.31 0.08 0.04 0.33 0.15 0.33 026 027 0.09 0.04
23.06.94 10 0.35 0.28 0.31 0.32 0.19 029 0.03 0.01 0.19 025 0.26 0.24 024 0.03 0.02
30.06.94 11 0.23 0.26 0.35 0.37 0.20 028 0.07 0.03 027 0.17 027 0.26 024 0.05 0.02
07.07.94 12 0.26 0.33 0.32 0.38 0.18 0.29 0.04 0.02 0.27 022 0.27 0.17 023 0.05 0.02
14.07.94 13 0.29 0.14 0.41 0.38 0.25 0.29 0.05 0.02 0.26 021 0.27 0.23 024 0.03 0.01
21.07.94 14 0.36 0.16 0.48 0.24 0.26 0.30 0.09 0.04 025 0.18 026 024 023 0.04 0.02
28.07.94 15 0.28 0.16 0.31 0.27 0 23 0.25 0.02 0.01 0.30 025 025 0.19 025 0.05 0.02
04.08.94 16 0.14 0.19 0.26 0.14 0.18 0.01 0.01 0.31 0.17 0.30 0.15 023 0.08 0.04
11.08.94 17 0.16 0.20 0.25 0.16 0.19 0.02 0.01 0.27 022 0.33 0.16 025 0.07 0.04
18.08.94 18 0.16 0.18 0.30 0.16 020 0.06 0.03 0.29 021 029 0.15 024 0.07 0.03
25.08.94 19 0.19 0.25 0.22 0.19 021 0.11 0.05 0.29 0.18 0.31 0.16 024 0.08 0.04
01.09.94 20 0.20 0.26 0.35 020 025 0.11 0.05 027 0.17 025 0.19 022 0.05 0.02
08.09.94 21 0.18 0.23 0.33 0.18 0.23 0.08 0.04 0.27 023 027 0.20 024 0.03 0.02
15.09.94 22 0.25 0.21 0.34 0.25 0.26 0.06 0.03 0.27 024 027 0.25 026 0.02 0.01
22.09.94 23 0.26 0.18 0.27 0.26 024 0.05 0.03 027 0.19 026 0.36 027 0.07 0.03
29.09.94 24 0,23 0.15 0.29 0.23 0.23 0.07 0.03 026 0.15 025 0.45 028 0.13 0.06
06.10.94 25 0.21 0.30 0.29 0.21 0.25 0.05 0.02 0.25 0.16 0.30 0.34 026 0.08 0.04
13.10.94 26 0.18 0.34 0.18 0.23 0.08 0.06 0.30 0.30
Appendix Table 4.31:
Eperiment 4: Sheep 23, 25, 27 and 31 infected with F. gigantica (Kenyan strain)
and sheep 21 and 31 as uninfected conLrols.
Glucose (mmol/ml)
WPI SH. 23 SI I. 25 SI I. 27 SH. 29 SH 21 SH. 31 SH. 23 SH. 25 SH. 27 SH. 29 SH. 21 SH. 31
2 3.10 3.40 3.54 2.90 3.50 3.50 0.35 0.48 0.37 0.49 0.55 0.33
1 2.90 3.48 3.21 2.80 3.00 2.80 0.36 0.48 0.70 0.29 0.33 0.47
0 2.40 3 29 2.87 1.80 2 20 2.20 0.36 0.45 0.61 0.43 0.47 0.40
1 2.10 1.63 2.19 1.60 3 48 2.70 0.28 0.53 0.59 0.47 0.46 0.48
2 2.00 2 57 2.47 1.90 3 29 2.50 0.37 051 0,35 0.39 0.39 0.39
3 2.30 1.73 2 49 2.00 2.00 2.10 0.41 0.33 0.45 0.47 0.44 0.47
4 1.90 1.41 2 60 1.70 2.10 2 60 0.30 0.46 0.47 0.38 0.42 0.38
5 2.30 1.82 1.80 2.30 2.20 2.30 0.31 0.41 0.48 0.37 0.40 0.44
6 2.10 1.83 2.10 2.10 2.00 2.10 0.43 0.52 0.46 0.39 0.33 0.47
7 2.30 1.63 1.90 1.80 2.00 2.00 0 59 0.54 0.75 0.48 0.47 0.46
8 2.70 1.70 1.70 1.80 2.00 2.30 0.52 0.38 0.45 0.48 0.51 0.39
9 2.90 2 40 2.30 2.20 2 40 2.70 0.44 0.39 0.56 0.45 0.44 0.44
10 1 90 1.63 1.90 1.70 2.50 2.00 0.54 0.48 0.73 0.53 0.35 0.42
11 2.70 2.22 1.10 2.00 2.40 2.50 0.52 0.41 0.50 0.51 0.36 0.40
12 2.50 1 70 2.00 1.80 2.30 2 00 0.58 0.38 0.31 0.33 0.36 0.54
13 2.10 1 33 2 10 1.30 2 50 2 00 0.43 0.41 0.59 0.46 0.28 0.44
14 2.60 1 35 1.30 1.30 2.10 2 10 0.51 0.36 0.53 0.41 0.37 0.46
15 2.30 2 02 2.10 1 90 2.60 2.30 0.39 0.39 0.46 0.52 0.41 0.44
16 2.12 2.00 1.70 2.30 2.50 0.41 0.25 0.54 0.30 0.35
17 1.90 1.20 2.39 2.10 0.44 0.37 0.31 0.36
18 1.96 1.80 2.52 2.60 0.39 0.41 0.31 0.36
19 2.24 1.40 259 2.30 0.68 0.39 0.46 0.28
20 1.94 1,80 2.50 1.70 0.46 0.33 0.31 0.37
21 2 11 2 20 2 10 2.00 0.29 0.26 0.35 0.39
.
22 2.47 1.90 2.60 1.50 0.31 0.35 0.41 0.40
391
Appendix Table: 4
Experiment 3: Calves 14c, 34c and 45c with single F. hepatica (peruvian strain) infection
Calves 15c and 23c with challenge infection and Calf 26c uninfected control.
Appendix Table 4.32:
Pact Cell Volume (PCV) (%) Egg per gram (EPG) counts
wpy 14c 15c 23c 26c 34c 45c 14C 15C 23C 26C 34C 45C
27 34 32 29 40 0 0 0 0
26 33 32 30 38 0 0 0 0
25 33 31 30 35 0 0 0 0
-24 33 30 29 39 0 0 0 0
-23 36 33 30 32 0 0 0 0
-22 33 30 30 31 0 0 0 0
-21 33 31 26 30 0 0 0 0
-20 35 31 29 30 0 0 0 0
-19 31 30 29 28 0 0 0 0
-18 31 30 30 28 0 0 0 0
-17 32 28 Z7 28 0 0 0 0
16 31 29 26 26 1 0 5 0
-15 34 28 29 28 3 0 19 0
-14 33 30 28 27 10 1 50 0
-13 31 30 26 27 15 3 36 0
-12 32 30 25 27 11.5 4 45 0
-11 27 29 TA 27 21 3 38 0
31 30 24 29 77 96 31 0
-9 29 28 26 28 107 94 54 0
-8 32 29 26 29 60 54 (A 0
-7 31 28 25 28 56 40 59 0
27 27 23 28 36 78 41 0
5 28 27 25 30 51 39 36 0
4 29 28 27 26 32 41 41 0
3 27 29 26 28 19 22 31 0
2 25 28 26 30 16 10 49 0
-1 28 28 29 28 21 6 30 0
0 27 26 29 29 33 18 4 26 0 0 0
1 27 26 31 29 33 15 5 31 0 0 0
2 28 28 28 26 33 18 3 12 0 0 0
3 30 28 31 27 29 13 5 18 0 0 0
6 30 29 28 28 36 12 1 0 0 0
5 30 29 30 27 32 11 2 0 0 0
4 30 31 30 28 30 13 4 0 0 0
7 29 30 31 28 10 2 0 0 0
8 30 30 26 32 15 6 0 4 3
9 28 30 30 31 9 1 6 11
10 29 30 7 0 9 22
11 29 30 8 0 26




Haemoglobin (g/dl.) RBC counts (xl012/l)
win 14C 15C 23C 26C 34C 45C 14c 15c 23c 26c 34c 45c
-27 13.9 13.0 111 16.0 11.055 9.244 7.596 9.602
-26 13.3 12.0 111 14.6 10.056 8.434 8.217 8.575
-25 14.0 12.4 117 13.6 10.210 8.282 9.156 8.808
-24 14.0 14.2 116 13.7 9.510 8.215 8.431 8.561
-23 14.6 12.0 119 14.6 9.334 7.801 7.610 8.123
-22 119 12.6 11.7 110 8.892 8.086 7.944 7.767
-21 14.7 14.6 11.5 11.5 9.383 8.519 7.616 7.622
-20 13.0 11.5 11.4 13.2 8.254 7.649 7.663 7.549
-19 13.0 12.5 113 11.0 10.117 7.592 7.754 7.840
-18 13.2 11.3 11.7 110 9.745 7.373 7.981 7.030
-17 112 11.3 115 116 9.843 7.605 7.888 6.743
15.0 12.5 111 10.1 10.832 7.428 6.793 7.119
-15 13.0 110 11.0 113 9.718 8.231 7.277 7.051
-14 119 11.6 11.1 10.8 9.324 7.793 9.606 6.792
-13 13.6 13.4 8.5 11.9 8.815 7.603 6.805 6.682
113 10.9 10.6 10.7 8.758 8.040 6.947 6.992
-11 112 12.1 11.0 112 9.100 7.758 6.518 6.891
11.4 12.1 11.5 11.2 8.580 7.300 5.935 6.907
-9 117 11.6 9.2 10.6 11.029 7.387 6.540 6.684
8 115 117 9.4 11.8 9.887 7.605 7.268 7.818
-7 10.8 11.7 9.8 11.0 8.416 7.068 7.417 6.571
6 10.4 9.8 9.7 11.0 8.033 7.227 7.428 6.775
5 10.9 10.5 9.5 11.9 8.400 6.916 6.623 7.042
A 11.3 112 9.5 111 9.933 8.072 7.035 6.448
-3 11.4 10.4 10.3 11.0 7.625 6.733 7.638 7.468
-2 11.2 10.9 10.2 10.5 8.116 6.776 7.125 7.196
-1 110 10.7 10.2 10.8 8.498 6.296 5.934 8.278
0 11.4 10.5 10.6 10.9 11.2 110 7.969 6.537 7.409 8.296 8.262 10.925
1 11.0 10.4 10.4 11.9 10.8 110 8.045 9.333 7.382 8.081 8.283 10.936
2 11.1 10.2 9.7 10.7 10.0 118 8.951 7.780 6.817 7.817 8.603 14.091
3 11.5 11.2 11.5 10.0 11.3 8.986 8.506 9.071 8.311 10.765
6 11.7 11.2 11.0 10.6 14.6 9.054 7.798 7.719 10.406 15.940
5 11.9 11.7 11.3 9.8 11.7 8.773 7.972 7.809 7.991 13.170
4 11.9 11.0 11.2 10.0 11.9 8.361 8.301 8.069 10.676 12.947
7 11.4 11.9 111 10.5 112 9.058 7.077 8.358 8.708 11.737
8 11.2 11.4 10.8 9.8 113 8.364 7.945 7.296 8.226 12.224



















MCH (pg) MCV (fl) MCHC (g/dl)
WPI 14c 15c 23c 26c 34c 45c 14c 15c 23c 26c 34c 45c 14c 15c 23c 26c 34c 45c
-27 12.57 14.06 15.93 16.66 30.76 34.62 43.44 41.66 40.88 40.63 36.67 40.00
-26 13.23 14.23 14.73 17.03 32.82 37.94 45.03 44.31 40.30 37.50 3270 38.42
-25 13.71 14.97 13.87 15.44 32.32 37.43 29.49 39.74 42.42 40.00 47.04 38.86
-24 14.72 17.29 14.94 16 34.70 36.52 34.40 45.56 42.42 47.33 43.45 35.13
-23 15.64 15.38 16.95 17.97 38.57 42.30 39.42 39.39 40.56 36.36 43.00 45.63
-22 14.51 15.58 14.73 15.45 37.11 37.10 37.76 39.91 39.09 42.00 39.00 38.71
-21 15.67 17.14 15.1 15.09 35.17 36.39 38.08 39.36 44.55 47.10 39.66 38.33
-20 15.75 15.03 14.88 17.49 42.40 40.53 39.15 39.74 37.14 37.10 38.00 44.00
-19 12.85 16.46 15.86 14.03 30.64 39.52 38.69 35.71 41.94 41.67 41.00 39.29
13.55 15.33 14.66 17.07 31.81 40.69 32.58 39.83 42.58 37.67 45.00 4286
-17 12.39 14 86 15.85 18.69 32.51 36.82 36.76 41.52 38.13 40.36 43.10 45.00
13.85 16.83 17.81 14.19 28 62 39.04 42.69 36.52 48.39 43.10 41.72 38.85
-15 13.38 14.58 15.12 17.44 34.99 34.02 41.23 39.71 38.24 42.86 36.67 43.93
14 13 84 14 89 11.56 15.9 35.39 38 50 28.11 39.75 39.09 38.67 41.11 40.00
-13 15.43 17.62 12.49 17.81 35.17 39.46 38.21 40.41 43.87 44.67 3269 44.07
12 14.04 13 56 15 26 15.3 36.54 37.31 41.74 38.62 38.44 36.33 36.55 39.63
-11 13 41 15 6 16.88 17 7 29.67 37.38 42.96 39.18 45.19 41.72 39.29 45.19
13 29 16 58 19.38 16 22 36.13 41.10 43.81 41.99 36.77 40.33 44.23 38.62
9 11.52 15 7 14 07 15.86 26 29 37.90 38.23 41.89 43.79 41.43 36.80 37.86
-8 12 64 16 7 12 93 15.09 32.37 38.13 33.02 37.09 39.06 43.79 39.17 40.69
7 12.83 16.55 13.21 16 74 36.83 39 62 32.36 42.61 34.84 41.79 40.83 39.29
6 12.95 13.56 13.06 16.24 33.61 37.36 35.00 41.33 38.52 36.30 37.31 39.29
-5 12.98 15.18 14.34 16 9 33.33 39.04 39.26 42.60 38.93 38.89 36.54 39.67
A 11 38 15.11 13.5 18.77 29.20 34.69 35.54 40.32 38.97 43.57 38.00 46.54
-3 14 95 15.45 13.49 14.73 35.41 43.07 30.11 37.49 42.22 35.86 44.78 39.29
2 13.8 16.09 14.32 14.59 30.80 41.32 35.09 41.69 44.80 38.93 40.80 35.00
1 14.12 16.99 17.19 13 05 32 95 44.47 45.50 33.82 42.86 38.21 37.78 38.57
0 14 31 16.06 14.31 13.14 13 56 10.98 3388 39.77 35.09 34.96 31.47 30.21 42.22 40.38 40.77 37.59 0.00 0.00
1 13 67 11.14 14.09 14 73 13.04 10.97 33.56 27.86 35.22 38.36 32.60 26.52 40.74 40.00 40.00 38.39 0.00 0.00
2 12.4 13.11 14.23 13 69 11.62 9 08 31 28 35.99 42.54 35.82 32.55 25.55 39.64 36.43 33.45 38.21 43.08 36.36
3 12 8 13.17 12 68 12 03 10.5 33 39 32.92 34.17 32.49 29.73 38.33 40.00 37.10 40.00 41.38
6 12.92 14.36 14 25 10.19 9.16 33 13 37.19 36.27 26.91 18.82 39.00 38.62 39.29 35.71 35.56
5 13.56 14 68 14 47 12.26 8.88 34.20 36 38 38.42 38.79 21.26 39.67 40.34 37.67 37.04 35.31
4 14.23 13.25 13 88 9.37 9.19 35.88 37.34 37.18 24.35 24.72 39.67 35.48 37.33 37.86 48.67
7 12.59 16 82 14 48 12.06 10.39 32.02 42.39 34.45 26.41 39.31 39-67 31.61 41.79
8 13.39 14 35 14.8 11 91 10.06 35.87 37.76 37.33 38.00 38.46 37.19
9 13 19 15 64 12.4 10.49 32.96 41.52 40.00 37.67 35.00 39.35
10 13.42 14 73 12.81 10.37 35.07 39.11 38.28 37.67
11 13.5 15.13 11.03 33.76 37.19 40.00 40.67




WBC counts (xl09/l) Eosinophil counts (xl09/l)
WPI 14c 15c 23c 26c 34c 45c 14C 15C 23C 26C 34C 45C
-27 12162 10.680 4.659 7.830 0.181 0.075 0.031 0.025
-26 11.670 8.715 5.694 9.724 0.056 0.031 0.006 0.013
-25 10.773 9.032 8.123 7.679 0.038 0.013 0.000 0.019
-24 12259 9.422 8.416 9.010 0.244 0.019 0.038 0.031
-23 11.643 10.031 6.757 8.470 0.600 0.106 0.575 0.019
-22 11.450 9.347 8.491 6.500 1.019 0.663 1.855 0.006
-21 10.671 9.979 8.864 7.677 0.381 0.731 3.206 0.013
-20 9.979 7.360 10.747 7.442 0.681 0.200 2819 0.000
-19 9.758 6.425 10.589 6.576 0.406 0.144 0.019 0.000
10.884 7.149 7.514 6.746 0.069 0.050 0.000 0.019
9.479 12827 7.242 6.980 0.188 0.650 0.063 0.013
13.916 8.432 8.107 9.504 0.2*16 0.263 2538 0.019
-15 12157 8.400 7.241 7.591 0.294 0.363 1.975 0.006
-14 11.482 7.519 8.914 7.244 0.338 0.063 1.750 0.038
-13 9.007 5.393 8.523 6.008 0.288 0.056 0.969 0.038
-12 11.255 9.480 6.835 5.020 0.219 0.381 1.550 0.038
-11 10.676 9.517 8.481 5.776 0.150 0.144 1.313 0.056
-10 8.837 7.487 8.217 6.842 0.250 0.100 1.381 0.019
-9 9.239 8.398 8.350 6.058 0.350 0.169 0.925 0.000
-8 9.827 7.120 8.305 5.833 0.631 0.081 0.994 0.256
-7 10.080 7.534 7.094 5.343 0.781 0.181 0.925 0.625
6 13.117 9.959 7.840 6.404 0.419 0.200 0.813 0.544
-5 9.757 6.972 7.365 6.127 0.656 0.119 0.819 0.388
4 11.424 7.554 6.926 6.536 1.325 0.275 0.956 0.338
-3 8.007 5.964 7.466 5.955 0.406 0.056 1.394 0.606
-2 10.576 7.511 7.9-10 6.363 0.538 0.519 0.931 0.400
1 10.552 5.687 7.584 7.001 0.819 0.856 0.331 0.300
0 9.178 8.287 7.319 6.319 7.302 11.192 0.700 0.900 0.925 0.263 0.000 0.294
1 11.895 8.192 7.505 6.518 9.773 8.244 1.569 0.425 0.606 0.213 0.138 0.088
2 10.526 7.418 7.773 5.588 10.081 11.065 1.363 0.794 0.406 0.275 0.294 0.188
3 9.863 8.588 6.058 6.359 9.279 10.328 0.606 0.456 0.331 0.225 0.756 0.163
6 10.924 9.687 5.470 5.725 14.845 1.006 1.681 0.119 0.519 0.144
5 10.162 9.364 6.504 8.165 8.089 1.206 1.163 0.213 1.225 0.000
4 9.118 9.492 5.470 9.456 9.843 0.881 0.700 0.231 1.494 0.431
7 10.979 10.817 6.710 9.213 11.455 1.063 0.981 0.213 1.194 1.600
8 8.035 8.068 5.492 7.093 13.283 0.494 0.819 0.069 0.706 1.000
9 9.880 8.310 5.492 6.914 10.705 0.319 0.456 1.000 1.169
10 10.147 7.940 6.650 12319 0.219 0.469 0.388 1.369
11 10.107 8.890 8.049 0.475 1.019 0.000 0.250




Neutrophils (xl09/l) Lymphocytes (xl09/l)
WPI 14c 15c 23c 26c 34c 45c 14c 15c 23c 26c 34c 45c
-27 3.892 4.165 1.305 1.488 7.054 5.233 3.168 5.481
-26 2.918 1.394 1.537 1.945 6.185 3.050 3.929 6.710
-25 3.232 5.058 1.950 2457 6.679 2890 5.849 4.684
-24 3.923 3.863 2188 3.244 6.988 4.617 5.723 4.505
-23 4.890 4.915 1.081 2626 5.822 4.313 4.865 4.997
-22 3.893 4.954 1.359 1.820 6.298 3.739 6.114 3.705
-21 2.988 2794 1.418 2764 6.829 5.588 5.939 4.222
-20 2.096 2502 2257 2307 6.786 3.974 5.159 4.465
-19 1.952 2634 3.706 1.118 7.026 2956 3.706 4.800
-18 2830 2073 2029 0.877 7.292 4.075 5.034 5.397
-17 1.896 6.285 2680 2303 6.635 5.516 4.200 3.350
-16 4.314 3.710 2027 4.752 8.210 3.794 4.459 2946
-15 5.835 3.108 2824 3.568 5.106 3.948 1.738 3.264
-14 3.330 3.384 2229 3.115 7.004 3.684 4.635 3.260
-13 2162 1.402 2216 2944 5.044 3.020 5.625 2644
-12 6.640 3.508 1.025 1.255 3.151 4.076 3.964 3.263
-11 4.057 3.236 2544 2368 5.552 4.663 4.241 3.177
-10 1.944 2995 1.561 1.847 5.125 3.369 5.752 4.310
9 1.940 2771 0.919 1.393 5.728 4.535 5.929 4.180
8 2948 2777 2575 1.458 5.896 4.058 4.402 2917
7 3.226 3.616 0.426 0.962 4.738 3.541 4.611 3.313
6 7.870 6.175 1.803 1.153 4.197 2589 4.390 4.099
-5 2049 1.952 1.694 1.287 6.147 4.880 4.272 3.983
A 3.998 2795 1.732 1.830 5.027 3.928 4.086 3.529
-3 1.601 2087 1.419 1.251 5.205 3.221 4.330 3.216
-2 3.384 2028 1.429 1.909 4.971 3.605 5.637 3.182
-1 3.060 0.626 1.896 1.610 6.331 4.152 4.550 4.271
0 1.285 2735 3.147 1.580 2702 2798 6.241 3.978 3.440 3.539 3.870 7.499
1 3.569 2376 1.726 2086 3.714 1.401 6.780 4.096 4.953 3.455 5.668 5.771
2 2105 1.706 3.031 1.397 3.528 2988 6.631 3.709 4.120 3.129 5.444 7.635
3 2367 2491 0.969 1.081 2320 2169 6.805 4.122 4.241 4.197 5.011 6.507
6 1.748 2712 1.094 0.859 5.790 6.554 4.747 3.610 3.550 8.313
5 2236 2903 1.821 1.551 0.485 6.504 4.495 3.707 4.572 6.390
4 1.368 3.607 1.313 1.986 1.870 6.747 4.366 3.446 5.768 7.087
7 1.757 3.678 2147 2211 1.146 7.576 4.651 4.227 5.344 8.019
8 1.446 2662 1.757 1.844 3.321 4.982 4.195 3.460 4.469 8.900
9 2766 2909 1.812 2143 2462 6.126 3.906 2911 3.872 6.744
10 4.059 1.667 1.064 1.109 5.175 4.843 4.722 10.348
11 1.415 2934 1.449 7.985 4.534 5.312




Monocytes(xl09/l) Eosinophils (xl09/l) Basophils (xl09/l)
WPI 14c 15c 23c 26c 34c 45c 14c 15c 23c 26c 34c 45c 14c 15c 23c 26c 34c 45c
-27 1.095 1.282 0.186 0.783 0.122 0.000 0.000 0.000 0.000 0.000 0.000 0.078
-26 0.000 0.174 0.228 0.972 2.567 4.009 0.000 0.000 0.000 0.087 0.000 0.000
-25 0.646 0.903 0.244 0.538 0.108 0.181 0.081 0.000 0.000 0.000 0.000 0.000
-24 1.103 0.848 0.505 1.171 0.245 0.094 0.000 0.090 0.000 0.000 0.000 0.000
-23 0.349 0.802 0.473 0.847 0.582 0.000 0.338 0.000 0.000 0.000 0.000 0.000
-22 0.687 0.748 0.594 0.975 0.573 0.000 0.425 0.000 0.000 0.000 0.000 0.000
-21 0.534 1.197 0.443 0.691 0.320 0.299 1.064 0.000 0.000 0.100 0.000 0.000
-20 0.699 0.662 1.075 0.670 0.299 0.221 2.149 0.000 0.100 0.000 0.000 0.000
-19 0.585 0.643 0.424 0.592 0.195 0.193 2.753 0.066 0.000 0.000 0.000 0.000
-18 0.762 0.858 0.451 0.472 0.000 0.071 0.000 0.000 0.000 0.071 0.000 0.000
-17 0.948 0.770 0.362 1.256 0.000 0.257 0.000 0.070 0.000 0.000 0.000 0.000
-16 1.392 0.675 0.619 1.711 0.000 0.253 0.973 0.095 0.000 0.000 0.000 0.000
-15 1.216 0.924 0.290 0.683 0.000 0.420 1390 0.000 0.000 0.000 0.000 0.000
-14 0.689 0.451 0.357 0.797 0.459 0.000 1.694 0.072 0.000 0.000 0.000 0.000
-13 1.531 0.917 0.426 0.360 0.270 0.000 0.256 0.060 0.000 0.054 0.000 0.000
-12 1.126 1.422 0.684 0.502 0.338 0.379 1.162 0.000 0.000 0.000 0.000 0.000
-11 1.068 1.618 0.594 0.231 0.000 0.000 1.103 0.000 0.000 0.000 0.000 0.000
-10 1.502 0.973 0.082 0.547 0.088 0.150 0.822 0.068 0.177 0.000 0.000 0.068
-9 0.924 0.924 0.501 0.485 0.647 0.168 0.919 0.000 0.000 0.000 0.000 0.000
-8 0.590 0.285 0.498 0.467 0.393 0.000 0.831 0.875 0.000 0.000 0.000 0.117
-7 0.504 0.377 0.922 0.481 0.605 0.000 0.993 0.588 0.000 0.000 0.142 0.000
-6 0.656 0.996 1.019 0.576 0.394 0.199 0.549 0.576 0.000 0.000 0.078 0.000
-5 1.171 0.139 0.368 0.674 0.390 0.000 1.031 0.184 0.000 0.000 0.000 0.000
-A 1.257 0.604 0.416 1.046 1.142 0.227 0.693 0.131 0.000 0.000 0.000 0.000
-3 0.881 0.596 0.373 0.953 0.320 0.060 1.344 0.536 0.000 0.000 0.000 0.000
-2 1.692 1.427 0.159 0.636 0.529 0.451 0.715 0.636 0.000 0.000 0.000 0.000
1 0.317 0.284 0.379 0.840 0.844 0.626 0.758 0.280 0.000 0.000 0.000 0.000
0 1.101 1.077 0.512 0.758 0.730 0.783 0.551 0.497 0.220 0.379 0.000 0.112 0.000 0.000 0.000 0.063 0.000 0.000
1 0.714 1.311 0.375 0.521 0.391 0.907 0.833 0.410 0.450 0.391 0.000 0.165 0.000 0.000 0.000 0.065 0.000 0.000
2 1.263 1.558 0.466 0.894 0.907 0.443 0.526 0.445 0.155 0.168 0.101 0.000 0.000 0.000 0.000 0.000 0.101 0.000
3 0.592 1.546 0.545 1.017 1.021 1.549 0.099 0.429 0.303 0.064 0.835 0.103 0.000 0.000 0.000 0.000 0.093 0.000
6 1.202 0.969 0.547 0.286 0.742 1.420 1.259 0.219 0.973 0.000 0.000 0.000 0.000 0.057 0.000
5 0.406 1.030 0.911 1.143 1.132 0.915 0.843 0.065 0.817 0.081 0.102 0.094 0.000 0.082 0.000
4 0.547 1.014 0.492 0.662 0.591 0.456 0.475 0.219 1.040 0.295 0.000 0.000 0.000 0.000 0.000
7 0.439 1.298 0.268 1.013 0.916 1.208 1.190 0.067 0.553 1.260 0.000 0.000 0.000 0.092 0.115
8 0.804 0.807 0.220 0.355 0.266 0.804 0.403 0.055 0.426 0.664 0.000 0.000 0.000 0.000 0.133
9 0.593 0.582 0.659 0.346 0.856 0.395 0.914 0.000 0.553 0.612 0.000 0.000 0.110 0.000 0.000
10 0.609 1.032 0.532 0.493 0.304 0.397 0.333 0.370 0.000 0.000 0.000 0.000
11 0.505 1.156 0.885 0.202 0.267 0.402 0.000 0.000




Albumin (8/0 ToUi Protein (g/dl)
WPI 14C 15C 13C 26C 34c 45c 14C 15C 23C 26C 34c 45c
-27 24.30 34.80 34.00 5.70 5.40 5.00 5.70 5.70
-26 30.80 34.70 35.10 5.50 5.70 5.60 610 5.50
-25 26.00 4160 38.60 5.10 5.60 680 5.7C 5.10
-24 2690 4610 37.00 5.10 5.60 760 5.70 5.10
-23 25.80 4660 40.90 5.40 630 5.60 5.70 5.40
-22 31.20 50.30 38.20 5.20 630 660 5.60 5.20
-21 33.70 48.90 35.90 640 7.60 5.20 5.50 640
-20 31.40 41.50 43.20 680 8.60 7.20 5.60 680
-19 31.40 40.30 33.50 5.10 5.60 5.80 4.20 5.10
-18 23.00 5110 3670 5.30 7.00 5.80 5.70 5.30
-17 28.00 34.80 41.50 5.90 660 610 5.70 5.90
-16 34.10 3680 41.30 8.00 7.80 620 610 8.00
-15 29.00 45.80 37.70 5.80 610 640 6.00 5.80
-14 28.60 38.30 3670 5.60 10.10 5.70 600 5.60
-13 28.30 39.40 38.90 5.80 7.40 5.70 610 5.80
-12 2630 4150 38.50 5.30 8.10 670 600 5.30
-11 37.10 37.20 38.90 610 620 5.80 650 610
-10 30.20 39.50 3150 5.90 660 7.00 680 5.90
-9 33.90 39.10 35.40 5.60 8.00 5.60 630 5.60
-8 22.80 41.20 35.90 5.90 6.60 5.40 6.70 5.90
-7 37.80 44.40 47.70 4.90 8.50 5.90 620 4.90
6 3660 4140 35.10 640 610 7.20 690 640
-5 31.10 35.20 3180 7.50 5.70 7.70 8.40 7.50
A 32.50 38.60 30.40 5.50 5.60 5.30 10.40 5.50
3 36.40 40.50 29.70 5.40 5.80 5.70 1150 5.40
-2 32.30 33.10 27.50 6<X) 7.10 5.80 7.80 600
-1 3170 40.50 3650 5.10 610 630 9.90 5.10
0 35.00 39.80 3600 5.30 25.50 38.40 610 5.70 8.00 5.30 670 10.20
1 26.70 35.20 34.60 5.70 34.40 34.30 5.70 9.50 9.40 5.70 670 620
2 29.10 34.90 3680 5.40 25.60 31.00 610 5.10 8.70 5.40 9.70 660
3 27.30 35.60 34.60 5.80 23.20 3170 630 10.30 8.30 5.80 4.60 7.10
6 31.70 39.40 27.30 5.40 29.00 27.40 620 10.50 7.20 5.40 660 7.40
5 26.20 3680 3630 5.60 24.60 37.20 7.70 610 7.70 5.60 7.60 9.20
4 24.40 39.80 35.40 610 24.30 28.40 8.20 9.20 8.70 610 670 9.60
7 27.80 4190 39.60 5.60 29.20 30.20 8.30 10.60 7.00 5.60 7.60 8.70
8 37.60 3690 34.60 29.20 30.70 650 9.30 5.80 8.80 7.70
9 27.60 37.70 37.1X) 28.90 34.10 9.40 7.70 10.70 650 9.30
10 15.10 39.70 3160 36.10 34.50 7.80 8.10 10.50 8.20 10.20
11 37.60 41.90 36.20 33.10 41.30 610 8.60 10.60 640 11.20
12 27.30 40.00 37.80 29.70 3140 9.70 8.80 1150 5.60 600




Glutamate dehydrogenase (IU) Gamma Glutamyltransferase (IU)
WPI 14C 15C 23C 26C 34c 45c 14C 15C 23C 26C 34c 45c
-27 34.9 19 3.3 24.7 24.3 9.3 17.8 8.5
-26 15 17.3 5.7 30 30.8 11.2 14.7 8.5
-25 23.2 12 17.9 19.2 26 13.5 15.1 6.9
-24 23.4 26 7 9.9 26.9 10.8 116 10
-23 45.3 50 9.8 17.2 25.8 14.7 11.6 10.8
-22 43.9 45.3 36.4 13.4 31.2 14.3 11.2 10
-21 86 18.1 24.4 20 33.7 13.9 12 12
-20 72.3 24 17.5 8 31.4 127 12 10.8
-19 56.5 52 14.2 19 31.4 13.5 9.8 12
-18 167.8 28.6 23.8 9 23 13.5 15.8 11.6
-17 108.5 58 29.1 11 28 19 124 127
-16 164.7 110.5 15 15.8 34.1 35.5 127 8.9
-15 99.5 65 31.3 21.9 29 33.6 9.3 13.5
-14 108 65 26.4 24 28.6 65.6 11.2 13.5
•13 43.1 44 20.1 19 28.3 21.2 11.2 14.3
-12 25.2 34.7 35.9 20.3 26.3 20.5 11.2 13.1
-11 15.2 319 43.9 21.9 37.1 228 11.6 15
13.4 20.5 34.1 20.3 30.2 13.9 10.8 15.1
9 28.2 21.7 58.7 16.8 33.9 13.9 13.8 127
-8 41.4 17.3 51.7 17.4 228 14.7 14.7 13.9
-7 28.2 9.9 110.2 9.9 37.8 13.5 15.1 12
6 64.8 39 106.8 14.1 36.6 23.9 25.5 15.4
-5 416 23.4 101.7 30 31.1 15.1 24.7 14.3
39.6 126 111.3 9 325 13.1 34 14.3
-3 514 421 928 26.7 36.4 17 29.3 14.7
-2 81.6 24.4 121.4 8.9 323 21.2 26.6 127
-1 35.3 8.7 108.2 25.5 327 14.3 41.7 13.5
0 46.5 6.6 99.9 15.2 8.3 122 35 16.6 39.4 13.1 10.4 12
1 20.7 8.7 429 21.2 3.2 13.2 26.7 14.7 31.7 124 11.2 124
2 21.1 14.4 429 17.3 6.3 21 29.1 14.3 25.5 13.1 127 12
3 19.7 13 61 8.9 19.1 69 27.3 13.9 24.3 124 11.6 127
6 11 29.7 28.2 19 34 67.3 31.7 23.2 21.2 11.6 12 17
5 24.2 11.8 229 11.3 14.6 116 26.2 16.6 20.1 127 124 22
4 18.5 9.3 35.7 14.4 13 38.2 24.4 18.1 16.6 124 14.3 18.9
7 9.3 4.3 15.8 17.1 42 1424 27.8 12 16.2 127 13.1 30.9
8 6.1 7.1 16.5 46.7 101.8 37.6 15.4 15.8 19.3 43.2
9 10 13.2 128 528 87.7 27.6 13.5 124 19.7 40.5
10 18.3 121 39.4 57.8 66.2 25.1 13.5 15.1 21.6 36.7
11 15.2 9.9 10.4 68.3 130 37.6 14.7 124 29 70
12 21.1 9.3 9.9 127.8 45.5 27.3 14.7 12 19.7 49.4




Glucose (mmol/ml) P-Hydroxyl-Butyrate (mmol/ml)
wpi 14c 15c 23c 26c 34c 45c 14c 15c 23c 26c 34c 45c
-27 1.10 3.20 193 120 0.15 0.58 0.39 0.46
-26 1.00 160 1.31 3.10 0.26 0.51 0.21 0.59
-25 2.20 1.30 1.72 158 0.34 0.20 0.47 0.59
-24 170 3.10 1.80 163 0.34 0.42 0.28 0.66
-23 130 3.00 164 1.69 0.35 0.38 0.34 0.20
-22 190 3.70 115 1.41 0.36 0.43 0.40 0.24
-21 1.90 140 3.19 1.66 0.38 0.39 0.70 0.34
-20 120 4.00 1.43 0.83 0.31 0.45 0.52 0.23
-19 150 1.70 124 0.21 0.30 0.16 0.36 0.21
-18 150 1.60 103 1.35 0.37 0.17 0.31 0.13
-17 1.70 1.90 116 1.97 0.28 0.36 0.18 0.23
-16 1.40 1.10 1.38 116 0.45 0.17 0.18 0.27
-15 3.90 1.00 0.48 0.78 0.24 0.07 0.09 0.18
-14 120 110 111 121 0.42 0.26 0.21 0.26
-13 150 110 1.17 109 0.36 0.19 0.14 0.23
-12 180 170 1.84 1.84 0.29 0.26 0.26 0.21
-11 1.50 1.30 133 1.45 0.32 0.28 0.27 0.49
10 160 120 0.81 0.83 0.34 0.24 0.21 0.18
-9 170 1.50 1.68 1.53 0.37 0.15 0.23 0.20
-8 130 1.80 178 141 0.29 0.18 0.25 0.27
-7 0.80 1.50 1.70 1.56 0.23 0.37 0.16 0.12
6 0.50 1.00 1.05 133 0.25 0.21 0.24 0.14
-5 140 130 1.18 1.89 0.25 0.26 0.33 0.19
110 1.30 155 1.91 0.20 0.09 0.37 0.19
-3 140 1.40 115 1.21 0.27 0.17 0.19 0.18
-2 1.80 130 1.90 1.94 0.28 0.29 0.25 0.15
-1 110 160 125 137 0.15 0.23 0.30 0.18
0 110 1.90 187 164 180 115 0.20 0.18 0.24 0.19 0.30 0.36
1 140 1.90 166 1.64 1.60 0.94 0.20 0.20 0.24 0.23 0.31 0.22
2 1.20 1.80 3.05 184 170 1.96 0.16 0.19 0.28 0.25 0.37 0.26
3 1.80 3.00 1.92 3.41 3.00 144 0.21 0.26 0.18 0.26 0.42 0.35
6 1.70 120 121 3.14 3.50 149 0.13 0.20 0.17 0.17 0.29 0.43
5 1.00 140 165 3.00 0.20 1.90 0.05 0.27 0.20 0.28 0.26 0.24
4 0.20 1.20 141 133 170 190 0.08 0.21 0.20 0.25 0.12 0.34
7 1.10 1.80 1.69 170 1.60 190 0.10 0.18 0.15 0.19 0.16 0.35
8 1.60 3.10 135 120 194 0.13 0.32 0.20 0.24 0.14 0.47
9 1.40 3.70 3.86 140 3.22 0.10 0.35 0.28 0.25 0.41
10 0.70 140 129 3.60 167 0.05 0.16 0.18 0.28 0.34
11 1.(10 100 3.16 3.29 0.09 0.14 0.23 0.21 0.38




Experiment 5: Calves 22, 23 and 24 infected with 400 F. gigantica metacercariae
(kcnyan strain) and uninfected control Calf 26.
Packed Cell Volume(%) Haemoglobin in g/dl Red Blood Cell x 1012/1
WPI Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26
-2 27 34 29 29 135 14.1 132 12.4 5.120 7.420 6.450 7.040
-1 33 33 33 34 13.4 142 13.4 125 5800 9.930 7.420 17570
0 31 38 34 34 14.2 16.0 173 165 8.040 10.090 6.900 11.110
1 30 29 33 28 14.7 15.4 142 15.4 5300 7.790 5.400 9.060
2 32 38 34 35 14.2 185 165 185 7.980 9.710 5540 7560
3 35 36 33 35 14.6 145 165 174 7.740 7.910 7550 7.740
4 33 30 35 32 142 16.7 16.0 15.4 7530 9.070 7.060 9320
5 34 33 34 34 14.7 155 165 16.0 9.950 7.980 6220 8.640
6 32 32 33 33 14.7 16.7 16.0 16.0 14.670 11830 7850
7.160
7 35 34 34 32 15.4 14.1 15.4 148 8.750 7.680 9.230 8.470
8 30 31 30 32 13.0 135 135 15.4 8.440 9800 7330 7800
9 32 30 32 31 135 135 14.1 15.4 8820 13550 6.200
8.720
10 32 31 34 30 13.0 14.1 13.4 16.0 9.620 8.260 6.950 7570
11 33 35 34 35 12.7 135 13.0 148 10.190 9380 7.190 9220
12 31 31 33 31 11.2 11.9 12.1 15.0 7390 7.730 8260
8500
13 26 31 33 33 12.4 12.4 12.4 14.9 10.120 8.650
7.160 7390
14 30 32 26 30 12.4 135 13.2 145 7.080 8.480 5800
7380
15 29 33 31 31 12.4 14.0 135 145 8540 13.960
6500 7.430
16 29 28 32 34 13.0 14.2 13.7 15.4 6.160 6.110
7.080 6.250
17 34 34 33 35 13.0 14.0 13.7 14.9 7.990 7390 6.900 7520
18 31 29 30 33 13.8 14.2 135 15.4 8.720 6.170 5.960 10810
19 33 31 32 34 16.2 14.2 17.0 153 9.150 6360 5.900
7380
20 31 32 35 35 16.2 18.0 16.0 16.0 5.720 6.150 6.640 6500
21 33 35 34 36 14.7 173 16.7 16.0 6800 10840 6.440 7.120
22 30 35 33 31 14.7 16.6 14.7 142 10.110 7.630 5880 5.970
23 34 35 33 39 16.0 16.0 18.0 153 13350 8.050 15.020 12.130
24 28 30 33 33 155 15.4 16.6 153 6.210 8.460 7330 7.980
25 35 38 37 36 16.0 18.0 18.0 153 7.470 7.730 6.860 6.620
26 38 34 38 36 17.0 17.0 18.0 16.0 6.930 8320 7.710 8.150
27 35 36 30 37 16.0 16.6 173 173 6.910 9300 6.040 7.250
28 35 34 34 35 16.0 16.0 173 16.0 6.420 7300 7.130 9.290
29 35 35 37 31 16.0 173 15.4 14.6 6.110 12340 12.000 7820
30 33 33 36 36 135 14.7 135 14.7 7310 6.750 6.650 7.420
31 36 35 37 35 14.1 16.6 17.4 16.6 9580 8.720 8.920 7.740
32 31 30 34 33 14.1 16.0 16.0 14.1 7.700 7310 7.180 8.970




MCV (xlO^/ml.) MCH (xlOA6/ml.) MCHC (xlOA6/ml.
Wl>| Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26
-2 52.7 45.8 45 41.2 26.4 19 203 17.6
-l 56.9 33.2 443 19.4 23.1 143 18.1 73 26.4 19 203 17.6
0 38.6 37.7 493 30.6 17.7 15.9 25.1 14.9 23.1 143 18.1 73
l 56.6 37.2 61.1 30.9 27.7 19.8 263 17 17.7 15.9 25.1 14.9
2 40.1 39.1 57.2 44 173? 19.1 27.8 23.4 27.7 198 263 17
3 45.2 453 43.7 45.2 18.9 183 21.9 223 178 19.1 278 23.4
4 433 33.1 49.6 343 18.6 18.4 22.7 163 18.9 183 21.9 223
5 34.2 41.4 54.7 39.4 143? 19.4 26.7 15 18.6 18.4 22.7 163
6 218 27 42 46.1 10 14.1 20.4 223 148 19.4 26.7 15
7 40 443 36.8 37.8 17.6 18.4 16.7 173 10 14.1 20.4 223
8 35.5 31.6 40.9 41 15.4 133? 18.4 173 17.6 18.4 16.7 173
9 363 22.1 51.6 353 153 10 22.7 17.7 15.4 138 18.4 173
10 333 373 48.9 39.6 133 17.1 23 17.7 153 10 22.7 17.7
11 314 373 473 38 14.4 14.4 21.4 16.1 133 17.1 23 17.7
12 41.9 40.1 40 363 15.2 15.4 14.6 143 14.4 14.4 21.4 16.1
13 25.7 35.8 46.1 44.7 123 143 173 168 152 15.4 14.6 143
14 42.4 37.7 44.8 40.7 173 15.9 228 17.6 123 143 173 168
15 34 23.6 47.7 41.7 143 10 208 188 173 15.9 228 17.6
16 47.1 45.8 45.2 54.4 21.1 23.2 19.4 21.1 143 10 208 188
17 42.6 46 47.8 463 163 18.9 19.9 18.9 21.1 23.2 19.4 21.1
18 35.6 47 503 303 15.8 23 22.7 13.4 163 18.9 19.9 18.9
19 36.1 48.7 54.2 46.1 17.7 223 288 19 158 23 22.7 13.4
20 54.2 52 52.7 53.8 283 293 24.1 24.6 17.7 223 288 19
21 483 32.3 52.8 50.6 21.6 16 25.9 223 283 293 24.1 24.6
22 29.7 45.9 56.1 51.9 143 213? 25 238 21.6 16 25.9 223
23 253 433 22 32.2 12 19.9 12 12.6 143 218 25 238
24 45.1 353 45 41.4 25 18.2 22.6 19.2 12 19.9 12 12.6
25 46.9 49.2 53 9 54.4 21.4 233 26.2 23.1 25 18.2 22.6 19.2
26 54.8 40.9 493 44.2 243 20.4 233 19.6 21.4 233 26.2 23.1
27 50.7 38.7 49.7 51 23.2 173? 28.6 23.9 243 20.4 233 19.6
28 543 46.6 47.7 37.7 24.9 21.9 243 17.2 23.2 178 28.6 23.9
29 573 28.4 30.8 39.6 26.2 14 128 18.7 24.9 21.9 243 17.2
30 45.1 48.9 54.1 483 183 21.8 203 198 26.2 14 128 18.7
31 37.6 40.1 413 45.2 14.7 19 193 21.4 183 218 203 198
32 40.3 41 47.4 36.8 183 21.9 223 15.7 14.7 19 193 21.4




WBC (xl09/l) Eosinophils (xl09/ml.) Nuetrophil (xl09/l)
WI>I Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26
-2 9.050 7.400 7.700 7800 0.181 0.074 0.231 0.078 3.258 2.072 1386 3652
-1 9.200 6850 9.100 5.150 0.184 0.069 0373 0.103 2852 1850 1.638 1.648
0 9.500 7550 6.850 5500 0.190 0.076 0.137 0.055 2375 1812 1333 3090
1 8.050 4.050 5.400 4.950 0.483 0.041 0.054 0.050 2.737 1315 1.188 1.980
2 9300 6.450 9.450 6.200 0837 0.194 1.701 0.062 2511 1.742 2.174 3046
3 8.700 8.400 11.700 5.750 0.957 0672 2340 0.173 1.740 2.184 2.457 1840
4 9.100 8350 7.400 6500 1.274 1.002 1.184 0.065 2.912 1.754 1.628 3405
5 25(X) 5.250 6.850 6.4<X) 0.175 0368 0.480 0.064 0800 1.260 1.713 3496
6 10.100 12250 10.450 5.050 0.404 1.960 1359 0.101 3333 3.675 2.090 1566
7 8.950 5.650 12.200 7.1CX) 0537 0.283 2.074 0.142 2.417 1.074 2.684 3414
8 11350 7.200 8.250 5.800 1.022 0576 0.660 0.116 2384 1368 1.403 1856
9 10.950 7.450 11550 5550 1.205 1.118 1.733 0.056 2519 1.639 1386 1.721
10 10.050 5.600 11300 5.600 1508 0.448 1.130 0.112 1.608 1.232 0.904 1.680
11 12.250 10.900 10.200 5.100 0858 1.417 1.938 0.051 2.205 1.635 3754 1326
12 13.200 10300 13.800 7.000 1.716 2.060 1.656 0.420 3.036 1854 3760 1820
13 10.450 9.100 9.450 4.050 1.150 1820 1512 0.041 2.299 1.638 0.662 1.458
14 10.600 9.950 12900 7.050 1.060 1.990 3.483 0.141 2.120 1.095 1.032 1.622
15 7.450 8.200 9.750 9.000 0.671 0.738 2.730 0.090 1.937 1.476 1.268 3700
16 13.600 8.8(X) 11.050 5350 0.272 0880 2.652 0.168 2.720 1.144 0332 0.910
17 13.450 8.250 9.750 5.400 0.135 0.660 1560 0.054 1.480 2.145 0.683 1890
18 12.200 5.650 9.900 4350 0.610 0.735 1.188 0.087 0.488 1300 0.495 0.609
19 12.150 8.050 6.850 5350 0.608 1.127 0.274 0.054 3.038 1852 0891 0.910
20 10.450 9.250 13.400 5.900 0.627 1.758 1.474 0.118 2.404 2590 3948 1.180
21 10.700 10.750 10.(XX) 6.100 0.642 2.795 1.100 0.183 2.247 1.935 1.600 1586
22 14.150 9500 8.700 5.050 0.283 1.615 1305 0.101 3538 1.140 0870 1.111
23 10.600 9.650 9.900 6.700 1.166 1.641 1.485 0.067 0.954 1544 1.683 1.139
24 12.700 11.250 9.150 4.950 0.127 0.225 1.739 0.050 2.413 3.938 0.915 0.941
15 11.850 10.050 10.150 6550 0.356 0.603 1320 0.066 2.607 2513 0.711 1572
26 115(X) 7.7(X) 16350 5.750 0.920 0.385 2.780 0.230 2.875 1.617 3780 1840
27 11 .(XX) 6.950 12650 8.150 0.440 0556 1518 0.082 2.860 1599 0886 3119
28 12.2CX) 85(X) 11.21X) 8.750 0.244 0.765 1.120 0.175 3.416 2.210 3128 3713
29 12500 8.850 10.300 8.(XX) 0.875 0.708 1854 0.080 2.125 2.213 0515 1.680
30 9.800 8500 13550 7.150 0.196 0.765 2.981 0.072 1862 2.040 3168 3.075
31 11.900 10.650 12.050 7.750 0.119 0.320 1.446 0.078 2.618 3515 1.687 1.705
32 14.7CX) 8.450 12750 8.750 0588 0.169 1.148 0.088 2.499 1.268 3933 3713




Lyphocytcs (xl09/ml.) Monocytes (xl09/ml.) Basophils (xl09/ml.)
WPI Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26 Calf 22 Calf 23 Calf 24 Calf 26
-2 4.435 4314 5.236 4.290 0.996 0.740 0847 0.702 0.181 0.000 0.000 0.078
-1 5.060 4.179 6.188 2.781 1.104 0.754 0.910 0318 0.000 0.000 0.091 0.000
0 5.795 5.059 5.001 3.080 1.045 0.604 0.411 0320 0.095 0.000 0.069 0.055
1 4.025 2349 3.996 2325 0805 0365 0.162 0347 0.000 0.081 0.000 0.050
2 5.115 4.257 4.631 3.410 0.744 0.258 0.945 0382 0.093 0.000 0.000 0.000
3 4.698 4.956 6318 2.990 1305 0388 0385 0.748 0.000 0.000 0.000 0.000
4 4368 5.177 4366 3.705 0346 0.418 0322 0325 0.000 0.000 0.000 0.000
5 1375 3308 4384 3.456 0.150 0315 0374 0384 0.000 0.000 0.000 0.000
6 5355 6.493 6.479 3.081 0808 0.123 0323 0303 0.000 0.000 0.000 0.000
7 5349 3.955 7.198 4.189 0.448 0339 0344 0355 0.000 0.000 0.000 0.000
8 6.810 4.752 5328 3.074 1.135 0304 0378 0.754 0.000 0.000 0.083 0.000
9 6.023 4.247 7392 3.441 1.205 0.447 1.040 0333 0.000 0.000 0.000 0.000
10 6.030 3.752 8.814 3.136 0804 0.168 0339 0.672 0.101 0.000 0.113 0.000
11 7.963 7303 5.202 3.264 1348 0345 0306 0.459 0.000 0.000 0.000 0.000
12 7.656 5.459 8356 4.060 0.792 0.927 0828 0.700 0.000 0.000 0.000 0.000
13 6.897 5.642 6.804 2.187 0.105 0.910 0.473 0365 0.000 0.000 0.000 0.000
14 6.784 5372 7.998 4.230 0.636 1.294 0387 1.058 0.000 0.000 0.000 0.000
15 4321 4.756 5.265 5.760 0322 1.230 0390 0.450 0.000 O.(XX) 0.098 0.000
16 10.064 6.072 7314 3.638 0344 0.704 0.442 0335 0.000 0.000 0.111 0.000
17 9.953 4.703 6.825 3.186 1.883 0.743 0.683 0.270 0.000 0.000 0.000 0.000
18 9394 2.995 7326 3.132 1.708 0.622 0891 0322 0.000 0.000 0.000 0.000
19 7.776 4.186 5.412 3.799 0.729 0886 0.274 0389 0.000 0.000 0.000 0.000
20 6384 4.070 8376 3.953 0.836 0833 0.402 0.649 0.000 0.000 0.000 0.000
21 6.848 5.160 7.000 4.148 0856 0860 0300 0.183 0.107 0.000 0.000 0.000
22 9.198 5.985 6.264 3.485 1.132 0.760 0.261 0303 0.000 0.000 0.000 0.051
23 8.268 5.790 6336 4824 0.212 0.676 0396 0.670 0.000 0.000 0.000 0.000
24 9.271 6.075 5.948 3.366 0889 1.013 0349 0345 0.000 0.000 0.000 0.000
25 8.295 6.734 7.816 4 585 0.474 0.201 0.203 0328 0.119 0.000 0.102 0.000
26 6355 5.005 9.647 3.163 1.150 0.616 0.981 0318 0.000 0.077 0.164 0.000
27 6.930 4379 9.994 5.053 0.770 0.417 0.253 0897 0.000 0.000 0.000 0.000
28 7.442 4.335 6.496 4.725 1.098 1.190 0360 1.138 0.000 0.000 0.000 0.000
29 9375 5.222 7.416 4.960 0.125 0.708 0315 1.280 0.000 0.000 0.000 0.000
30 6.468 5.015 7.046 3361 1.274 0.680 1355 0.644 0.000 0.000 0.000 0.000
31 8.211 6.284 8.194 5.038 0.952 0333 0.723 0.930 0.000 0.000 0.000 0.000
32 10.143 5.915 7.650 4.900 1.470 1.099 1.020 1.050 0.000 0.000 0.000 0.000




Glucose (mmol/ml) (3-Hyclroxyl-Butyrate (m
W P 14C 15C 23C 26C 22 23 24 26
-2 2.80 3.20 193 120 033 0.26 0.29 0.22
-1 1.60 160 115 3.10 031 031 0.27 0.21
0 2.70 130 1.94 238 031 0.26 0.18 0.18
1 3.00 3.10 1.96 163 0.25 035 0.26 0.25
2 330 3.00 144 3.70 0.29 032 0.23 0.28
3 2.70 3.70 149 140 0.26 0.24 0.21 0.24
4 1.60 140 1.90 100 031 034 0.23 034
5 2.20 4.00 190 180 037 035 027 023
6 2.40 3.70 190 1.60 033 0.29 0.42 021
7 3.60 140 194 170 0.29 038 0.44 0.28
8 1.70 2.00 3.22 3.00 0.47 034 030 023
9 1.40 1.70 167 330 0.41 038 0.49 027
10 3.90 1.00 3.29 190 035 0.47 039 030
11 2.20 2.10 111 2.90 0.43 0.26 035 0.26
12 230 2.10 1.17 194 0.47 0.41 0.43 0.23
13 2.80 170 1.84 3.22 0.41 0.26 0.24 0.21
14 130 130 233 2.67 035 0.28 034 0.22
15 2.60 120 0.81 170 034 0.24 035 0.18
16 2.70 130 1.68 3.CX) 037 0.49 0.47 0.20
17 230 1.80 178 330 0.29 0.28 0.41 0.27
18 0.80 130 1.70 136 0.23 037 034 0.12
19 030 1.00 1.05 2.33 0.25 0.21 038 0.14
20 2.40 2.30 1.18 2.35 0.25 0.26 033 0.19
21 2.10 130 155 3.86 0.20 0.09 037 0.20
22 2.40 1.40 115 129 0.27 0.17 0.19 0.20
23 1.80 230 1.90 3.16 0.28 0.29 0.25 0.16
24 2.10 160 125 145 0.15 0.23 030 0.21
25 2.10 1.90 187 2.64 0.20 0.18 0.24 0.13
26 140 1.90 2.66 1.64 0.20 0.20 0.24 0.25
Z7 1.20 1.80 3.05 2.84 0.16 0.19 0.28 0.19
28 1 ^0 3.00 1.92 3.41 0.21 0.26 0.18 0.26
29 1.70 2.20 2.21 3.14 0.13 0.20 0.17 0.17
30 1.00 2.40 2.65 3.00 0.25 0.27 0.20 0.28
31 0.20 1.20 2.41 233 0.19 0.24 0.20 0.25
32 1.10 1.80 1.69 170 0.20 0.24 0.15 0.19




OPTICAL DENSITIES AT 450 NM FOR ELISA TITRATIONS
Titration for total Ig showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected sheep
Appendix Table 4.46:
Antigen (|jg/ml)
F. hepatica F. gigantica
FhESP B N PI P2 FgESP B N PI P2
20 0.2105 0.4883 1.634 1.580 20 0.097 0.393 1.151 1.304
10 0.2281 0.4586 1.497 1.457 10 0.101 0.292 1.039 1.182
5 0.2187 0.3023 1.415 1.258 5 0.101 0.220 0.866 0.982
2.5 0.1797 0.25 1.258 1.214 2.5 0.075 0.122 0.742 0.723
1.25 0.1663 0.157 1.0623 0.914 1.25 0.088 0.215 0.547 0.428
0.625 0.188 0.25 0.82 0.541 0.625 0.071 0.124 0.337 0.313
0.3125 0.192 0.09 0.6063 0.340 0.3125 0.060 0.098 0.214 0.119
BBS 0.1408 0.3023 0.3366 0.124 BBS 0.040 0.078 0.072 0.086
Serum titrations
F. hepatica F. gigantica
Serum B N PI P2 Serum B N PI P2
100 0.005 0.647 1.424 1.308 100 0.099 0.569 0.984 0.987
200 0.011 0.474 1.257 1.261 200 0.101 0.451 0.884 0.800
400 0.009 0.274 1.003 1.058 400 0.101 0.324 0.766 0.714
800 0.015 0.175 0.715 0.826 800 0.097 0.253 0.627 0.600
1600 0.025 0.104 0.454 0.518 1600 0.103 0.176 0.402 0.458
3200 0.014 0.066 0.285 0.324 3200 0.096 0.155 0.316 0.231
Conjugate titration
F. hepatica F gigantica
Conj. B N PI P2 Conj. B N PI P2
1000 0.104 0.154 0.852 1.304 1000 0.084 0.183 0.682 0.994
2000 0.057 0.159 0.582 1.182 2000 0.076 0.165 0.471 0.765
4000 0.011 0.066 0.295 0.982 4000 0.046 0.154 0.274 0.424
8000 0.004 0.027 0.139 0.723 8000 0.028 0.089 0.151 0.180
16000 0.005 0.017 0.060 0.428 16000 0.013 0.042 0.085 0.022




Titrations for IgG! showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected sheep
Antigen (fig/ml)
F. hepatica F. gigantica
FhESP B N P 1 P 2 FgESP B N P 1 P 2
20 0.032 0.017 0.597 0.806 20 0.033 0.351 0.975 0.931
10 0.029 0.012 0.770 0.772 10 0.034 0.073 0.772 0.721
5 0.031 0.017 0.761 0.945 5 0.033 0.023 0.526 0.506
2.50 0.026 0.012 0.613 0.659 2.50 0.027 0.025 0.213 0.025
1.25 0.026 0.029 0.194 0.171 1.25 0.032 0.027 0.107 0.037
0.63 0.018 0.018 0.103 0.121 0.63 0.033 0.030 0.052 0.032
0.31 0.025 0.023 0.048 0.056 0.31 0.028 0.021 0.050 0.002
BBS 0.027 0.028 0.030 0.045 BBS 0.031 0.033 0.033 0.032
Serum Titrations
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.018 0.023 0.565 0.548 50 0.019 0.028 0.788 0.197
100 0.018 0.025 0.556 0.495 100 0.018 0.026 0.803 0.117
200 0.017 0.032 0.493 0.453 200 0.020 0.026 0.715 0.066
400 0.022 0.018 0.418 0.393 400 0.026 0.023 0.623 0.045
800 0.027 0.020 0.276 0.273 800 0.028 0.024 0.413 0.030
1600 0.021 0.017 0.147 0.108 1600 0.024 0.021 0.216 0.023
Monoclonal Antibody titration
F. hepatica F. gigantica
McAb B N P 1 P 2 McAb B N P 1 P 2
10 0.036 0.100 1.084 1.011 10 0.030 0.060 0.826 0.251
20 0.035 0.082 0.975 1.003 20 0.036 0.041 0.776 0.222
40 0.032 0.059 0.717 0.813 40 0.031 0.042 0.581 0.148
80 0.033 0.034 0.374 0.356 80 0.034 0.034 0.310 0.159
160 0.029 0.019 0.204 0.258 160 0.029 0.028 0.138 0.066
320 0.029 0.018 0.089 0.160 320 0.033 0.042 0.062 0.037
Conjugate Titration
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.027 0.028 0.808 0.156 1000 0.021 0.022 0.662 0.082
2000 0.015 0.020 0.504 0.085 2000 0.016 0.015 0.369 0.052
4000 0.021 0.017 0.279 0.059 4000 0.013 0.015 0.190 0.027
8000 0.014 0.015 0.154 0.038 8000 0.013 0.013 0.114 0.019
16000 0.011 0.009 0.078 0.020 16000 0.011 0.011 0.051 0.016




Titration for total IgM showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected sheep
Antigen (jag/ml)
F. hepatica F. gigantica
FhESP B N PI P 2 FgESP B N P 1 P 2
20 0.017 0.311 1.090 0.919 20 0.023 0.495 0.774 0.924
10 0.013 0.314 0.986 0.903 10 0.015 0.433 0.766 0.887
5 0.016 0.279 0.944 0.874 5 0.010 0.366 0.690 0.926
2.50 0.012 0.273 0.828 0.731 2.50 0.021 0.205 0.475 0.856
1.25 0.008 0.221 0.684 0.694 1.25 0.013 0.317 0.617 0.892
0.63 0.011 0.124 0.491 0.220 0.63 0.008 0.326 0.312 0.326
Serum Titrations
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.029 0.640 0.954 0.889 50 0.028 0.580 0.878 0.749
100 0.021 0.430 0.903 0.784 100 0.022 0.420 0.739 0.617
200 0.019 0.290 0.823 0.629 200 0.024 0.297 0.581 0.453
400 0.018 0.159 0.672 0.456 400 0.017 0.350 0.393 0.350
800 0.019 0.099 0.545 0.309 800 0.013 0.208 0.272 0.208
1600 0.017 0.051 0.391 0.194 1600 0.015 0.105 0.156 0.105
Conjugate Titrations
F. hepatica F gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.029 0.437 0.916 0.649 1000 0.033 0.383 0.555 0.610
2000 0.023 0.274 0.606 0.478 2000 0.032 0.228 0.306 0.360
4000 0.024 0.149 0.320 0.242 4000 0.016 0.125 0.148 0.178
8000 0.018 0.064 0.152 0.129 8000 0.020 0.069 0.084 0.105
16000 0.018 0.034 0.083 0.076 16000 0.012 0.026 0.034 0.053




Titrations for IgG2 showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected sheep
Antigen (fig/ml)
F. hepatica F. gigantica
FhESP B N PI P 2 FgESP B N PI P 2
20 0.023 0.037 0.306 0.115 20 0.033 0.030 0.196 0.133
10 0.019 0.032 0.479 0.081 10 0.034 0.052 0.120 0.163
5 0.023 0.027 0.470 0.254 5 0.033 0.002 0.074 0.048
2.50 0.017 0.042 0.322 0.168 2.50 0.027 0.004 0.061 0.037
1.25 0.017 0.029 0.003 -0.020 1.25 0.032 0.006 0.002 0.049
0.63 0.017 0.038 0.012 -0.070 0.63 0.033 0.009 0.040 0.044
0.31 0.012 0.023 -0.043 -0.035 0.31 0.028 0.000 0.038 0.014
BBS 0.011 0.028 -0.061 -0.046 BBS 0.031 0.012 0.021 0.044
Serum Titration
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.018 0.023 0.278 0.445 50 0.019 0.028 0.164 0.086
100 0.018 0.025 0.200 0.276 100 0.018 0.026 0.179 0.006
200 0.017 0.032 0.151 0.142 200 0.020 0.026 0.091 0.006
400 0.022 0.018 0.112 0.078 400 0.026 0.023 -0.001 -0.015
800 0.027 0.020 0.075 0.056 800 0.028 0.024 -0.011 -0.030
1600 0.021 0.017 0.072 0.038 1600 0.024 0.021 -0.028 -0.037
Monoclonal antibody titration
F. hepatica F. gigantica
McAb B N P 1 P 2 McAb B N P 1 P 2
10 0.017 0.112 0.653 0.255 10 0.017 0.044 0.184 0.221
20 0.014 0.102 0.623 0.272 20 0.018 0.040 0.168 0.227
40 0.018 0.090 0.522 0.225 40 0.021 0.036 0.157 0.215
80 0.016 0.068 0.402 0.153 80 0.018 0.032 0.137 0.192
160 0.010 0.044 0.240 0.093 160 0.015 0.032 0.109 0.154
320 0.010 0.020 0.114 0.042 320 0.014 0.028 0.099 0.143
Conjugate Titration
F. hepatica F gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.027 0.028 0.365 0.156 1000 0.021 0.022 0.512 0.082
2000 0.015 0.020 0.421 0.112 2000 0.016 0.015 0.369 0.052
4000 0.021 0.017 0.279 0.059 4000 0.013 0.015 0.312 0.027
8000 0.014 0.015 0.154 0.028 8000 0.013 0.013 0.114 0.019
16000 0.011 0.009 0.078 0.020 16000 0.011 0.011 0.051 0.016




Titrations for IgA showing the mean OD (450 nm)values obtained in
F. hepatica and F. gigantica infected and uninfected sheep
Antigen (pg/ml)
F. hepatica F. gigantica
FhESP B N PI P 2 FgESP B N P 1 P 2
20 0.069 0.206 0.081 1.101 20 0.077 0.066 0.069 0.077
10 0.070 0.073 0.062 0.067 10 0.063 0.066 0.052 0.058
5 0.047 0.007 0.057 0.064 5 0.050 0.046 0.051 0.084
2.50 0.040 0.010 0.043 0.060 2.50 0.037 0.026 0.050 0.011
1.25 0.029 0.002 0.031 0.034 1.25 0.032 0.006 0.002 0.049
0.63 0.018 0.012 0.019 0.012 0.61 0.033 0.009 0.040 0.044
0.31 0.012 0.023 -0.043 -0.035 0.31 0.028 0.000 0.038 0.014
BBS 0.011 0.028 -0.061 -0.046 BBS 0.031 0.012 0.021 0.044
Serum titrations
F. hepatica F gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.018 0.023 0.278 0.445 50 0.019 0.028 0.164 0.086
100 0.018 0.025 0.200 0.276 100 0.018 0.026 0.179 0.006
200 0.017 0.032 0.151 0.142 200 0.020 0.026 0.091 0.006
400 0.022 0.018 0.112 0.078 400 0.026 0.023 -0.001 -0.015
800 0.027 0.020 0.075 0.056 800 0.028 0.024 -0.011 -0.030
1600 0.021 0.017 0.072 0.038 1600 0.024 0.021 -0.028 -0.037
Monoclonal antibody titrations
F. hepatica F gigantica
McAb B N P 1 P 2 McAb B N P 1 P 2
10 0.017 0.112 0.653 0.255 10 0.017 0.044 0.184 0.221
20 0.014 0.102 0.623 0.272 20 0.018 0.040 0.168 0.227
40 0.018 0.090 0.522 0.225 40 0.021 0.036 0.157 0.215
80 0.016 0.068 0.402 0.153 80 0.018 0.032 0.137 0.192
160 0.010 0.044 0.240 0.093 160 0.015 0.032 0.109 0.154
320 0.010 0.020 0.114 0.042 320 0.014 0.028 0.099 0.143
Conjugate Titration
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N PI P 2
1000 0.027 0.028 0.305 0.156 1000 0.021 0.022 0.212 0.082
2000 0.015 0.020 0.221 0.112 2000 0.016 0.015 0.169 0.052
4000 0.021 0.017 0.179 0.059 4000 0.013 0.015 0.112 0.027
8000 0.014 0.015 0.054 0.028 8000 0.013 0.013 0.114 0.019
16000 0.011 0.009 0.028 0.020 16000 0.011 0.011 0.051 0.016




Titration for total Ig showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected calves
Antigen (ng/ml) Titration
F. hepatica F. gigantica
FhESP B N P 1 P 2 FgESP B N P 1 P 2
20 0.154 0.468 1.439 1.242 20 0.032 0.108 1.156 1.092
10 0.106 0.237 1.440 1.196 10 0.047 0.084 1.03 0.938
5 0.060 0.149 1.251 1.064 5 0.041 0.067 0.967 0.889
2.5 0.019 0.039 1.123 0.998 2.5 0.032 0.027 0.898 0.794
1.25 0.022 0.039 0.906 0.872 1.25 0.021 0.03 0.771 0.671
0.625 0.019 0.025 0.501 0.432 0.625 0.022 0.021 0.597 0.428
0.3125 0.016 0.016 0.339 0.158 0.3125 0.023 0.019 0.365 0.33
BBS 0.018 0.024 0.016 0.140 BBS 0.015 0.016 0.075 0.016
Serum Titrations
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.027 0.104 1.302 0.980 50 0.025 0.105 0.887 0.782
100 0.028 0.075 1.165 0.867 100 0.021 0.068 0.698 0.738
200 0.024 0.048 0.929 0.667 200 0.024 0.048 0.598 0.668
i 400 0.025 0.036 0.725 0.424 400 0.019 0.044 0.403 0.554
800 0.023 0.024 0.558 0.261 800 0.019 0.036 0.384 0.350
1600 0.024 0.025 0.415 0.155 1600 0.210 0.042 0.231 0.202
Conjugate titrations
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.125 0.097 1.547 1.020 1000 0.02 0.08 1.249 1.111
2000 0.078 0.048 1.210 0.755 2000 0.014 0.033 0.874 0.764
4000 0.036 0.028 0.725 0.698 4000 0.012 0.014 0.537 0.388
8000 0.026 0.025 0.443 0.444 8000 0.01 0.01 0.238 0.17
16000 0.017 0.015 0.297 0.289 16000 0.009 0.004 0.0117 0.089




Titration for IgG( showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected calves
Antigen (fig/ml) Titration
F. hepatica F. gigantica
FhESP B N P 1 P 2 FgESP B N P 1 P 2
20 0.169 0.422 1.419 1.500 20 0.12 1.583 1.901 1.891
10 0.176 0.387 1.371 1.364 10 0.125 1.417 1.753 1.734
5 0.146 0.276 1.397 1.452 5 0.12 1.235 1.684 1.656
2.5 0.137 0.201 1.210 1.316 2.5 0.104 0.893 1.535 1.656
1.25 0.126 0.160 0.995 1.233 1.25 0.082 0.242 0.927 1.187
0.625 0.111 0.111 0.678 0.993 0.625 0.065 0.191 0.73 1.073
0.3125 0.120 0.098 0.443 0.811 0.3125 0.075 0.213 0.639 0.919
BBS 0.111 0.103 0.286 0.542 BBS 0.097 0.158 0.179 0.224
Serum titrations
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.417 0.398 1.321 1.870 50 0.094 0.823 1.230 1.265
100 0.325 0.329 0.972 1.712 100 0.078 0.564 1.054 1.205
200 0.312 0.301 0.740 1.342 200 0.067 0.311 0.860 0.998
400 0.285 0.257 0.714 1.256 400 0.065 0.164 0.747 0.934
( 800 0.245 0.249 0.617 0.997 800 0.066 0.119 0.522 0.766
1600 0.218 0.224 0.548 0.682 1600 0.062 0.080 0.338 0.539
Conjugate titrations
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N PI P 2
1000 0.483 0.590 1.551 1.690 1000 0.19 0.442 1.126 1.207
2000 0.285 0.418 1.423 1.563 2000 0.133 0.346 1.023 1.23
4000 0.183 0.264 1.364 1.532 4000 0.082 0.22 0.754 0.891
8000 0.137 0.159 1.288 1.501 8000 0.05 0.112 0.49 0.644
16000 0.060 0.117 1.157 1.347 16000 0.027 0.076 0.244 0.38




Titrations for total IgM showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected calves
Antigen (pg/ml) Titration
F. hepatica F. gigantica
FhESP B N P 1 P 2 FgESP B N P 1 P 2
20 0.026 0.396 1.306 1.250 20 0.021 0.738 0.805 1.298
10 0.023 0.386 1.261 1.180 10 0.02 0.643 0.714 1.154
5 0.023 0.329 1.032 1.001 5 0.016 0.541 0.726 1.151
2.5 0.018 0.212 0.890 0.804 2.5 0.017 0.463 0.592 0.852
1.25 0.019 0.152 0.595 0.616 1.25 0.017 0.322 0.464 0.667
0.625 0.013 0.085 0.450 0.440 0.625 0.016 0.22 0.31 0.454
0.3125 0.017 0.062 0.363 0.364 0.3125 0.021 0.196 0.253 0.398
BBS 0.012 0.051 0.244 0.320 BBS 0.009 0.2 0.141 0.18
j Serum titration
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.027 0.29 0.948 0.944 50 0.008 1.095 1.316 1.437
100 0.028 0.153 0.621 0.654 100 0.010 0.669 0.859 1.123
200 0.027 0.0743 0.362 0.371 200 0.008 0.353 0.596 0.765
400 0.027 0.0288 0.217 0.17 400 0.008 0.174 0.354 0.450
800 0.022 0.0173 0.127 0.104 800 0.012 0.102 0.182 0.254
1600 0.026 0.021 0.066 0.063 1600 0.013 0.041 0.088 0.139
Conjugate titrations
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.031 1.432 1.503 0.238 1000 0.016 0.319 0.37 0.504
2000 0.035 1.283 1.332 0.190 2000 0.012 0.183 0.306 0.329
4000 0.026 1.006 1.145 0.143 4000 0.01 0.11 0.185 0.222
8000 0.015 0.830 0.748 0.081 8000 0.01 0.049 0.101 0.118
16000 0.014 0.484 0.518 0.037 16000 0.014 0.039 0.044 0.067




Titrations for IgG2 showing the mean OD (450 nm) values obtained
in /■' hepatica and F. gigantica infected and uninfected calves
Antigen (|4g/ml) Titration
F. hepatica F. gigantica
FhESP B N PI P 2 FgESP B N P 1 P 2
20 0.052 0.034 0.407 1.155 20 0.04 0.111 1.075 1.573
10 0.047 0.033 0.306 1.099 10 0.044 0.077 0.827 1.36
5 0.038 0.017 0.189 0.942 5 0.038 0.04 0.423 1.175
2.5 0.044 0.012 0.101 0.557 2.5 0.031 0.021 0.243 0.511
1.25 0.035 0.031 0.075 0.290 1.25 0.043 0.042 0.133 0.247
0.625 0.029 0.022 0.043 0.174 0.625 0.031 0.033 0.07 0.141
0.3125 0.030 0.027 0.040 0.077 0.3125 0.035 0.03 0.05 0.84
BBS 0.029 0.024 0.038 0.079 BBS 0.033 0.033 0.042 0.42
Serum titrations
F. hepatica F. gigantica
Serum B N PI P 2 Serum B N P 1 P 2
50 0.076 0.093 0.386 1.320 50 0.054 0.272 1.870 1.782
100 0.079 0.083 0.244 1.206 100 0.035 0.130 0.922 1.709
200 0.089 0.082 0.126 0.672 200 0.035 0.074 0.670 1.279
400 0.095 0.077 0.106 0.290 400 0.036 0.038 0.393 1.005
800 0.090 0.074 0.076 0.220 800 0.031 0.028 0.251 0.721
1600 0.096 0.078 0.084 0.129 1600 0.038 0.022 0.151 0.378
Conjugate titrations
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.058 0.033 0.184 0.702 1000 0.053 0.082 0.47 0.758
2000 0.034 0.090 0.126 0.505 2000 0.039 0.044 0.284 0.498
4000 0.020 -0.014 0.082 0.254 4000 0.028 0.021 0.158 0.284
8000 0.013 -0.021 0.032 0.156 8000 0.019 0.009 0.088 0.173
16000 0.009 -0.034 0.027 0.097 16000 0.016 0 0.04 0.097




Titrations for IgA showing the mean OD (450 nm) values obtained
in F. hepatica and F. gigantica infected and uninfected calves
Antigen (ng/ml) Titration
F. hepatica F. gigantica
FhESP B N PI P 2 FgESP B N P 1 P 2
20 0.037 0.026 0.300 0.640 20 0.035 0.012 0.066 0.326
10 0.026 0.011 0.224 0.452 10 0.026 0 0.054 0.28
5 0.023 0.003 0.188 0.401 5 0.034 0.002 0.043 0.27
2.5 0.023 0.009 0.011 0.311 2.5 0.035 0.001 0.043 0.181
1.25 0.022 0.026 0.090 0.246 1.25 0.023 0.022 0.02 0.086
0.625 0.024 0.017 0.043 0.160 0.625 0.018 0.015 0.019 0.043
0.3125 0.022 0.017 0.033 0.193 0.3125 0.029 0.023 0.015 0.033
BBS 0.018 0.024 0.028 0.164 BBS 0.16 0.021 0.016 0.019
Serum Titrations
F. hepatica F. gigantica
Serum B N P 1 P 2 Serum B N P 1 P 2
50 0.049 0.038 0.178 0.505 50 0.028 0.047 0.076 0.750
100 0.032 0.036 0.106 0.292 100 0.024 0.026 0.050 0.548
200 0.039 0.031 0.066 0.176 200 0.031 0.008 0.037 0.337
400 0.033 0.038 0.036 0.112 400 0.031 0.006 0.027 0.208
800 0.031 0.034 0.032 0.068 800 0.022 0.002 0.016 0.132
1600 0.037 0.041 0.033 0.051 1600 0.028 -0.001 0.013 0.100
Conjugate Titrations
F. hepatica F. gigantica
Conj. B N P 1 P 2 Conj. B N P 1 P 2
1000 0.027 0.048 0.337 0.630 1000 0.026 0.066 0.095 0.662
2000 0.025 0.042 0.200 0.435 2000 0.02 0.038 0.05 0.542
4000 0.025 0.000 0.116 0.305 4000 0.015 0.023 0.015 0.327
8000 0.015 -0.002 0.064 0.180 8000 0.014 0.01 0.013 0.195
16000 0.013 -0.023 0.043 0.070 16000 0.014 0.005 -0.003 0.094




Titration for total Igand isotypes showing mean OD values obtained
in F. hepatica and F. gigantica infected and uninfected sheep
using Fh-cathepsin. as antigen
Appendix Table 4.75
Titration for total Ig showing the mean OD (450 nm)values obtained
in F. hepatica and F. gigantica infected and uninfected sheep.
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.254 0.629 1.137 1.215 4 0.142 0.518 1.187 1.141
2 0.248 0.489 0.968 1.069 2 0.149 0.337 0.337 1.124
1 0.146 0.333 1.192 1.278 1 0.102 0.391 1.169 1.269
Serum B N PI P2 Serum B N PI P2
50 0.025 0.911 1.663 1.602 50 0.015 0.626 1,416 1.483
100 0.015 0.607 1.541 1.471 100 0.015 0.342 1.369 1.355
200 0.011 0.571 1.537 1.391 200 0.015 0.227 1.270 1.262
400 0.01 0.433 1.468 1.269 400 0.014 0.200 1.175 1.050
Conj. B N PI P2 Conj. B N PI P2
1000 0.029 0.523 1.563 1.583 1000 0.015 0.424 0.102 1.459
2000 0.021 0.315 1.541 1.471 2000 0.015 0.227 1.270 1.262
4000 -0.032 0.254 1.552 1.466 4000 -0.04 0.185 1.150 1.150
8000 0.008 0.156 1.251 1.190 8000 0.006 0.056 0.797 1.262
Appendix Table 4.76
Titration for IgGj showing the mean OD (450nm) values obtained
in F. hepatica and F. gigantica infected and uninfected sheep
Antigen (pg/ml) Titration IgGi
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.031 0.439 1.917 1.204 4 0.041 0.059 0.365 1.692
2 0.055 0.361 1.422 1.003 2 0.039 0.040 0.280 1.107
1 0.043 0.265 0.979 0.750 1 0.027 0.031 0.245 0.543
Serum B N PI P2 Serum B N PI P2
50 0.051 0.090 0.691 0.502 50 0.050 0.064 0.179 0.368
100 0.049 0.040 0.602 0.419 100 0.043 0.051 0.165 0.317
200 0.065 0.087 0.230 0.282 200 0.023 0.034 0.160 0.259
400 0.070 0.060 0.135 0.171 400 0.020 0.029 0.068 0.090
McAb B N PI P2 McAb B N PI P2
20 0.049 0.186 0.602 0.419 20 0.043 0.051 0.165 0.317
40 0.068 0.194 0.480 0.371 40 0.060 0.057 0.135 0.168
80 0.081 0.136 0.211 0.224 80 0.071 0.075 0.110 0.149
160 0.087 0.102 0.151 0.158 160 0.074 0.071 0.094 0.117
Conj. B N PI P2 Conj. B N PI P2
1000 0.055 0.140 1.619 0.278 1000 0.084 0.114 0.265 0.346
2000 0.044 0.110 1.216 0.222 2000 0.066 0.085 0.187 0.210
4000 0.041 0.062 0.849 0.129 4000 0.059 0.065 0.112 0.122
8000 0.039 0.050 0.490 0.087 8000 0.052 0.052 0.088 0.092
16000 0.045 0.038 0.287 0.067 16000 0.054 0.052 0.070 0.068




Titrations for total IgM showing mean OD (450 nm) values obtained in F. hepatica
and F. gigantica infected and uninfected sheep Fh-Cathepsin (pg/ml) as antigen
Antigen (ng/ml) Titration
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.190 1.406 0.517 1.327 4 0.230 1.114 1.483 1.946
2 0.245 1.428 1.151 1.380 2 0.234 1.153 1.152 1.326
1 0.049 0.670 0.414 0.452 1 0.074 0.362 0.503 0.820
Serum B N PI P2 Serum B N PI P2
50 0.049 0.067 0.414 0.452 50 0.027 0.268 0.426 0.350
100 0.055 0.498 0.255 0.367 100 0.250 0.170 0.523 0.266
200 0.044 0.333 0.182 0.311 200 0.032 0.105 0.248 0.192
400 0.047 0.172 0.121 0.202 400 0.033 0.119 0.199 0.089
Conj. B N PI P2 Conj. B N PI P2
1000 0.100 0.075 1.150 0.965 1000 0.060 0.343 0.646 0.560
2000 0.035 0.389 0.681 0.570 2000 0.025 0.170 0.523 0.266
4000 0.028 0.162 0.251 0.127 4000 0.014 0.073 0.168 0.129
8000 0.032 0.101 0.189 0.154 8000 0.019 0.027 0.073 0.046
Appendix Table 4.78
Titrations for IgG2 showing the mean OD (450 nm) values obtained in F. hepatica
and F. gigantica infected and uninfected sheep Fh-Cathepsin (pg/ml) as antigen
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.052 0.084 0.195 0.088 4 0.042 0.050 0.050 0.040
2 0.048 0.067 0.138 0.073 2 0.041 0.059 0.052 0.050
1 0.051 0.073 0.086 0.072 1 0.051 0.057 0.059 0.044
Serum B N PI P2 Serum B N PI P2
50 0.123 0.229 0.203 0.149 50 0.100 0.129 0.129 0.114
100 0.054 0.075 0.088 0.074 100 0.051 0.057 0.059 0.044
McAb B N PI P2 McAb B N PI P2
10 0.108 0.285 0.250 0.165 10 0.097 0.152 0.131 0.124
20 0.123 0.229 0.203 0.149 20 0.100 0.129 0.129 0.114
40 0.102 0.102 0.138 0.122 40 0.084 0.137 0.103 0.106
80 0.089 0.103 0.124 0.122 80 0.079 0.09 0.09 0.091
Conj. B N PI P2 Conj. B N PI P2
1000 0.082 0.123 0.125 0.183 1000 0.084 0.019 0.112 0.117
2000 0.066 0.088 0.094 0.112 2000 0.070 0.074 0.076 0.079
4000 0.057 0.079 0.076 0.078 4000 0.057 0.065 0.063 0.064
8000 0.056 0.072 0.061 0.062 8000 0.058 0.054 0.052 0.055
16000 0.055 0.062 0.050 0.060 16000 0.051 0.048 0.053 0.052




Titrations for IgA showing the mean OD (450 nm) values obtained in
F. hepatica and F. gigantica infected and uninfected sheep
F. hepatica F.gigantica
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.041 0.391 0.565 0.811 4 0.044 0.920 0.751 0.591
2 0.193 0.369 0.491 0.763 2 0.051 0.778 0.776 0.556
1 0.078 0.339 0.405 0.607 1 0.061 0.701 0.614 0.495
Serum B N PI P2 Serum B N PI P2
50 0.082 0.102 0.078 0.119 50 0.075 0.084 0.076 0.087
100 0.053 0.082 0.066 0.083 100 0.074 0.064 0.062 0.075
McAb B N PI P2 McAb B N PI P2
10 0.079 0.100 0.067 0.079 10 0.070 0.071 0.072 0.072
20 0.082 0.102 0.078 0.083 20 0.075 0.084 0.076 0.080
40 0.079 0.099 0.075 0.087 40 0.072 0.093 0.080 0.076
; 80 0.075 0.095 0.074 0.082 80 0.069 0.074 0.071 0.072
Conj. B N PI P2 Conj. B N PI P2
1000 0.053 0.082 0.066 0.119 1000 0.074 0.064 0.062 0.087
2000 0.039 0.050 0.042 0.068 2000 0.037 0.040 0.041 0.050
4000 0.029 0.031 0.025 0.041 4000 0.033 0.029 0.029 0.037
8000 0.028 0.026 0.018 0.030 8000 0.024 0.023 0.029 0.028
16000 0.022 0.025 0.017 0.027 16000 0.023 0.021 0.019 0.021
32000 0.026 0.027 0.018 0.026 32000 0.031 0.022 0.027 0.029
Table 4.80 Titration for total IgG showing the mean OD values obtained in F. hepatica
and F. gigantica infected and uninfected Cattle, Fh-Cathepsin (pg/ml) as antigen
F. hepatica F. gigantica
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.013 0.047 1.243 1.017 4 0.017 0.176 1.227 1.460
2 0.013 0.038 1.289 0.924 2 0.015 0.141 1.250 1.379
1 0.012 0.022 1.134 0.762 1 0.008 0.077 1.201 1.370
F. hepatica F. gigantica
Serum B N PI P2 Serum B N PI P2
50 0.001 0.038 1.460 1.144 50 0.006 0.167 1.494 1.57
100 -0.001 0.021 1.276 0.917 100 0.005 0.094 1.309 1.449
200 -0.001 0.015 1.063 0.669 200 0.002 0.05 1.131 1.33
400 -0.002 0.011 0.816 0.413 400 0.003 0.032 0.824 1.211
800 0.005 0.006 0.534 0.264 800 0.007 0.01 0.607 0.754
1600 0.000 0.012 0.390 0.175 1600 0.003 0.01 0.292 0.661
F. hepatica F. gigantica
conj. B N PI P2 conj. B N PI P2
1000 0.034 0.105 1.332 1.086 1000 0.04 0.197 1.31 1.472
2000 0.022 0.073 1.275 0.847 2000 0.022 0.108 1.192 1.272
4000 0.011 0.05 1.053 0.637 4000 0.014 0.084 1.065 1.15
8000 0.011 0.032 0.819 0.474 8000 0.012 0.06 0.812 0.952
16000 0.005 0.029 0.57 0.28 16000 0.011 0.03 0.585 0.969
32000 0.008 0.014 0.351 0.167 32000 0.015 0.021 0.355 0.415
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Table 4.81:_Titration for IgGl showing the mean OD values obtained in F. hepatica
and F. gigantica infected and uninfected Cattle, Fh-Cathepsin (pg/ml) as antigen
F. hepatica F. gigantica
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.017 0.100 1.479 1.361 4 0.034 0.393 1.534 1.702
2 0.021 0.077 1.599 1.297 2 0.019 0.363 1.606 1.542
1 0.020 0.057 1.490 1.224 1 0.017 0.177 1.476 1.684
F. hepatica F. gigantica
Serum B N PI P2 Serum B N PI P2
50 0.014 0.119 1.609 1.461 50 0.011 0.407 1.628 1.766
100 0.01 0.094 1.411 1.378 100 0.012 0.306 1.608 1.742
200 0.014 0.048 1.497 1.213 200 0.022 0.124 1.524 1.676
400 0.017 0.032 1.347 0.911 400 0.013 0.08 1.331 1.522
800 0.009 0.023 1.119 0.666 800 0.012 0.045 1.099 1.444
1600 0.013 0.023 0.872 0.483 1600 0.014 0.039 0.78 1.105
F. hepatica F. gigantica
conj. B N PI P2 conj. B N PI P2
1000 0.046 0.092 1.897 1.230 1000 0.050 0.250 1.934 1.859
2000 0.026 0.056 1.669 0.894 2000 0.026 0.137 1.458 1.806
4000 0.022 0.040 1.288 0.650 4000 0.024 0.081 1.041 1.389
8000 0.013 0.017 0.851 0.348 8000 0.013 0.039 0.618 0.942
16000 0.011 0.015 0.542 0.193 16000 0.011 0.024 0.428 0.594
32000 0.010 0.011 0.394 0.104 32000 0.010 0.022 0.312 0.401
Table:4.82 Titration for IgM showing the mean OD values obtained in F. hepatica
and F. gigantica infected and uninfected Cattle, Fh-Cathepsin (pg/ml) as antigen
F. hepatica F. gigantica
Antigen conc. B N PI P2 Antigen conc. B N PI P2
4 0.013 0.256 0.607 0.620 4 0.007 0.758 0.722 1.185
2 0.005 0.204 0.532 0.502 2 0.004 0.664 0.562 1.008
1 0.008 0.162 0.354 0.439 1 0.012 0.563 0.484 0.940
F. hepatica F. gigantica
Serum B N PI P2 Serum B N PI P2
100 0.069 0.198 0.741 0.512 100 0.042 0.578 0.912 0.857
200 0.049 0.109 0.562 0.457 200 0.035 0.511 0.803 0.749
400 0.035 0.099 0.279 0.31 400 0.041 0.365 0.451 0.384
800 0.022 0.072 0.221 0.124 800 0.025 0.219 0.354 0.325
1600 0.012 0.032 128 0.081 1600 0.033 0.102 0.234 0.241
3200 0.003 0.021 0.087 0.033 3200 0.054 0.088 0.142 0.149
F. hepatica F. gigantica
conj. B N PI P2 conj. B N PI P2
1000 0.029 0.287 0.807 0.605 1000 0.027 0.627 0.927 0.957
2000 0.013 0.176 0.477 0.367 2000 0.022 0.596 0.709 0.900
4000 0.011 0.103 0.358 0.205 4000 0.021 0.355 0.473 0.424
8000 0.009 0.067 0.199 0.154 8000 0.015 0.234 0.346 0.313
16000 0.06 0.037 0.108 0.063 16000 0.010 0.126 0.216 0.213
32000 0.003 0.028 0.062 0.046 32000 0.013 0.067 0.172 0.177
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Table 4.83 Titration for IgG2 showing the mean OD values obtained in F. hepatica
and F. gigantica infected and uninfected Cattle, Fh-Cathepsin (pg/ml) as antigen
F. hepatica F. gigantica
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.078 0.1 0.139 0.591 4 0.078 0.232 0.257 0.436
2 0.054 0.097 0.1 0.36 2 0.054 0.132 0.174 0.332
1 0.076 0.113 0.116 0.272 1 0.084 0.084 0.136 0.246
F. hepatica F. gigantica
Serum B N PI P2 Serum B N PI P2
50 0.051 0.074 0.137 0.658 50 0.044 0.112 0.285 0.735
100 0.03 0.035 0.055 0.171 100 0.031 0.042 0.104 0.208
200 0.018 0.018 0.032 0.126 200 0.018 0.032 0.048 0.071
400 0.019 0.008 0.021 0.061 400 0.018 0.028 0.029 0.038
800 0.014 0.009 0.016 0.039 800 0.010 0.010 0.018 0.018
1600 0.005 0.006 0.01 0.017 1600 0.009 0.005 0.014 0.011
F. hepatica F. gigantica
conj. B N PI P2 conj. B N PI P2
1000 0.084 0.171 0.330 1.034 1000 0.114 0.308 0.442 0.493
2000 0.041 0.088 0.194 0.709 2000 0.073 0.160 0.277 0.314
4000 0.035 0.057 0.114 0.330 4000 0.045 0.010 0.135 0.141
8000 0.025 0.032 0.062 0.191 8000 0.030 0.048 0.075 0.160
16000 0.024 0.021 0.340 0.103 16000 0.023 0.028 0.046 0.051
32000 0.015 0.019 0.270 0.061 32000 0.035 0.023 0.046 0.035
Table 4.84 Titration for IgA showing the mean OD values obtained in F. hepatica
and F. gigantica infected and uninfected Cattle, Fh-Cathepsin (pg/ml) as antigen
F. hepatica F. gigantica
Cathepsin B N PI P2 Cathepsin B N PI P2
4 0.037 0.160 0.214 0.180 4 0.070 0.108 0.325 0.151
2 0.028 0.037 0.303 0.100 2 0.028 0.037 0.290 0.111
1 0.032 0.023 0.255 0.058 1 0.009 0.023 0.255 0.106
F. hepatica F gigantica
Serum B N PI P2 Serum B N PI P2
50 0.034 0.044 0.385 0.109 50 0.034 0.044 0.325 0.193
100 0.029 0.025 0.203 0.156 100 0.029 0.035 0.187 0.156
200 0.030 0.022 0.167 0.070 200 0.024 0.026 0.081 0.119
400 0.024 0.028 0.088 0.024 400 0.019 0.017 0.041 0.089
800 0.011 0.015 0.024 0.014 800 0.014 0.008 0.024 0.065
1600 0.011 0.020 0.019 0.021 1600 0.009 0.001 0.029 0.054
F. hepatica F. gigantica
conj. B N PI P2 conj. B N PI P2
1000 0.034 0.044 0.185 0.090 1000 0.037 0.060 0.160 0.190
2000 0.029 0.025 0.103 0.056 2000 0.028 0.037 0.103 0.100
4000 0.030 0.040 0.067 0.035 4000 0.032 0.023 0.055 0.058
8000 0.024 0.028 0.038 0.024 8000 0.038 0.023 0.039 0.037
16000 0.011 0.015 0.024 0.014 16000 0.026 0.012 0.020 0.030




ADJUSTED OPTICAL DENSITY (450 ran) VALUES OF
F. HEPATICA INFECTED SHEEP AND CATTLE
Experiment One (1): Adjusted values for F. hepatica (British and
Peruvian strain) infected sheep (5, 6, 7, 9 and 10) and uninfected sheep (8)
Appendix Table 4.56
Adjusted total Ig values Adjusted IgGj values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH.5 SH.6 SH.7 SH.8 SH.9 SH. 10
-2 0.06 0.044 0.065 0.057 0.065 0.057 -2 0.005 0.032 0.027 0.032 0.001 0.027
-1 0.063 0.035 -0.014 0.082 0.039 0.04 -1 0.004 -0.001 0.011 -0.001 -0.01 0.018
0 0.09 0.039 -0.014 0.044 0.07 0.065 0 0.004 0.024 0.054 0.024 -0.005 0.043
1 0.073 0.127 0.025 0.063 0.604 0.379 1 0.006 0.056 0.062 0.056 0.46 0.378
2 0.372 0.48 0.068 0.082 0.472 0.549 2 0.152 0.73 0.067 0.027 0.677 0.473
3 0.463 0.656 0.228 0.038 0.611 0.432 3 0.499 0.564 0.223 0.011 0.606 0.622
4 0.514 0.597 0.324 0.032 0.628 0.421 4 0.629 0.844 0.424 0.054 0.597 0.624
5 0.554 0.746 0.441 0.001 0.78 0.581 5 0.66 0.984 0.505 0.062 0.643 0.62
6 0.665 0.72 0.681 0.051 0.768 0.74 6 0.7 1.009 0.68 0.067 0.667 0.667
7 0.739 0.824 0.759 -0.042 0.814 0.627 7 0.706 1.029 0.747 0.027 0.7 0.68
8 0.572 0.86 0.836 0.101 0.7 0.705 8 0.636 1.087 0.678 0.018 0.783 0.769
9 0.717 0.747 0.783 0.029 0.67 0.756 9 0.593 1.017 0.723 0.043 0.817 0.841
10 0.484 0.695 0.819 0.046 0.917 0.842 10 0.379 1.026 0.789 0.032 0.862 0.84
11 0.582 0.424 0.571 0.128 0.872 0.831 11 0.42 0.905 0.757 -0.001 0.893 0.899
12 0.634 0.67 0.643 0.04 0.806 0.713 12 0.344 0.558 0.394 0.024 0.894 0.83
13 0.76 0.699 0.096 0.742 0.587 13 0.283 0.433 0.056 0.902 0.875
14 0.694 0.628 0.046 0.689 0.505 14 0.253 0.497 0.027 0.898 0.888
15 0.67 0.481 0.027 0.851 0.521 15 0.64 0.347 0.011 0.896 0.843
16 0.634 0.587 0.092 0.881 0.58 16 0.483 0.256 0.054 0.939 0.861
17 0.688 0.509 0.093 0.788 0.623 17 0.718 0.311 0.062 0.871 0.692
Appendix Table 4.57
Adjusted IgG2 OD values Adjusted IgM OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.04 0.008 0.002 0.004 0.019 0.008 -2 -0.027 0.069 -0.062 -0.043 -0.029 0.058
-1 0.019 0.01 0 0.003 0.044 0.019 -1 -0.055 -0.031 -0.069 -0.049 0.014 0.034
0 0.018 0.018 0.01 0.005 0.014 0.028 0 -0.046 -0.06 -0.054 -0.029 0.004 0.123
1 0.025 0.03 0.008 0.004 0.028 0.013 1 0.009 -0.017 -0.032 0.002 0.038 0.072
2 0.03 0.111 0.01 0.007 0.033 0.01 2 0.109 0.027 0.251 0.023 0.08 0.325
3 0.037 0.072 0.103 0.004 0.051 0.015 3 0.223 0.074 0.154 0.01 0.237 0.172
4 0.056 0.086 0.136 0 0.036 0.021 4 0.089 0.149 0.266 0.029 0.185 0.366
5 0.078 0.105 0.111 0.002 0.077 0.033 5 0.185 0.194 0.268 -0.022 0.391 0.465
6 0.077 0.167 0.122 0.004 0.048 0.024 6 0.228 0.308 0.414 -0.043 0.439 0.182
7 0.066 0.069 0.144 0.006 0.024 0.052 7 0.213 0.345 0.428 -0.028 0.411 0.231
8 0.094 0.065 0.004 0.008 0.045 0.021 8 0.229 0.091 0.394 -0.034 0.282 0.582
9 0.103 0.055 0.006 -0.007 0.042 0.049 9 0.202 0.369 0.422 -0.017 0.528 0.371
10 0.057 0.056 0.019 0.004 0.033 0.033 10 0.043 0.385 0.347 -0.046 0.49 0.364
11 0.071 0.01 0.027 0.007 0.03 0.038 11 -0.002 0.423 0.398 -0.066 0.41 0.169
12 0.076 0.007 0.007 0.006 0.015 0.021 12 0.134 0.569 0.293 -0.009 0.475 0.428
13 0.03 0.008 0.003 0.036 0.044 13 0.305 0.218 -0.01 0.527 0.327
14 0.052 0.049 0.002 0.019 0.016 14 0.122 0.259 -0.046 0.18 0.232
15 0.02 0.027 0.004 0.048 0.033 15 0.113 0.114 0.014 0.252 0.18
16 0.01 0.032 0.008 0.038 0.02 16 0.198 0.194 -0.139 0.502 0.534




Adjusted IgA OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.036 0.067 0.048 0.084 0.031 0.005
-1 0.033 0.074 0.049 0.048 0.041 0.11
0 0.051 0.109 0.023 0.023 0.089 0.008
1 0.234 0.058 0.021 0.048 0.071 0.084
2 0.768 1.718 0.406 0.004 1.178 0.632
3 0.17 0.914 0.124 0.063 0.836 0.418
4 0.112 0.479 0.07 0.05 0.505 0.288
5 0.196 0.629 0.064 0.05 0.135 0.265
6 0.089 0.298 0.038 0.02 0.084 0.536
7 0.064 0.207 -0.005 0.053 0.158 0.031
8 0.066 0.386 0.006 0.111 0.217 0.031
9 0.07 0.297 -0.001 0.065 0.163 0.036
10 0.107 0.077 0.019 0.065 0.332 0.077
11 0.088 0.035 0.006 0.059 0.122 0.01
12 0.198 0.044 0.033 0.053 0.105 0.043
13 0.114 0.113 0.049 0.084 0.064
14 0.193 0.26 0.063 0.051 0.13
15 0.214 0.52 0.025 0.252 0.059
16 0.292 0.275 0.031 0.247 0.11
17 0.419 0.244 0.031 0.222 0.092
Experiment 2: Adjusted mean OD (450 nm) values for F. hepatica (British
strain) infected sheep (24, 26, 28 and 30) and uninfected sheep (22 and 32)
Appendix Table 4.59
Adjusted total Ig OD values Adjusted IgGj OD values
WPI SH24 SH26 SH28 SH30 SH22 SH32 WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32
-2 0.095 0.16 0.192 0.179 0.18 0.189 -2 0.037 0.048 0.026 0.027 0.023 0.03
0 0.074 0.158 0.2 0.162 0.246 0.246 0 0.032 0.052 0.054 0.005 0.017 0.024
2 0.191 0.125 0.211 0.173 0.198 0.204 2 0.029 0.046 0.016 -0.008 0.07 0.037
4 0.232 0.412 0.725 0.526 0.153 0.165 4 0.022 0.031 0.012 0.005 0.032 0.039
6 0.594 0.576 0.666 0.798 0.258 0.257 6 0.199 0.089 0.038 0.069 0.029 0.036
8 0.863 0.638 0.79 0.656 0.194 0.201 8 0.579 0.132 0.032 0.638 0.04 0.047
9 0.923 0.749 0.854 0.755 0.165 0.176 9 0.774 0.958 0.484 0.849 0.011 0.018
10 1.063 0.758 0.823 0.805 0.168 0.179 10 0.74 1.125 0.75 0.987 0.023 0.03
11 1.114 0.997 0.867 0.987 0.127 0.143 11 1.065 1.232 0.86 1.095 0.034 0.041
12 1.041 1.046 0.912 0.932 0.17 0.18 12 1.168 1.142 1.164 1.233 0.053 0.06
13 1.209 1.192 0.871 0.921 0.085 0.106 13 1.135 1.243 1.286 1.25 0.036 0.043
14 1.044 1.233 0.908 1.02 0.123 0.139 14 1.182 1.264 1.482 1.257 0.026 0.033
15 0.977 1.218 0.956 1.086 0.178 0.187 15 1.189 1.206 1.378 1.482 0.023 0.03
16 0.598 0.919 0.882 1.057 0.174 0.183 16 1.2 1.253 1.034 1.602 0.027 0.034
17 0.937 0.522 0.857 0.995 0.224 0.227 17 1.189 1.264 1.198 1.673 0.031 0.038
18 0.828 1.022 0.905 0.886 0.199 0.206 18 1.126 1.229 0.744 1.314 0.026 0.033
19 1.082 0.902 0.948 0.835 0.196 0.203 19 1.069 1.088 0.772 1.166 0.023 0.02
20 0.829 0.835 0.751 0.745 0.192 0.199 20 1.084 1.114 0.654 1.19 0.016 0.033
21 0.77 0.503 0.846 0.769 0.15 0.163 21 1.121 0.83 0.65 1.097 0.018 0.025




Adjusted IgM OD values Adjusted IgG2 OD Values
WPI SH.24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32 WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32
-2 0.129 0.17 0.096 0.124 0.124 0.093 -2 0.046 0.073 0.062 0.086 0.033 0.037
0 0.119 0.192 0.268 0.104 0.14 0.149 0 0.048 0.053 0.066 0.067 0.032 0.071
2 0.331 0.465 0.641 0.592 0.026 0.208 2 0.117 0.239 0.149 0.2 0.024 0.049
4 0.737 0.507 0.925 0.495 0.088 0.076 4 0.477 0.385 0.182 0.253 0.023 0.074
6 0.652 0.555 0.901 0.495 0.02 0.148 6 0.625 0.422 0.288 0.422 0.024 0.04
8 0.525 0.759 0.816 0.998 0.074 0.064 8 0.517 0.363 0.346 0.515 0.022 0.028
9 0.608 0.698 0.811 0.87 0.066 0.025 9 0.454 0.334 0.305 0.45 0.028 0.032
10 0.512 0.711 0.786 0.856 0.039 0.043 10 0.18 0.482 0.343 0.51 0.019 0.033
11 0.487 0.555 0.914 0.737 0.048 0.071 11 0.264 0.486 0.164 0.224 0.025 0.046
12 0.419 0.443 0.884 0.983 0.065 0.071 12 0.184 0.213 0.122 0.157 0.045 0.011
13 0.508 0.717 0.797 0.722 0.06 0.04 13 0.121 0.163 0.1 0.122 0.038 0.027
14 0.589 0.608 0.868 0.909 0.153 0.088 14 0.072 0.165 0.092 0.109 0.034 0.037
15 0.665 0.56 0.69 0.592 0.101 0.066 15 0.054 0.145 0.082 0.093 0.028 0.044
16 0.621 0.415 0.749 0.567 0.184 0.046 16 0.032 0.1 0.096 0.115 0.037 0.036
17 0.479 0.466 0.788 0.559 0.169 0.039 17 0.003 0.155 0.09 0.106 0.052 0.034
18 0.476 0.585 0.596 0.488 0.17 0.126 18 0.002 0.127 0.109 0.136 0.03 0.022
19 0.679 0.58 0.686 0.457 0.155 0.185 19 0.017 0.189 0.128 0.166 0.027 0.021
20 0.308 0.311 0.556 0.403 0.157 0.152 20 0.072 0.105 0.109 0.136 0.034 0.025
21 0.291 0.548 0.548 0.643 0.141 0.106 21 -0.011 0.218 0.062 0.061 0.022 0.023
22 0.208 0.49 0.59 0.445 0.156 0.1 22 0.001 0.153 0.084 0.096 0.039 0.017
Appendix Table 4.61
Adjusted IgA OD values
WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32
-2 -0.008 -0.021 -0.011 -0.005 -0.021 -0.012
0 0.016 -0.008 -0.009 -0.008 -0.035 -0.014
2 0.119 0.048 0.087 0.021 -0.019 -0.012















9 0.111 0.044 0.012 0.022 -0.015 -0.009
10 0.064 0.018 0.008 0.012 0 -0.014
11 0.088 0.031 -0.001 -0.004 0.011 -0.011
12 0.029 -0.001 0.023 -0.011 0.026 -0.016
13 0.146 0.063 0.036 -0.006 -0.01 -0.014
14 0.077 0.025 0.045 -0.005 -0.015 -0.011
15 0.127 0.052 0.06 -0.006 -0.013 -0.012
16 0.061 0.017 0.084 -0.002 -0.02 -0.014
17 0.1 0.038 0.171 0.009 -0.011 -0.008
18 0.117 0.047 0.218 0.052 -0.009 -0.011
19 0.171 0.076 0.301 0.098 -0.008 -0.006
20 0.436 0.219 0.288 0.055 0.001 -0.011
21 0.481 0.244 0.17 0.019 -0.009 -0.016
22 0.171 0.076 0.148 0.027 -0.004 -0.016
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Experiment three (3): Adjusted mean OD (450 nm) values for F.gigantica
(Kenyan strain) infected sheep and uninfected sheep
Appendix Table 4.62
Adjusted total Ig OD values
Infected sheep Uninfected Sheep
WPI SH.11 SH. 12 SH. 13 SH. 14 SH. 15 Mean SDEV SEM SH. 16 SH. 17 SH. 18 SH. 19 |Mean SDEV SEM
-2 0.150 0.149 0.135 0.149 0.130 0.143 0.01 0.004 0.142 0.157 0.150 0.133 0.146 0.010 0.005
-1 0.091 0.223 0.109 0.164 0.108 0.139 0.05 0.024 0.303 0.091 0.186 0.105 0.171 0.097 0.049
0 0.093 0.175 0.169 0.165 0.287 0.178 0.07 0.031 0.291 0.176 0.185 0.142 0.199 0.064 0.032
1 0.255 0.214 0.150 0.207 0.349 0.235 0.07 0.033 0.326 0.231 0.289 0.165 0.253 0.070 0.035
2 0.570 0.309 0.453 0.377 0.748 0.491 0.17 0.077 0.189 0.254 0.239 0.064 0.187 0.086 0.043
3 0.734 0.869 0.925 1.094 1.159 0.956 0.17 0.077 0.253 0.028 0.191 0.022 0.124 0.117 0.058
4 0.871 1.371 1.169 1.265 1.251 1.185 0.19 0.085 0.264 0.215 0.079 0.158 0.179 0.080 0.040
5 0.841 1.330 1.220 1.250 1.463 1.221 0.23 0.104 0.153 0.008 0.088 0.069 0.080 0.060 0.030
6 1.002 1.384 1.444 1.142 1.541 1.303 0.22 0.100 0.202 0.265 0.166 0.172 0.201 0.045 0.023
7 1.038 1.533 1.532 1.173 1.430 1.341 0.22 0.100 0.118 0.304 0.150 0.235 0.202 0.084 0.042
8 1.027 1.497 1.404 1.247 1.687 1.372 0.25 0.112 0.177 0.106 0.186 0.112 0.145 0.042 0.021
9 1.484 1.399 1.688 1.330 1.434 1.467 0.14 0.061 0.174 0.215 0.185 0.158 0.183 0.024 0.012
10 1.355 1.487 1.459 1.276 1.332 1.382 0.09 0.040 0.209 0.018 0.289 0.029 0.136 0.134 0.067
11 1.464 1.586 1.454 1.324 1.339 1.433 0.11 0.048 0.380 0.142 0.239 0.016 0.194 0.154 0.077
12 1.383 1.541 1.646 1.939 1.258 1.553 0.26 0.117 0.236 0.127 0.191 0.120 0.169 0.055 0.028
13 1.471 1.614 1.512 1.364 1.264 1.445 0.14 0.060 0.299 0.293 0.079 0.192 0.216 0.104 0.052
14 1.402 1.634 1.522 1.379 1.127 1.413 0.19 0.085 0.254 0.041 0.088 0.028 0.103 0.104 0.052
15 1.463 1.681 1.295 1.320 1.272 1.406 0.17 0.076 0.241 0.254 0.166 0.052 0.178 0.093 0.046
16 1.521 1.652 1.535 1.207 1.145 1.412 0.22 0.100 0.184 0.041 0.150 0.017 0.098 0.082 0.041
17 1.076 1.704 1.326 1.259 1.340 1.341 0.23 0.102 0.177 0.060 0.186 0.091 0.129 0.063 0.031
18 1.055 1.553 1.350 1.272 1.308 0.21 0.103 0.242 0.192 0.185 0.148 0.192 0.039 0.019
19 1.042 1.566 1.253 1.247 1.277 0.22 0.108 0.189 0.111 0.289 0.114 0.176 0.084 0.042
20 0.978 1.587 1.227 1.232 1.256 0.25 0.125 0.253 0.199 0.239 0.252 0.236 0.025 0.013
21 1.084 1.440 1.236 1.127 1.222 0.16 0.080 0.196 0.358 0.191 0.317 0.266 0.085 0.042
22 1.041 1.404 1.273 1.272 1.248 0.15 0.076 0.209 0.170 0.079 0.277 0.184 0.083 0.041
23 1.015 1.563 1.176 1.145 1.225 0.24 0.118 0.225 0.161 0.088 0.135 0.152 0.057 0.029
24 1.031 1.348 1.283 0.903 1.141 0.21 0.105 0.175 0.212 0.166 0.157 0.178 0.024 0.012
25 1.023 1.081 1.153 1.051 1.077 0.06 0.028 0.178 0.158 0.103 0.134 0.143 0.032 0.016
26 1.264 1.081 1.173 0.13 0.092 0.092 0.187 0.140 0.067 0.048
Appendix Table 4.63
Adjusted IgG! OD values
Infected sheep Uninfected Sheep
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean SDEV SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean SDEV SEM
-2 0.105 0.069 0.048 0.038 0.046 0.061 0.03 0.012 0.054 0.060 0.057 0.051 0.056 0.004 0.002
0 0.245 0.258 0.013 0.023 0.051 0.118 0.12 0.055 0.024 0.036 0.049 0.027 0.034 0.011 0.006
2 1.752 0.298 0.495 1.538 0.183 0.853 0.74 0.329 0.034 0.044 0.037 0.066 0.045 0.014 0.007
4 1.883 0.696 1.127 1.303 0.708 1.143 0.49 0.219 0.098 0.055 0.068 0.086 0.077 0.019 0.010
6 1.669 1.048 1.221 1.367 0.918 1.245 0.29 0.131 0.068 0.071 0.064 0.062 0.066 0.004 0.002
8 1.652 1.387 1.800 1.816 1.046 1.540 0.33 0.146 0.054 0.060 0.073 0.051 0.060 0.010 0.005
9 1.728 1.821 1.948 1.772 1.128 1.679 0.32 0.143 0.089 0.088 0.071 0.079 0.082 0.008 0.004
10 1.812 1.831 1.757 1.772 1.106 1.656 0.31 0.138 0.084 0.027 0.049 0.105 0.066 0.035 0.018
11 1.739 1.826 1.859 1.191 1.060 1.535 0.38 0.170 0.056 0.062 0.075 0.053 0.062 0.010 0.005
12 1.897 1.760 1.494 1.183 1.176 1.502 0.33 0.147 0.035 0.045 0.058 0.036 0.044 0.011 0.005
13 1.755 1.782 1.497 1.596 1.143 1.555 0.26 0.115 0.058 0.063 0.076 0.054 0.063 0.010 0.005
14 1.863 1.431 1.369 1.283 1.033 1.396 0.3C 0.135 0.040 0.049 0.062 0.040 0.048 0.010 0.005
15 1.795 1.408 1.142 0.931 1.319 0.37 0.186 0.029 0.040 0.053 0.031 0.038 0.011 0.005
16 1.796 1.492 0.867 0.769 1.231 0.49 0.247 0.035 0.035 0.048 0.026 0.036 0.009 0.005
17 1.668 1.043 0.704 0.851 1.066 0.42 0.212 0.026 0.028 0.041 0.029 0.031 0.007 0.003
18 1.519 1.206 0.571 0.570 0.966 0.48 0.237 0.031 0.022 0.035 0.043 0.033 0.009 0.004
19 1.451 1.117 0.434 0.533 0.884 0.48 0.242 0.020 0.046 0.068 0.018 0.038 0.024 0.012
20 1.128 1.007 0.495 0.546 0.794 0.32 0.160 0.038 0.027 0.040 0.024 0.032 0.008 0.004
21 1.172 0.722 0.490 0.585 0.742 0.30 0.151 0.051 0.015 0.069 0.026 0.040 0.024 0.012




Adjusted IgM OD values
Infected sheep Uninfected Sheep
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean SDEV SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean SDEV SEM
-2 0.106 0.050 0.048 0.078 0.043 0.065 0.03 0.012 0.045 0.102 0.041 0.049 0.059 0.029 0.014
0 0.051 0.075 0.054 0.066 0.024 0.054 0.02 0.009 0.056 0.118 0.058 0.051 0.071 0.032 0.016
2 0.258 0.193 0.226 0.228 0.306 0.242 0.04 0.019 0.013 0.003 0.077 0.021 0.029 0.033 0.017
4 0.287 0.090 0.227 0.317 0.236 0.231 0.09 0.039 0.019 0.023 0.062 0.014 0.030 0.022 0.011
6 0.278 0.322 0.446 0.342 0.174 0.312 0.10 0.044 0.019 0.064 0.062 0.010 0.039 0.028 0.014
8 0.294 0.203 0.348 0.267 0.191 0.261 0.07 0.029 0.074 0.087 0.084 0.063 0.077 0.011 0.005
9 0.287 0.142 0.319 0.450 0.202 0.280 0.12 0.053 0.044 0.046 0.040 0.043 0.043 0.003 0.001
10 0.241 0.133 0.338 0.225 0.364 0.260 0.09 0.042 0.026 0.033 0.037 0.058 0.039 0.014 0.007
11 0.260 0.104 0.346 0.318 0.339 0.273 0.10 0.045 0.026 0.030 0.013 0.086 0.039 0.032 0.016
12 0.354 0.114 0.282 0.530 0.276 0.311 0.15 0.067 0.005 0.069 0.065 0.071 0.053 0.032 0.016
13 0.324 0.225 0.268 0.534 0.383 0.347 0.12 0.054 0.068 0.054 0.048 0.071 0.060 0.011 0.006
14 0.376 0.317 0.291 0.492 0.308 0.357 0.08 0.037 0.060 0.068 0.064 0.054 0.062 0.006 0.003
15 0.405 0.269 0.528 0.256 0.365 0.13 0.064 0.075 0.075 0.041 0.138 0.082 0.041 0.020
16 0.346 0.221 0.464 0.251 0.321 0.11 0.055 0.068 0.035 0.040 0.060 0.051 0.016 0.008
17 0.337 0.234 0.444 0.205 0.305 0.11 0.054 0.039 0.073 0.080 0.056 0.062 0.018 0.009
18 0.326 0.180 0.282 0.223 0.253 0.06 0.032 0.036 0.035 0.028 0.063 0.041 0.015 0.008
19 0.283 0.218 0.366 0.199 0.267 0.08 0.038 0.042 0.044 0.037 0.053 0.044 0.007 0.003
20 0.182 0.170 0.323 0.194 0.217 0.07 0.036 0.045 0.024 0.125 0.082 0.069 0.044 0.022
21 0.295 0.117 0.195 0.095 0.176 0.09 0.045 0.071 0.084 0.080 0.062 0.074 0.010 0.005
22 0.126 0.100 0.231 0.318 0.194 0.10 0.050 0.012 0.002 0.076 0.021 0.028 0.033 0.017
Appendix Table 4.65
Adjusted IgG2 OD values
Infected sheep Uninfected Sheep
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean SDEV SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean SDEV SEM
-2 0.032 0.032 0.034 0.036 0.036 0.034 0.002 0.001 0.034 0.038 0.043 0.032 0.037 0.005 0.002
0 0.045 0.031 0.036 0.023 0.043 0.036 0.009 0.004 0.019 0.026 0.028 0.014 0.022 0.006 0.003
2 0.027 0.032 0.038 0.029 0.004 0.026 0.013 0.006 0.035 0.038 0.044 0.034 0.038 0.005 0.002
4 0.034 0.025 0.033 0.031 0.018 0.028 0.007 0.003 0.021 0.028 0.030 0.017 0.024 0.006 0.003
6 0.040 0.020 0.022 0.034 0.032 0.030 0.008 0.004 0.011 0.020 0.020 0.005 0.014 0.007 0.004
8 0.026 0.032 0.042 0.044 0.002 0.029 0.017 0.008 0.049 0.049 0.058 0.050 0.052 0.004 0.002
9 0.033 0.016 0.017 0.031 0.016 0.023 0.009 0.004 0.055 0.053 0.064 0.058 0.058 0.005 0.002
10 0.034 0.007 0.028 0.023 0.020 0.022 0.010 0.005 0.009 0.019 0.018 0.002 0.012 0.008 0.004
11 0.030 0.018 0.019 0.032 0.009 0.022 0.009 0.004 0.016 0.024 0.025 0.011 0.019 0.007 0.003
12 0.052 0.012 0.027 0.027 0.059 0.035 0.020 0.009 0.008 0.018 0.017 0.001 0.011 0.008 0.004
13 0.047 0.032 0.016 0.020 0.049 0.033 0.015 0.U07 0.012 0.021 0.021 0.006 0.015 0.007 0.004
14 0.052 0.027 0.017 0.023 0.059 0.036 0.019 0.008 0.014 0.023 0.023 0.008 0.017 0.007 0.004
15 0.028 0.012 0.012 0.005 0.014 0.010 0.005 0.003 0.014 0.012 0.019 0.012 0.007 0.003
16 0.031 0.021 0.012 0.013 0.019 0.009 0.004 0.025 0.031 0.034 0.022 0.028 0.005 0.003
17 0.062 0.025 0.023 0.081 0.048 0.029 0.014 0.031 0.035 0.040 0.029 0.034 0.005 0.002
18 0.042 0.016 0.031 0.036 0.031 0.011 0.006 0.046 0.047 0.055 0.047 0.049 0.004 0.002
19 0.033 0.018 0.010 0.016 0.019 0.010 0.005 0.030 0.035 0.039 0.028 0.033 0.005 0.002
20 0.031 0.005 0.022 0.013 0.018 0.011 0.006 0.061 0.058 0.070 0.065 0.064 0.005 0.003
21 0.027 0.019 0.018 0.004 0.017 0.010 0.005 0.036 0.039 0.045 0.035 0.039 0.005 0.002




Adjusted IgA OD values
Infected sheep Uninfected Sheep
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean SDEV SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean SDEV SEM
-2 0.030 0.030 0.034 0.033 0.031 0.032 0.002 0.001 0.024 0.023 0.035 0.027 0.027 0.005 0.003
0 0.037 0.041 0.031 0.038 0.040 0.037 0.004 0.002 0.047 0.046 0.058 0.050 0.050 0.005 0.003
2 0.045 0.050 0.043 0.045 0.047 0.046 0.003 0.001 0.036 0.035 0.047 0.039 0.039 0.005 0.003
4 0.060 0.044 0.029 0.057 0.042 0.046 0.013 0.006 0.034 0.033 0.045 0.037 0.037 0.005 0.003
6 0.081 0.043 0.020 0.074 0.041 0.052 0.025 0.011 0.049 0.048 0.060 0.052 0.052 0.005 0.003
8 0.045 0.038 0.025 0.045 0.037 0.038 0.008 0.004 0.039 0.038 0.050 0.042 0.042 0.005 0.003
9 0.049 0.033 0.039 0.048 0.033 0.040 0.008 0.003 0.023 0.022 0.034 0.026 0.026 0.005 0.003
10 0.028 0.035 0.033 0.031 0.035 0.032 0.003 0.001 0.046 0.045 0.057 0.049 0.049 0.005 0.003
11 0.031 0.033 0.027 0.034 0.033 0.032 0.003 0.001 0.048 0.047 0.059 0.051 0.051 0.005 0.003
12 0.034 0.043 0.029 0.036 0.041 0.037 0.006 0.003 0.034 0.033 0.045 0.037 0.037 0.005 0.003
13 0.031 0.031 0.025 0.034 0.032 0.031 0.003 0.002 0.020 0.019 0.031 0.023 0.023 0.005 0.003
14 0.030 0.038 0.039 0.033 0.037 0.035 0.004 0.002 0.034 0.033 0.045 0.037 0.037 0.005 0.003
15 0.028 0.031 0.031 0.032 0.031 0.002 0 001 0.020 0.019 0.031 0.023 0.023 0.005 0.003
16 0.035 0.029 0.037 0.030 0.033 0.004 0.002 0.029 0.028 0.040 0.032 0.032 0.005 0.003
17 0.023 0.034 0.027 0.034 0.030 0.005 0.003 0.017 0.016 0.028 0.020 0.020 0.005 0.003
18 0.021 0.031 0.026 0.032 0.028 0.005 0.003 0.036 0.035 0.047 0.039 0.039 0.005 0.003
19 0.024 0.025 0.028 0.027 0.026 0.002 0.001 0.026 0.025 0.037 0.029 0.029 0.005 0.003
20 0.030 0.026 0.033 0.028 0.029 0.003 0.001 0.027 0.026 0.038 0.030 0.030 0.005 0.003
21 0.030 0.031 0.033 0.032 0.032 0.001 0.001 0.029 0.048 0.040 0.032 0.037 0.009 0.004
22 0.038 0.024 0.039 0.026 0.032 0.008 0.004 0.039 0.048 0.050 0.032 0.042 0.008 0.004
Experiment 4: Adjusted mean OD (450 nra) values for F. gigantica (Kenyan
strain) infected sheep (23, 25, 27 and 29) and uninfected sheep (21 and 31)
Appendix Table 4.67
Adjusted total Ig OD values AdjustedlgG, OD values
WPI SH.27 SH. 29 SH. 23 SH. 25 SH. 21 SH. 31 WPI SH. 21 SH. 23 SH. 25 SH. 27 SH. 29 SH. 31
-2 0.205 0.205 0.201 0.211 0.209 0.207 -2 0.026 0.017 0.016 0.015 0.105 0.018
-1 0.175 0.242 0.046 0.252 0.226 0.224 0 0.019 0.091 0.024 0.021 0.115 0.023
0 0.252 0.194 0.209 0.374 0.162 0.157 2 0.025 0.107 0.179 0.179 0.02 0.004
1 0.237 0.324 0.246 0.424 0.148 0.142 4 0.018 0.395 0.734 0.809 0.96 0.033
2 0.167 0.335 0.268 0.257 0.044 0.031 6 0.02 0.602 0.828 1.061 1.329 0.029
3 0.323 0.456 0.656 0.204 0.252 0.252 8 0.021 0.801 0.869 1.215 1.23 0.018
4 0.522 0.69 0.816 0.527 0.208 0.206 9 0.018 1.056 0.805 1.313 1.366 0.019
5 0.535 0.63 0.854 0.725 0.123 0.115 10 0.019 1.062 1.071 1.287 1.386 0.006
6 0.537 0.69 0.84 0.782 0.182 0.178 11 0.013 1.059 1.01 1.232 1.063 0.02
7 0.552 0.785 0.905 0.808 0.15 0.144 12 0.02 1.02 0.805 1.371 0.729 0.003
8 0.723 0.841 1.115 0.863 0.267 0.268 13 0.021 1.034 0.955 1.331 0.469 0.021
9 0.725 0.87 1.072 1.023 0.232 0.231 14 0.034 0.827 0.811 1.199 0.626 0.007
10 0.74 0.855 1.084 1.067 0.117 0.234 15 0.038 0.813 0.945 1.077 0.873 0.018
11 0.717 0.858 1.132 0.999 0.125 0.118 16 0.025 1.124 0.882 0.972 0.013
12 0.782 0.996 1.124 0.946 0.166 0.161 17 0.021 0.981 0.812 0.026
13 0.793 0.937 1.217 0.934 0.196 0.193 18 0.03 0.644 0.392 0.02
14 0.728 0.913 1.196 1.109 0.232 0.231 19 0.035 0.599 0.543 0.005
15 0.78 0.912 1.147 1.046 0.292 0.295 20 0.041 0.615 0.41 0.025
16 0.703 0.907 0.997 0.248 0.248 21 0.029 0.662 0.297 0.013
17 0.758 0.85 0.946 0.161 0.155 22 0.028 0.612 0.162 0.004
18 0.747 0.787 0.153 0.167
19 0.772 0.842 0.212 0.078
20 0.734 0.82 0.18 0.188
21 0.683 0.776 0.297 0.142




Adjusted IgM OD values Adjusted IgG2 OD values
WPI SH. 21 SH. 23 SH. 25 SH. 27 SH. 29 SH. 31 WPI SH. 21 SH. 23 SH. 25 SH. 27 SH. 29 SH. 31
-2 0.152 0.108 0.131 0.178 0.142 0.103 -2 0.033 0.037 0.029 0.042 0.032 0.038
0 0.134 0.101 0.116 0.166 0.112 0.112 0 0.027 0.025 0.01 0.024 0.02 0.034
2 0.114 0.121 0.118 0.433 0.376 0.085 2 0.03 0.038 0.022 0.035 0.033 0.036
4 0.11 0.515 0.453 0.511 0.506 0.133 4 0.026 0.026 0.029 0.042 0.022 0.033
6 0.064 0.297 0.383 0.357 0.666 0.088 6 0.023 0.018 0.001 0.014 0.014 0.03
8 0.09 0.293 0.395 0.306 0.4 0.076 8 0.028 0.049 0.004 0.018 0.044 0.034
9 0.11 0.426 0.414 0.409 0.499 0.046 9 0.027 0.054 0.002 0.016 0.049 0.034
10 0.09 0.417 0.756 0.37 0.671 0.03 10 0.029 0.017 0.01 0.023 0.012 0.035
11 0.082 0.304 0.511 0.39 0.459 0.079 11 0.029 0.022 0.01 0.023 0.018 0.035
12 0.134 0.325 0.34 0.399 0.515 0.028 12 0.019 0.016 0.011 0.025 0.011 0.027
13 0.136 0.332 0.39 0.556 0.448 0.107 13 0.033 0.019 0.02 0.034 0.014 0.038
14 0.066 0.384 0.4 0.624 0.655 0.13 14 0.027 0.021 0.014 0.028 0.016 0.034
15 0.05 0.466 0.534 0.642 0.547 0.142 15 0.017 0.012 0.009 0.022 0.007 0.026
16 0.136 0.445 0.538 0.918 0.07 16 0.019 0.03 0.01 0.024 0.025 0.027
17 0.138 0.573 0.47 0.122 17 0.021 0.034 0.014 0.027 0.03 0.029
18 0.074 0.455 0.347 0.058 18 0.023 0.046 0.006 0.02 0.042 0.03
19 0.13 0.419 0.432 0.169 19 0.037 0.034 0.005 0.018 0.029 0.042
20 0.054 0.409 0.326 0.12 20 0.026 0.058 0.01 0.024 0.054 0.033
21 0.04 0.298 0.205 0.049 21 0.02 0.038 0.002 0.016 0.034 0.028
22 0.158 0.231 0.167 0.113 22 0.033 0.035 -0.009 0.005 0.03 0.038
Appendix Table 4.69
Adjusted IgA OD values
WPI SH. 21 SH. 23 SH. 25 SH. 27 SH. 29 SH. 31
-2 0.024 0.03 0.034 0.003 0.127 0.035
0 0.047 0.069 0.054 0.042 0.166 0.058
2 0.036 0.067 0.083 0.04 0.164 0.047
4 0.034 0.072 0.114 0.045 0.169 0.045
6 0.049 0.758 0.278 0.731 0.855 0.06
8 0.039 0.273 0.405 0.246 0.37 0.05
9 0.023 0.243 0.593 0.216 0.34 0.034
10 0.046 0.151 0.691 0.124 0.248 0.057
11 0.048 0.113 0.061 0.086 0.21 0.059
12 0.034 0.086 0.128 0.059 0.183 0.045
13 0.02 0.11 0.244 0.083 0.207 0.031
14 0.034 0.093 0.224 0.066 0.19 0.045
15 0.02 0.273 0.27 0.246 0.37 0.031
16 0.029 0.4 0.373 0.257 0.04
17 0.017 0.284 0.238 0.028
18 0.036 0.264 0.295 0.047
19 0.026 0.31 0.284 0.037
20 0.027 0.47 0.187 0.038
21 0.049 0.294 0.318 0.06
22 0.049 0.31 0.434 0.06
427
Experiment 5 and 6: Calves (14c, 15c, 23c, 34c and 45c) infected with
F. hepatica and uninfected calf (26c) and F. gigantica infected
calves (22,23 and 24) and uninfected calf (26)
Adjusted mean OD (450 rnn) values in response to Fh-E/S and Fh-E/S
Appendix Table 4.70
Adjusted total Ig OD values
F. hepatica F. Gigntica
WPI 14c 15c 23c 26c 34c 45c WPI calf 22 calf 23 calf 24 calf 26
-27 0.012 0.037 0.081 0.081 0 0.013 -0.007 0.011 -0.001
-26 0.030 0.010 0.078 0.043 l 0.024 -0.019 -0.021 -0.033
-25 0.022 0.016 0.012 0.026 2 0.087 0.085 0.097 0.009
-24 C.039 0.003 0.012 0.020 3 0.034 0.092 0.063 0.035
-23 0.081 0.011 0.033 0.026 4 0.103 0.149 0.292 -0.079
-22 0.171 -0.075 0.006 -0.017 5 0.426 0.606 0.734 -0.125
-21 0.396 0.422 -0.007 -0.005 6 0.791 0.766 0.785 0.028
-20 0.592 0.496 -0.012 -0.004 7 0.897 0.741 1.055 -0.073
-19 0.717 1.221 -0.023 -0.025 8 1.014 0.697 0.942 0.043
-18 1.008 0.980 -0.020 -0.017 9 0.997 0.684 1.130 0.114
-17 1.012 1.645 0.005 -0.001 10 0.915 0.979 0.995 -0.025
-16 1.358 1.243 -0.001 0.004 11 1.032 0.940 0.800 0.028
-15 0.816 0.965 0.026 0.038 12 0.906 0.728 0.969 -0.118
-14 0.691 1.409 0.060 0.020 13 0.941 0.848 1.013 -0.133
-13 0.593 1.458 0.046 0.019 14 0.811 0.939 1.160 -0.015
-12 0.571 1.259 -0.005 0.003 15 0.807 0.995 0.997 0.065
-11 0.560 0.754 0.399 0.001 16 1.006 0.963 1.111 -0.119
-10 0.818 0.660 0.961 -0.017 17 1.008 1.016 0.982 -0.154
-9 0.887 1.284 1.052 -0.016 18 0.996 1.035 1.086 -0.131
-8 1.088 1.131 0.957 -0.018 19 0.980 0.856 1.186 -0.048
-7 1.232 1.079 1.199 -0.009 20 0.842 0.832 1.088 0.016
-6 1.046 1.179 1.285 0.021 21 0.914 0.955 1.116 -0.023
-5 1.369 1.121 1.190 0.035 22 0.844 0.937 0.935 0.133
-4 1.192 1.217 1.161 0.053 23 0.970 0.974 0.971 0.205
-3 1.140 1.269 1.173 0.014 24 0.933 1.066 1.226 0.160
-2 1.150 1.538 1.095 0.014 25 0.824 1.150 0.883 0.001
-1 0.956 1.557 1.169 0.023 0.066 0.007 26 0.914 1.104 1.056 0.026
0 0.998 1.652 1.177 0.053 0.093 0.087 27 0.736 1.005 1.011 0.000
1 0.984 1.427 1.148 0.015 0.193 0.183 28 0.889 0.991 0.891 0.060
2 0.932 1.647 1.039 0.070 0.242 0.198 29 0.906 1.075 1.071 0.096
3 0.958 1.646 1.235 0.038 0.306 0.140 30 0.870 0.993 0.944 0.095
4 1.195 1.680 1.067 0.014 0.385 0.368 31 0.788 1.112 1.063 0.199
5 1.164 1.688 1.004 0.006 0.479 0.948 32 0.935 1.107 0.986 0.149
6 1.398 1.759 0.857 0.017 0.949 1.066 33 0.936 1.098 0.969 0.101
7 1.261 1.706 0.743 0.841 1.402 34 0.825 1.113 1.018 -0.011
8 1.062 1.677 0.982 1.699 1.504 0.709 1.143 1.256 -0.003
9 1.132 1.679 0.645 0.657 1.079 0.672 0.076
10 0.995 1.465 0.891 1.480 1.135




Adjusted IgGt OD values
F. hepatica F. Gigntica
WPI 14c 15c 23c 26c 34c 45c WPI calf 22 calf 23 calf 24 calf 26
-27 0.146 -0.009 0.140 0.030 -2 0.088 0.076 0.056 0.074
-26 0.024 0.088 0.111 0.007 -1 -0.04 0.006 0.004 0.005
-25 0.024 0.007 0.085 0.011 0 -0.04 -0.023 -0.028 0.032
-24 0.028 -0.077 0.031 -0.013 1 0.00 0.156 0.024 0.115
-23 0.053 -0.039 0.004 0.024 2 -0.02 0.128 -0.223 -0.024
-22 0.067 0.071 -0.036 -0.046 3 0.37 0.292 0.573 0.082
-21 0.274 0.608 -0.014 -0.082 4 0.591 0.835 0.800 0.056
-20 0.739 1.014 -0.030 -0.104 5 0.557 0.830 0.800 0.120
-19 0.968 1.223 -0.040 -0.064 6 0.598 0.746 0.518 0.074
-18 1.185 1.326 -0.061 -0.107 7 0.536 0.695 0.661 0.052
-17 1.319 1.404 -0.018 -0.054 8 0.650 0.811 0.789 0.108
-16 1.269 1.290 0.225 -0.062 9 0.627 0.807 0.741 0.098
-15 1.302 1.324 0.185 -0.084 10 0.453 0.737 0.616 -0.014
-14 1.327 1.404 0.284 -0.084 11 0.369 0.789 0.700 0.128
-13 1.211 1.447 0.404 -0.055 12 0.320 0.700 0.707 0.037
-12 1.211 1.069 0.933 -0.069 13 0.656 0.988 0.695 0.100
-11 1.090 1.103 1.036 -0.082 14 0.732 0.986 0.825 0.083
-10 1.031 1.076 1.159 0.019 15 0.647 0.801 0.798 0.065
-9 1.237 1.234 1.185 -0.036 16 0.641 0.746 0.932 0.075
-8 1.109 1.207 1.254 -0.028 17 0.501 0.754 1.030 0.109
-7 1.369 1.139 1.259 0.004 18 0.454 0.928 0.522 0.116
-6 1.287 1.297 1.264 0.005 19 0.643 0.826 0.620 0.088
-5 1.299 1.248 1.251 -0.054 20 0.479 0.607 0.664 0.111
A 1.305 1.207 1.266 -0.007 21 0.665 0.683 0.785 0.074
-3 1.324 1.213 1.304 0.011 22 0.492 0.890 0.729 0.103
-2 1.287 1.077 1.269 0.009 23 0.622 0.991 0.395 0.014
-1 1.170 1.220 1.161 0.061 24 0.536 1.037 0.434 0.102
0 1.046 0.985 1.268 -0.014 0.033 0.127 25 0.491 0.873 0.437 0.074
1 1.232 1.284 1.143 -0.036 0.400 0.609 26 0.467 0.743 0.451 0.154
2 1.206 1.482 1.123 0.003 0.782 0.784 27 0.584 0.692 0.493 0.099
3 1.108 1.484 1.226 -0.035 0.698 0.494 28 0.456 1.141 0.214 0.104
4 1.030 1.508 1.278 0.013 0.637 0.453 29 0.503 0.904 0.226 0.004
5 1.097 1.488 1.131 -0.032 0.833 0.876 30 0.582 0.917 0.517 -0.025
6 0.967 1.533 1.059 -0.069 1.080 1.275 31 0.553 0.833 0.310 0.086
7 1.287 1.539 1.169 1.377 1.503 32 0.454 0.771 0.223 0.126
8 1.160 1.548 0.969 1.374 1.451 33 0.447 0.826 0.164 0.074
9 0.995 1.533 1.100 1.525 1.473
10 0.959 1.487 1.159 1.479 1.594
11 1.007 1.501 1.021 1.475 1.584




Adjusted IgM OD values values
F. hepatica F. Gigntica
WPI 14c 15c 23 c 26c 34c 45c WPI calf22 calf 23 calf 24 calf 26
-27 0.045 0.032 0.018 0.038 -2 0.040 0.088 0.080 0.051
-26 0.132 -0.01 0.013 0.005 -1 0.020 -0.074 0.002 0.042
-25 0.177 -0.01 0.098 0.014 0 0.061 0.054 0.122 0.048
-24 0.097 0.065 0.137 -0.020 1 0.111 -0.031 0.050 0.132
-23 0.895 0.566 0.052 0.020 2 0.051 0.240 0.256 0.047
-22 1.104 0.681 0.129 -0.058 3 0.370 0.610 0.273 -0.003
-21 1.165 0.670 0.104 -0.105 4 0.495 0.504 0.467 0.055
-20 1.068 0.522 0.054 -0.139 5 0.286 0.515 0.319 0.070
-19 0.561 0.996 0.017 -0.083 6 0.331 0.568 0.243 0.011
-18 0.543 0.759 0.077 -0.140 7 0.126 0.336 0.030 0.066
-17 0.734 0.739 0.123 -0.064 8 0.102 0.427 0.005 0.039
-16 0.531 0.741 0.098 -0.080 9 0.323 0.583 0.141 -0.048
-15 0.668 0.913 0.137 -0.106 10 0.383 0.548 0.167 0.084
-14 0.415 0.650 0.373 -0.111 11 0.624 0.517 0.533 0.005
-13 0.483 0.592 1.266 -0.073 12 0.622 0.512 0.543 0.034
-12 0.402 0.807 1.237 -0.096 13 0.442 0.327 0.549 -0.067
-11 0.538 1.314 0.852 -0.121 14 0.462 0.408 0.590 -0.013
-10 0.635 0.932 0.628 0.010 15 0.289 0.341 0.480 0.057
-9 0.818 0.815 0.569 -0.056 16 0.176 0.522 0.621 0.059
-8 0.837 1.165 0.740 -0.024 17 0.266 0.440 0.762 0.015
-7 0.965 0.818 0.588 0.004 18 0.400 0.336 0.585 0.000
-6 0.817 0.755 0.526 0.004 19 0.461 0.320 0.780 -0.018
-5 0.779 0.657 0.427 -0.070 20 0.156 0.284 0.788 0.060
A 0.777 0.539 0.468 -0.005 21 0.222 0.415 0.641 0.049
-3 0.678 0.930 0.652 0.011 22 0.113 0.707 0.484 0.044
-2 0.176 0.716 0.631 0.005 23 0.304 0.435 0.546 0.007
-1 0.746 0.614 0.572 0.071 24 0.284 0.361 0.760 0.001
0 0.672 0.640 0.788 -0.024 0.050 0.017 25 0.207 0.435 0.541 0.098
1 0.779 0.446 0.500 -0.053 0.250 0.059 26 0.061 0.381 0.653 -0.008
2 0.470 0.507 0.688 0.004 0.293 0.235 27 0.186 0.363 0.561 0.016
3 0.708 0.487 0.712 -0.050 0.277 0.289 28 0.245 0.050 0.507 0.030
4 0.580 0.562 0.775 0.015 0.452 0.293 29 0.135 0.177 0.572 0.035
5 0.738 0.462 0.752 -0.046 0.551 0.685 30 0.273 0.269 0.534 0.045
6 0.550 0.334 0.844 -0.093 0.911 0.950 31 0.098 0.295 0.483 0.063
7 0.651 0.441 0.871 0.689 1.306 32 0.069 0.010 0.428 -0.040
8 0.670 0.542 0.718 0.706 1.120 33 0.129 0.247 0.534 0.036
9 0.586 0.408 0.695 0.659 0.792
10 0.639 0.578 0.630 0.572 0.838
11 0.838 0.528 0.561 0.637 0.850




Adjusted IgG2 OD values
F. hepatica F gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI calf 22 calf 23 calf24 calf 26
-27 0.020 0.009 0.019 0.017 -2 0.010 0.052 0.005 0.012
-26 0.022 0.014 0.023 0.020 -1 0.007 0.037 0.007 0.023
-25 0.025 0.024 0.037 0.020 0 0.049 0.079 0.013 0.036
-24 0.029 0.016 0.042 0.029 1 0.105 0.091 0.028 0.026
-23 0.025 0.009 0.033 0.017 2 0.006 0.147 0.009 -0.081
-22 -0.01 -0.012 0.012 -0.014 3 0.00 0.070 0.029 0.042
-21 0.00 0.028 -0.003 -0.011 4 0.042 0.085 0.104 0.083
-20 0.011 0.074 -0.001 -0.017 5 0.026 0.040 0.166 0.070
-19 0.024 0.128 0.011 -0.011 6 0.078 0.101 0.225 0.019
-18 0.069 0.195 0.001 -0.002 7 0.087 0.048 0.270 0.004
-17 0.086 0.646 0.035 0.033 8 0.153 0.104 0.226 0.045
-16 0.189 0.593 0.041 0.029 9 0.131 0.087 0.221 0.056
-15 0.144 0.117 0.034 0.032 10 0.076 0.419 0.186 0.055
-14 0.575 0.419 0.032 0.024 11 0.046 0.412 0.222 0.036
-13 0.159 0.382 0.042 0.025 12 0.047 0.489 0.094 0.025
-12 0.118 0.407 0.120 -0.005 13 0.092 0.247 0.231 0.035
-11 0.078 0.315 0.271 -0.006 14 0.222 0.129 0.313 0.064
-10 0.094 0.462 0.351 -0.009 15 0.204 0.392 0.273 0.040
-9 0.223 0.723 0.378 -0.002 16 0.189 0.312 0.304 0.023
-8 0.465 0.481 0.475 -0.003 17 0.168 0.476 0.005 -0.010
-7 0.828 0.546 0.617 0.020 18 0.143 0.343 0.229 -0.009
-6 0.795 0.771 0.745 0.025 19 0.138 0.254 0.251 0.041
-5 0.891 0.977 0.647 0.019 20 0.139 0.350 0.209 0.023
-4 0.963 0.905 0.745 0.036 21 0.227 0.334 0.236 0.028
-3 0.997 1.092 0.580 0.056 22 0.147 0.467 0.325 0.000
-2 0.844 1.302 0.512 0.053 23 0.242 0.407 0.181 0.024
-1 1.175 1.354 0.487 0.052 24 0.221 0.562 0.290 0.037
0 1.004 1.474 0.805 0.046 0.014 0.012 25 0.151 0.489 0.239 0.053
1 1.050 1.555 0.667 0.041 0.017 0.027 26 0.137 0.445 0.277 0.001
2 0.910 1.452 0.703 0.057 0.035 0.043 27 0.174 0.595 0.332 0.030
3 0.992 1.288 0.493 0.039 0.050 0.041 28 0.162 0.702 0.287 0.025
4 0.907 1.453 0.661 0.045 0.061 0.026 29 0.130 0.508 0.316 0.072
5 1.133 1.409 0.634 0.040 0.067 0.817 30 0.168 0.876 0.315 0.026
6 0.942 1.212 0.646 0.024 0.111 0.057 31 0.168 0.600 0.313 0.052
7 0.848 0.992 0.821 0.230 0.164 32 0.128 0.782 0.297 0.013
8 1.018 1.139 1.354 0.580 0.312 33 0.093 0.765 0.301 0.002
9 0.906 1.080 1.352 0.867 0.409
10 0.835 1.022 1.207 0.622 0.419
11 0.915 0.882 1.418 0.778 0.479




Adjusted IgA Values values
F. hepatica F. Gigntica
WPI 14c 15c 23 c 26c 34c 45c WPI calf 22 calf 23 calf 24 calf 26
-27 0.010 0.029 -0.040 0.017 -2 0.049 0.042 -0.012 0.018
-26 0.007 0.027 -0.018 0.008 -1 0.018 0.012 -0.006 0.008
-25 0.009 0.033 0.020 0.019 0 0.098 0.089 -0.010 0.038
-24 0.003 0.027 0.024 0.020 1 0.056 0.048 0.009 0.043
-23 0.028 0.055 -0.015 0.047 2 0.044 0.037 -0.006 0.057
-22 0.073 0.048 -0.061 0.000 3 0.074 0.066 0.053 0.031
-21 0.059 0.029 -0.064 0.012 4 0.074 0.066 0.084 0.026
-20 0.031 0.049 -0.049 -0.004 5 0.025 0.018 0.046 0.019
-19 -0.006 0.102 -0.058 0.005 6 0.021 0.014 0.025 0.025
-18 0.017 0.086 -0.039 -0.001 7 0.033 0.026 0.008 0.036
-17 0.064 0.087 0.011 0.031 8 0.039 0.032 0.009 0.030
-16 0.041 0.098 0.013 0.038 9 0.037 0.030 0.023 0.026
-15 0.030 0.124 0.006 0.023 10 0.022 0.015 -0.007 0.032
-14 0.046 0.106 0.005 0.027 11 0.062 0.054 0.001 0.011
-13 0.035 0.124 0.381 0.007 12 0.088 0.079 0.021 0.050
-12 0.017 0.066 0.483 0.010 13 0.034 0.027 0.049 0.019
-11 0.040 0.172 0.248 0.003 14 0.008 0.002 0.039 0.033
-10 0.120 0.079 0.098 -0.005 15 0.00 -0.009 0.029 0.048
-9 0.275 0.139 0.045 0.009 16 -0.01 -0.017 0.012 0.045
-8 0.402 0.168 0.090 0.005 17 0.034 0.027 0.015 0.035
-7 0.505 0.106 0.088 0.014 18 0.032 0.025 0.021 0.032
-6 0.271 0.121 0.090 0.013 19 0.051 0.043 0.054 0.017
-5 0.336 0.193 0.070 0.016 20 0.065 0.057 0.010 0.018
-4 0.315 0.257 0.059 0.019 21 0.245 0.231 0.043 0.017
-3 0.153 0.336 0.093 0.033 22 0.580 0.554 0.039 0.034
-2 0.445 0.371 0.054 0.028 23 0.344 0.327 0.101 0.050
-1 0.482 0.355 0.041 0.024 24 0.240 0.226 0.128 0.053
0 0.388 0.350 0.046 0.023 0.011 0.021 25 0.196 0.184 0.243 0.018
1 0.408 0.301 0.035 0.020 0.029 0.019 26 0.130 0.120 0.568 0.033
2 0.527 0.275 0.049 0.018 0.054 0.025 27 0.419 0.399 0.432 0.038
3 0.487 0.411 0.080 0.026 0.051 0.059 28 0.335 0.318 0.474 0.044
4 0.768 0.415 0.170 0.030 0.057 0.046 29 0.357 0.339 0.208 0.044
5 0.647 0.309 0.216 0.039 0.115 0.105 30 0.298 0.282 0.486 0.041
6 0.787 0.133 0.149 0.033 0.143 0.093 31 0.380 0.361 0.473 0.026
7 0.677 0.104 0.224 0.098 0.088 32 0.600 0.574 0.657 0.030
8 0.229 0.108 0.286 0.119 0.097 33 0.434 0.413 0.620 0.029
9 0.247 0.098 0.373 0.083 0.094
10 0.247 0.212 0.445 0.156 0.123
11 0.486 0.120 0.380 0.116 0.097
12 0.441 0.097 0.239 0.092
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Appendix Table 4
Titration for total Igand isotypes showing mean OD values obtained
in F. hepatica and F. gigantica infected and uninfected sheep
using I*h-cathcpsin. as antigen
Appendix Table 4.75
Titration for total Ig showing the mean OD (450 nm)valucs obtained
in F. hepatica and F. gig"itica infected and uninfected sheep.
Calhcpsin H N PI P2 Ca litepet in B N PI P2
4 0.254 0.629 1.137 1315 4 0.142 0518 1.187 1.141
2 0.248 0.489 0.968 1669 2 0.149 0337 0337 1.124
1 0.146 0333 1.192 1378 1 0.102 0391 1.169 1369 j
Scrum It N PI 1*2 Scrum B N PI P2
50 0.025 0.911 1.663 1.602 50 0.015 0626 1.416 1.483
100 0.015 0607 1541 1.471 100 0.015 0342 1369 1355
200 0.011 0571 1537 1391 200 0.015 0327 1370 1362
400 0.01 0.433 1.468 1.269 400 0.014 0300 1.175 1.050
Conj. It N PI 1*2 Conj. B N PI P2
1000 0.029 0523 1563 1583 1000 0.015 0.424 0.102 1.459
2TOO 0.021 0315 1541 1.471 2000 0.015 0327 1370 1362
4000 -0.032 0.254 1552 1.466 4000 -0.04 0.185 1.150 1.150
8000 0.008 0.156 1351 1.190 8000 0.006 0.056 0.797 1362
Appendix Table 4.76
Titration for IgGj showing the mean OD (450nm) values obtained
in F. hepatica and F. gigantica infected and uninfected sheep
Antigen (jig/ml) Titration IgGj
Calhcpsin B N PI P2 Cathepsin B N PI P2
4 0.031 0.439 1517 1304 4 0.041 0.059 0365 1692
2 0.055 0361 1.422 1603 2 0639 0.040 0380 1.107
1 0.043 0.265 0.979 0.750 1 0.027 0.031 0345 0543
Scrum B N PI P2 Scrum B N PI P2
50 0.051 0.090 0691 0502 50 0650 0.064 0.179 0368
100 0.049 0.040 0602 0.419 100 0.043 0.051 0.165 0317
200 0.065 0.087 0.230 0.282 200 0.023 0.034 0.160 0359
400 0.070 0.060 0.135 0.171 400 0.020 0.029 0668 0.090
McAb B N PI 1*2 McAb B N PI P2
20 0.049 0.186 0602 0.419 20 0.043 0.051 0.165 0317
40 0.068 0.194 0.480 0371 40 0.060 0.057 0.135 0.168
80 0.081 0.136 0.211 0324 80 0.071 0.075 0.110 0.149
160 0.087 0.102 0.151 0.158 160 0.074 0.071 0.094 0.117
Conj. It N PI P2 Conj. B N PI P2
1000 0.055 0.140 1.619 0.278 1000 0.084 0.114 0365 0346
2000 0.044 0.110 1.216 0.222 2000 0.066 0.085 0.187 0310
4000 0.041 0.062 0849 0.129 4000 0.059 0.065 0.112 0.122
8(60 0.039 0.050 0.490 0.087 8000 0.052 0.052 0.088 0.092
16000 0.045 0.038 0.287 0.067 16000 0.054 0.052 0.070 0.068
32000 0.048 0.043 0.153 0.059 32000 0.060 0.054 0.063 0.068
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Appendix Tabic 4.77
Titrations for total IgM showing mean OD (450 nm) values obtained in F. fiepatica
and F. giganlica infected and uninfected sheep Fh-Cathepsin (p.g/ml) as antigen
Antigen (jig/ml) Titration
Callicpsin B N PI P2 Cathepsin B N PI P2
4 0.190 1.406 0.517 1327 4 0330 1.114 1.483 1546
2 0.245 1.428 1.151 1380 2 0334 1.153 1.152 1326
1 0XM9 0.670 0.414 0.452 1 0.074 0362 0.503 0820
Scrum B N PI P2 Scrum B N PI P2
50 0.049 0.067 0.414 0.452 50 0.027 0368 0.426 0350
100 0.055 0.498 0355 0367 100 0350 0.170 0323 0366
200 0.044 0333 0.182 0311 200 0.032 0.105 0348 0.192
400 0.O47 0.172 0.121 0302 400 0.033 0.119 0.199 0.089
C(Hlj. B N PI 1*2 Conj. B N PI P2
1000 0.100 0.075 1.150 0.965 1000 0.060 0343 0.646 0360
2000 0.035 0389 0.681 0370 2000 0.025 0.170 0323 0366
4000 0.028 0.162 0.251 0.127 4000 0.014 0.073 0.168 0.129
8000 0.032 0.101 0.189 0.154 8000 0.019 0.027 0.073 0.046
Appendix Table 4.78
Titrations for IgG2 showing the mean OD (450 nm) values obtained in F. hepatica
and F. giganlica infected and uninfected sheep Fh-Cathepsin (jig/ml) as antigen
Cathepsin B N PI P2 Cathepsin B N PI P2
4 01)52 0.084 0.195 0.088 4 0.042 0.050 0.050 0.040
2 0.048 0.067 0.138 0.073 2 0.041 0.059 0.052 0.050
1 0.051 0.073 0.086 0.072 1 0.051 0.057 0.059 0.044
Scrum B N PI P2 Scrum B N PI P2
50 0.123 0.229 0.203 0.149 50 0.100 0.129 0.129 0.114
100 0.054 0.075 0.088 0.074 100 0.051 0.057 0.059 0.044
McAb B N PI P2 McAb B N PI P2
10 0.108 0.285 0.250 0.165 10 0.097 0.152 0.131 0.124
20 0.123 0.229 0.203 0.149 20 0.100 0.129 0.129 0.114
40 0.102 0.102 0.138 0.122 40 0.084 0.137 0.103 0.106
80 0.089 0.103 0.124 0.122 80 0.079 0.09 0.09 0.091
Conj. B N PI P2 Conj. B N PI P2
1000 0.082 0.123 0.125
' 0.183 1000 0.084 0.019 0.112 0.117
2M0 0.066 0.088 0.094 0.112 2000 0.070 0.074 0.076 0.079
4000 0.057 0.079 0.076 0.078 4000 0.057 0.065 0.063 0.064
8000 0.056 0.072 0.061 0.062 8000 0.058 0.054 0.052 0.055
16000 0.055 0.062 0.050 0.060 16000 0.051 0.048 0.053 0.052




Titrations for IgA showing the mean OI) (450 nin) values obtained in
F. hepalica and F. giganlica infected and uninfected sheep
I*, hcpalica F.gigantica
Catlicpsin H N PI 1*2 Cathepsin B N PI P2
4 0.041 0391 0365 0.811 4 0.044 0520 0.751 0391
2 0.193 0369 0.491 0.763 2 0.051 0.778 0.776 0356
1 0.078 0339 0.405 0307 1 0.061 0.701 0314 0.495
Scrum B N PI P2 Scrum B N PI P2
50 0.082 0.102 0.078 0.119 50 0X775 0.084 0X776 0.087
100 0.053 0.082 0.066 0.083 100 0X774 0.064 0.062 0.075
McAb B N PI P2 McAb B N PI P2
10 0.079 0.100 0.067 0X779 10 0X770 0X771 0X772 0X772
20 0.082 0.102 0.078 0.083 20 0X775 0X384 0.076 0.080
40 0.079 0.099 0.075 0.087 40 0X772 0.093 0.080 0.076
80 0.075 0.095 0.074 0.082 80 0X)69 0.074 0.071 0X772
Conj. B N PI P2 Conj. B N PI P2
1000 0.053 0.082 0.066 0.119 1000 0.074 0.064 0.062 0X387
2000 0.039 0.050 0.042 0.068 2000 0.037 0.040 0.041 0.050
4000 0.029 0.031 0.025 0.041 4000 0.033 0.029 0.029 0.037
8000 0.028 0.026 0.018 0.030 8000 0.024 0.023 0.029 0.028
16000 0.022 0.025 0.017 0.027 16000 0.023 0.021 0.019 0.021
32000 0.026 0.027 0.018 0.026 32000 0.031 0.022 0.027 0X329
Table 4.80 Titration for total IgG showing the mean OD values obtained in F. hepatica
and F. giganlica infected and uninfected Cattle, Fh-Cathepsin (jig/ml) as antigen
F. hepatica F. giganlica
Cathepsin B N PI P2 Cathepsin B N PI P2





















/•". hepatica F. gigantica
Scrum B N PI P2 Scrum B N PI P2
50 0.001 0.038 1.460 1.144 50 0.006 0.167 1.494 137
100 -0.001 0.021 1276 0.917 100 0.005 0.094 1309 1.449
200 -0.001 0.015 1.063 0.669 200 0.002 0.05 1.131 133
400 -0.002 0.011 0.816 0.413 400 0.003 0X332 0824 1211
800 0.005 0.006 0.534 0.264 800 0.007 0.01 0X507 0.754
1600 0.000 0.012 0390 0.175 1600 0.003 0.01 0292 0X561
F. hepatica F. giganlica
COIlj. B N PI 1*2 conj. B N PI P2
1000 0.034 0.105 1332 1.086 1000 0.04 0.197 131 1.472
2000 0.022 0.073 1.275 0847 2000 0.022 0.108 1.192 1272
4000 0.011 0.05 1.053 0.637 4000 0.014 0.084 1.065 1.15
8000 0.011 0.032 0819 0.474 8000 0.012 0.06 0812 0.952
16000 0.005 0.029 037 0.28 16000 0.011 0.03 0385 0.969
32XXK) 0.008 0.014 0351 0.167 32000 0.015 0.021 0355 0415
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Appendices
Table 4.8 1 :_'l ilralion for IgGl showing ihc mean OD values obtained in F. hepalir.a
and F. giganlica infected and uninfected Cattle, bh-Cathqisin (fig/ml) as antigen
F. hejxitica F. gigantica
Calltcpsin It N PI 1*2 Cathcpsin B PI P2
0.017 0.100 1.479 1361 0/734 0393 1334 1.702
0/121 01777 1.599 1397 0.019 0363 1606 1342
1 0.020 0j057 1.490 1324 1 0.017 0.177 1.476 1684
F. hrjxitica F gigantica
Scrum it N PI 1*2 Scrum B N PI P2
50 0/714 0.119 1609 1.461 50 0/711 0.407 1628 1.766
100 0.01 0.094 1.411 1378 100 0.012 0306 1608 1.742
2CX) 0.014 0/748 1.497 1313 200 0.022 0.124 1324 1.676
400 0.017 0.032 1347 0.911 400 0.013 0.08 1331 1322
800 0.009 0.023 1.119 0666 800 0/712 0.045 1/799 1.444
I (XX) 0.013 0/723 0872 0.483 1600 0/714 0.039 0.78 1.105
F. hepalica F. gigantica
conj. It N PI P2 conj. B N PI P2
1000 0.046 0/792 1.897 1330 1000 0/750 0350 1.934 1.859
2000 0.026 0/)56 1.669 0894 2000 0/726 0.137 1.458 1806
4000 0.022 0/740 13X8 0650 4000 0/724 0/781 1/741 1389
8000 0.013 0.017 0.851 0348 8000 0/713 0.039 0618 0.942
16000 0.011 0/715 0342 0.193 16000 0/711 0.024 0.428 0394
32000 0.010 0/711 0394 0.104 32000 0/710 0/722 0312 0.401
Tablc:4.82 Titration for IgtM showing the mean OD values obtained in F. kepatica
and F. gigantica infected and uninfected Cattle, Fh-Cathepsin (pg/ml) as antigen
F. hepalica F. gigantica
Antigen conc. B N PI P2 Antigen conc. B N PI P2
4 0.013 0356 0.607 0620 4 0.007 0.758 0.722 1.185
2 0.005 0304 0332 0302 2 0.004 0.664 0362 1.008
1 0.008 0.162 0354 0.439 1 0.012 0363 0.484 0940
h. hepalica F. gigantica
Scrum B N PI P2 Scrum B N PI P2
100 0.069 0.198 0.741 0312 100 0.042 0378 0.912 0857
200 0.049 0.109 0362 0.457 200 0.035 0311 0803 0.749
400 0.035 0.099 0.279 031 400 0.041 0365 0.451 0384
800 0.022 0.072 0.221 0.124 800 0.025 0219 0354 0325
1600 0.012 0.032 128 0/781 1600 0/733 0.102 0234 0241
3200 0.003 0.021 0.087 0/733 3200 0.054 0.088 0.142 0.149
F. hepalica F. gigantica
conj. It X PI P2 conj. B N PI P2
1000 0.029 0.2X7 0807 0605 1000 0/727 0627 0927 0957
2000 0.013 0.176 0.477 0367 2000 0.022 0396 0.709 0900
4000 0.011 0.103 0358 0205 4000 0.021 0355 0.473 0.424
8000 0.009 0/767 0.199 0.154 8000 0/715 0234 0346 0313
16000 0.06 0.037 0.108 0663 16000 0/710 0.126 0216 0213
32XXX7 0.003 0.028 0.062 0646 32000 0.013 0.067 0.172 0.177
436
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Tabic 4.83 Titration for IgG2 showing the mean OD values obtained in F. hepalica
and F. ^i^aniica infected and uninfected Otitic, Fh-Cathcpsin (|ig/ml) as antigen
/•". he,palira F. giganlica
Catlcpsiri B N PI 1*2 Cathcpsin B N PI P2
0.078 0.1 0.139 0391 0.078 0232 0257 0.436
0.054 0.097 0.1 036 0054 0.132 0.174 0332
1 0.076 0.113 0.116 0272 1 0.084 0.084 0.136 0246
/*". hepattea F. giganlica
.Scrum B N PI P2 Scrum B N PI P2
50 0.051 0X774 0.137 0.658 50 0.044 0.112 0285 0.735
100 0.03 0.035 0.055 0.171 100 0.031 0.042 0.104 0208
200 0j018 0.018 0.032 0.126 200 0.018 0/132 0.048 0/771
400 0.019 0/108 0.021 0.061 400 0.018 0/128 0.029 0/138
800 0.014 0.009 0.016 0.039 800 0.010 0.010 0.018 0/118
1600 0.005 0.006 0.01 0/117 1600 0.009 0/105 0/114 0/111
c. hepalica F. giganlica
COIlj. B N PI P2 conj. B N PI P2
1000 0X184 0.171 0330 1.034 1000 0.114 0308 0.442 0.493
2/XX1 0XM1 0.088 0.194 0.709 2000 0.073 0.160 0277 0314
40CX) 0.035 0.057 0.114 0330 4000 0.045 0/110 0.135 0.141
8CXX) 0.025 0.032 0.062 0.191 8000 0.030 0.048 0.075 0.160
16000 0024 0.021 0340 0.103 16000 0.023 0.028 0.046 0/151 j
32TKX) 0.015 0.019 0270 0.061 32000 0.035 0.023 0.046 0/135
Table 4.84 Titration for IgA showing the mean OD values obtained in F. hepalica
and F. giganlica infected and uninfected Otitic, Fh-Cathcpsin (jig/ml) as antigen
F. hepatica F giganlica
Cathcpsin B N PI P2 Cathcpsin B N PI P2
4 0/137 0.160 0214 0.180 4 0.070 0.108 0325 0.151
2 0/728 0.037 0303 0.100 2 0.028 0.037 0290 0.111
1 0/132 0/123 0255 0.058 1 0.009 0/123 0255 0-106
F. hepatica F. giganlica
Scrum B N PI P2 Scrum B N PI P2
50 0.034 0.044 0385 0.109 50 0.034 0.044 0325 0.193
100 0.029 0.025 0203 0.156 100 0/129 0.035 0.187 0.156
200 0.030 0.022 0.167 0.070 200 0.024 0.026 0.081 0.119
400 0.024 0.028 0/188 0.024 400 0.019 0/117 0/141 0/189
800 0.011 0.015 0.024 0.014 800 0.014 0.008 0.024 0.065
1600 0.011 0.020 0/119 0.021 1600 0.009 0.001 0/129 0/154
F. hepalica F. giganlica
conj. R N PI 1*2 conj. B N PI P2
1000 0.034 0.044 0.185 0.090 1000 0.037 0.060 0.160 0.190
2000 0/729 0.025 0.103 0.056 2000 0/128 0/137 0.103 0.100
4(XX> 0.030 0.M0 0.067 0.035 4000 0.032 0.023 0.055 0/158
8(XX> 0.024 0.028 0/138 0.024 8000 0.038 0.023 0.039 0/137
i am 0/111 0.015 0.024 0.014 16000 0.026 0/112 0.020 0/130




Adjusted OD values for antibody response to F. hepatica cathepsin LI protease
Experiment One (1): Adjusted values for F. hepatica
(British and Peruvian strain) infected sheep and uninfected sheep
Appendix Table 4.85
Adjusted total Ig OD values Adjusted IgGj OD values
WPI SH.5 SH. 6 SH. 7 SH. 9 SH. 10 SH. 8 WPI SH.5 SH. 6 SH. 7 SH. 9 SH.10 SH. 8
-2 0.004 0.033 0.033 0.028 0.210 0.040 -2 0.004 0.007 0.013 0.012 0.023 0.020
-1 -0.022 0.001 0.081 -0.095 0.063 0.074 -1 0.001 0.006 0.021 -0.014 0.034 0.024
0 -0.015 -0.004 0.147 -0.043 0.126 0.095 0 0.002 0.010 -0.002 0.027 0.019 0.021
1 0.019 -0.033 0.101 -0.088 0.072 0.088 1 0.026 0.012 -0.001 -0.017 0.048 0.021
2 0.013 0.930 0.419 0.365 0.615 0.035 2 0.007 0.376 0.312 0.048 0.068 0.019
3 -0.008 0.973 1.227 0.559 1.304 0.056 3 0.192 1.004 0.864 0.169 0.047 0.018
4 0.297 1.166 1.158 0.840 1.811 0.038 4 0.181 1.014 0.873 0.253 0.314 0.019
5 0.512 1.329 1.147 0.608 1.392 0.026 5 0.264 1.198 1.035 0.241 0.200 0.017
6 1.149 1.150 1.199 0.668 1.500 0.093 6 0.531 1.324 1.146 0.209 0.284 0.020
7 1.246 1.061 1.188 0.889 1.898 0.021 7 0.717 1.038 0.894 0.243 0.304 0.026
8 1.163 1.347 1.080 0.709 1.574 0.067 8 0.545 1.156 0.848 0.270 0.265 0.025
9 1.238 1.298 1.102 0.679 1.520 0.078 9 0.334 1.034 0.891 0.348 0.405 0.020
10 0.839 1.272 1.077 0.593 1.365 0.083 10 0.337 1.027 0.884 0.237 0.232 0.026
11 1.267 1.397 1.147 0.608 1.392 0.065 11 0.446 1.239 0.895 0.173 0.270 0.026
12 1.111 1.416 1.227 0.866 1.858 0.110 12 0.404 0.816 0.699 0.245 0.169 0.020
13 1.061 1.290 0.958 0.694 1.547 0.057 13 0.958 1.026 0.884 0.270 0.205 0.029
14 1.466 0.786 0.435 0.851 1.831 0.088 14 0.790 0.676 0.403 0.100 0.021
15 1.244 0.699 0.600 1.379 0.043 15 0.943 0.634 0.424 0.128 0.025
16 0.918 1.037 0.686 1.534 0.078 16 0.328 0.269 0.288 0.084 0.028
5.5 0.893 1.216 0.413 1.041 0.083 17 0.470 0.394 0.218 0.063 0.024
Appendix Table 4.86
Adjusted IgM OD values Adjusted IgG2 OD values
WPI SH.5 SH. 6 SH. 7 SH. 9 SH.10 SH. 8 WPI SH.5 SH. 6 SH. 7 SH. 9 SH.10 SH. 8
-2 0.017 0.037 0.036 0.036 0.014 0.035 -2 0.021 0.035 0.024 0.012 0.031 0.021
-1 0.027 0.023 0.019 0.117 0.069 0.071 -1 0.038 0.055 0.012 0.014 0.018 0.018
0 0.045 0.034 0.032 0.116 0.092 0.011 0 0.023 0.037 0.025 0.008 0.018 0.031
1 0.079 0.046 0.048 0.150 0.097 0.047 1 0.038 0.060 0.041 0.027 0.034 0.028
2 0.070 0.065 0.191 0.328 0.159 0.041 2 0.023 0.029 0.033 0.046 0.043 0.024
3 0.109 0.066 0.318 0.329 0.157 0.041 3 0.046 0.021 0.017 0.039 0.015 0.013
4 0.138 0.081 0.090 0.384 0.177 0.039 4 0.034 0.027 0.027 0.052 0.039 0.020
5 0.153 0.196 0.230 0.322 0.139 0.014 5 0.055 0.060 0.020 0.055 0.048 0.008
6 0.149 0.192 0.226 0.255 0.143 -0.006 6 0.036 0.042 0.040 0.056 0.045 0.005
7 0.166 0.423 0.506 0.270 0.095 0.039 7 0.028 0.040 0.039 0.013 0.053 0.014
8 0.098 0.483 0.578 0.323 0.159 0.033 8 0.050 0.053 0.007 0.017 0.066 0.048
9 0.098 0.313 0.372 0.230 0.204 0.039 9 0.059 0.027 0.007 0.040 0.101 0.042
10 0.090 0.267 0.571 0.161 0.123 0.020 10 0.030 0.024 0.043 0.060 0.078 0.039
11 0.064 0.313 0.372 0.226 0.164 0.033 11 0.023 0.056 0.039 0.037 0.080 0.041
12 0.090 0.194 0.228 0.266 0.140 0.020 12 0.050 0.043 0.040 0.054 0.015
13 0.140 0.271 0.322 0.228 0.234 0.043 13 0.058 0.021 0.005 0.050 0.011
14 0.495 0.594 0.275 0.101 0.044 14 0.024 0.010 0.052 0.033 0.011
15 0.359 0.428 0.222 0.152 0.020 15 0.031 0.041 0.073 0.052 0.013
16 0.158 0.184 0.237 0.091 0.030 16 0.053 0.043 0.059 0.040 0.000





WPI SH.5 SH. 6 SH. 7 SH. 9 SH.10 SH. 8
-2 0.017 0.021 0.026 0.018 0.024 0.021
-1 0.022 0.030 0.008 0.011 0.020 0.018
0 0.026 0.037 0.018 0.019 0.018 0.018
1 0.027 0.027 0.035 0.007 0.023 0.015
2 0.049 0.034 0.037 0.021 0.031 0.014
3 0.023 0.046 0.012 0.011 0.011 0.012
4 0.022 0.021 0.009 0.016 0.029 0.004
5 0.030 0.027 0.008 0.021 0.017 0.016
6 0.023 0.049 0.012 0.023 0.008 0.022
7 0.032 0.042 0.020 0.024 0.010 0.018
8 0.022 0.034 0.020 0.029 0.012 0.006
9 0.033 0.035 0.014 0.042 0.041 0.025
10 0.031 0.034 0.020 0.029 0.034 0.013
11 0.024 0.031 0.035 0.029 0.028 0.023
12 0.030 0.069 0.034 0.042 0.045 0.029
13 0.032 0.075 0.035 0.039 0.029 0.017
14 0.049 0.024 0.084 0.030 0.022
15 0.024 0.033 0.056 0.036 0.012
16 0.022 0.020 0.043 0.046 0.021
17 0.031 0.014 0.037 0.029 0.011
Experiment two (2): Adjusted values for F. hepatica
(British strain) infected and uninfected sheep
Appendix Table 4.88
Adjusted IgG OD values Adjusted IgG, OD values
WPI sh. 24 sh.26 sh. 28 sh.30 sh. 22 sh. 32 WPI sh.24 sh.26 sh.28 sh.30 sh.22 sh.32
-2 0.064 0.050 0.048 -0.048 0.039 0.046 -2 0.009 0.034 -0.029 -0.029 0.010 -0.001
0 0.022 0.154 0.072 0.090 0.039 -0.004 0 0.071 0.019 -0.009 -0.024 0.023 0.006
2 0.360 0.432 0.295 0.137 0.053 0.008 2 0.089 0.048 -0.017 -0.024 0.023 -0.003
4 0.417 0.268 0.072 0.295 0.026 0.004 4 0.073 0.035 -0.002 -0.024 0.015 -0.003
6 0.404 0.696 0.241 0.317 0.075 -0.026 6 0.159 0.181 0.023 -0.002 0.037 0.012
8 1.230 1.154 0.980 1.079 0.058 -0.014 8 1.028 0.943 -0.042 0.081 -0.001 0.004
9 0.806 0.984 0.966 1.015 0.094 0.051 9 1.029 1.107 0.000 0.517 0.012 -0.003
10 1.168 1.066 1.055 1.004 0.104 -0.030 10 0.911 1.109 1.085 0.606 0.043 -0.003
11 1.236 1.019 1.066 1.053 0.048 -0.085 11 1.051 1.284 1.303 0.745 0.017 -0.008
12 1.137 1.148 1.034 1.042 -0.028 -0.033 12 1.193 1.332 1.330 1.291 0.010 -0.012
13 1.172 1.013 1.017 0.941 0.041 -0.046 13 1.324 1.466 1.467 1.059 0.010 -0.012
14 1.083 1.004 0.946 0.961 0.009 -0.002 14 1.258 1.174 1.384 0.999 -0.001 0.001
15 1.080 1.088 0.996 0.938 0.017 -0.088 15 1.211 1.008 1.457 1.309 0.006 -0.005
16 1.091 0.988 0.860 1.004 0.041 -0.049 16 1.237 1.109 1.552 1.299 0.006 -0.010
17 1.080 0.973 0.902 1.079 0.026 0.016 17 1.172 1.087 1.474 0.997 0.008 -0 010
18 0.998 1.038 0.905 0.826 -0.056 -0.061 18 1.290 1.321 1.401 0.715 0.012 -0.008
19 1.043 1.027 0.768 0.332 0.072 -0.049 19 1.027 1.113 1.399 0.532 0.030 -0.012
20 0.922 1.024 0.905 0.581 0.074 -0.048 20 0.510 0.870 1.348 0.434 0.008 -0.012
21 1.196 0.779 0.892 0.900 -0.056 -0.043 21 0.262 0.376 0.508 0.219 0.021 -0.012




Adjusted IgM OD values Adjusted IgG2 OD values
WPI sh. 24 sh.26 sh. 28 sh.30 sh. 22 sh. 32 WPI sh. 24 sh.26 sh. 28 sh.30 sh. 22 sh. 32
-2 0.523 0.243 0.221 0.339 0.576 -0.049 -2 -0.012 0.024 0.001 -0.001 -0.003 -0.004
0 0.389 0.182 0.363 0.377 0.653 0.073 0 0.021 0.047 0.007 0.000 0.010 -0.003
2 0.374 0.196 0.417 0.466 0.392 -0.128 2 0.019 0.046 0.009 0.001 0.009 -0.004
4 0.378 0.327 0.421 0.353 0.387 -0.007 4 -0.013 0.023 0.010 0.000 0.002 -0.003
6 0.723 0.356 0.393 0.440 0.582 -0.028 6 0.004 0.035 0.009 0.003 -0.001 -0.003
8 0.405 0.374 0.357 0.368 0.561 -0.028 8 0.064 0.077 0.008 0.021 0.004 -0.005
9 0.865 0.239 0.257 0.396 0.478 -0.034 9 -0.046 0.000 0.011 0.027 -0.004 0.001
10 0.401 0.426 0.262 0.288 0.449 -0.117 10 0.010 0.039 0.012 0.026 -0.005 -0.007
11 0.637 0.392 0.342 0.372 0.372 -0.185 11 -0.015 0.021 0.010 0.019 0.004 -0.011
12 0.665 0.245 0.303 0.373 0.191 -0.034 12 -0.017 0.020 0.015 0.014 -0.003 -0.004
13 0.407 0.035 0.337 0.322 0.582 -0.054 13 -0.031 0.010 0.008 0.014 -0.006 -0.005
14 0.421 0.082 0.315 0.191 0.526 -0.034 14 0.001 0.033 0.008 0.010 -0.004 -0.001
15 0.708 0.279 0.373 0.252 0.446 -0.099 15 -0.004 0.029 0.005 0.009 -0.001 -0.002
16 0.456 0.206 0.464 0.297 0.271 -0.054 16 -0.026 0.014 0.009 0.007 -0.009 -0.007
17 0.676 0.185 0.468 0.463 0.253 -0.096 17 -0.032 0.010 0.010 0.015 0.003 -0.008
18 1.192 0.153 0.503 0.368 0.295 -0.022 18 -0.032 0.010 0.005 0.015 0.009 0.002
19 0.055 0.047 0.441 0.423 0.434 0.159 19 -0.031 0.010 0.004 0.008 -0.010 0.000
20 1.443 0.070 0.409 0.311 0.259 0.111 20 -0.037 0.006 -0.001 0.005 0.010 -0.006
21 0.645 0.151 0.461 0.238 0.244 -0.063 21 -0.024 0.015 0.004 0.000 -0.003 -0.006
22 0.606 0.165 0.431 0.487 0.558 0.014 22 -0.014 -0.005
Appendix Table 4.90
Adjusted IgA values
WPI sh. 24 sh.26 sh. 28 sh.30 sh. 22 sh. 32
-2 0.003 0.012 0.031 0.010 0.038 -0.019
0 0.012 0.032 0.011 0.015 0.010 -0.043
2 0.021 0.092 0.022 0.024 -0.005 -0.014
4 0.023 0.115 0.041 0.019 0.024 -0.034
6 0.072 0.108 0.044 0.017 -0.010 -0.029
8 0.014 0.135 0.016 0.075 0.010 -0.014
9 0.001 0.101 0.012 0.069 -0.005 -0.010
10 0.030 0.258 0.011 0.066 0.005 -0.043
11 0.014 0.075 0.016 0.073 -0.048 -0.034
12 0.034 0.193 0.025 0.075 -0.043 -0.019
13 0.012 0.041 0.025 0.062 -0.005 0.034
14 0.037 0.043 0.018 0.041 -0.010 0.010
15 0.032 0.041 0.024 0.042 -0.024 0.029
16 0.017 0.034 0.041 0.038 -0.019 -0.014
17 0.030 0.119 0.040 0.034 0.058 0.096
18 0.034 0.066 0.041 0.031 0.029 0.024
19 0.034 0.075 0.029 0.034 0.000 0.058
20 0.059 0.019 0.039 0.036 -0.019 0.053
21 0.039 0.017 0.047 0.024 -0.019 0.053
22 0.033 0.038 -0.062 0.043
440
Appendices
Experiment three (3): Adjusted values for F. gigantica
(Kenyan strain) infected and uninfected sheep
Appendix Table 4.91
Adjusted total Ig OD values
Infected Uninfected
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 Mean (+] SEM SH.16 SH. 17 SH. 18 SH. 19 Mean (- StDev SEM
-2 -0.128 -0.004 -0.053 0.067 -0.021 -0.028 0.064 0.032 -0.077 -0.015 -0.011 -0.024 -0.003 0.027 0.009
0 -0.029 0.000 -0.041 0.148 -0.038 0.008 0.071 0.036 -0.025 0.008 0.013 -0.009 -0.023 0.015 0.016
2 0.564 0.120 0.057 0.251 0.009 0.200 0.199 0.100 -0.008 0.015 -0.049 -0.051 -0.028 0.028 0.010
4 0.317 0.249 0.222 0.312 0.196 0.259 0.048 0.024 -0.010 -0.025 -0.021 -0.057 -0.039 0.017 0.017
6 0.417 0.189 0.746 0.354 0.658 0.473 0.203 0.102 -0.015 -0.012 -0.085 -0.045 -0.045 0.029 0.020
8 0.344 0.291 0.705 0.360 0.828 0.506 0.218 0.109 -0.003 -0.025 -0.096 -0.054 -0.014 0.035 0.026
9 0.582 0.321 0.605 0.754 1.209 0.694 0.293 0.146 0.013 0.016 0.007 -0.090 0.000 0.044 0.019
10 0.270 0.682 0.743 0.858 0.749 0.660 0.203 0.102 0.025 -0.052 0.034 -0.006 -0.020 0.034 0.027
11 0.539 0.821 0.858 0.823 0.635 0.735 0.125 0.063 0.037 -0.077 0.015 -0.054 -0.063 0.047 0.026
12 0.660 0.731 0.822 0.779 0.428 0.684 0.139 0.069 0.006 -0.122 -0.066 -0.070 -0.054 0.046 0.026
13 0.983 0.631 0.435 0.697 0.395 0.628 0.211 0.105 0.020 -0.100 -0.081 -0.054 -0.037 0.046 0.025
14 0.548 0.816 0.476 0.823 0.188 0.570 0.237 0.118 -0.012 -0.066 0.020 -0.090 -0.026 0.043 0.021
15 0.417 0.683 0.927 0.541 0.120 0.538 0.269 0.134 -0.018 0.029 -0.067 -0.048 -0.038 0.036 0.007
16 0.344 0.582 0.553 0.618 0.524 0.107 0.062 -0.022 -0.039 -0.036 -0.054 -0.012 0.011 0.009
17 0.582 0.474 0.597 0.441 0.524 0.067 0.039 -0.022 -0.030 0.012 -0.006 -0.017 0.016 0.029
18 0.134 0.562 0.390 0.386 0.368 0.153 0.088 0.025 -0.025 0.028 -0.095 -0.029 0.050 0.021
19 0.033 0.541 0.411 0.296 0.320 0.187 0.108 -0.012 -0.001 -0.011 -0.090 -0.013 0.036 0.024
20 0.044 0.472 0.492 0.328 0.334 0.179 0.103 -0.018 0.030 0.013 -0.077 -0.033 0.041 0.008
21 0.149 0.398 0.456 0.354 0.339 0.116 0.067 -0.022 -0.019 -0.037 -0.055 -0.037 0.014 0.029
22 0.018 0.375 0.586 0.315 0.324 0.203 0.117 0.037 -0.030 -0.105 -0.048 -0.029 0.051 0.021
Appendix Table 4.92
Adjusted IgG, OD values
Infected Uninfected
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 Mean (+) StDev SEMean SH.16 SH. 17 SH. 18 SH. 19 TrMean StDev SEMean
-2 0.059 0.046 0.021 0.025 0.026 0.035 0.016 0.007 0.031 0.036 0.045 0.020 0.03 0.01 0.01
0 -0.045 -0.058 0.008 0.010 0.009 -0.015 0.034 0.015 0.037 0.042 0.051 0.026 0.04 0.01 0.01
2 -0.035 -0.048 0.011 0.006 0.004 -0.012 0.027 0.012 0.037 0.042 0.051 0.026 0.04 0.01 0.01
4 0.016 0.003 0.020 0.072 0.080 0.038 0.035 0.016 0.033 0.038 0.047 0.022 0.04 0.01 0.01
6 0.149 0.136 0.006 0.165 0.186 0.128 0.071 0.032 0.043 0.048 0.057 0.032 0.05 0.01 0.01
8 0.560 0.547 0.614 0.281 0.318 0.464 0.153 0.068 0.026 0.031 0.040 0.015 0.03 0.01 0.01
9 1.020 1.007 1.071 0.423 0.481 0.800 0.320 0.143 0.032 0.037 0.046 0.021 0.03 0.01 0.01
10 1.109 1.096 0.953 0.743 0.847 0.950 0.158 0.071 0.046 0.051 0.060 0.035 0.05 0.01 0.01
11 1.197 1.184 1.093 0.946 1.078 1.100 0.101 0.045 0.034 0.039 0.048 0.023 0.04 0.01 0.01
12 1.245 1.232 1.235 0.971 1.107 1.158 0.119 0.053 0.031 0.036 0.045 0.020 0.03 0.01 0.01
13 1.379 1.366 1.366 1.098 1.252 1.292 0.120 0.054 0.031 0.036 0.045 0.020 0.03 0.01 0.01
14 1.087 1.074 1.300 1.050 1.280 1.158 0.121 0.054 0.026 0.031 0.040 0.015 0.03 0.01 0.01
15 0.921 0.908 1.253 0.944 1.319 1.069 0.200 0.089 0.029 0.034 0.043 0.018 0.03 0.01 0.01
16 0.921 0.908 1.177 1.342 1.087 0.210 0.105 0.029 0.034 0.043 0.018 0.03 0.01 0.01
17 1.022 1.009 1.105 1.260 1.099 0.115 0.058 0.030 0.035 0.044 0.019 0.03 0.01 0.01
18 0.785 0.772 1.037 1.182 0.944 0.200 0.100 0.032 0.037 0.046 0.021 0.03 0.01 0.01
19 0.677 0.664 1.035 1.180 0.889 0.259 0.130 0.040 0.045 0.054 0.029 0.04 0.01 0.01
20 0.719 0.706 0.988 1.126 0.885 0.207 0.103 0.030 0.035 0.044 0.019 0.03 0.01 0.01
21 0.784 0.758 0.766 0.588 0.724 0.091 0.046 0.036 0.041 0.050 0.025 0.04 0.01 0.01




Adjusted IgM OD values
Infected Uninfected
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 TrMean StDev SEMean SH. 16 SH. 17 SH. 18 SH. 19 TrMean StDev SEMean
-2 0.052 0.041 0.099 0.043 0.038 0.0546 0.036 0.016 0.017 0.069 0.076 0.031 0.0482 0.0287 0.0144
0 0.067 0.016 0.166 0.083 0.059 0.082 0.051 0.0228 0.085 0.137 0.144 0.099 0.062 0.0287 0.0144
2 0.354 0.303 0.185 0.232 0.143 0.2434 0.086 0.0383 0.111 0.163 0.17 0.125 0.0723 0.0287 0.0144
4 0.382 0.379 0.224 0.252 0.117 0.2708 0.112 0.0501 0.06 0.112 0.119 0.074 0.0913 0.0287 0.0144
6 0.49 0.439 0.218 0.304 0.257 0.3416 0.118 0.0526 0.03 0.082 0.089 0.044 0.0613 0.0287 0.0144
8 0.274 0.223 0.238 0.108 0.488 0.2662 0.139 0.062 0.071 0.123 0.13 0.085 0.1023 0.0287 0.0144
9 0.283 0.232 0.202 0.256 0.473 0.2892 0.107 0.0479 0.037 0.089 0.096 0.051 0.0683 0.0287 0.0144
10 0.237 0.186 0.216 0.233 0.375 0.2494 0.073 0.0327 0.077 0.129 0.136 0.091 0.1082 0.0287 0.0144
11 0.162 0.111 0.178 0.17 0.413 0.2068 0.118 0.0529 0.113 0.165 0.172 0.127 0.1043 0.0287 0.0144
12 0.142 0.091 0.248 0.209 0.29 0.196 0.08 0.0358 0.068 0.12 0.127 0.082 0.0993 0.0287 0.0144
13 0.199 0.148 0.094 0.107 0.34 0.1776 0.1 0.0445 0.097 0.149 0.156 0.111 0.083 0.0287 0.0144
14 0.269 0.218 0.011 0.112 0.326 0.1872 0.126 0.0564 0.009 0.061 0.068 0.023 0.0402 0.0287 0.0144
15 0.136 0.085 0.052 0.189 0.313 0.155 0.103 0.0458 0.07 0.122 0.129 0.084 0.1013 0.0287 0.0144
16 0.051 0 0.167 0.348 0.1415 0.154 0.0772 0.055 0.107 0.114 0.069 0.0862 0.0287 0.0144
17 0.02 -0.031 0.177 0.275 0.1103 0.141 0.0705 0.096 0.148 0.155 0.11 0.073 0.0287 0.0144
18 0.106 0.055 0.091 0.213 0.1163 0.068 0.034 0.11 0.162 0.169 0.124 0.0912 0.0287 0.0144
19 0.144 0.093 0.12 0.237 0.1485 0.063 0.0313 0.079 0.131 0.138 0.093 0.102 0.0287 0.0144
20 0.255 0.204 0.13 0.24 0.2072 0.056 0.0279 0.063 0.115 0.122 0.077 0.0943 0.0287 0.0144
21 0.16 0.109 0.177 0.3 0.1865 0.081 0.0405 0.111 0.163 0.17 0.125 0.1023 0.0287 0.0144
22 0.177 0.126 0.155 0.185 0.1608 0.026 0.0132 0.121 0.173 0.12 0.105 0.1023 0.0287 0.0144
Appendix Table 4.94
Adjusted IgG2 OD values
Infected Uninfected
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 TrMean StDev SEMean SH.16 SH. 17 SH. 18 SH. 19 TrMean StDev SEMean
-2 0.022 0.016 0.027 0.005 0.018 0.056 0.008 0.004 0.018 0.019 0.022 0.022 0.051 0.002 0.001
0 0.024 0.018 0.024 0.006 0.020 0.058 0.007 0.003 0.044 0.013 0.010 0.021 0.054 0.015 0.008
2 0.018 0.012 0.018 0.002 0.014 0.052 0.006 0.003 0.032 0.022 0.038 0.036 0.057 0.007 0.004
4 0.038 0.032 0.027 0.016 0.032 0.068 0.008 0.004 0.020 0.015 0.030 0.028 0.053 0.007 0.004
6 0.057 0.051 0.053 0.029 0.049 0.077 0.022 0.010 0.018 0.017 0.018 0.014 0.050 0.002 0.001
8 0.050 0.044 0.069 0.024 0.043 0.101 0.010 0.004 0.036 0.035 0.038 0.019 0.058 0.009 0.004
9 0.063 0.057 0.052 0.033 0.054 0.091 0.011 0.005 0.029 0.024 0.035 0.014 0.055 0.009 0.004
10 0.066 0.060 0.019 0.035 0.057 0.086 0.020 0.009 0.033 0.035 0.030 0.033 0.058 0.002 0.001
11 0.067 0.061 0.033 0.035 0.058 0.090 0.016 0.007 0.019 0.037 0.013 0.010 0.045 0.012 0.006
12 0.023 0.017 0.010 0.005 0.019 0.048 0.007 0.003 0.025 0.011 0.037 0.010 0.054 0.013 0.006
13 0.027 0.021 0.028 0.008 0.022 0.051 0.008 0.004 0.045 0.035 0.028 0.030 0.054 0.008 0.004
14 0.051 0.045 0.026 0.024 0.044 0.062 0.012 0.005 0.047 0.015 0.037 0.020 0.060 0.015 0.007
15 0.071 0.065 0.024 0.038 0.061 0.071 0.020 0.009 0.032 0.010 0.012 0.030 0.048 0.012 0.006
16 0.048 0.042 0.022 0.041 0.079 0.011 0.006 0.026 0.036 0.022 0.033 0.062 0.006 0.003
17 0.051 0.045 0.024 0.044 0.083 0.012 0.006 0.047 0.019 0.033 0.010 0.053 0.016 0.008
18 0.015 0.009 0.045 0.012 0.066 0.017 0.008 0.039 0.035 0.010 0.037 0.058 0.014 0.007
19 0.063 0.057 0.033 0.054 0.052 0.013 0.007 0.036 0.030 0.010 0.031 0.054 0.011 0.006
20 0.084 0.078 0.047 0.073 0.062 0.016 0.008 0.044 0.014 0.030 0.018 0.059 0.014 0.007
21 0.045 0.045 0.016 0.023 0.064 0.015 0.008 0.043 0.018 0.026 0.031 0.062 0.010 0.005






WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 Mean(+) StDev SEMean SH.16 SH. 17 SH. 18 SH. 19 TrMean StDev SEMean
-2 0.022 0.022 0.014 0.020 0.022 0.020 0.005 0.002 0.020 0.007 0.022 0.009 0.015 0.005 0.002
0 0.031 0.032 0.022 0.028 0.032 0.029 0.005 0.002 0.028 0.013 0.031 0.020 0.023 0.005 0.002
2 0.022 0.034 0.032 0.021 0.034 0.029 0.008 0.003 0.021 0.007 0.022 0.008 0.015 0.005 0.002
4 0.005 0.036 0.034 0.023 0.005 0.021 0.011 0.004 0.023 0.005 0.005 0.036 0.017 0.013 0.006
6 0.008 0.032 0.022 0.034 0.008 0.021 0.012 0.005 0.034 0.008 0.008 0.032 0.020 0.010 0.005
8 0.011 0.038 0.028 0.040 0.006 0.025 0.013 0.006 0.040 0.006 0.011 0.038 0.024 0.013 0.006
9 0.012 0.020 0.033 0.008 0.005 0.015 0.013 0.005 0.008 0.005 0.012 0.020 0.011 0.007 0.003
10 0.013 0.025 0.044 0.011 0.019 0.022 0.012 0.005 0.011 0.019 0.013 0.025 0.017 0.003 0.001
11 0.013 0.016 0.035 0.012 0.011 0.017 0.013 0.005 0.012 0.011 0.013 0.016 0.013 0.005 0.002
12 0.012 0.004 0.029 0.013 0.033 0.018 0.008 0.003 0.013 0.033 0.012 0.004 0.016 0.005 0.002
13 0.013 0.013 0.020 0.013 0.044 0.021 0.010 0.004 0.013 0.044 0.013 0.013 0.021 0.005 0.002
14 0.027 0.015 0.024 0.012 0.035 0.023 0.010 0.004 0.012 0.035 0.027 0.015 0.022 0.005 0.002
15 0.038 0.028 0.006 0.013 0.029 0.023 0.013 0.005 0.013 0.029 0.038 0.028 0.027 0.010 0.004
16 0.041 0.032 0.044 0.008 0.031 0.005 0.002 0.044 0.008 0.041 0.032 0.031 0.010 0.005
17 0.026 0.013 0.035 0.010 0.021 0.011 0.005 0.035 0.010 0.026 0.013 0.021 0.005 0.002
i 18 0.031 0.020 0.029 0.013 0.023 0.012 0.005 0.029 0.013 0.031 0.020 0.023 0.005 0.002
19 0.031 0.020 0.031 0.012 0.024 0.009 0.004 0.031 0.012 0.031 0.020 0.024 0.005 0.002
20 0.027 0.015 0.029 0.011 0.021 0.008 0.004 0.029 0.011 0.027 0.015 0.021 0.005 0.002
21 0.028 0.016 0.033 0.010 0.022 0.008 0.004 0.033 0.010 0.028 0.016 0.022 0.005 0.002
22 0.018 0.004 0.033 0.008 0.016 0.009 0.004 0.033 0.008 0.018 0.004 0.016 0.008 0.004
Experiment three (4): Adjusted values for F. gigantica
(Kenyan strain) infected and uninfected sheep
Appendix Table 4.96
Adjusted total Ig OD values Adjusted IgG, OD values
WPI sh. 23 sh. 25 sh. 27 sh. 29 sh. 21 sh. 31 WPI sh. 23 sh. 25 sh. 27 sh. 29 sh. 21 sh. 31
-2 -0.069 -0.065 -0.094 -0.048 -0.068 0.068 -2 -0.031 0.101 -0.006 -0.023 0.025 -0.017
0 -0.035 -0.010 0.084 -0.054 0.095 0.032 0 0.040 0.056 -0.040 -0.016 0.016 -0.018
2 0.056 -0.030 0.029 0.077 -0.052 0.061 2 0.108 0.084 -0.007 -0.007 0.021 -0.011
4 -0.018 -0.016 0.256 0.086 0.053 0.090 4 0.366 0.055 -0.019 -0.003 0.015 0.002
6 0.096 0.291 0.260 0.252 0.046 -0.056 6 0.355 -0.011 -0.017 0.034 0.015 -0.008
8 1.000 1.036 0.489 0.628 0.027 -0.068 8 0.345 0.068 0.053 0.169 -0.002 -0.008
9 0.465 1.155 0.608 0.915 0.009 0.052 9 0.256 0.065 0.354 0.357 0.001 -0.006
10 1.016 1.284 0.911 0.679 0.087 0.057 10 0.367 0.121 0.361 0.278 0.010 -0.005
11 1.185 1.301 1.119 0.826 0.055 -0.008 11 0.400 0.093 0.455 0.440 0.005 -0.005
12 1.300 1.453 1.128 1.275 0.019 -0.040 12 0.268 0.213 0.471 0.648 0.007 0.007
13 1.310 1.382 1.217 1.097 0.063 0.018 13 0.181 0.117 0.599 0.383 0.003 -0.009
14 1.257 1.279 1.144 1.095 0.029 0.028 14 0.093 0.089 0.931 0.144 0.001 -0.001
15 1.313 1.100 1.226 1.230 0.009 0.074 15 0.103 0.056 0.136 0.286 0.001 0.001
16 1.149 1.217 1.098 0.009 0.133 16 0.027 0.126 0.185 0.003 -0.007
17 1.047 0.991 -0.042 0.013 17 0.182 0.092 0.012 0.001
18 1.206 1.027 0.012 -0.007 18 0.008 0.135 -0.005 -0.011
19 1.118 0.962 0.096 0.020 19 -0.014 0.109 -0.005 -0.004
20 1.065 1.290 0.065 0.020 20 0.111 0.118 0.005 0.003
21 0.729 0.788 0.019 0.055 21 0.135 0.152 -0.005 0.001




Adjusted IgM OD values Adjusted IgG2 OD values
WPI sh. 23 sh. 25 sh. 27 sh. 29 sh. 21 sh. 31 WPI sh. 23 sh. 25 sh. 27 sh. 29 sh. 21 sh. 31
-2 0.034 0.026 0.001 0.046 0.004 0.020 -2 0.011 0.008 0.023 -0.019 0.006 -0.001
0 0.034 0.023 0.054 0.039 0.002 0.027 0 0.014 0.016 0.041 -0.012 0.005 0.002
2 0.123 0.075 0.235 0.207 0.005 0.024 2 0.008 0.026 0.080 -0.012 0.009 0.002
4 0.056 0.051 0.207 0.239 0.003 0.022 4 -0.005 -0.002 0.076 -0.012 0.004 0.003
6 0.089 0.040 0.276 0.172 0.003 0.016 6 -0.002 0.019 0.047 -0.014 0.003 -0.001
8 0.100 0.070 0.079 0.160 -0.001 0.003 8 0.008 0.001 0.004 -0.012 -0.005 -0.001
9 0.074 0.054 0.041 0.176 0.002 0.023 9 0.006 -0.002 0.006 -0.012 -0.007 -0.001
10 0.061 0.040 0.237 0.153 0.002 0.018 10 0.004 0.000 0.054 -0.014 -0.003 0.001
11 0.012 0.034 0.208 0.182 0.001 0.017 11 0.003 0.003 0.049 -0.010 -0.001 -0.002
12 0.183 0.012 0.212 0.191 0.000 0.020 12 0.008 0.010 0.068 -0.008 -0.005 -0.004
13 0.011 0.004 0.161 0.143 -0.002 0.009 13 0.001 0.013 0.035 -0.006 -0.010 -0.003
14 0.106 -0.010 0.266 0.092 0.010 0.012 14 0.006 0.001 0.039 -0.006 -0.007 -0.003
15 0.079 -0.004 0.224 0.153 0.000 0.022 15 0.010 0.001 0.031 -0.008 -0.005 0.001
16 -0.012 0.196 0.240 -0.002 0.033 16 0.004 0.035 -0.010 -0.010 -0.007
17 0.214 0.267 -0.004 0.031 17 0.070 -0.008 -0.010 0.002
18 0.222 0.142 0.001 0.009 18 0.043 -0.010 -0.006 0.000
19 0.250 0.136 0.022 0.009 19 0.054 -0.010 -0.007 -0.002
20 0.186 0.129 0.005 0.010 20 0.047 -0.010 -0.004 0.004
21 0.106 0.133 0.001 0.033 21 -0.004 -0.012 -0.006 0.008
22 0.055 0.097 -0.001 0.025 22 -0.010 -0.010 -0.005 0.003
Appendix Table 4.98
Adjusted IgA values
WPI sh. 23 sh. 25 sh. 27 sh. 29 sh. 21 sh. 31
-2 0.012 -0.010 0.015 0.004 0.020 0.024
0 0.036 0.010 0.014 0.003 0.030 0.032
2 0.049 0.036 0.016 0.001 0.018 0.021
4 -0.006 -0.012 0.016 -0.001 0.014 0.029
6 0.007 -0.001 0.023 0.002 0.013 0.023
8 -0.006 -0.008 0.008 0.001 0.013 0.019
9 -0.008 -0.010 -0.001 0.001 0.009 0.023
10 -0.001 -0.008 0.003 -0.001 0.007 0.019
11 0.001 -0.006 0.002 -0.002 -0.001 0.011
12 0.007 0.003 0.006 0.002 0.006 0.014
13 -0.012 -0.001 0.002 -0.001 0.011 0.018
14 -0.010 -0.004 0.003 0.003 0.015 0.027
15 -0.006 -0.004 0.002 0.002 0.010 0.018
16 -0.001 0.001 0.001 0.004 0.018
17 0.002 0.012 0.003 0.034
18 0.008 0.008 0.015 0.016
19 0.020 0.007 0.014 0.048
20 0.012 0.007 0.008 0.025
21 -0.001 0.011 0.006 0.028
22 -0.003 0.002 0.004 0.048
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Table 4.99 Adjusted total Ig OD values ofF. hepatica and F. gigantica infected calves
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI 22 23 24 26
-27 0.007 0.028 0.088 0.049 -2 0.045 -0.028 0.009 0.059
-26 0.002 0.056 0.083 0.005 -1 0.002 -0.032 0.026 0.004
-25 0.006 0.144 0.053 0.024 0 0.033 -0.025 0.040 0.028
-24 0.024 -0.015 -0.003 -0.005 1 -0.016 -0.047 0.023 -0.009
-23 0.012 0.024 -0.010 -0.008 2 -0.019 -0.041 0.012 -0.013
-22 0.054 -0.012 -0.004 -0.004 3 -0.027 -0.018 0.029 -0.008
-21 0.551 0.025 -0.031 -0.001 4 -0.018 0.005 0.023 -0.004
-20 1.047 0.085 -0.036 -0.012 5 0.045 0.046 0.053 -0.018
-19 1.141 0.166 -0.019 -0.030 6 0.002 0.033 0.047 -0.040
-18 1.063 1.415 -0.043 -0.029 7 0.018 0.542 0.395 -0.039
-17 1.350 1.561 -0.016 -0.015 8 0.016 0.785 0.346 -0.021
-16 1.337 0.763 -0.039 -0.034 9 0.066 0.710 0.510 -0.045
-15 1.165 1.115 -0.043 -0.027 10 0.455 0.880 0.760 -0.036
-14 0.992 1.389 -0.029 -0.026 11 0.442 0.944 0.825 -0.035
-13 0.687 1.193 -0.023 -0.021 12 0.261 1.106 0.870 -0.029
-12 0.806 1.073 -0.013 -0.025 13 0.844 1.137 0.759 -0.034
-11 0.679 0.786 0.019 -0.017 14 0.792 1.219 1.032 -0.024
-10 0.830 0.554 0.156 -0.024 15 0.867 1.189 1.068 -0.033
-9 0.428 0.401 0.473 -0.027 16 0.939 1.261 1.170 -0.036
-8 0.312 0.488 1.166 -0.039 17 0.762 1.212 1.130 -0.051
-7 0.550 0.576 1.491 -0.032 18 0.731 1.126 1.067 -0.043
-6 0.420 0.262 1.508 -0.019 19 0.948 0.895 1.109 -0.026
-5 0.348 0.314 1.624 -0.019 20 0.754 1.091 1.112 -0.026
-4 0.274 0.183 1.618 -0.010 21 0.721 1.100 1.080 -0.015
-3 0.213 0.329 1.585 0.022 22 0.607 1.218 1.192 -0.043
-2 0.434 0.347 1.381 -0.015 23 0.697 1.214 1.030 -0.026
-1 0.318 0.432 1.514 -0.021 24 0.673 0.918 0.923 -0.026
0 0.230 0.306 1.555 -0.021 0.008 -0.038 25 0.575 1.091 1.113 -0.015
1 0.154 0.301 1.510 -0.022 0.030 -0.016 26 0.615 1.132 1.053 0.025
2 0.137 0.421 1.475 -0.005 0.015 -0.014 27 0.537 1.104 1.281 -0.021
3 0.162 0.498 1.640 -0.021 0.068 -0.013 28 0.552 1.060 1.139 -0.029
4 0.171 0.280 1.310 -0.012 0.689 0.027 29 0.468 1.027 1.072 -0.029
5 0.173 0.243 1.368 -0.015 1.309 0.094 30 0.456 1.105 1.038 -0.030
6 0.150 0.287 1.160 -0.003 1.426 0.183 31 0.347 1.108 0.883 -0.009
7 0.108 0.345 1.496 0.005 1.329 1.558 32 0.333 0.948 0.759 -0.029
8 0.159 0.654 1.303 -0.016 1.688 1.719
9 0.120 0.699 0.901 -0.013 1.671 0.840
10 0.059 0.405 0.930 -0.012 1.227
11 0.104 0.332 1.108 -0.015
12 0.216 0.314 0.673 -0.003
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Table 4.100 Adjusted IgGl OD values ofF. hepatica and F. gigantica
infected calves
F. hepatica F. gigantira
WPI 14c 15c 23 c 26c 34c 45c WPI 22 23 24 26
-27 0.017 0.065 0.165 0.142 -2 0.156 -0.022 0.045 0.165
-26 -0.008 0.142 0.155 0.126 -1 0.063 -0.004 0.149 0.147
-25 0.034 0.259 0.084 0.116 0 0.076 -0.017 0.123 0.135
-24 0.057 -0.040 -0.023 0.145 1 0.048 -0.029 0.118 0.168
-23 0.013 0.141 -0.041 0.095 2 0.053 -0.029 0.079 0.111
-22 0.204 -0.019 -0.041 0.025 3 0.038 -0.002 0.130 0.029
-21 0.942 0.079 -0.092 0.070 4 0.045 0.011 0.085 0.081
-20 1.161 0.208 -0.117 0.028 5 0.085 0.067 0.221 0.033
-19 1.161 0.329 -0.101 0.047 6 0.100 0.050 0.282 0.054
-18 1.084 1.349 -0.091 -0.017 7 0.139 0.475 1.161 -0.020
-17 1.441 1.459 -0.086 -0.021 8 0.075 1.178 0.960 -0.025
-16 1.359 1.144 -0.140 0.065 9 0.133 1.014 1.393 0.076
-15 1.190 1.386 -0.118 -0.033 10 0.678 1.060 1.425 -0.039
-14 0.999 1.302 -0.014 -0.013 11 0.584 0.816 1.477 -0.015
-13 0.942 1.397 -0.050 0.007 12 0.477 1.072 1.613 0.008
-12 1.222 1.390 -0.050 -0.034 13 1.381 1.671 1.408 -0.040
-11 0.940 0.812 -0.062 -0.015 14 1.487 1.646 1.779 -0.018
-10 0.812 0.836 0.257 -0.049 15 1.334 1.597 1.681 -0.057
-9 0.742 0.671 0.841 -0.037 16 1.226 1.273 1.730 -0.044
-8 0.625 0.899 1.162 -0.014 17 1.181 1.199 1.599 -0.016
-7 0.889 0.906 1.144 -0.050 18 1.381 1.577 1.674 -0.058
-6 0.571 0.521 1.117 -0.019 19 1.531 1.265 1.662 -0.022
-5 0.670 0.468 0.920 -0.025 20 1.226 1.127 1.714 -0.029
-4 0.594 0.210 0.887 0.009 21 0.943 1.046 1.769 0.005
-3 0.331 0.636 1.320 0.026 22 1.266 1.246 1.761 0.030
-2 0.806 0.701 1.227 -0.043 23 1.252 1.632 1.597 -0.050
-1 0.525 0.571 1.067 -0.013 24 1.291 1.344 1.663 -0.015
0 0.417 0.530 1.102 -0.039 0.034 -0.096 25 1.196 1.239 1.714 -0.046
1 0.399 0.462 1.003 -0.031 0.057 -0.126 26 1.226 1.163 1.718 -0.036
2 0.333 0.762 1.084 -0.006 0.013 -0.108 27 0.995 1.005 1.792 -0.007
3 0.605 0.715 1.227 -0.024 0.204 -0.022 28 1.083 1.489 1.734 -0.028
4 0.436 0.373 1.165 0.048 0.942 0.086 29 1.083 1.133 1.735 0.055
5 0.413 0.427 0.873 0.059 1.161 0.228 30 1.039 1.061 1.753 0.068
6 0.388 0.635 1.238 0.016 1.161 0.360 31 0.854 0.950 1.561 0.019
7 0.306 0.712 1.341 0.024 1.084 1.481 32 0.846 0.649 0.487 0.028
8 0.483 1.114 1.120 -0.038 1.441 1.602
9 0.417 1.017 1.193 -0.099 1.359 1.256
10 0.213 0.752 1.121 -0.057 1.190 1.522
11 0.316 0.678 1.058 -0.077 1.430
12 0.449 0.872 1.076 -0.076
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Table4.101 Adjusted IgMOD values ofF. hepatica and F. gigantica
infected calves
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI 22 23 24 26
-27 0.017 0.049 -0.023 0.057 ! "2 0.035 -0.03 0.101 0.109
-26 0.050 0.084 -0.039 0.023 -1 0.134 0.009 0.126 0.018
-25 0.045 0.067 0.032 0.045 0 0.161 0.031 0.12 0.078
-24 0.084 0.026 0.028 0.046 1 0.228 0.197 0.155 0.080
-23 0.114 0.264 -0.023 0.038 2 0.374 0.031 0.35 0.060
-22 0.288 0.392 -0.039 0.058 3 0.669 0.584 0.978 0.111
-21 0.343 0.151 0.036 0.083 4 1.134 0.733 0.725 0.058
-20 0.238 0.138 -0.012 0.079 5 0.644 0.717 0.678 0.068
-19 0.284 0.107 -0.021 0.108 6 0.675 0.468 0.656 0.046
-18 0.253 0.064 -0.043 0.054 7 0.534 0.405 0.815 0.101
-17 0.254 0.112 0.012 0.068 8 0.6 0.301 0.387 0.137
-16 0.493 0.075 0.176 0.020 9 0.462 0.465 0.389 0.010
-15 0.283 0.079 0.258 0.065 10 0.636 0.447 0.762 0.131
-14 0.347 0.115 0.261 0.082 11 0.383 0.52 0.833 0.175
-13 0.426 0.218 0.167 0.064 12 0.356 0.721 0.906 0.127
-12 0.493 0.598 0.402 0.076 13 0.467 0.146 0.606 0.159
-11 0.416 1.145 0.466 0.181 14 0.486 0.362 1.112 0.040
-10 0.463 0.938 0.431 0.038 15 0.345 0.252 0.455 0.058
-9 0.415 0.394 0.482 0.003 16 0.243 0.468 0.791 -0.034
-8 0.398 0.502 0.422 0.071 17 0.363 0.761 0.876 0.145
-7 0.524 0.338 0.543 0.055 18 0.873 0.691 0.735 0.103
-6 0.325 0.106 0.414 0.108 19 0.299 0.769 0.563 0.131
-5 0.441 0.109 0.509 0.115 20 0.591 0.69 0.779 0.175
-4 0.518 0.046 0.641 0.157 21 0.225 0.355 0.731 0.127
-3 0.188 0.510 0.644 0.173 22 0.342 1.019 0.719 0.159
-2 0.961 0.214 0.616 0.147 23 0.281 0.286 0.456 0.040
-1 0.731 0.277 0.810 0.068 24 0.29 0.396 0.567 0.139
0 0.539 0.190 0.757 0.078 0.030 0.079 25 0.107 0.489 0.533 0.165
1 0.358 0.145 0.665 0.080 0.150 0.444 26 0.225 0.583 0.702 0.169
2 0.378 0.273 0.662 0.187 0.331 0.233 27 0.425 0.763 1.214 0.159
3 0.460 0.367 0.858 0.221 0.334 0.425 28 0.429 0.773 0.965 0.040
4 0.392 0.146 0.797 0.160 0.220 0.485 29 0.438 0.671 0.851 0.139
5 0.411 0.105 0.480 0.179 0.507 0.629 30 0.297 0.587 0.833 0.034
6 0.301 0.179 0.582 0.125 0.585 0.420 31 0.083 0.63 0.701 0.090
7 0.352 0.152 0.517 0.216 0.542 0.667 32 0.227 0.261 0.684 0.133
8 0.426 0.218 0.256 0.140 0.605 0.576
9 0.373 0.217 0.394 0.151 0.531 0.650
10 0.178 0.160 0.617 0.076 0.679 0.746
11 0.436 0.118 0.582 0.099 0.906
12 0.533 0.223 0.445 0.107
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Table 4.102 Adjusted IgG2 OD values ofF hepatica and F. gigantica
infected calves
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI 22 23 24 26
-27 0.021 0.012 0.009 0.008 -2 0.027 -0.032 -0.038 0.033
-26 -0.025 0.046 0.011 0.001 -1 0.032 0.087 0.060 0.025
-25 0.021 0.020 0.042 0.005 0 0.004 0.079 0.035 0.029
-24 0.032 0.026 0.004 0.017 1 0.017 0.091 0.037 0.043
-23 0.008 0.037 0.019 0.006 2 0.067 0.072 0.052 0.031
-22 0.002 0.002 -0.020 0.006 3 0.280 0.086 0.022 0.031
-21 -0.012 0.007 -0.020 0.026 4 0.193 0.049 -0.026 0.053
-20 0.014 -0.008 -0.024 -0.030 5 0.269 0.044 0.000 -0.009
-19 0.031 0.014 -0.026 0.005 6 0.162 -0.003 0.005 0.029
-18 0.038 0.050 -0.003 -0.012 7 0.197 0.101 0.068 0.011
-17 0.114 0.077 0.042 0.003 8 0.281 0.085 -0.037 -0.017
-16 0.075 0.007 -0.022 0.009 9 0.193 0.049 0.041 -0.011
-15 0.044 0.003 -0.014 -0.018 10 0.193 0.144 0.139 0.004
-14 0.017 0.053 0.016 0.006 11 0.191 0.187 0.146 0.031
-13 0.037 0.058 0.047 -0.022 12 0.223 0.296 0.140 0.000
-12 -0.002 0.039 0.027 0.010 13 0.358 0.292 0.195 0.036
-11 0.028 0.076 0.008 0.042 14 0.277 0.355 0.323 0.071
-10 0.037 0.012 0.134 -0.021 15 0.307 0.331 0.259 0.001
-9 0.028 0.015 0.104 -0.024 16 0.211 0.409 0.356 -0.003
-8 0.033 0.038 0.104 0.003 17 0.210 0.414 0.276 0.028
-7 0.069 0.036 0.230 0.036 18 0.223 0.237 0.340 0.064
-6 0.129 -0.004 0.251 0.010 19 0.214 0.400 0.195 0.052
-5 0.169 0.015 0.496 0.046 20 0.219 0.415 0.211 0.076
-4 0.204 -0.006 0.397 0.014 21 0.160 0.231 0.227 0.040
-3 0.375 0.038 0.341 0.037 22 0.222 0.358 0.361 0.065
-2 0.108 0.346 0.263 0.070 23 0.231 0.134 0.220 0.101
-1 0.116 0.589 0.342 -0.031 24 0.197 0.130 0.326 -0.011
0 0.056 0.558 0.279 0.013 -0.039 0.025 25 0.234 0.225 0.264 0.038
1 0.024 0.326 0.286 0.022 -0.046 0.032 26 0.167 0.204 0.223 0.049
2 0.039 0.586 0.235 0.022 0.008 0.046 27 0.183 0.230 0.425 0.049
3 0.058 0.277 0.239 0.078 0.002 0.002 28 0.205 0.181 0.326 0.111
4 0.037 0.160 0.228 0.030 -0.012 0.009 29 0.219 0.135 0.166 0.058
5 0.071 0.140 0.307 0.056 0.014 -0.010 30 0.196 0.214 0.181 0.087
6 0.025 0.174 0.122 0.027 0.031 0.018 31 0.204 0.245 0.023 0.054
7 0.038 0.112 0.092 0.039 0.038 0.062 32 0.194 0.170 -0.004 0.068
8 0.190 0.165 0.117 -0.002 0.113 0.096
9 0.120 0.223 0.114 -0.005 0.074 0.009
10 0.050 0.117 0.093 -0.056 0.003
11 0.094 0.081 0.155 0.032
12 0.173 0.151 0.062 0.062
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Table 4.103 Adjusted IgA OD values ofF. hepatica and F. gigantica
infected calves
F. hepatica F. gigantica
WPI 14c 15c 23c 26c 34c 45c WPI 22 23 24 26
-27 0.063 0.017 -0.002 0.015
-26 -0.008 0.007 -0.007 0.015 -2 0.032 0.019 0.017 0.038
-25 0.032 0.018 0.018 -0.029 -1 0.044 0.019 0.043 0.038
-24 0.058 0.011 -0.016 -0.021 0 0.033 0.025 0.019 0.010
-23 0.015 c.:;9 0.002 -0.011 1 0.031 0.026 0.015 0.015
-22 0.028 0.020 -0.023 -0.004 2 0.031 0.043 0.015 0.022
-21 0.074 0.014 -0.043 0.028 3 0.046 0.037 0.047 0.026
-20 0.152 0.009 -0.036 0.000 4 0.022 0.033 -0.004 0.046
-19 0.107 -0.006 -0.005 -0.011 5 0.012 0.019 -0.026 0.029
-18 0.065 0.156 -0.011 0.004 6 0.021 0.018 -0.006 0.022
-17 0.149 0.218 0.009 -0.003 7 0.054 0.065 0.051 0.031
-16 0.119 0.041 -0.007 0.013 8 0.054 0.103 0.086 0.027
-15 0.072 0.101 0.014 0.000 9 0.C70 0.071 0.083 0.037
-14 0.056 0.126 0.041 -0.001 10 0.065 0.082 0.105 0.029
-13 0.011 0.161 0.047 -0.006 11 0.103 0.111 0.090 0.028
-12 0.098 0.117 0.072 0.007 12 0.102 0.147 0.150 0.025
-11 0.070 0.258 0.022 0.020 13 0.105 0.151 0.208 0.034
-10 0.067 0.137 0.036 -0.031 14 0.083 0.144 0.201 0.041
-9 0.126 0.032 0.094 -0.023 15 0.173 0.147 0.111 0.009
-8 0.031 0.026 0.207 -0.030 16 0.079 0.155 0.180 0.014
-7 0.091 0.060 0.315 0.013 17 0.174 0.153 0.210 0.010
-6 0.051 0.009 0.275 0.061 18 0.163 0.158 0.205 0.037
-5 0.095 -0.002 0.311 0.024 19 0.102 0.101 0.158 0.068
-4 0.017 -0.006 0.302 -0.019 20 0.099 0.118 0.152 0.044
-3 0.061 0.026 0.250 -0.004 21 0.072 0.131 0.184 0.017
-2 0.082 0.024 0.297 -0.014 22 0.089 0.189 0.193 0.026
-1 0.100 0.033 0.301 -0.013 23 0.102 0.182 0.270 0.020
0 0.008 0.018 0.230 0.005 -0.017 0.017 24 0.073 0.155 0.169 0.021
1 0.001 -0.005 0.227 -0.015 -0.026 0.001 25 0.078 0.128 0.167 0.032
2 -0.014 0.035 0.221 -0.013 -0.015 0.003 26 0.140 0.132 0.173 0.019
3 0.010 0.024 0.293 -0.009 0.000 0.064 27 0.127 0.135 0.126 0.021
4 0.004 0.012 0.236 -0.008 0.093 0.110 28 0.185 0.160 0.259 0.023
5 0.010 -0.003 0.211 -0.006 0.126 0.187 29 0.143 0.139 0.197 0.024
6 0.021 0.029 0.214 -0.023 0.123 0.143 30 0.188 0.146 0.190 0.025
7 -0.012 0.041 0.275 0.009 0.091 0.101 31 0.150 0.155 0.118 0.014
8 0.068 0.086 0.270 -0.021 0.077 0.184 32 0.171 0.121 0.188 0.034
9 0.026 0.099 0.211 -0.023 0.128 0.154
10 -0.001 0.035 0.184 -0.020 0.081 0.108
11 0.000 0.065 0.279 -0.024 0.092




Optical Density titration for ELISA using Fasciola hepatica
Glutathion S-Transferase (FhGST).
Appendix Table 4.104
Titrationsof total Ig showing mean OD values obtained in F. hepatica and
F. gigantica infected calves.
Antigen (mg/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.083 0.250 0.745 0.842 2 0.114 0.136 0.432 0.412
1 0.064 0.181 0.642 0.754 1 0.183 0.141 0.445 0.315
0.5 0.057 0.190 0.516 0.808 0.5 0.087 0.134 0.385 0.421
Serum
F. hepatica. F. gigantic
Serun B N PI P2 Serun B N PI P2
25 0.0833 0.40525 0.74475 0.84175 25 0.114 0.356 0.351 0.551
50 0.064 0.181 0.642 0.554 50 0.1083 0.199 0.245 0.422
100 0.05725 0.09025 0.216 0.308 100 0.08675 0.141 0.185 0.27
200 0.0285 0.072 0.13725 0.192 200 0.084 0.102 0.15 0.19
400 0.072 0.059 0.09575 0.14 400 0.071 0.09 0.096 0.148
800 0.051 0.04275 0.064 0.086 800 0.092 0.069 0.076 0.118
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.038 0.101 0.177 0.266 1000 0.035 0.075 0.184 0.315
2000 0.025 0.052 0.101 0.149 2000 0.022 0.037 0.071 0.181
4000 0.017 0.039 0.061 0.104 4000 0.020 0.019 0.050 0.096
8000 0.016 0.025 0.032 0.063 8000 0.016 0.015 0.035 0.059
16000 0.018 0.005 0.016 0.043 16000 0.017 0.003 0.026 0.045
32000 0.012 0.001 0.008 0.024 32000 0.021 -0.001 0.010 0.027
Appendix Table 4.105
Titration of IgGl Showing mean OD values obtained in F. hepatica and
F. gigantica infected calves.
Antigen (mg/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.1011 0.0500 0.6100 0.6500 2 0.0833 0.4205 0.0750 0.6750
1 0.0900 0.0300 0.6230 0.5900 1 0.0640 0.4810 0.6420 0.5540
0.5 0.0894 0.4120 0.7980 0.6870 0.5 0.0573 0.4025 0.6000 0.5800
Serum
F. hepatica. F. gigantic
Serum B N PI P2 Serum B N PI P2
50 0.0110 0.0500 0.6100 0.6500 50 0.0833 0.40525 0.74475 0.84175
100 0.0900 0.0300 0.2300 0.5900 100 0.064 0.181 0.642 0.554
200 0.0100 0.0600 0.1900 0.1500 200 0.05725 0.09025 0.216 0.308
400 0.0080 0.0490 0.2400 0.3300 400 0.0285 0.072 0.13725 0.192
800 0.0070 0.0300 0.2000 0.3100 800 0.072 0.059 0.09575 0.14
1600 0.0080 0.0270 0.1400 0.2500 1600 0.051 0.04275 0.064 0.086
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.214 0.412 0.798 0.687 1000 0.100 0.223 0.694 0.583
2000 0.165 0.161 0.632 0.480 2000 0.087 0.122 0.528 0.376
4000 0.147 0.138 0.379 0.312 4000 0.064 0.109 0.275 0.208
8000 0.131 0.121 0.227 0.249 8000 0.044 0.067 0.123 0.145
16000 0.111 0.157 0.205 0.187 16000 0.032 0.068 0.101 0.083




Titration of IgM Showing mean OD values obtained in F. hepatica and
F. gigantica infected calves.
Antigen (mg/ml)
t. hepatica. t. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.106 0.295 0.872 0.642 2 0.087 0.387 0.483 0.527
1 0.084 0.264 0.887 0.594 1 0.081 0.288 0.614 0.668
0.5 0.076 0.211 0.614 0.541 0.5 0.064 0.316 0.414 0.451
Serum
t. hepatica. t. gigantic
Seium B N PI P2 Serum B N PI P2
50 0.106 0.295 0.872 0.642 50 0.087 0.387 0.983 0.727
100 0.084 0.264 0.887 0.594 100 0.081 0.288 0.614 0.668
200 0.076 0.211 0.614 0.411 200 0.064 0.159 0.414 0.451
400 0.053 0.224 0.340 0.204 400 0.056 0.169 0.330 0.301
800 0.037 0.180 0.228 0.190 800 0.064 0.146 0.191 0.211
1600 0.220 0.144 0.161 0.183 1600 0.061 0.105 0.176 0.209
Conjugate
t. hepatica. t. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.179 0.318 0.913 0.709 1000 0.084 0.252 0.910 0.725
2000 0.159 0.229 0.510 0.398 2000 0.102 0.215 0.500 0.583
4000 0.119 0.218 0.421 0.259 4000 0.098 0.124 0.891 0.625
8000 0.083 0.201 0.336 0.215 8000 0.77 0.119 0.215 0.213
16000 0.046 0.188 0.201 0.192 16000 0.068 0.098 0.154 0.125
32000 0.022 0.096 0.117 0.184 32000 0.520 0.078 0.097 0.078
Titrations of IgG2 Showing mean OD values obtained in F. hepatica and
F. gigantica infected calves.
Antigen (mg/ml)
t. hepatica. t\ gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.043 0.102 0.201 0.380 2 0.087 0.092 0.198 0.109
1 0.037 0.119 0.260 0.298 1 0.054 0.065 0.107 0.109
0.5 0.028 0.082 0.391 0.277 0.5 0.053 0.038 0.192 0.161
Serum
t. hepatica. F. gigantic
Serum B N PI P2 Serum B N PI P2
50 0.043 0.102 0.244 0.108 50 0.087 0.092 0.198 0.087
100 0.037 0.119 0.126 0.098 100 0.054 0.065 0.107 0.088
200 0.028 0.082 0.091 0.077 200 0.053 0.038 0.092 0.061
400 0.022 0.031 0.074 0.056 400 0.034 0.021 0.064 0.040
800 0.013 0.020 0.061 0.035 800 0.018 0.011 0.034 0.038
1600 0.006 0.010 0.049 0.029 1600 0.005 0.008 0.018 0.024
Conjugate
t\ hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.031 0.033 0.060 0.095 1000 0.027 0.063 0.099 0.098
2000 0.028 0.030 0.050 0.035 2000 0.020 0.052 0.071 0.091
4000 0.022 0.025 0.022 0.031 4000 0.014 0.044 0.064 0.058
8000 0.020 0.026 0.027 0.033 8000 0.012 0.041 0.022 0.049
16000 0.029 0.030 0.020 0.029 16000 0.006 0.043 0.019 0.028




Titrations of IgA Showing mean OD values obtained in F. hepatica and
F. gigantica infected calves.
Antigen (mg/ml)
b\ hepatica. b\ gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.032 0.078 0.253 0.157 2 0.039 0.045 0.113 0.157
1 0.029 0.041 0.208 0.158 1 0.033 0.039 0.108 0.158
0.5 0.012 0.040 0.100 0.093 0.5 0.024 0.040 0.101 0.108
Serum
b\ hepatica. b. gigantic
Serum B N ri P2 Serum B N PI P2
50 0.032 0.078 0.253 0.157 50 0.039 0.045 0.113 0.157
100 0.029 0.041 0.208 0.158 100 0.033 0.039 0.108 0.158
200 0.012 0.040 0.100 0.093 200 0.024 0.040 0.100 0.093
400 0.011 0.032 0.070 0.054 400 0.250 0.026 0.076 0.054
800 0.009 0.025 0.049 0.032 800 0.019 0.021 0.029 0.032
1600 0.004 0.037 0.058 0.025 1600 0.014 0.017 0.022 0.025
Conjugate
b\ hepatica. b. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.031 0.033 0.060 0.095 1000 0.027 0.063 0.079 0.099
2000 0.028 0.030 0.050 0.085 2000 0.020 0.052 0.065 0.087
4000 0.022 0.025 0.022 0.031 4000 0.014 0.044 0.042 0.072
8000 0.020 0.026 0.027 0.033 8000 0.012 0.041 0.022 0.053
16000 0.029 0.030 0.020 0.031 16000 0.006 0.043 0.019 0.049
32000 0.011 0.031 0.030 0.029 32000 0.003 0.056 0.008 0.028
Appendix Table 4.109
Titration of total Ig Showing mean OD values obtained in F. hepatica and
F. gigantica infected sheep
Antigen (tig/ml)
b. hepatica. b. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.117 0.161 0.278 0.367 2 0.112 0.156 0.450 0.433
1 0.124 0.131 0.495 0.348 1 0.183 0.141 0.500 0.305
0.5 0.105 0.141 0.252 0.434 0.5 0.087 0.134 0.385 0.207
Serum
F. hepatica F. gigantic
Serum B N PI P2 Serum B N PI P2
25 0.06 0.492 0.645 0.59 25 0.061 0.565 0.73 0.77
50 0.058 0.33 0.423 0.471 50 0.056 0.406 0.567 0.553
100 0.054 0.265 0.281 0.27 100 0.06 0.26 0.384 0.359
200 0.055 0.208 0.22 0.228 200 0.065 0.206 0.248 0.274
400 0.076 0.14 0.165 0.157 400 0.056 0.175 0.158 0.18
800 0.077 0.112 0.114 0.116 800 0.05 0.089 0.125 0.145
Conjugate
b. hepatica. b\ gigantic
Conj. B N PI P2 Conj. B N PI P2 [
1000 0.042 0.392 0.687 0.59 1000 0.071 0.565 0.795 0.57
2000 0.035 0.333 0.623 0.471 2000 0.06 0.406 0.67 0.453
4000 0.028 0.274 0.359 0.352 4000 0.04 0.247 0.404 0.136
8000 0.021 0.087 0.195 0.233 8000 0.046 0.088 0.241 0.119
16000 0.014 0.056 0.074 0.114 16000 0.041 0.071 0.078 0.098




Titration of IgGl Showing mean OD values obtained in F. hepatica and
F. gigantica infected sheep
Antigen (pg/ml)
b\ hepatica. b gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.288 0.530 0.445 0.670 2 0.02 0.52 0.79 1.095
1 0.259 0.580 0.508 0.745 1 0.019 0.37 0.863 0.63
0.5 0.354 0.594 0.681 0.936 0.5 0.022 0.192 0.35 0.41
Serum
b. hepatica. b gigantic
Serum B N PI P2 Serum B N PI P2
50 0.0120 0.1580 0.6600 0.7800 50 0.012 0.2 0.8 0.695
100 0.0110 0.1320 0.5310 0.4300 100 0.019 0.137 0.51 0.63
200 0.0120 0.1090 0.2900 0.1800 200 0.028 0.2 0.35 0.41
Monoclonal antibody
b. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.120 0.272 0.452 0.341 10 0.12 0.1542 0.465 0.3095
20 0.011 0.142 0.310 0.253 20 0.109 0.169 0.509 0.263
40 0.010 0.061 0.230 0.136 40 0.026 0.079 0.372 0.245
80 0.009 0.056 0.209 0.087 80 0.033 0.049 0.211 0.134
160 0.008 0.055 0.127 0.101 160 0.04 0.021 0.135 0.121
320 0.007 0.103 0.090 0.027 320 0.047 0.014 0.09 0.16
Conjugate
b. hepatica. b. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.012 0.158 0.690 0.680 1000 0.012 0.162 0.87 0.95
2000 0.011 0.082 0.310 0.530 2000 0.019 0.137 0.59 0.63
4000 0.010 0.060 0.300 0.360 4000 0.026 0.092 0.32 0.45
8000 0.009 0.050 0.239 0.210 8000 0.033 0.055 0.21 0.24
16000 0.008 0.031 0.127 0.220 16000 0.04 0.038 0.15 0.21
32000 0.007 0.026 0.090 0.140 32000 0.047 0.011 0.09 0.16
Appendix Table 4.111
Titrations of IgM Showing mean OD values obtained in F. hepatica and
F. gigantica infected sheep.
Antigen (pg/ml)
b. hepatica. b. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.106 0.295 0.872 0.642 2 0.087 0.387 0.483 0.527
1 0.084 0.264 0.887 0.594 1 0.081 0.288 0.614 0.668
0.5 0.076 0.211 0.614 0.541 0.5 0.064 0.316 0.414 0.451
Serum
b. hepatica. b. gigantic
Serum B N PI P2 Serum B N PI P2
50 0.016 0.532 0.830 0.829 50 0.020 0.549 0.771 0.744
100 0.013 0.345 0.764 0.590 100 0.014 0.534 0.705 0.680
200 0.004 0.369 0.389 0.305 200 0.007 0.221 0.264 0.299
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
, 1000 0.179 0.318 0.913 0.709 1000 0.084 0.252 0.910 0.725
2000 0.159 0.229 0.510 0.398 2000 0.102 0.215 0.500 0.583
4000 0.119 0.218 0.421 0.259 4000 0.098 0.124 0.891 0.625




Titrations of IgG2 Showing mean OD values obtained in F. hepatica and
F. gigantica infected sheep.
Antigen (pg/ml)
b\ hepatica. b. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.084 0.091 0.091 0.108 2 0.041 0.032 0.049 0.044
1 0.081 0.070 0.101 0.066 1 0.039 0.032 0.045 0.042
0.5 0.079 0.080 0.089 0.088 0.5 0.031 0.027 0.041 0.027
Serum
b. hepatica. b. gigantic
Serum B N PI P2 Serum B N PI P2
50 0.008 0.012 0.016 0.011 50 0.015 0.009 0.010 0.020
100 0.008 0.009 0.018 0.006 100 0.014 0.010 0.011 0.015
200 0.008 0.008 0.010 0.007 200 0.011 0.017 0.018 0.009
Monoclonal antibody
b. hepatica. b. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.008 0.012 0.110 0.150 10 0.009 0.011 0.014 0.020
20 0.008 0.009 0.016 0.016 20 0.011 0.014 0.013 0.018
40 0.008 0.008 0.014 0.017 40 0.012 0.012 0.012 0.019
Conjugate
b. hepatica. I b. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.031 0.033 0.060 0.095 1000 0.027 0.063 0.099 0.098
2000 0.028 0.030 0.050 0.035 2000 0.020 0.052 0.071 0.091
4000 0.022 0.025 0.022 0.031 4000 0.014 0.044 0.064 0.058
8000 0.020 0.026 0.027 0.033 8000 0.012 0.041 0.022 0.049
Appendix Table 4.113
Titrations of IgA Showing mean OD values obtained in F. hepatica and
F. gigantica infected sheep.
Antigen (pg/ml)
b. hepatica. b. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.066 0.058 0.050 0.034 2 0.031 0.047 0.053 0.032
1 0.047 0.041 0.058 0.044 1 0.039 0.041 0.046 0.050
0.5 0.048 0.040 0.024 0.029 0.5 0.038 0.028 0.060 0.032
Serum
b. hepatica. b. gigantic
Serum B N PI P2 Serum B N PI P2
50 0.020 0.014 0.020 0.018 50 0.027 0.021 0.023 0.021
100 0.017 0.019 0.021 0.022 100 0.014 0.017 0.013 0.032
200 0.020 0.015 0.017 0.016 200 0.022 0.020 0.024 0.030
Monoclonal antibody
F. hepatica. h gigantic
McAb B N PI P2 McAb B N PI P2
10 0.012 0.013 0.022 0.028 10 0.022 0.023 0.024 0.024
20 0.017 0.018 0.023 0,022 20 0.016 0.027 0.013 0.022
40 0.019 0.015 0.017 0.016 40 0.022 0.021 0.024 0.023
Conjugate
b. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.031 0.033 0.060 0.095 1000 0.027 0.063 0.079 0.099
2000 0.028 0.030 0.050 0.085 2000 0.020 0.052 0.065 0.087
4000 0.022 0.025 0.022 0.031 4000 0.014 0.044 0.042 0.072
8000 0.020 0.026 0.027 0.033 8000 0.012 0.041 0.022 0.053
16000 0.029 0.030 0.020 0.031 16000 0.006 0.043 0.019 0.049




Adjusted OD values for Antibody Responses to Glutathion S-Transferase (FhGST)
By F. hepatica and F. gigantica infected sheep and cattle.
Experiment One (1): Adjusted values for F. hepatica
(British and Peruvian strain) infected sheep and uninfected sheep
Appendix Table 4.114
Adjusted Total Ig OD values Adjusted IgG, OD values
WPI SH.5 SH.6 SH.7 SH.9 SH. 10 SH. 8 WPI SH.5 SH.6 SH.7 SH.9 SH. 10 SH. 8
-2 0.173 0.113 0.161 0.137 0.066 0.125 -2 0.072 0.063 0.023 0.141 0.027 0.028
-1 0.181 0.108 0.101 0.164 0.016 0.006 -1 0.064 0.069 0.084 0.168 0.035 0.032
0 0.179 0.029 0.174 0.176 0.168 0.030 0 0.042 0.045 0.077 0.030 0.017 0.013
1 0.160 0.181 0.104 0.206 0.128 0.062 1 0.045 0.088 0.048 0.156 0.005 0.048
2 0.154 0.167 0.109 0.200 0.131 0.048 2 0.018 0.129 0.143 0.117 0.020 0.081
3 0.091 0.125 0.054 0.219 0.308 0.082 3 0.026 0.094 0.336 0.147 0.278 0.073
4 0.264 0.375 0.158 0.227 0.393 0.125 4 0.020 0.105 0.560 0.425 0.252 0.062
5 0.265 0.333 0.161 0.225 0.293 0.135 5 0.044 0.101 0.489 0.402 0.221 0.026
6 0.124 0.444 0.176 0.247 0.245 0.125 6 0.108 0.160 0.470 0.444 0.326 0.106
7 0.246 0.645 0.160 0.139 0.245 0.146 7 0.107 0.137 0.423 0.629 0.365 0.032
8 0.247 0.444 0.248 0.278 0.405 0.194 8 0.071 0.084 0.531 0.638 0.377 0.045
9 0.121 0.401 0.446 0.167 0.768 0.195 9 0.070 0.072 0.501 0.437 0.330 0.027
10 0.198 0.339 0.553 0.244 0.288 0.055 10 0.066 0.121 0.542 0.420 0.243 0.070
11 0.307 0.909 0.439 0.353 0.504 0.176 11 0.107 0.140 0.561 0.426 0.467 0.090
12 0.108 0.888 0.406 0.154 0.415 0.177 12 0.049 0.165 0.440 0.359 0.240 0.057
13 0.172 0.547 0.422 0.218 0.405 0.125 13 0.067 0.199 0.474 0.456 0.297 0.068
14 0.399 0.135 0.307 0.245 0.135 14 0.128 0.603 0.407 0.288 0.045
15 0.717 0.122 0.425 0.484 0.209 15 0.151 0.612 0.366 0.221 0.027
16 0.242 0.160 0.050 0.333 0.059 16 0.129 0.659 0.318 0.042 0.082
17 0.514 0.169 0.022 0.305 0.174 17 0.127 0.519 0.243 -0.017 0.080
Adjusted IgM OD values
Appendix Table 4.115
Adjusted IgG2 OD values
WPI SH.5 SH.6 SH.7 SH.9 SH. 10 SH. 8 WPI SH.5 SH.6 SH. 7 SH. 9 SH. 10 SH. 8
-2 0.229 0.145 0.322 0.111 0.216 0.188 -2 0.062 0.078 0.038 0.045 0.046 0.058
-1 0.291 0.124 0.245 0.003 0.230 0.253 -1 0.037 0.050 0.039 0.034 0.047 0.044
0 0.229 0.138 0.261 0.040 0.333 0.272 0 0.074 0.067 0.060 0.046 0.038 0.038
1 0.410 0.283 0.052 0.424 0.106 0.271 1 0.053 0.098 0.057 0.036 0.038 0.055
2 0.352 0.267 0.146 0.382 0.425 0.348 2 0.055 0.067 0.059 0.041 0.049 0.058
3 0.409 0.565 0.243 0.906 0.187 0.215 3 0.059 0.057 0.052 0.034 0.052 0.033
4 0.406 0.553 0.367 0.875 0.389 0.197 4 0.066 0.067 0.063 0.033 0.056 0.063
5 0.367 0.620 0.414 0.787 0.718 0.264 5 0.058 0.074 0.055 0.041 0.054 0.040
6 0.331 0.736 0.347 1.055 0.646 0.275 6 0.055 0.098 0.067 0.039 0.035 0.052
7 0.425 0.397 0.315 0.726 0.594 0.267 7 0.048 0.101 0.054 0.060 0.048 0.064
8 0.223 0.327 0.371 0.541 0.644 0.373 8 0.071 0.091 0.056 0.062 0.037 0.062
9 0.352 0.309 0.596 0.493 0.927 0.357 9 0.083 0.088 0.055 0.055 0.048 0.060
10 0.231 0.635 0.819 0.678 0.407 0.198 10 0.077 0.207 0.042 0.041 0.038 0.062
11 0.145 0.624 0.684 1.063 0.614 0.225 11 0.122 0.135 0.066 0.044 0.056 0.037
12 0.271 0.393 0.473 0.716 0.632 0.321 12 0.075 0.173 0.062 0.039 G.058 0.057
13 0.252 0.169 0.392 0.122 0.754 0.308 13 0.073 0.084 0.065 0.046 0.036 0.035
14 0.444 0.313 0.851 0.536 0.189 14 0.193 0.051 0.061 0.054 0.053
15 0.410 0.371 0.761 0.911 0.242 15 0.095 0.066 0.039 0.044 0.051
16 0.326 0.144 0.538 0.464 0.248 16 0.135 0.055 0.049 0.042 0.031




Adjusted IgA OP values
WPI SH. 5 SH. 6 SH. 7 SH. 9 SH. 10 SH. 8
-2 0.017 0.016 0.000 0.014 0.025 0.014
-1 0.022 0.015 0.003 0.016 0.019 0.017
0 0.041 0.017 0.014 0.010 0.019 0.013
1 0.041 0.028 0.006 0.034 0.022 0.012
2 0.032 0.040 0.024 0.055 0.039 0.011
3 0.045 0.017 0.014 0.042 0.020 0.014
4 0.026 0.019 0.035 0.047 0.019 0.014
5 0.017 0.022 0.022 0.042 0.021 0.018
6 0.019 0.028 0.022 0.060 0.021 0.022
7 0.023 0.021 0.021 0.053 0.032 0.023
8 0.018 0.023 0.019 0.061 0.024 0.016
9 0.016 0.018 0.024 0.080 0.030 0.019
10 0.016 0.020 0.026 0.075 0.037 0.022
11 0.013 0.035 0.023 0.060 0.050 0.020
12 0.027 0.039 0.015 0.039 0.046 0.016
13 0.033 0.033 0.015 0.065 0.059 0.021
14 0.036 0.026 0.080 0.045 0.019
15 0.039 0.032 0.035 0.045 0.022
16 0.027 0.035 0.048 0.033 0.019
17 0.032 0.028 0.057 0.027 0.026
Appendix Table 4.117
Experiment two (2): Adjusted values for F. hepatica
(British strain) infected and uninfected sheep
Adjusted Total Ig OD values Adjusted IgGl OD values
WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32 WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32
-2 0.044 0.097 0.004 0.034 0.031 0.002 -2 0.082 0.094 0.082 0.092 0.065 0.086
0 0.052 0.071 0.074 0.005 0.096 -0.028 0 0.090 0.085 0.080 0.086 0.085 0.079
2 0.258 0.169 0.165 0.019 0.100 0.098 2 0.073 0.074 0.082 0.105 0.071 0.072
4 0.522 0.331 0.790 0.299 0.036 0.077 4 0.074 0.081 0.089 0.086 0.075 0.069
6 0.502 0.191 0.597 0.189 0.105 0.050 6 0.070 0.085 0.076 0.094 0.073 0.078
8 0.668 0.243 0.472 0.252 0.091 0.002 8 0.091 0.095 0.079 0.126 0.074 0.080
9 0.715 0.754 0.403 0.375 0.131 0.059 9 0.086 0.098 0.089 0.088 0.078 0.083
10 0.722 0.255 0.361 0.249 0.113 0.083 10 0.083 0.086 0.089 0.102 0.080 0.074
11 0.699 0.331 0.351 0.237 0.095 0.035 11 0.078 0.090 0.082 0.096 0.075 0.069
12 0.532 0.158 0.487 0.431 0.070 0.108 12 0.071 0.116 0.080 0.088 0.073 0.069
13 0.826 0.261 0.259 0.321 0.129 0.116 13 0.087 0.111 0.075 0.096 0.088 0.072
14 0.944 0.102 0.240 0.237 0.132 0.115 14 0.072 0.100 0.097 0.090 0.075 0.070
15 1.038 0.130 0.318 0.206 0.178 0.104 15 0.074 0.101 0.099 0.088 0.074 0.077
16 0.637 0.031 0.578 0.377 0.103 0.117 16 0.086 0.101 0.086 0.088 0.076 0.074
17 0.698 0.121 0.380 0.360 0.030 0.102 17 0.095 0.093 0.081 0.100 0.079 0.072
18 0.665 0.043 0.431 0.162 0.134 0.101 18 0.103 0.079 0.077 0.094 0.073 0.070
19 0.563 0.242 0.184 0.073 0.156 0.033 19 0.074 0.080 0.086 0.086 0.075 0.074
20 0.367 0.120 0.124 0.197 0.107 0.081 20 0.082 0.092 0.111 0.096 0.078 0.068
21 0.471 0.064 0.413 0.146 0.087 0.001 21 0.083 0.082 0.079 0.092 0.074 0.073




Adjusted IgM OP values Adjusted IgG2 OD values
WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32 WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32
-2 0.178 0.124 0.179 0.148 0.124 0.082 -2 0.041 0.032 0.049 0.044 0.042 0.045
0 0.153 0.130 0.068 0.199 0.178 0.017 0 0.039 0.032 0.045 0.042 0.042 0.045
2 0.098 0.352 0.402 0.164 0.145 0.032 2 0.031 0.027 0.041 0.027 0.044 0.029
4 0.133 0.322 0.171 0.218 0.112 0.101 4 0.036 0.026 0.036 0.046 0.038 0.033
6 0.168 0.268 0.257 0.214 0.125 0.059 6 0.031 0.026 0.054 0.044 0.030 0.031
8 0.468 0.580 0.449 0.284 0.103 0.154 8 0.033 0.029 0.048 0.047 0.038 0.039
9 0.468 0.472 0.413 0.302 0.176 0.175 9 0.029 0.027 0.035 0.029 0.047 0.046
10 0.398 0.454 0.316 0.251 0.196 0.033 10 0.028 0.025 0.035 0.046 0.030 0.034
11 0.283 0.604 0.317 0.298 0.126 0.044 11 0.033 0.029 0.054 0.041 0.029 0.035
12 0.243 0.574 0.249 0.238 0.075 0.077 12 0.028 0.026 0.045 0.033 0.029 0.046
13 0.483 0.232 0.165 0.228 0.129 0.130 13 0.031 0.028 0.059 0.040 0.037 0.037
14 0.423 0.166 0.253 0.187 0.120 0.092 14 0.031 0.028 0.040 0.041 0.041 0.045
15 0.228 0.166 0.245 0.186 0.096 0.085 15 0.030 0.027 0.059 0.047 0.046 0.029
16 0.308 0.112 0.184 0.221 0.138 0.062 16 0.025 0.025 0.053 0.040 0.036 0.040
17 0.198 0.064 0.239 0.309 0.129 0.101 17 0.028 0.028 0.056 0.047 0.038 0.035
18 0.348 0.208 0.275 0.157 0.090 0.127 18 0.031 0.029 0.049 0.040 0.033 0.032
19 0.293 0.142 0.145 0.189 0.161 0.100 19 0.030 0.031 0.056 0.037 0.029 0.039
20 0.303 0.106 0.128 0.200 0.165 0.166 20 0.030 0.033 0.035 0.030 0.034 0.033
21 0.088 0.142 0.200 0.113 0.122 0.092 21 0.028 0.028 0.059 0.032 0.042 0.038
22 0.103 0.178 0.228 0.101 0.114 0.139 22 0.023 0.033 0.062 0.034 0.033 0.038
Appendix Table 4.119
Adjusted IgA OD values
WPI SH. 24 SH. 26 SH. 28 SH. 30 SH. 22 SH. 32
-2 0.044 0.044 0.052 0.033 0.026 0.035
0 0.036 0.040 0.041 0.044 0.023 0.022
2 0.031 0.038 0.033 0.049 0.023 0.028
4 0.036 0.042 0.038 0.049 0.042 0.021
6 0.044 0.027 0.036 0.029 0.022 0.027
8 0.042 0.042 0.051 0.033 0.034 0.040
9 0.042 0.033 0.026 0.045 0.039 0.033
10 0.028 0.029 0.029 0.045 0.028 0.024
11 0.045 0.028 0.023 0.035 0.037 0.025
12 0.024 0.042 0.044 0.051 0.029 0.024
13 0.043 0.034 0.038 0.028 0.038 0.023
14 0.025 0.029 0.045 0.038 0.038 0.029
15 0.045 0.024 0.025 0.036 0.035 0.039
16 0.039 0.040 0.025 0.030 0.042 0.027
17 0.043 0.036 0.023 0.039 0.039 0.042
18 0.024 0.029 0.026 0.054 0.038 0.032
19 0.036 0.044 0.041 0.046 0.041 0.033
20 0.039 0.037 0.046 0.051 0.032 0.032
21 0.033 0.046 0.045 0.054 0.031 0.036
22 0.038 0.024 0.025 0.036 0.035 0.039
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Appendices
Experiment three (3): Adjusted values for F. gigantica
(Kenyan strain) infected and uninfected sheep
Appendix Table 4.120
Adjusted total Ig OD values
Infected sheep Uninfected sheep
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH.16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.037 0.057 0.078 0.088 0.084 0.069 0.010 0.072 0.074 0.077 0.052 0.029 0.012
0 -0.021 0.152 0.072 0.127 0.255 0.117 0.046 0.00 0.046 0.049 0.024 0.044 0.008
2 0.432 0.196 0.024 0.475 0.259 0.277 0.082 0.025 0.056 0.060 0.035 0.048 0.008
4 0.348 0.239 0.126 0.350 0.202 0.253 0.043 0.032 0.059 0.062 0.037 0.046 0.008
6 0.285 0.186 0.132 0.302 0.367 0.254 0.042 0.028 0.058 0.061 0.036 0.062 0.006
8 0.482 0.225 0.085 0.246 0.431 0.294 0.072 0.060 0.069 0.072 0.047 0.031 0.012
9 0.278 0.244 0.153 0.336 0.516 0.305 0.060 0.000 0.047 0.051 0.025 0.095 0.011
10 0.318 0.260 0.077 0.409 0.236 0.260 0.055 0.123 0.092 0.095 0.070 0.015 0.016
11 0.328 0.307 0.193 0.340 0.514 0.336 0.052 -0.03 0.036 0.039 0.014 0.024 0.014
12 0.349 0.302 0.161 0.258 0.432 0.300 0.045 -0.01 0.043 0.046 0.021 0.065 0.006
13 0.272 0.115 0.077 0.136 0.476 0.215 0.073 0.066 0.071 0.075 0.049 0.034 0.011
14 0.247 0.108 0.109 0.316 0.354 0.227 0.051 0.006 0.049 0.053 0.028 0.039 0.010
15 0.255 0.167 0.329 0.321 0.236 0.262 0.030 0.016 0.053 0.056 0.031 0.054 0.007
16 0.200 0.156 0.313 0.264 0.233 0.014 0.044 0.063 0.067 0.041 0.094 0.010
17 0.099 0.116 0.266 0.278 0.190 0.014 0.120 0.091 0.094 0.069 0.079 0.007
18 0.081 0.150 0.310 0.264 0.201 0.012 0.091 0.081 0.084 0.059 0.095 0.011
19 0.251 0.023 0.535 0.246 0.264 0.017 0.123 0.092 0.095 0.070 0.087 0.009
20 0.170 0.045 0.207 0.244 0.167 0.013 0.107 0.086 0.090 0.064 0.021 0.014
21 0.243 0.017 0.189 0.105 0.139 0.013 -0.019 0.040 0.044 0.018 0.032 0.011
22 0.242 0.074 0.101 0.158 0.144 0.013 0.003 0.048 0.052 0.026 0.028 0.010
Appendix Table 4.121
Adjusted IgGl OD values
Infected sheep Uninfected sheep
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 Mean (+) SEMean SH.16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.032 0.066 0.015 0.076 0.043 0.046 0.011 0.045 0.042 0.062 0.045 0.049 0.005
0 0.093 0.145 0.091 0.153 0.047 0.106 0.020 0.048 0.109 0.088 0.087 0.083 0.013
2 0.422 0.531 0.503 0.564 0.089 0.422 0.087 0.076 0.120 -0.001 0.018 0.053 0.028
4 0.652 0.719 0.790 0.851 0.103 0.623 0.134 0.085 0.066 -0.003 0.060 0.052 0.019
6 0.719 0.687 0.874 0.935 0.118 0.667 0.145 0.095 0.053 0.064 0.053 0.066 0.010
8 0.986 0.811 0.675 0.636 0.112 0.644 0.146 0.091 0.043 0.057 0.053 0.061 0.010
9 0.660 1.014 0.929 0.684 0.085 0.674 0.162 0.073 0.049 0.028 0.051 0.050 0.009
10 0.875 0.871 0.750 0.348 0.113 0.591 0.154 0.091 0.060 0.018 0.022 0.048 0.017
11 0.562 0.906 0.794 0.684 0.099 0.609 0.140 0.082 0.053 -0.008 -0.001 0.032 0.022
12 0.822 0.472 0.251 0.616 0.062 0.445 0.133 0.058 0.098 -0.070 0.051 0.034 0.036
13 0.517 0.777 0.633 0.561 0.093 0.516 0.115 0.078 0.086 0.064 0.043 0.068 0.009
14 0.343 0.761 0.613 0.585 0.112 0.483 0.114 0.091 0.072 0.044 0.051 0.065 0.011
15 0.506 0.497 0.283 0.641 0.102 0.406 0.095 0.084 0.051 0.017 0.028 0.045 0.015
16 0.416 0.533 0.471 0.124 0.386 0.091 0.099 0.101 -0.042 0.043 0.050 0.034
17 0.286 0.361 0.411 0.033 0.273 0.084 0.039 0.082 -0.048 0.029 0.026 0.027
18 0.263 0.530 0.595 0.123 0.378 0.111 0.098 0.078 -0.034 0.055 0.049 0.029
19 0.366 0.366 0.528 0.120 0.345 0.084 0.096 0.050 0.013 0.116 0.069 0.023
20 0.177 0.485 0.518 0.111 0.323 0.104 0.090 0.107 -0.046 0.100 0.063 0.036
21 0.152 0.384 0.386 0.029 0.238 0.089 0.036 0.062 -0.052 0.040 0.022 0.025




Adjusted IgM OD values
Infected sheep Uninfected sheep
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 TrMean SEMean SH.16 SH. 17 SH. 18 SH. 19 TrMean SEM
-2 0.086 0.063 0.139 0.026 0.083 0.079 0.018 0.108 0.162 0.137 0.140 0.137 0.011
0 0.183 0.145 0.048 0.140 0.241 0.151 0.032 0.024 0.141 0.052 0.086 0.076 0.025
2 0.888 0.096 0.281 0.234 0.245 0.349 0.038 0.056 0.149 0.084 0.106 0.099 0.020
4 0.845 0.132 0.245 0.180 0.193 0.319 0.033 0.063 0.151 0.091 0.110 0.104 0.019
6 0.801 0.090 0.276 0.210 0.345 0.344 0.042 0.059 0.150 0.087 0.108 0.101 0.019
8 0.783 0.068 0.284 0.165 0.404 0.341 0.051 0.094 0.158 0.123 0.131 0.127 0.013
9 0.691 0.150 0.338 0.214 0.483 0.375 0.073 0.024 0.141 0.052 0.086 0.076 0.025
10 0.718 0.131 0.344 0.470 0.570 0.447 0.099 0.028 0.142 0.056 0.088 0.079 0.025
11 0.658 0.103 0.350 0.303 0.481 0.379 0.025 0.064 0.176 0.193 0.176 0.177 0.006
12 0.682 0.076 0.225 0.195 0.405 0.317 0.050 -0.01 0.133 0.021 0.065 0.053 0.031
13 0.630 0.112 0.131 0.275 0.446 0.319 0.082 0.014 0.138 0.042 0.079 0.068 0.027
14 0.572 0.113 0.071 0.148 0.333 0.247 0.070 0.101 0.160 0.130 0.135 0.132 0.012
15 0.479 0.166 0.099 0.188 0.224 0.231 0.065 0.035 0.144 0.063 0.092 0.091 0.022
16 0.464 0.105 0.189 0.250 0.252 0.078 0.045 0.146 0.073 0.099 0.114 0.016
17 0.305 0.088 0.086 0.263 0.186 0.058 0.077 0.154 0.105 0.119 0.175 0.006
18 0.418 0.006 0.126 0.250 0.200 0.079 0.161 0.175 0.189 0.173 0.152 0.008
19 0.649 -0.047 0.069 0.233 0.226 0.060 0.129 0.167 0.158 0.153 0.177 0.006
20 0.465 -0.017 0.090 0.231 0.192 0.040 0.164 0.176 0.193 0.176 0.164 0.006
21 0.568 -0.036 0.095 0.103 0.183 0.031 0.147 0.171 0.175 0.164 0.063 0.028
22 0.518 0.041 0.308 0.151 0.255 0.050 0.007 0.137 0.035 0.074 0.069 0.006
Appendix Table 4.123
Adjusted IgG2 OD values
Infected sheep Uninfected sheep
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 TrMean SEM SH.16 SH. 17 SH. 18 SH. 19 TrMean SEM
-2 0.081 0.106 0.022 0.169 0.081 0.051 0.024 0.093 0.081 0.065 0.063 0.040 0.019
0 0.093 0.081 0.035 0.079 0.128 0.043 0.015 0.010 0.085 0.082 0.058 0.059 0.017
2 0.110 0.089 0.017 0.024 0.129 0.050 0.023 0.00 0.073 0.073 0.048 0.048 0.018
4 0.074 0.076 0.029 0.006 0.184 0.074 0.031 0.034 0.109 0.101 0.076 0.080 0.017
6 0.046 0.071 0.002 0.091 0.165 0.075 0.027 0.003 0.078 0.076 0.052 0.052 0.018
8 0.037 0.084 -0.040 0.120 0.207 0.082 0.030 0.093 0.081 0.065 0.063 0.040 0.017
9 0.081 0.125 0.139 0.128 0.083 0.111 0.012 0.010 0.085 0.082 0.058 0.059 0.017
10 0.178 0.116 0.074 0.088 0.121 0.115 0.018 0.00 0.073 0.073 0.048 0.048 0.017
11 0.116 0.102 -0.067 0.155 0.129 0.087 0.030 0.025 0.100 0.094 0.070 0.072 0.017
12 0.217 0.111 0.083 0.162 0.168 0.148 0.023 0.028 0.103 0.096 0.072 0.074 0.017
13 0.152 0.142 0.092 0.115 0.166 0.133 0.013 0.016 0.091 0.087 0.063 0.064 0.017
14 0.114 0.137 0.034 0.113 0.194 0.118 0.026 0.045 0.120 0.110 0.085 0.090 0.017
15 0.100 0.086 0.073 0.066 0.136 0.092 0.012 0.029 0.104 0.097 0.073 0.076 0.017
16 0.044 0.119 -0.011 0.051 0.051 0.027 0.035 0.110 0.102 0.077 0.081 0.017
17 0.025 0.096 -0.050 0.233 0.076 0.030 0.026 0.101 0.095 0.071 0.073 0.017
18 0.040 0.094 -0.044 0.094 0.046 0.033 0.024 0.099 0.093 0.069 0.071 0.017
19 0.096 0.084 -0.026 0.132 0.072 0.034 0.003 0.078 0.076 0.052 0.052 0.018
20 0.062 0.111 -0.051 0.082 0.051 0.036 0.003 0.078 0.076 0.052 0.052 0.018
21 0.067 0.096 -0.023 0.031 0.043 0.026 0.004 0.079 0.077 0.053 0.053 0.018




Adjusted IgA OD values
Infected sheep Uninfected sheep
WPI SH.ll SH.12 SH. 13 SH. 14 SH. 15 Mean (+) SEMean SH.16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.009 0.025 0.022 0.017 0.026 0.014 0.003 0.011 0.006 0.006 0.009 0.008 0.001
0 0.017 0.019 0.015 0.043 0.009 0.015 0.006 0.007 0.000 0.010 0.010 0.007 0.002
2 0.016 0.006 0.029 0.017 0.009 0.015 0.004 0.011 0.025 0.016 0.006 0.015 0.004
4 0.029 0.007 0.014 0.039 0.023 0.022 0.006 0.019 0.020 0.010 0.006 0.014 0.003
6 0.028 0.003 0.025 0.023 0.025 0.021 0.005 -0.01 0.023 0.013 0.013 0.010 0.007
8 0.021 0.004 0.033 0.010 0.005 0.015 0.006 -0.01 0.019 0.009 0.013 0.009 0.006
9 0.017 0.023 0.026 0.023 0.024 0.023 0.002 0.012 0.016 0.006 0.010 0.011 0.002
10 0.027 0.001 0.024 0.004 0.026 0.016 0.006 0.006 0.015 0.005 -0.001 0.006 0.003
11 0.026 0.027 0.022 0.004 0.004 0.017 0.005 0.014 0.004 -0.006 0.010 0.006 0.004
12 0.014 0.022 0.033 0.033 0.025 0.025 0.004 0.012 -0.010 0.000 0.011 0.003 0.005
13 0.019 0.006 0.016 0.017 0.023 0.016 0.003 0.016 0.004 -0.006 0.018 0.008 0.006
14 0.010 0.007 0.034 0.004 0.011 0.013 0.005 0.001 -0.005 -0.005 0.003 -0.002 0.002
15 0.010 0.006 0.042 0.012 0.028 0.020 0.007 0.010 0.012 0.002 0.011 0.009 0.002
16 0.006 0.002 0.025 0.015 0.012 0.005 0.007 0.006 0.016 0.014 0.011 0.003
17 0.021 0.021 0.039 0.017 0.025 0.005 -0.01 0.013 0.013 0.016 0.009 0.005
18 0.003 0.000 0.013 0.007 0.006 0.003 0.016 0.012 0.012 0.015 0.014 0.001
19 0.010 0.000 0.027 0.028 0.016 0.007 0.011 0.018 0.008 0.008 0.011 0.002
20 0.005 0.002 0.006 0.014 0.007 0.003 0.019 0.013 0.003 0.006 0.010 0.004
21 0.014 0.024 0.012 0.022 0.018 0.003 -0.01 0.000 0.010 0.007 0.003 0.003
22 0.015 0.010 0.021 0.028 0.011 0.065 0.006 0.004 0.014 0.010 0.009 0.002
Experiment Four (4): Adjusted values for F. gigantica
(Kenyan strain) infected and uninfected sheep
Appendix Table 4.125
Adjusted total Ig OD values Adjusted IgGl OD values
WPI SH.23 SH.25 SH. 27 SH. 29 SH. 21 SH.31 WPI SH.23 SH.25 SH. 27 SH. 29 SH. 21 SH.31
-2 0.023 0.020 0.081 0.053 0.036 0.003 -2 0.045 0.053 0.012 0.059 0.036 0.025
0 0.018 0.053 -0.104 0.065 0.023 0.006 0 0.043 0.149 0.086 0.097 0.040 0.108
2 0.971 0.755 -0.072 0.190 0.049 0.172 2 0.484 0.616 0.484 0.531 0.079 0.121
4 0.834 0.639 0.141 0.167 0.038 -0.040 4 0.814 0.843 0.762 0.691 0.091 0.054
6 0.917 0.586 0.066 0.114 0.021 0.123 6 0.798 0.805 0.843 0.730 0.106 0.038
8 0.793 0.893 -0.033 0.514 0.204 0.131 8 1.006 0.793 1.166 0.572 0.100 0.025
9 0.636 0.701 -0.033 0.759 0.188 0.029 9 0.995 0.547 0.772 0.819 0.075 0.034
10 0.554 0.657 0.045 0.684 0.170 -0.047 10 0.785 0.699 1.032 0.742 0.101 0.047
11 0.552 0.620 0.096 0.306 -0.005 0.015 11 0.747 0.778 0.653 0.701 0.088 0.038
12 0.476 0.431 0.246 0.039 -0.122 -0.044 12 0.820 0.711 0.968 0.450 0.053 0.094
13 0.625 0.543 0.033 0.257 -0.040 -0.152 13 0.767 0.593 0.599 0.517 0.083 0.079
14 0.558 0.440 0.225 0.361 -0.018 0.033 14 0.637 0.572 0.388 0.436 0.100 0.062
15 0.557 0.380 0.699 0.251 -0.068 0.109 15 0.693 0.511 0.586 0.633 0.091 0.035
16 0.570 0.573 0.118 0.024 0.053 16 0.465 0.477 0.175 0.111 0.098
17 0.507 -0.016 0.090 -0.017 17 0.319 0.367 0.027 0.074
18 0.588 -0.021 0.135 0.109 18 0.292 0.339 0.110 0.069
19 1.128 0.133 0.047 -0.014 19 0.416 0.463 0.107 0.034
20 0.633 0.003 0.108 -0.082 20 0.188 0.235 0.099 0.104
21 1.413 -0.049 0.169 -0.056 21 0.157 0.204 0.023 0.049




Adjusted IgM OP values Adjusted IgG2 OP values
WPI SH.23 SH.25 SH. 27 SH. 29 SH. 21 SH.31 WPI SH.23 SH.25 SH. 27 SH. 29 SH. 21 SH.31
-2 0.137 0.161 0.159 0.130 0.043 0.076 -2 0.055 0.051 0.003 0.033 0.052 0.001
0 -0.02 0.086 0.036 0.007 0.082 0.107 0 0.011 0.047 0.014 0.073 0.041 0.051
2 0.045 0.173 0.085 0.056 0.067 0.121 2 0.059 0.067 0.059 0.058 0.058 0.031
4 0.076 0.100 0.110 0.081 0.060 0.012 4 0.035 0.010 0.054 0.070 0.012 0.010
6 0.161 0.129 0.178 0.149 0.096 0.131 6 0.034 0.006 0.051 0.063 -0.002 0.002
8 0.339 0.200 0.320 0.291 0.039 0.099 8 0.096 0.010 0.101 0.062 0.030 0.060
9 0.237 0.176 0.239 0.210 0.121 0.024 9 0.104 0.017 0.090 0.026 0.031 0.016
10 0.076 0.128 0.110 0.081 0.033 0.13! 10 0.109 0.025 0.039 0.057 0.040 0.000
11 0.087 0.156 0.119 0.090 0.024 0.023 11 0.084 0.014 0.030 0.008 0.007 0.036
12 0.262 0.094 0.259 0.230 0.023 0.086 12 0.130 0.009 0.015 0.022 0.024 0.044
13 0.106 0.125 0.134 0.105 0.066 0.053 13 0.096 0.006 0.101 0.012 0.009 0.020
14 0.114 0.086 0.140 0.111 0.035 0.092 14 0.039 0.094 0.063 0.074 0.028 0.019
15 0.140 0.078 0.161 0.133 0.046 0.026 15 0.045 0.001 0.098 0.038 0.042 0.040
16 0.098 0.199 0.010 0.070 0.127 16 0.000 0.012 0.030 0.037 0.090 0.024
17 0.118 0.097 0.027 0.012 17 0.000 0.071 0.002 0.046 -0.01
18 -0.011 0.004 0.035 0.094 18 0.077 0.027 0.040 0.023
19 0.021 0.007 0.016 0.058 19 0.072 0.101 0.023 0.037
20 0.046 0.134 0.040 0.064 20 0.056 0.086 0.010 0.000
21 -0.073 -0.001 0.053 0.107 21 0.140 0.106 0.012 0.053
22 0.006 0.078 0.043 0.076 22 0.056 0.071 0.043 0.002
Appendix Table 4.127
Adjusted IgA OD values
WPI SH.23 SH.25 SH. 27 SH. 29 SH. 21 SH.31
-2 0.026 0.002 0.020 0.005 0.018 0.016
0 0.019 0.003 0.014 0.023 0.001 0.013
2 0.033 0.020 0.001 0.005 0.001 0.016















9 0.030 0.014 0.018 0.009 0.016 0.017
10 0.028 0.015 -0.004 -0.004 0.018 0.011
11 0.026 0.015 0.022 -0.004 -0.004 0.019
12 0.037 0.018 0.017 0.016 0.017 0.017
13 0.020 0.022 0.001 0.005 0.015 0.021
14 0.038 0.023 0.002 -0.003 0.003 0.006
15 0.046 0.028 0.001 0.002 0.020 0.015
16 0.039 -0.003 0.011 0.007 0.013
17 0.016 0.020 0.009 -0.002
18 -0.005 0.003 -0.001 0.022
19 -0.005 0.012 0.020 0.016
20 -0.003 -0.002 0.006 0.024
21 0.019 0.002 0.014 0.000
22 -0.004 -0.005 0.020 0.012
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Appendices
Experiment 5 and 6: Calves infected with F.hepatica and F. gigantica respectively,
Adjusted Antibody values in response to Fh-E/S and Fh-E/S
Appendix Table 4.128
Adjusted total Ig OD values
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI Calf22 calf23 calf24 calf26
-2 0.029 0.032 0.071 0.026 -2 0.022 0.017 0.059 0.077
-1 0.051 0.026 0.07 0.016 -1 0.016 0.013 0.039 0.074
0 0.027 0.039 0.078 0.025 0 0.016 0.04 0.11 0.063
-24 0.069 0.021 0.086 0.031 1 0.023 0.089 0.03 0.077
-23 0.065 0.022 0.07 0.03 2 0.126 0.2 0.079 0.092
-22 0.073 0.014 0.057 0.018 3 0.185 0.63 0.053 0.009
-21 0.059 0.007 0.014 0.031 4 0.15 0.266 0.013 0.016
-20 0.077 0.013 0.019 0.035 5 0.134 0.419 0.131 0.001
-19 0.063 0.027 0.027 0.025 6 0.155 0.439 0.133 0.027
-18 0.073 0.034 0.078 0.024 7 0.274 0.296 0.179 0.038
-17 0.082 0.071 0.086 0.027 8 0.213 0.366 0.119 0.032
-16 0.093 0.05 0.05 0.014 9 0.315 0.276 0.144 0.047
-15 0.113 0.017 0.012 0.043 10 0.229 0.327 0.187 0.043
-14 0.126 0.04 0.056 0.018 11 0.164 0.503 0.299 0.069
-13 0.124 0.039 0.012 0.016 12 0.263 0.277 0.341 0.063
-12 0.089 0.044 0.041 0.025 13 0.354 0.574 0.431 0.024
-11 0.106 0.06 0.034 0.031 14 0.201 0.409 0.259 0.039
-10 0.098 0.047 0.049 0.03 15 0.176 0.456 0.286 0.028
-9 0.098 0.044 0.018 0.035 16 0.144 0.593 0.438 0.015
-8 0.136 0.042 0.013 0.025 17 0.258 0.392 0.44 0.005
-7 0.114 0.066 0.265 0.024 18 0.251 0.397 0.202 0.066
-6 0.112 0.087 0.27 0.037 19 0.391 0.289 0.187 0.055
-5 0.166 0.063 0.177 0.03 20 0.144 0.357 0.228 0.024
-4 0.138 0.054 0.2 0.04 21 0.258 0.705 0.193 0.041
-3 0.124 0.094 0.098 0.037 22 0.27 0.459 0.181 0.062
-2 0.161 0.123 0.157 0.03 23 0.341 0.234 0.194 0.03
-1 0.158 0.091 0.318 0.036 24 0.25 0.349 0.123 0.042
0 0.154 0.112 0.091 0.035 0.006 0.034 25 0.198 0.242 0.098 0.034
1 0.138 0.119 0.118 0.024 0.018 0.023 26 0.233 0.317 0.141 0.035
2 0.194 0.099 0.33 0.022 0.013 0.19 27 0.229 0.344 0.129 0.049
3 0.188 0.131 0.426 0.02 0.026 0.124 28 0.279 0.418 0.118 0.055
6 0.219 0.091 0.385 0.025 0.181 0.214 29 0.244 0.372 0.156 0.024
5 0.164 0.103 0.27 0.024 0.074 0.174 30 0.283 0.296 0.228 0.041















9 0.164 0.15 0.222 0.354 0.096
10 0.31 0.161 0.26 0.143




Adjusted IgG, OD values
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI Calf22 calf23 calf24 calf26
-2 0.02 0.015 0.094 0.011
-1 0.097 0.071 0.071 0.01 -2 0.063 0.002 0.009 0.021
0 0.178 0.081 0.119 0.006 -1 0.096 0.018 0.113 0.02
-24 0.064 0.22 0.077 0.052 0 0.16 0.031 0.151 0.016
-23 0.134 0.117 0.016 0.021 1 0.021 0.127 0.208 0.06
-22 0.022 0.385 0.131 0.075 2 0.168 0.085 0.171 0.03
-21 0.091 0.264 0.015 0.058 3 0.216 0.358 0.303 0.262
-20 0.031 0.284 0.025 0.145 4 0.356 0.401 0.271 0.066
-19 0.145 0.111 0.061 0.157 5 0.134 0.191 0.009 0.148
-18 0.14 0.204 0.021 0.075 6 0.069 0.312 0.086 0.159
-17 0.152 0.352 0.038 0.115 7 0.108 0.448 0.201 0.082
-16 0.244 0.146 0.073 0.064 8 0.268 0.283 0.035 0.12
-15 0.789 0.355 0.305 0.093 9 0.254 0.239 0.041 0.071
-14 0.192 0.366 0.274 0.031 10 0.307 0.437 0.326 0.099
-13 0.269 0.242 0.062 0.012 11 0.238 0.691 0.381 0.04
-12 0.258 0.227 0.14 0.08 12 0.246 0.961 0.336 0.022
-11 0.211 0.232 0.046 0.004 13 0.547 0.914 0.129 0.086
-10 0.289 0.52 0.242 0.05 14 0.438 1.156 0.18 0.014
-9 0.343 0.298 0.786 0.026 15 0.408 1.104 0.595 0.058
-8 0.356 0.686 0.419 0.025 16 0.282 1.172 0.255 0.035
-7 0.393 0.679 0.426 0.1 17 0.442 0.97 0.349 0.034
-6 0.353 0.289 0.822 0.102 18 0.567 0.896 0.209 0.105
-5 0.295 0.346 0.721 0.103 19 0.299 0.983 0.383 0.107
-4 0.234 0.333 0.463 0.088 20 0.476 1.172 0.59 0.108
-3 0.326 0.309 0.145 0.112 21 0.411 1.184 0.981 0.094
-2 0.681 0.379 0.255 0.058 22 0.327 0.836 0.659 0.117
-1 0.494 0.54 0.437 0.004 23 0.646 0.547 0.275 0.066
0 0.401 0.588 0.454 0.1 0.021 0.048 24 0.661 0.736 0.514 0.014
1 0.336 0.422 0.493 0.012 0.061 -0.003 25 0.622 0.568 0.71 0.105
2 0.356 0.66 0.274 0.117 0.127 -0.002 26 0.457 1.252 0.413 0.022
3 0.493 0.659 0.382 0.056 0.086 0.352 27 0.461 0.738 0.415 0.148
6 0.363 0.788 0.38 0.021 0.276 0.231 28 0.272 0.653 0.236 0.064
5 0.317 0.713 0.421 0.088 0.301 0.251 29 0.73 0.821 0.021 0.03
4 0.523 0.788 0.495 0.089 0.445 0.319 30 0.597 0.85 0.378 0.094
7 0.468 0.718 0.389 0.109 0.437 0.338 31 0.681 1.044 0.51 0.095
8 0.46 0.41 0.712 0.75 0.318 32 0.401 0.846 0.221 0.114
9 0.357 0.563 0.593 0.631 0.322
10 0.383 0.768 0.566 0.409




Adjusted IgM OD values
F. hepatica F. gigantica
WPI 14c 15c 23c 26c 34c 45c WPI Calf22 calf23 calf24 calf26
-2 0.231 0.078 0.215 0.064 -2 0.054 0.039 0.039 0.099
-1 0.244 0.028 0.146 0.05 -1 0.017 0.094 0.055 0.094
0 0.32 0.033 0.146 0.066 0 0.088 0.009 0.081 0.1
-24 0.231 0.305 0.238 0.005 1 0.171 0.133 0.185 0.077
-23 0.244 0.127 0.087 0.077 2 0.87 0.086 0.434 0.104
-22 0.32 0.258 0.081 0.163 3 0.448 0.175 0.444 0.136
-21 0.495 0.223 0.107 0.08 4 0.566 0.126 0.804 0.105
-20 0.439 0.273 0.088 0.239 5 0.569 0.284 0.683 0.165
-19 0.591 0.471 0.124 0.118 6 0.682 0.186 0.574 0.119
-18 0.659 0.513 0.081 0.014 7 0.507 0.139 0.518 0.08
-17 0.682 0.4 0.079 0.071 8 0.414 0.021 0.439 0.101
-16 0.844 0.525 0.238 0.217 9 0.5 0.019 0.596 0.156
-15 0.8 0.434 0.246 0.08 10 0.712 0.149 0.713 0.105
-14 0.862 0.458 0.228 0.102 11 0.542 0.271 0.566 0.113
-13 0.665 0.395 0.683 0.095 12 0.567 0.47 0.693 0.111
-12 0.635 0.434 0.73 0.111 13 0.696 0.241 0.814 0.117
-11 0.651 1.345 0.686 0.033 14 0.752 0.69 0.843 0.008
-10 0.692 0.883 0.808 0.059 15 0.434 0.283 0.451 0.097
-9 0.905 0.151 0.649 0.109 16 0.44 0.503 0.559 0.116
-8 0.943 0.244 0.59 0.055 17 0.574 0.548 0.686 0.095
-7 0.629 0.288 0.755 0.064 18 0.901 0.413 0.723 0.099
-6 0.879 0.146 0.607 0.01 19 0.686 0.525 0.579 0.078
-5 0.799 0.273 0.826 0.095 20 0.719 0.838 0.495 0.111
-4 0.751 0.153 0.922 0.066 21 0.74 0.543 0.725 0.1
-3 0.776 0.67 0.513 0.005 22 0.695 0.476 0.84 0.077
-2 0.346 0.343 0.609 0.077 23 0.803 0.344 0.698 0.104
-1 0.696 0.394 0.76 0.055 24 0.791 0.219 0.71 0.095
0 0.902 0.268 1.058 0.109 0.066 0.054 25 0.72 0.33 0.464 0.116
1 0.604 0.237 0.77 0.066 0.1 0.128 26 0.549 0.355 0.563 0.1
2 0.695 0.564 1 0.005 0.226 0.144 27 0.585 0.38 0.655 0.077
3 0.795 0.678 1.249 0.077 0.561 0.22 28 0.657 0.449 0.741 0.104
6 0.668 0.275 1.323 0.071 0.79 0.395 29 0.591 0.433 0.489 0.101
5 0.89 0.615 1.463 0.138 0.562 0.339 30 0.707 0.175 0.355 0.127
4 0.748 0.446 1.466 0.104 0.606 0.491 31 0.544 0.378 0.442 0.114
7 0.933 0.479 1.468 0.075 0.689 0.559 32 0.527 0.253 0.38 0.103
8 0.736 0.399 0.82 0.519 0.29
9 0.884 0.376 0.656 0.532
10 0.839 0.55 0.989 0.459




Adjusted IgG2 OD values
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI Calf22 calf23 calf24 calf26
-2 0.074 0.045 0.108 0.036 -2 0.068 0.043 0.039 0.053
-1 0.104 0.043 0.086 0.038 -1 0.085 0.069 0.093 0.055
0 0.081 0.051 0.069 0.072 0 0.076 0.067 0.117 0.089
-24 0.092 0.058 0.041 0.038 1 0.067 0.072 0.047 0.055
-23 0.077 0.027 0.03 0.046 2 0.043 0.075 0.123 0.063
-22 0.053 0.06 0.026 0.034 3 0.093 0.096 0.041 0.051
-21 0.043 0.025 0.021 0.042 4 0.054 0.05 0.053 0.059
-20 0.023 0.037 0.021 0.023 5 0.068 0.082 0.03 0.04
-19 0.048 0.03 0.004 0.063 6 0.039 0.086 0.007 0.08
-18 0.017 0.03 0.059 0.032 7 0.043 0.156 0.026 0.049
-17 0.048 0.035 0.053 0.054 8 0.037 0.076 0.038 0.071
-16 0.032 0.018 0.027 0.022 9 0.031 0.072 0.024 0.039
-15 0.014 0.062 0.013 0.047 10 0.022 0.11 0.027 0.064
-14 0.004 0.051 0.072 0.016 11 0.017 0.113 0.007 0.033
-13 0.063 0.038 0.061 0.05 12 0.054 0.178 0.05 0.067
-12 0.087 0.022 0.062 0.042 13 0.089 0.117 0.104 0.059
-11 0.023 0.053 0.05 0.028 14 0.039 0.127 0.053 0.045
-10 0.015 0.06 0.016 0.04 15 0.022 0.124 0.043 0.057
-9 0.032 0.054 0.097 0.009 16 0.022 0.131 0.038 0.026
-8 0.013 0.013 0.05 0.06 17 0.024 0.063 0.068 0.077
-7 0.052 0.058 0.126 0.048 18 0.041 0.086 0.038 0.065
-6 0.029 0.05 0.026 0.038 19 0.028 0.128 0.015 0.055
-5 0.018 0.027 0.035 0.038 20 0.028 0.088 0.048 0.055
-4 0.002 0.007 0.021 0.025 21 0.028 0.077 0.02 0.042
-3 0.088 0.043 0.009 0.04 22 0.052 0.047 0.016 0.057
-2 0.109 0.097 0.099 0.038 23 0.057 0.102 0.003 0.055
-1 0.067 0.043 0.035 0.036 24 0.033 0.036 0.104 0.053
0 0.036 0.022 0.055 0.028 0.054 0.044 25 0.028 0.049 0.048 0.045
1 0.035 0.042 0.037 0.038 0.065 0.051 26 0.017 0.025 0.02 0.055
2 0.03 0.258 0.058 0.019 0.05 0.02 27 0.033 0.112 0.016 0.036
3 0.096 0.102 0.124 0.071 0.026 0.053 28 0.05 0.068 0.018 0.088
6 0.029 0.145 0.102 0.064 0.016 0.018 29 0.076 0.062 0.02 0.081
5 0.038 0.095 0.373 0.038 0.01 0.03 30 0.03 0.06 0.016 0.055
4 0.056 0.198 0.256 0.036 0.026 0.044 31 0.056 0.15 0.021 0.053
7 0.073 0.183 0.145 0.037 0.016 0.051 32 0.033 0.121 0.02 0.054
8 0.137 0.141 0.122 0.024 0.02
9 0.087 0.122 0.152 0.025 0.043
10 0.078 0.177 0.157 0.015 0.05




Adjusted IgA OD values
F. hepatica F. gigantica
WPI 14c 15c 23 c 26c 34c 45c WPI Calf22 calf23 calf24 calf26
-2 0.037 0.031 0.043 0.036 -2 0.051 0.03 0.032 0.029
-1 0.041 0.045 0.044 0.044 -1 0.033 0.033 0.038 0.04
0 0.029 0.059 0.04 0.016 0 0.035 0.045 0.016 0.041
-24 0.07 0.069 0.053 0.04 1 0.023 0.05 0.035 0.029
-23 0.057 0.053 0.036 0.041 2 0.026 0.059 0.066 0.032
-22 0.042 0.041 0.032 0.034 3 0.019 0.043 0.03 0.024
-21 0.078 0.025 0.033 0.025 4 0.028 0.016 0.023 0.033
-20 0.023 0.01 0.04 0.033 5 0.017 0.021 0.029 0.022
-19 0.03 0.027 0.021 0.024 6 0.02 0.034 0.022 0.025
-18 0.011 0.034 0.031 0.034 7 0.029 0.027 0.03 0.035
-17 0.017 0.028 0.015 0.023 8 0.015 0.037 0.021 0.019
-16 0.017 0.025 0.032 0.03 9 0.017 0.021 0.027 0.022
-15 0.019 0.023 0.029 0.013 10 0.009 0.02 0.013 0.013
-14 0.005 0.026 0.063 0.034 11 0.01 0.017 0.03 0.014
-13 0.037 0.046 0.088 0.015 12 0.033 0.067 0.015 0.029
-12 0.053 0.031 0.064 0.046 13 0.006 0.048 0.04 0.032
-11 0.014 0.112 0.076 0.029 14 0.013 0.05 0.026 0.024
-10 0.013 0.019 0.073 0.04 15 0.013 0.054 0.035 0.017
-9 0.008 0.037 0.039 0.016 16 0.012 0.045 0.016 0.016
-8 0.023 0.027 0.042 0.019 17 0.016 0.038 0.018 0.021
-7 0.014 0.06 0.029 0.013 18 0.016 0.041 0.013 0.01
-6 0.01 0.045 0.037 0.023 19 0.016 0.046 0.021 0.033
-5 0.008 0.032 0.019 0.028 20 0.006 0.036 0.025 0.037
-4 0.006 0.022 0.06 0.019 21 0.007 0.028 0.018 0.011
-3 0.009 0.027 0.027 0.016 22 0.006 0.025 0.016 0.01
-2 0.026 0.042 0.048 0.028 23 0.028 0.032 0.025 0.021
-1 0.009 0.035 0.039 0.03 24 0.045 0.016 0.027 0.04
0 0.005 0.041 0.035 0.034 0.019 0.04 25 0.071 0.034 0.03 0.029
1 0.005 0.031 0.026 0.035 0.017 0.027 26 0.058 0.025 0.031 0.017
2 0.006 0.037 0.05 0.026 0.02 0.04 27 0.061 0.008 0.024 0.016
3 0.017 0.064 0.036 0.013 0.04 0.081 28 0.058 0.001 0.013 0.021
6 0.024 0.038 0.05 0.046 0.025 0.068 29 0.09 0.022 0.04 0.021
5 0.025 0.048 0.037 0.024 0.106 0.053 30 0.084 0.018 0.022 0.021
4 0.007 0.037 0.046 0.023 0.013 0.089 31 0.12 0.021 0.021 0.01
7 0.027 0.089 0.044 0.034 0.031 0.034 32 0.091 0.004 0.03 0.011
8 0.061 0.069 0.052 0.021 0.041
9 0.093 0.087 0.049 0.054 0.022
10 0.063 0.082 0.08 0.028




Optical Density titration for ELISA using
Fasciola spp. Excretory /Secretory products (FhES & FgES).
Titrations of faecal total Ig Showing mean OD values
from F. hepatica and F. gigantica infected sheep
Appendix Table 4.133
Antigen (pg/ml)
F. hepatica. F. gigantic
FhESP B N PI P2 FgESP B N PI P2
20 0.118 0.292 i.500 0.797 20 0.238 6.368 0.991 0.614
10 0.145 0.365 1.569 0.618 10 0.255 0.325 0.914 0.812
5 0.192 0.295 0.962 0.557 5 0.337 0.407 0.895 0.458
2.5 0.145 0.124 0.870 0.500 2.5 0.249 0.319 0.845 0.548
1.25 0.246 0.115 0.351 0.230 1.25 0.305 0.375 0.412 0.214
BBS 0.251 0.311 0.245 0.308 BBS 0.184 0.168 0.134 0.154
conjugal e
P. hepatica. P. gigantic




0.321 0.365 1.200 0.754
0.201 0.125 0.879 0.551




0.312 0.325 0.914 0.812
0.207 0.235 0.689 0.511
0.137 0.245 0.246 0.347
Appendix Table 4.134
Titrations of faecal IgGj showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (p.g/ml)
p. hepatica. P. gigantic
FhESP B N PI P2 FgESP B N PI P2
26 6.681 6.687 0.112 0.162 20 0.016 6.616 0.045 0.026
10 0.088 0.096 0.14 0.186 10 0.021 0.021 0.051 0.018
5 0.106 0.111 0.156 0.193 5 0.013 0.020 0.054 0.044
2.5 0.113 0.115 0.156 0.183 2.5 0.013 0.014 0.041 0.024
1.25 0.104 0.102 0.15 0.153 1.25 0.020 0.015 0.043 0.018
BBS 0.094 0.101 0.134 0.105 BBS 0.012 0.012 0.042 0.024
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
16 0.014 6.616 6.615 6.617 10 0.018 0.020 0.023 6.636
20 0.021 0.017 0.016 0.012 20 0.017 0.031 0.028 0.022
40 0.013 0.014 0.018 0.010 40 0.013 0.021 0.019 0.026
Conjugale
P. hepatica. P. gigantic
Conj. B N PI P2 Conj. B N PI P2
1666 6.666 0.020 0.012 0.019 1000 0.014 0.028 0.025 0.025
2000 0.016 0.010 0.011 0.016 2000 0.012 0.031 0.024 0.030
4000 0.011 0.009 0.015 0.015 4000 0.012 0.025 0.027 0.023
Titrations of faecal IgM showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (pg/ml)
p. hepatica. P. gigantic
FhESP B N PI P2 FgESP B N PI P2
20 6.626 6.622 0.013 0.024 20 0.035 0.032 0.051 6.655
10 0.017 0.021 0.023 0.024 10 0.039 0.042 0.053 0.031
5 0.023 0.015 0.014 0.015 5 0.038 0.045 0.038 0.030
2.5 0.019 0.023 0.016 0.021 2.5 0.044 0.055 0.051 0.037
1.25 0.024 0.023 0.017 0.022 1.25 0.047 0.033 0.041 0.044
BBS 0.019 0.024 0.015 0.013 BBS 0.047 0.045 0.039 0.037
P. hepatica. P. gigantic




0.023 0.021 0.020 0.014
0.016 0.017 0.023 0.017




6.633 6.645 0.039 0.035
0.040 0.050 0.044 0.043
0.031 0.042 0.040 0.044
467
Appendix Table 4.136
Titrations of faecal lgG2 showing mean OD values
From F. hepatica and F. gigantica infected sheep
Antigen (pg/ml)
/\ hepatica. /'. gigantic
FhESP B N PI P2 FgESP B N PI P2
20 0.0.1.1 0.036 0.035 0.036 20 0.024 0.023 0.04 1 0.016
10 0.0.11 0.034 0.037 0.037 10 0.022 0.038 0.040 0.022
5 0.0.12 0.035 0.037 0.035 5 0.040 0.026 0.030 0.023
2.5 0.0.1.1 0.036 0.041 0.040 2.5 0.041 0.033 0.034 0.023
1.25 0.043 0.052 0.061 0.043 1.25 0.029 0.032 0.023 0.017
BBS 0.055 0.088 0.038 0.043 BBS 0.029 0.033 0.033 0.016
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.033 0.036 0.035 0.036 10 0.024 0.023 0.041 0.016
20 0.031 0.034 0.037 0.037 20 0.022 0.038 0.040 0.022
40 0.032 0.035 0.037 0.035 40 0.040 0.026 0.030 0.023
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.031 0.034 0.037 0.037 1000 0.034 0.023 0.041 0.016
2000 0.032 0.035 0.037 0.035 2000 0.023 0.017 0.040 0.022
4000 0.033 0.036 0.041 0.040 4000 0.033 0.016 0.030 0.023
Appendix Table 4.137
Titrations of faecal IgA showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (pg/nil)
t. hepatica. t. gigantic
FliESP B N PI P2 FgESP B N PI P2
20 0.340 0.365 0.966 0.472 20 0.087 0.057 0.990 0.615
10 0.134 0.122 0.814 0.314 10 0.079 0.058 0.810 0.590
5 0.116 0.106 0.714 0.359 5 0.091 0.041 0.675 0.490
2.5 0.102 0.125 0.411 0.168 2.5 0.119 0.078 0.141 0.138
1.25 0.073 0.098 0.124 0.102 1.25 0.115 0.049 0.060 0.185
BBS 0.071 0.090 0.085 0.065 BBS 0.193 0.148 0.176 0.152
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.423 0.248 0.812 0.418 10 0.124 0.049 0.701 0.510
20 0.119 0.167 0.786 0.402 20 0.151 0.058 0.673 0.421
40 0.104 0.221 0.321 0.138 40 0.187 0.068 0.247 0.37
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.235 0.314 0.679 0.528 1000 0.155 0.049 0.654 0.419
2000 0.216 0.111 0.312 0.267 2000 0.131 0.058 0.312 0.187




Adjusted OD values For Faecal Antibody Responses to Fasciola spp. Excretory/Secretory
Products (FhESP or FgESP) By F. hepatica and F. gigantica infected sheep
Experiment One (1): Adjusted values for F. hepatica (British and Peruvian strain)
infected sheep and uninfected sheep
Appendix Table 4.138
Adjusted Total faecal Ig OD values Adjusted faecal IgGl OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.120 0.031 0.023 0.120 0.102 0.125 -2 0.003 0.003 0.010 0.006 0.008 0.017
-1 0.174 0.104 0.070 0.149 0.198 0.128 -1 0.007 0.005 0.012 0.010 0.008 0.012
0 0.268 0.034 0.126 0.104 0.126 0.170 0 0.006 0.011 0.017 0.006 0.008 0.018
1 0.616 0.125 0.117 0.126 0.220 0.149 1 0.002 0.006 0.008 0.008 0.012 0.007
2 0.626 0.118 0.110 0.149 0.468 0.215 2 0.006 0.002 0.013 0.008 0.013 0.009
3 0.586 0.559 0.551 0.098 0.159 0.242 3 0.001 0.006 0.014 0.009 0.004 0.007
4 0.744 0.450 0.826 0.091 0.333 0.147 4 0.003 0.009 0.014 0.007 0.002 0.015
5 0.608 0.949 0.606 0.055 0.374 0.404 5 0.001 0.011 0.013 0.010 0.004 0.016
6 0.614 0.374 0.886 0.112 0.225 0.560 6 0.001 0.008 0.016 0.006 0.008 0.007
7 1.016 0.206 1.066 0.098 0.468 0.207 7 0.002 0.007 0.006 0.004 0.008 0.021
8 0.946 0.799 0.649 0.154 0.206 0.275 8 0.004 0.008 0.008 0.008 0.002 0.011
9 0.918 0.308 0.875 0.087 0.463 0.117 9 0.003 0.009 0.008 0.004 0.006 0.012
10 0.890 0.179 0.171 0.107 0.206 0.269 10 0.000 0.012 0.005 0.006 0.009 0.017
11 0.704 0.276 0.814 0.201 0.319 0.162 11 0.006 0.008 0.005 0.007 0.014 0.012
12 0.090 0.082 0.100 0.341 0.087 12 0.010 0.012 0.009 0.014 0.005
13 0.204 0.196 0.164 0.163 0.360 13 0.012 0.008 0.008 0.002 0.010
14 0.215 0.207 0.107 0.385 0.500 14 0.006 0.005 0.011 0.007 0.018
15 0.109 0.101 0.085 0.644 0.492 15 0.004 0.004 0.008 0.008 0.008
16 0.055 0.047 0.080 0.550 0.288 16 0.008 0.004 0.010 0.002 0.012
17 0.043 0.035 0.107 0.237 0.302 17 0.003 0.008 0.011 0.003 0.009
Appendix Table 4.139
Adjusted faecal IgM OD values Adjusted faecal IgG2 OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.012 0.009 0.005 0.009 0.009 0.010 -2 0.017 0.009 0.013 0.012 0.017 0.019
-1 0.009 0.008 0.015 0.009 0.015 0.005 -1 0.014 0.008 0.014 0.013 0.015 0.019
0 0.015 0.000 0.006 0.004 0.010 0.014 0 0.016 0.008 0.014 0.011 0.013 0.017
1 0.011 0.010 0.008 0.007 0.016 0.010 1 0.018 0.009 0.016 0.016 0.012 0.022
2 0.016 0.010 0.009 0.008 0.015 0.005 2 0.037 0.021 0.028 0.019 0.013 0.016
3 0.011 0.011 0.007 0.003 0.012 0.015 3 0.060 0.048 0.014 0.019 0.015 0.014
4 0.015 0.008 0.012 0.003 0.010 0.006 4 0.030 0.023 0.019 0.012 0.013 0.019
5 0.008 0.003 0.015 0.005 0.016 0.014 5 0.048 0.020 0.015 0.013 0.012 0.012
6 0.014 0.009 0.014 0.006 0.006 0.009 6 0.016 0.046 0.012 0.013 0.011 0.011
7 0.008 0.013 0.009 0.006 0.005 0.015 7 0.030 0.009 0.019 0.013 0.009 0.011
8 0.013 0.004 0.007 0.005 0.012 0.014 I 8 0.041 0.008 0.013 0.012 0.006 0.005
9 0.016 0.008 0.005 0.007 0.015 0.011 9 0.060 0.011 0.009 0.013 0.011 0.006
10 0.016 0.001 0.013 0.004 0.007 0.006 10 0.033 0.011 0.008 0.016 0.008 0.014
11 0.014 0.013 0.006 0.009 0.012 0.011 11 0.055 0.013 0.010 0.015 0.009 0.015
12 0.008 0.004 0.014 0.009 0.009 0.005 12 0.023 0.014 0.012 0.014 0.014
13 0.011 0.003 0.006 0.006 0.005 0.010 13 0.011 0.010 0.015 0.015 0.009
14 0.005 0.004 0.014 0.008 0.014 0.010 14 0.025 0.010 0.013 0.015 0.010
15 0.011 0.003 0.010 0.009 0.011 0.012 15 0.013 0.012 0.009 0.022 0.009
16 0.009 0.001 0.007 0.006 0.010 0.011 16 0.016 0.017 0.011 0.013 0.009

































































Adjusted Faecal IgA OD values
SH5 SH6 SH7 SH8 SH9 SH10
0.028 0.077 0.069 0.023 0.029 0.037
0.024 0.065 0.059 0.059 0.173 0.053
0.021 0.082 0.087 0.017 0.210 0.055
0.043 0.137 0.120 0.039 0.520 0.069
0.069 0.134 0.150 0.069 0.669 0.125
0.133 0.909 0.162 0.037 0.344 0.132
0.079 0.443 0.181 0.000 0.532 0.201
0.070 0.415 0.191 0.046 0.332 0.147
0.140 0.242 0.171 0.049 0.583 0.224
0.085 0.224 0.121 0.003 0.274 0.233
0.033 0.124 0.098 0.018 0.232 0.183
0.078 0.101 0.118 -0.115 0.759 0.232
0.183 0.142 0.078 0.003 0.796 0.089
0.017 0.015 0.083 0.028 1.386 0.392
0.017 0.019 0.034 1.608 0.215
0.042 0.075 0.035 0.469 0.132
0.053 0.045 -0.012 1.186 0.196
0.006 0.001 0.057 1.744 0.226
0.009 0.523 0.055 0.500 0.014
-0.004 0.543 0.031 1.274 0.055
Appendix Table 4.141
Experiment two (3): Adjusted values for F. gigantica
Kenyan strain) infected and uninfected sheep
Adjusted Total faecal Ig OD values
SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-)
0.113 0.062 0.078 0.055 0.059 0.073 0.011 0.051 0.071 0.082 0.076 0.070
0.171 0.084 0.130 0.116 0.049 0.110 0.021 0.082 0.102 0.107 0.096 0.097
0.041 0.124 0.093 0.105 0.046 0.082 0.016 0.035 0.054 0.069 0.066 0.056
0.549 0.104 0.052 0.175 0.092 0.194 0.091 0.059 0.078 0.088 0.081 0.077
0.768 0.151 0.025 0.129 0.672 0.349 0.154 0.082 0.102 0.107 0.096 0.097
0.793 0.224 0.102 0.470 0.446 0.407 0.119 0.027 0.047 0.063 0.061 0.050
0.918 0.105 0.403 0.785 0.540 0.550 0.143 0.020 0.039 0.057 0.056 0.043
0.897 0.613 0.347 0.587 0.419 0.573 0.095 0.210 0.001 0.088 0.031 0.083
0.651 0.902 0.414 0.685 0.682 0.667 0.078 0.044 0.063 0.076 0.071 0.064
0.759 0.938 0.523 0.656 0.410 0.657 0.092 0.034 0.113 0.058 0.036 0.060
0.793 1.119 0.504 0.496 0.645 0.711 0.115 0.089 0.108 0.112 0.100 0.102
1.007 1.009 0.925 0.567 0.741 0.850 0.086 0.016 0.036 0.054 0.053 0.040
0.758 1.106 0.883 0.161 0.066 0.595 0.205 0.037 0.057 0.071 0.067 0.058
0.555 1.232 1.245 0.245 0.082 0.672 0.244 0.140 0.159 0.153 0.134 0.147
1.082 1.129 0.313 0.475 0.301 0.660 0.185 0.030 0.049 0.065 0.062 0.052
1.097 1.032 0.204 0.341 0.410 0.617 0.186 0.100 0.119 0.121 0.108 0.112
1.346 1.029 0.496 0.174 0.217 0.652 0.231 0.037 0.057 0.071 0.067 0.058
1.055 0.962 0.109 0.116 0.560 0.259 0.014 0.033 0.052 0.052 0.038
0.780 0.723 0.426 0.137 0.516 0.148 0.007 0.027 0.047 0.048 0.032























































































Adjusted faecal IgGl OD values
SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-)
0.032 0.024 0.019 0.008 0.012 0.019 0.004 0.006 0.018 0.005 0.023 0.013
0.030 0.030 0.009 0.000 0.010 0.016 0.006 0.021 0.024 0.007 0.005 0.014
0.020 0.033 0.041 0.009 -0.004 0.020 0.008 -0.003 0.021 0.018 0.027 0.016
0.014 0.020 0.016 0.008 -0.004 0.011 0.004 -0.003 0.003 0.027 0.020 0.012
0.014 0.022 0.009 0.000 -0.010 0.007 0.006 0.018 0.006 0.007 0.005 0.009
0.021 0.021 0.016 0.005 -0.010 0.011 0.006 -0.006 -0.003 0.014 0.018 0.006
0.017 0.023 0.018 0.001 -0.010 0.010 0.006 -0.003 0.009 0.020 0.005 0.008
0.018 0.021 0.018 0.004 0.010 0.014 0.003 0.003 0.012 0.018 0.007 0.010
0.010 0.027 0.018 0.013 0.006 0.015 0.004 0.006 -0.003 0.018 0.007 0.007
0.012 0.025 0.016 0.003 0.000 0.011 0.005 0.012 -0.009 0.018 0.011 0.008
0.015 0.023 0.040 -0.003 0.012 0.017 0.007 -0.006 0.018 0.016 0.018 0.012
0.017 0.027 0.014 0.006 -0.008 0.011 0.006 -0.009 0.009 0.018 0.018 0.009
0.011 0.024 0.011 0.000 -0.010 0.007 0.006 0.003 0.006 0.005 0.011 0.006
0.013 0.023 0.000 0.000 0.011 0.005 -0.009 0.012 0.014 0.027 0.011
0.017 0.031 0.003 -0.004 0.013 0.006 0.009 0.000 0.014 0.027 0.013
0.028 0.449 0.013 -0.008 0.010 0.006 0.021 -0.012 0.023 0.009 0.010
0.023 0.025 0.001 0.006 0.020 0.008 0.015 0.006 0.000 0.011 0.008
0.012 0.041 0.010 0.014 0.019 0.006 0.018 -0.006 0.011 0.025 0.012
0.017 0.025 0.004 0.014 0.018 0.005 -0.003 0.009 0.027 0.007 0.010
0.013 0.023 0.005 0.000 0.013 0.005 0.018 0.003 0.009 0.005 0.009
Appendix Table 4.143
Adjusted faecal IgM OD values
SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-)
0.028 0.022 0.022 0.028 0.025 0.025 0.001 0.020 0.028 0.019 0.015 0.021
0.032 0.016 0.012 0.029 0.033 0.024 0.004 0.023 0.015 0.034 0.018 0.023
0.020 0.020 0.021 0.031 0.011 0.021 0.003 0.017 0.026 0.020 0.040 0.026
0.018 0.019 0.024 0.017 0.010 0.018 0.002 0.021 0.029 0.024 0.026 0.025
0.013 0.025 0.033 0.029 0.016 0.023 0.004 0.012 0.028 0.024 0.015 0.020
0.029 0.028 0.013 0.020 0.023 0.023 0.003 0.020 0.020 0.034 0.036 0.028
0.033 0.028 0.024 0.018 0.016 0.024 0.003 0.020 0.016 0.025 0.043 0.026
0.033 0.014 0.024 0.018 0.015 0.021 0.004 0.015 0.012 0.014 0 038 0.020
0.019 0.021 0.029 0.023 0.022 0.023 0.002 0.028 0.020 0.020 0.025 0.023
0.033 0.012 0.021 0.019 0.023 0.022 0.003 0.028 0.015 0.033 0.021 0.024
0.015 0.014 0.016 0.027 0.020 0.018 0.002 0.025 0.027 0.016 0.026 0.024
0.018 0.014 0.018 0.013 0.022 0.019 0.002 0.025 0.025 0.036 0.030 0.029
0.019 0.021 0.015 0.029 0.017 0.021 0.002 0.025 0.026 0.018 0.043 0.028
0.023 0.012 0.017 0.018 0.018 0.002 0.016 0.013 0.035 0.036 0.025
0.013 0.017 0.032 0.025 0.019 0.004 0.032 0.028 0.035 0.030 0.031
0.026 0.034 0.024 0.020 0.027 0.003 0.014 0.019 0.026 0.029 0.022
0.023 0.025 0.021 0.010 0.020 0.003 0.011 0.030 0.044 0.033 0.030
0.021 0.035 0.028 0.012 0.026 0.004 0.031 0.019 0.034 0.018 0.026
0.011 0.014 0.013 0.023 0.015 0.002 0.021 0.013 0.033 0.044 0.028




Adjusted faecal IgG2 OD values
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.028 0.036 0.024 0.023 0.035 0.029 0.003 0.014 0.017 0.024 0.025 0.020 0.003
0 0.027 0.035 0.021 0.046 0.033 0.032 0.004 0.023 0.014 0.020 0.014 0.018 0.002
2 0.017 0.025 0.049 0.027 0.018 0.027 0.006 0.024 0.014 0.016 0.029 0.021 0.004
4 0.021 0.029 0.050 0.038 0.024 0.032 0.005 0.024 0.018 0.021 0.015 0.020 0.002
6 0.010 0.018 0.032 0.036 0.008 0.021 0.006 0.015 0.026 0.014 0.030 0.021 0.004
8 0.020 0.028 0.032 0.038 0.023 0.028 0.003 0.014 0.021 0.018 0.025 0.020 0.002
9 0.023 0.031 0.049 0.033 0.027 0.033 0.004 0.018 0.023 0.023 0.026 0.023 0.002
10 0.014 0.022 0.040 0.024 0.014 0.023 0.005 0.021 0.018 0.029 0.014 0.020 0.003
11 0.014 0.022 0.041 0.029 0.014 0.024 0.005 0.015 0.026 0.018 0.026 0.021 0.003
12 0.016 0.024 0.029 0.050 0.017 0.027 0.006 0.021 0.018 0.023 0.025 0.022 0.002
13 0.019 0.027 0.043 0.032 0.021 0.028 0.004 0.024 0.015 0.026 0.024 0.022 0.002
14 0.025 0.033 0.041 0.032 0.030 0.032 0.003 0.018 0.018 0.018 0.023 0.019 0.001
15 0.017 0.025 0.030 0.023 0.018 0.023 0.002 0.023 0.026 0.014 0.015 0.019 0.003
16 0.014 0.022 0.023 0.041 0.014 0.023 0.005 0.027 0.023 0.027 0.023 0.025 0.001
17 0.006 0.014 0.030 0.043 0.002 0.019 0.008 0.020 0.026 0.018 0.023 0.022 0.002
18 0.028 0.036 0.033 0.033 0.035 0.033 0.001 0.024 0.021 0.026 0.018 0.022 0.002
19 0.030 0.038 0.030 0.040 0.038 0.035 0.002 0.018 0.018 0.028 0.026 0.023 0.003
20 0.019 0.027 0.038 0.033 0.021 0.028 0.004 0.023 0.017 0.016 0.018 0.018 0.002
21 0.014 0.022 0.044 0.046 0.014 0.028 0.007 0.020 0.024 0.024 0.027 0.024 0.002
22 0.008 0.016 0.049 0.049 0.005 0.025 0.010 0.023 0.023 0.023 0.014 0.021 0.002
Appendix Table 4.145
Adjusted faecal IgA OD values
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.102 0.041 0.078 0.048 0.050 0.064 0.011 0.056 0.045 0.038 0.050 0.047 0.004
0 0.104 0.033 0.080 0.053 0.045 0.063 0.013 0.078 0.066 0.034 0.046 0.056 0.010
2 0.052 0.045 0.038 0.043 0.003 0.036 0.009 0.078 0.066 0.000 0.012 0.039 0.019
4 0.944 0.573 0.630 0.553 0.615 0.663 0.109 0.061 0.049 0.010 0.022 0.036 0.012
6 0.364 0.469 0.758 1.003 0.340 0.587 0.087 0.075 0.063 0.270 0.282 0.173 0.060
8 0.764 0.886 0.755 1.003 0.175 0.717 0.095 0.042 0.031 0.138 0.150 0.090 0.031
9 0.095 0.237 0.073 0.030 0.183 0.124 0.038 0.063 0.052 0.144 0.156 0.104 0.027
10 0.014 0.104 0.013 0.073 0.225 0.086 0.039 0.080 0.068 0.178 0.190 0.129 0.032
11 0.130 0.144 0.055 0.118 0.173 0.124 0.020 0.078 0.066 0.136 0.148 0.107 0.021
12 0.018 0.073 0.225 0.003 0.173 0.098 0.044 0.061 0.049 0.136 0.148 0.099 0.025
13 0.241 0.292 0.440 0.540 0.225 0.348 0.050 0.045 0.033 0.178 0.190 0.112 0.042
14 0.008 0.139 1.005 0.025 0.078 0.251 0.190 0.014 0.002 0.060 0.072 0.037 0.017
15 0.061 0.306 0.278 -0.055 0.055 0.129 0.070 0.085 0.073 0.042 0.054 0.064 0.010
16 0.137 0.011 1.313 0.135 0.073 0.334 0.095 0.049 0.038 0.056 0.068 0.053 0.006
17 0.018 0.048 0.263 0.150 0.048 0.105 0.045 0.099 0.087 0.036 0.048 0.068 0.015
18 0.011 0.023 0.140 0.068 0.048 0.026 0.071 0.059 0.052 0.064 0.062 0.004
19 0.343 0.094 0.650 0.200 0.257 0.114 0.021 0.009 0.158 0.170 0.090 0.043
20 0.639 1.430 1.390 0.500 0.792 0.044 0.073 0.061 0.238 0.250 0.156 0.051
21 0.302 0.155 0.548 0.248 0.251 0.090 0.061 0.049 0.196 0.208 0.129 0.043
22 0.047 0.047 0.178 0.195 0.093 0.039 0.000 -0.012 0.154 0.166 0.077 0.048
472
Appendix Table 4
Optical Density titration for ELISA using
F. hepatica CathepsinLl protease
Titrations of faecal total Ig Showing mean OD values
from F. hepatica and F. gigantica infected sheep
Appendix Table 4.146
Antigen (mg/ml)
F. hepatica. F. gigantic




6.1 li 6 Ui 6.347
0.087 0.131 0.495 0.230




6.113 0.13 0.277 0.177
0.092 0.109 0.223 0.156
0.120 0.117 0.232 0.212
Conjugate
F. hepatica. F. gigantic




0.042 0.1314 0.387 0.29
0.035 0.1333 0.423 0.281




0.135 0.114 0.355 0.131
0.136 0.115 0.287 0.236
0.103 0.075 0.1094 0.277
Appendix Table 4.147
Titrations of faecal IgG, showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (mg/ml)
F. hepatica. F. gigantic
CAthepsin B N PI P2 Athepsi B N Pi P2
2 0.040 0.054 0.079 0.072 2 0.121 0.112 0.121 0.139
1 0.053 0.056 0.081 0.087 1 0.122 0.123 0.143 0.145
0.5 0.041 0.038 0.061 0.083 0.5 0.123 0.130 0.136 0.124
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N Pi P2
10 0.060 0.054 0.060 0.075 16 0.143 0.135 0.135 0.142
20 0.063 0.049 0.073 0.076 20 0.121 0.144 0.131 0.145
40 0.058 0.064 0.075 0.068 40 0.118 0.134 0.149 0.118
Conjugate
F. hepatica. F. gigantic




6.656 6.656 6.675 6.646
0.053 0.037 0.084 0.077




6.146 6.124 6.145 6.117
0.121 0.130 0.119 0.135
0.125 0.117 0.136 0.124
Appendix Table 4.148
Titrations of faecal IgM showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (mg/ml)
F. hepatica. F. gigantic




6.61 § 6.615 6.614 6.614
0.011 0.011 0.018 0.013




0.047 0.052 0.055 0.085
0.051 0.048 0.056 0.058
0.063 0.043 0.066 0.095
Conjugate
F. hepatica. F. gigantic




5.616 5.616 6.665 5.615
0.015 0.007 0.011 0.015




0.060 0.064 0.060 0.062
0.040 0.056 0.076 0.089




Titrations of faecal IgG2 showing mean OD values
From F. hepatica and F. gigantica infected sheep
Antigen (mg/ml)
F. hepatica. F. gigantic
CAthepsin B N PI P2 Athepsi B N PI P2
2 0.0117 0.0161 0.0278 0.0367 2 0.025 0.031 0.032 0.039
1 0.0124 0.0131 0.495 0.0348 1 0.031 0.026 0.027 0.036
0.5 0.0105 0.0141 0.0252 0.0434 0.5 0.033 0.038 0.033 0.024
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.06 0.0492 0.0645 0.059 10 0.026 0.034 0.031 0.040
20 0.058 0.033 0.0423 0.0471 20 0.025 0.024 0.041 0.041
40 0.054 0.0265 0.0281 0.027 40 0.026 0.042 0.039 0.026
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.042 0.0392 0.0687 0.059 1000 0.027 0.042 0.038 0.037
2000 0.035 0.0333 0.0623 0.0471 2000 0.030 0.026 0.026 0.034
4000 0.028 0.0274 0.0359 0.0352 4000 0.026 0.028 0.038 0.035
Appendix Table 4.150
Titrations of faecal IgA showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (mg/ml)
F. hepatica. F. gigantic
CAthepsin B N PI P2 Athepsi B N PI P2
2 0.216 0.223 0.841 0.551 2 0.325 0.412 0.625 0.416
1 0.224 0.157 0.734 0.497 1 0.287 0.333 0.621 0.379
0.5 0.109 0.248 0.512 0.511 0.5 0.400 0.321 0.539 0.485
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.214 0.308 0.741 0.627 10 0.149 0.187 0.625 0.416
20 0.102 0.241 0.683 0.568 20 0.156 0.171 0.621 0.379
40 0.148 0.234 0.559 0.403 40 0.166 0.188 0.539 0.485
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.182 0.222 0.787 0.59 1000 0.215 0.185 0.795 0.57
2000 0.145 0.233 0.623 0.514 2000 0.241 0.169 0.67 0.453




Adjusted OD values For Faecal Antibody Responses to F. hepatica cathepsin LI protease
By F. hepatica and F. gigantica infected sheep
Experiment One (1): Adjusted values for F. hepatica (British and Peruvian strain)
infected sheep and uninfected sheep
Appendix Table 4.151
Adjusted Total faecal Ig OD values Adjusted faecal IgGl OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.022 0.023 0.024 0.023 0.024 0.023 -2 0.017 0.018 0.020 0.016 0.017 0.037
-1 0.046 0.018 0.033 0.040 0.034 0.012 -1 0.020 0.003 0.031 0.024 0.032 0.021
0 0.052 0.045 0.132 0.045 0.020 0.068 0 0.003 0.019 0.007 0.004 0.020 0.030
1 0.080 0.118 0.066 0.045 0.065 0.006 1 0.008 0.012 0.027 0.028 0.037 0.021
2 0.219 0.256 0.233 0.065 0.174 0.255 2 0.017 0.005 0.034 0.012 0.035 0.022
3 0.088 0.229 0.068 0.031 0.224 0.312 3 0.013 0.017 0.012 0.010 0.013 0.025
4 0.151 0.172 0.177 0.026 0.242 0.245 4 0.009 0.020 0.010 0.033 0.031 0.016
5 0.155 0.248 0.206 0.043 0.169 0.265 5 0.027 0.014 0.007 0.022 0.033 0.021
6 0.229 0.446 0.357 0.046 0.303 0.346 6 0.030 0.011 0.020 0.023 0.020 0.012
7 0.235 0.236 0.390 0.044 0.160 0.507 7 0.025 0.021 0.022 0.015 0.018 0.021
8 0.225 0.346 0.236 0.072 0.235 0.217 8 0.018 0.003 0.025 0.023 0.034 0.031
9 0.246 0.235 0.186 0.068 0.160 0.112 9 0.006 0.007 0.021 0.013 0.019 0.015
10 0.219 0.238 0.138 0.026 0.162 0.221 10 0.006 0.010 0.029 0.006 0.034 0.030
11 0.162 0.199 0.164 0.033 0.135 0.195 11 0.007 0.014 0.026 0.019 0.018 0.023
12 0.260 0.038 0.058 0.177 0.193 12 0.016 0.028 0.034 0.039 0.021
13 0.311 0.147 0.055 0.211 0.266 13 0.003 0.008 0.030 0.023 0.027
14 0.151 0.045 0.023 0.103 0.483 14 0.015 0.027 0.009 0.027 0.015
15 0.301 0.011 0.037 0.205 0.335 15 0.013 0.011 0.016 0.018 0.019
16 0.156 0.026 0.039 0.106 0.210 16 0.015 0.020 0.037 0.014 0.034
17 0.138 0.060 0.031 0.094 0.071 17 0.003 0.027 0.020 0.014 0.014
Appendix Table 4.152
Adjusted faecal IgM OD values Adjusted faecal IgG2 OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.020 0.012 0.014 0.016 0.014 -0.004 -2 0.029 0.021 0.028 0.013 0.017 0.016
-1 0.006 0.008 0.022 0.010 0.000 0.014 -1 0.021 0.022 0.016 0.022 0.016 0.024
0 0.010 0.002 0.008 0.012 0.004 0.006 0 0.016 0.027 0.024 0.013 0.024 0.013
1 0.010 0.010 0.008 0.002 0.008 0.010 1 0.017 0.029 0.020 0.021 0.024 0.014
2 0.004 0.006 0.004 0.014 -0.002 0.000 2 0.012 0.023 0.028 0.021 0.028 0.024
3 0.014 0.000 0.008 0.014 0.006 0.014 3 0.029 0.013 0.012 0.015 0.027 0.017
4 0.010 0.000 0.006 0.014 0.018 0.000 4 0.025 0.027 0.008 0.016 0.024 0.026
5 0.008 0.012 0.012 0.016 0.012 0.018 5 0.014 0.011 0.022 0.024 0.017 0.016
6 0.008 0.016 0.008 -0.004 0.006 0.004 6 0.028 0.017 0.027 0.027 0.020 0.017
7 0.016 0.004 -0.002 0.000 0.006 -0.002 7 0.020 0.009 0.015 0.026 0.021 0.022
8 0.002 0.002 0.002 0.004 0.006 0.000 8 0.011 0.025 0.018 0.021 0.017 0.012
9 0.016 0.016 0.008 0.000 0.004 0.016 9 0.024 0.020 0.013 0.011 0.013 0.024
10 0.014 0.010 0.014 0.018 0.004 0.006 10 0.021 0.010 0.027 0.024 0.027 0.019
11 0.012 0.014 0.002 0.002 0.016 0.012 11 0.019 0.012 0.011 0.014 0.028 0.024
12 0.020 0.012 0.004 0.004 0.010 12 0.018 0.027 0.017 0.026 0.013
13 0.000 0.008 0.014 0.002 0.008 13 0.027 0.013 0.022 0.024 0.018
14 0.004 0.016 0.018 0.012 0.002 14 0.010 0.031 0.021 0.011 0.020
15 0.002 0.020 0.010 0.002 0.012 15 0.024 0.024 0.026 0.028 0.027
16 0.008 0.012 -0.002 0.016 0.004 16 0.007 0.026 0.021 0.026 0.023

































































Adjusted faecal IgA OD values



















































































































Experiment three (3): Adjusted values for F. gigantica
(Kenyan strain) infected and uninfected sheep
Appendix Table 4.154
Adjusted Total faecal Ig OD values
SH.11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-)
0.113 0.062 0.078 0.055 0.059 0.073 0.011 0.051 0.071 0.082 0.076 0.070
0.171 0.084 0.130 0.116 0.049 0.110 0.021 0.082 0.102 0.107 0.096 0.097
0.041 0.124 0.093 0.105 0.046 0.082 0.016 0.035 0.054 0.069 0.066 0.056
0.549 0.104 0.052 0.175 0.092 0.194 0.091 0.059 0.078 0.088 0.081 0.077
0.768 0.151 0.025 0.129 0.672 0.349 0.154 0.082 0.102 0.107 0.096 0.097
0.793 0.224 0.102 0.470 0.446 0.407 0.119 0.027 0.047 0.063 0.061 0.050
0.918 0.105 0.403 0.785 0.540 0.550 0.143 0.020 0.039 0.057 0.056 0.043
0.897 0.613 0.347 0.587 0.419 0.573 0.095 0.210 0.001 0.088 0.031 0.083
0.651 0.902 0.414 0.685 0.682 0.667 0.078 0.044 0.063 0.076 0.071 0.064
0.759 0.938 0.523 0.656 0.410 0.657 0.092 0.034 0.113 0.058 0.036 0.060
0.793 1.119 0.504 0.496 0.645 0.711 0.115 0.089 0.108 0.112 0.100 0.102
1.007 1.009 0.925 0.567 0.741 0.850 0.086 0.016 0.036 0.054 0.053 0.040
0.758 1.106 0.883 0.161 0.066 0.595 0.205 0.037 0.057 0.071 0.067 0.058
0.555 1.232 1.245 0.245 0.082 0.672 0.244 0.140 0.159 0.153 0.134 0.147
1.082 1.129 0.313 0.475 0.301 0.660 0.185 0.030 0.049 0.065 0.062 0.052
1.097 1.032 0.204 0.341 0.410 0.617 0.186 0.100 0.119 0.121 0.108 0.112
1.346 1.029 0.496 0.174 0.217 0.652 0.231 0.037 0.057 0.071 0.067 0.058
1.055 0.962 0.109 0.116 0.560 0.259 0.014 0.033 0.052 0.052 0.038
0.780 0.723 0.426 0.137 0.516 0.148 0.007 0.027 0.047 0.048 0.032




Adjusted faecal IgGl OD values
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.032 0.024 0.019 0.008 0.012 0.019 0.004 0.006 0.018 0.005 0.023 0.013 0.004
0 0.030 0.030 0.009 0.000 0.010 0.016 0.006 0.021 0.024 0.007 0.005 0.014 0.005
i 2 0.020 0.033 0.041 0.009 -0.004 0.020 0.008 -0.003 0.021 0.018 0.027 0.016 0.007
4 0.014 0.020 0.016 0.008 -0.004 0.011 0.004 -0.003 0.003 0.027 0.020 0.012 0.007
6 0.014 0.022 0.009 0.000 -0.010 0.007 0.006 0.018 0.006 0.007 0.005 0.009 0.003
8 0.021 0.021 0.016 0.005 -0.010 0.011 0.006 -0.006 -0.003 0.014 0.018 0.006 0.006
9 0.017 0.023 0.018 0.001 -0.010 0.010 0.006 -0.003 0.009 0.020 0.005 0.008 0.005
10 0.018 0.021 0.018 0.004 0.010 0.014 0.003 0.003 0.012 0.018 0.007 0.010 0.003
11 0.010 0.027 0.018 0.013 0.006 0.015 0.004 0.006 -0.003 0.018 0.007 0.007 0.004
12 0.012 0.025 0.016 0.003 0.000 0.011 0.005 0.012 -0.009 0.018 0.011 0.008 0.006
13 0.015 0.023 0.040 -0.003 0.012 0.017 0.007 -0.006 0.018 0.016 0.018 0.012 0.006
14 0.017 0.027 0.014 0.006 -0.008 0.011 0.006 -0.009 0.009 0.018 0.018 0.009 0.005
15 0.011 0.024 0.011 0.000 -0.010 0.007 0.006 0.003 0.006 0.005 0.011 0.006 0.002
16 0.013 0.023 0.020 0.000 0.000 0.011 0.005 -0.009 0.012 0.014 0.027 0.011 0.005
17 0.017 0.031 0.016 0.003 -0.004 0.013 0.006 0.009 0.000 0.014 0.027 0.013 0.006
18 0.028 0.449 0.010 0.013 -0.008 0.010 0.006 0.021 -0.012 0.023 0.009 0.010 0.004
19 0.023 0.025 0.045 0.001 0.006 0.020 0.008 0.015 0.006 0.000 0.011 0.008 0.003
20 0.012 0.041 0.019 0.010 0.014 0.019 0.006 0.018 -0.006 0.011 0.025 0.012 0.007
21 0.017 0.025 0.030 0.004 0.014 0.018 0.005 -0.003 0.009 0.027 0.007 0.010 0.006
22 0.013 0.023 0.025 0.005 0.000 0.013 0.005 0.018 0.003 0.009 0.005 0.009 0.003
Appendix Table 4.156
Adjusted faecal IgM OD values
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-) SEM
-2 0.028 0.022 0.022 0.028 0.025 0.025 0.001 0.020 0.028 0.019 0.015 0.021 0.003
0 0.032 0.016 0.012 0.029 0.033 0.024 0.004 0.023 0.015 0.034 0.018 0.023 0.004
2 0.020 0.020 0.021 0.031 0.011 0.021 0.003 0.017 0.026 0.020 0.040 0.026 0.005
4 0.018 0.019 0.024 0.017 0.010 0.018 0.002 0.021 0.029 0.024 0.026 0.025 0.002
6 0.013 0.025 0.033 0.029 0.016 0.023 0.004 0.012 0.028 0.024 0.015 0.020 0.004
8 0.029 0.028 0.013 0.020 0.023 0.023 0.003 0.020 0.020 0.034 0.036 0.028 0.004
9 0.033 0.028 0.024 0.018 0.016 0.024 0.003 0.020 0.016 0.025 0.043 0.026 0.006
10 0.033 0.014 0.024 0.018 0.015 0.021 0.004 0.015 0.012 0.014 0.038 0.020 0.006
11 0.019 0.021 0.029 0.023 0.022 0.023 0.002 0.028 0.020 0.020 0.025 0.023 0.002
12 0.033 0.012 0.021 0.019 0.023 0.022 0.003 0.028 0.015 0.033 0.021 0.024 0.004
13 0.015 0.014 0.016 0.027 0.020 0.018 0.002 0.025 0.027 0.016 0.026 0.024 0.003
14 0.018 0.014 0.026 0.013 0.022 0.019 0.002 0.025 0.025 0.036 0.030 0.029 0.003
15 0.019 0.021 0.021 0.029 0.017 0.021 0.002 0.025 0.026 0.018 0.043 0.028 0.005
16 0.023 0.012 0.021 0.017 0.018 0.018 0.002 0.016 0.013 0.035 0.036 0.025 0.006
17 0.013 0.017 0.010 0.032 0.025 0.019 0.004 0.032 0.028 0.035 0.030 0.031 0.001
18 0.026 0.034 0.033 0.024 0.020 0.027 0.003 0.014 0.019 0.026 0.029 0.022 0.003
19 0.023 0.025 0.022 0.021 0.010 0.020 0.003 0.011 0.030 0.044 0.033 0.030 0.007
20 0.021 0.035 0.032 0.028 0.012 0.026 0.004 0.031 0.019 0.034 0.018 0.026 0.004
21 0.011 0.014 0.013 0.013 0.023 0.015 0.002 0.021 0.013 0.033 0.044 0.028 0.007























































































Adjusted faecal IgG2 OD values
SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-)
0.028 0.036 0.024 0.023 0.035 0.029 0.003 0.014 0.017 0.024 0.025 0.020
0.027 0.035 0.021 0.046 0.033 0.032 0.004 0.023 0.014 0.020 0.014 0.018
0.017 0.025 0.049 0.027 0.018 0.027 0.006 0.024 0.014 0.016 0.029 0.021
0.021 0.029 0.050 0.038 0.024 0.032 0.005 0.024 0.018 0.021 0.015 0.020
0.010 0.018 0.032 0.036 0.008 0.021 0.006 0.015 0.026 0.014 0.030 0.021
0.020 0.028 0.032 0.038 0.023 0.028 0.003 0.014 0.021 0.018 0.025 0.020
0.023 0.031 0.049 0.033 0.027 0.033 0.004 0.018 0.023 0.023 0.026 0.023
0.014 0.022 0.040 0.024 0.014 0.023 0.005 0.021 0.018 0.029 0.014 0.020
0.014 0.022 0.041 0.029 0.014 0.024 0.005 0.015 0.026 0.018 0.026 0.021
0.016 0.024 0.029 0.050 0.017 0.027 0.006 0.021 0.018 0.023 0.025 0.022
0.019 0.027 0.043 0.032 0.021 0.028 0.004 0.024 0.015 0.026 0.024 0.022
0.025 0.033 0.041 0.032 0.030 0.032 0.003 0.018 0.018 0.018 0.023 0.019
0.017 0.025 0.030 0.023 0.018 0.023 0.002 0.023 0.026 0.014 0.015 0.019
0.014 0.022 0.023 0.041 0.014 0.023 0.005 0.027 0.023 0.027 0.023 0.025
0.006 0.014 0.030 0.043 0.002 0.019 0.008 0.020 0.026 0.018 0.023 0.022
0.028 0.036 0.033 0.033 0.035 0.033 0.001 0.024 0.021 0.026 0.018 0.022
0.030 0.038 0.030 0.040 0.038 0.035 0.002 0.018 0.018 0.028 0.026 0.023
0.019 0.027 0.038 0.033 0.021 0.028 0.004 0.023 0.017 0.016 0.018 0.018
0.014 0.022 0.044 0.046 0.014 0.028 0.007 0.020 0.024 0.024 0.027 0.024
0.008 0.016 0.049 0.049 0.005 0.025 0.010 0.023 0.023 0.023 0.014 0.021
Appendix Table 4.158
Adjusted faecal IgA OD values
SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 Mean (-)
0.102 0.041 0.078 0.048 0.050 0.064 0.011 0.056 0.045 0.038 0.050 0.047
0.104 0.033 0.080 0.053 0.045 0.063 0.013 0.078 0.066 0.034 0.046 0.056
0.052 0.045 0.038 0.043 0.003 0.036 0.009 0.078 0.066 0.000 0.012 0.039
0.944 0.573 0.630 0.553 0.615 0.663 0.109 0.061 0.049 0.010 0.022 0.036
0.364 0.469 0.758 1.003 0.340 0.587 0.087 0.075 0.063 0.270 0.282 0.173
0.764 0.886 0.755 1.003 0.175 0.717 0.095 0.042 0.031 0.138 0.150 0.090
0.095 0.237 0.073 0.030 0.183 0.124 0.038 0.063 0.052 0.144 0.156 0.104
0014 0 104 0.013 0 073 0 225 0.086 0 039 0 080 0 068 0 178 0 190 0 129
0.130 0.144 0.055 0.118 0.173 0.124 0.020 0.078 0.066 0.136 0.148 0.107
0.018 0.073 0.225 0.003 0.173 0.098 0.044 0.061 0.049 0.136 0.148 0.099
0.241 0.292 0.440 0.540 0.225 0.348 0.050 0.045 0.033 0.178 0.190 0.112
0.008 0.139 1.005 0.025 0.078 0.251 0.190 0.014 0.002 0.060 0.072 0.037
0.061 0.306 0.278 -0.055 0.055 0.129 0.070 0.085 0.073 0.042 0.054 0.064
0.137 0.011 1.313 0.135 0.073 0.334 0.095 0.049 0.038 0.056 0.068 0.053
0.018 0.048 0.263 0.150 0.048 0.105 0.045 0.099 0.087 0.036 0.048 0.068
0.011 0.023 0.140 0.068 0.048 0.026 0.071 0.059 0.052 0.064 0.062
0.343 0.094 0.650 0.200 0.257 0.114 0.021 0.009 0.158 0.170 0.090
0.639 1.430 1.390 0.500 0.792 0.044 0.073 0.061 0.238 0.250 0.156
0.302 0.155 0.548 0.248 0.251 0.090 0.061 0.049 0.196 0.208 0.129




Optical Density titration for ELISA using
F. hepatica Glutathion S-Transferase (FhGST)
Titrations of faecal total Ig Showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (pg/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.102 0.197 0.425 0.377 2 0.113 0.163 0.3 0.142
1 0.195 0.101 0.317 0.259 1 0.044 0.074 0.28 0.121
05 0.172 0.189 0.266 0.200 0.5 0.120 0.117 0.232 0.177
Conjugate
F. hepatica. F. gigantic




0.121 0.114 0.512 0.215
0.07 0.085 0.536 0.209




0.087 0.142 0.289 0.147
0.051 0.082 0.26 0.126
0.033 0.089 0.181 0.103
Appendix Table 4.160
Titrations of faecal IgG! showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (jig/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.050 0.059 0.042 0.062 2 0.123 0.130 0.136 0.124
1 0.053 0.037 0.060 0.054 1 0.124 0.113 0.119 0.136
0.5 0.036 0.061 0.063 0.049 0.5 0.143 0.135 0.135 0.142
Monoclonal antibody
F. hepatica. F gigantic
McAb B N PI P2 McAb B N PI P2
10 0.084 0.077 0.087 0.065 10 0.113 0.131 0.150 0.127
20 0.060 0.057 0.065 0.063 20 0.135 0.136 0.139 0.139
40 0.080 0.081 0.063 0.086 40 0.124 0.113 0.130 0.122
Conjugate
F. hepatica. F. gigantic




0.051 0.038 0.041 0.051
0.039 0.044 0.050 0.040




0.121 0.144 0.131 0.145
0.118 0.134 0.149 0.118
0.148 0.143 0.132 0.129
Appendix Table 4.161 Titrations of faecal IgM showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (pg/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.065 0.063 0.075 0.068 2 0.060 0.064 0.043 0.051
1 0.063 0.086 0.078 0.076 1 0.046 0.047 0.054 0.059
0.5 0.060 0.075 0.074 0.066 0.5 0.038 0.032 0.032 0.032
Conjugate
F. hepatica. F. gigantic




0.050 0.040 0.058 0.064
0.046 0.058 0.051 0.038




0.088 0.054 0.060 0.054
0.055 0.085 0.094 0.087
0.056 0.058 0.060 0.062
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Appendix Table 4.162
Titrations of faecal IgG2 showing mean OD values
From F. hepatica and F. gigantica infected sheep
Antigen (pg/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.058 0.050 0.041 0.052 2 0.025 0.031 0.032 0.039
1 0.050 0.051 0.058 0.042 1 0.031 0.026 0.027 0.036
0.5 0.045 0.056 0.054 0.056 0.5 0.033 0.038 0.033 0.024
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.049 0.069 0.037 0.062 10 0.037 0.026 0.039 0.027
20 0.057 0.068 0.051 0.073 20 0.025 0.033 0.040 0.036
40 0.041 0.061 0.056 0.076 40 0.035 0.033 0.029 0.022
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.044 0.075 0.056 0.072 1000 0.026 0.042 0.039 0.026
2000 0.047 0.069 0.040 0.060 2000 0.035 0.022 0.027 0.038
4000 0.042 0.056 0.056 0.063 4000 0.036 0.035 0.042 0.029
Appendix Table 4.163
Titrations of faecal IgA showing mean OD values
from F. hepatica and F. gigantica infected sheep
Antigen (pg/ml)
F. hepatica. F. gigantic
FhGST B N PI P2 FhGST B N PI P2
2 0.148 0.112 0.423 0.384 2 0.063 0.174 0.462 0.267
1 0.167 0.142 0.504 0.312 1 0.098 0.167 0.449 0.269
0.5 0.069 0.111 0.436 0.286 0.5 0.102 0.108 0.351 0.199
Monoclonal antibody
F. hepatica. F. gigantic
McAb B N PI P2 McAb B N PI P2
10 0.146 0.166 0.286 0.221 10 0.065 0.124 0.385 0.197
20 0.410 0.142 0.305 0.209 20 0.075 0.116 0.397 0.263
40 0.132 0.133 0.214 0.135 40 0.340 0.084 0.265 0.21
Conjugate
F. hepatica. F. gigantic
Conj. B N PI P2 Conj. B N PI P2
1000 0.121 0.125 0.327 0.214 1000 0.098 0.142 0.695 0.457
2000 0.147 0.181 0.365 0.251 2000 0.105 0.204 0.362 0.422




Adjusted OD values For Faecal Antibody Responses to Glutathion S-Transferase (FhGST) by
By F. hepatica and F. gigantica infected sheep
Experiment One (1): Adjusted values for F. hepatica (British and Peruvian strain)
infected sheep and uninfected sheep
Adjusted Total Faecal Ig OD values Adjusted Faecal IgGl OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.101 0.102 0.195 0.172 0.105 0.148 -2 0.050 0.059 0.073 0.069 0.028 0.048
-1 0.125 0.197 0.101 0.189 0.119 0.137 -1 0.053 0.037 0.084 0.077 0.043 0.032
0 0.131 0.124 0.167 0.194 0.099 0.193 0 0.036 0.061 0.060 0.057 0.031 0.041
1 0.159 0.197 0.230 0.194 0.164 0.131 1 0.041 0.051 0.080 0.081 0.048 0.032
2 0.298 0.335 0.234 0.114 0.325 0.380 2 0.050 0.040 0.087 0.065 0.046 0.033
3 0.167 0.308 0.308 0.180 0.398 0.437 3 0.046 0.058 0.065 0.063 0.024 0.036
4 0.230 0.251 0.314 0.175 0.425 0.370 4 0.042 0.062 0.063 0.086 0.042 0.027
5 0.234 0.327 0.216 0.152 0.317 0.390 5 0.060 0.054 0.060 0.075 0.044 0.032
6 0.308 0.425 0.317 0.166 0.515 0.471 6 0.063 0.049 0.073 0.076 0.031 0.023
7 0.314 0.355 0.339 0.193 0.305 0.532 7 0.058 0.064 0.075 0.068 0.029 0.032
8 0.304 0.425 0.236 0.121 0.415 0.342 8 0.051 0.038 0.078 0.076 0.045 0.042
9 0.325 0.314 0.203 0.117 0.304 0.237 9 0.039 0.044 0.074 0.066 0.030 0.026
10 0.298 0.317 0.171 0.175 0.307 0.346 10 0.039 0.048 0.082 0.059 0.045 0.041
11 0.241 0.278 0.188 0.182 0.368 0.320 11 0.040 0.054 0.079 0.072 0.029 0.034
12 0.339 0.104 0.107 0.329 0.318 12 0.053 0.056 0.081 0.087 0.050 0.032
13 0.390 0.177 0.104 0.380 0.391 13 0.041 0.038 0.061 0.083 0.034 0.038
14 0.423 0.109 0.172 0.220 0.508 14 0.055 0.080 0.062 0.038 0.026
15 0.380 0.186 0.186 0.370 0.460 15 0.052 0.064 0.069 0.029 0.030
16 0.235 0.196 0.108 0.225 0.335 16 0.055 0.073 0.090 0.025 0.045
17 0.217 0.119 0.180 0.207 0.196 17 0.037 0.080 0.073 0.025 0.025
Appendix Table 4.165
Adjusted Faecal IgM OD values Adjusted Faecal IgG2 OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10 WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.018 0.013 0.014 0.016 0.015 0.006 -2 0.058 0.050 0.057 0.058 0.063 0.062
-1 0.011 0.011 0.018 0.013 0.008 0.015 -1 0.050 0.051 0.045 0.070 0.062 0.073
0 0.013 0.008 0.011 0.014 0.010 0.011 0 0.045 0.056 0.053 0.058 0.072 0.059
1 0.013 0.012 0.011 0.009 0.012 0.013 1 0.046 0.058 0.049 0.069 0.072 0.060
2 0.010 0.010 0.009 0.015 0.007 0.008 2 0.041 0.052 0.057 0.068 0.077 0.073
3 0.015 0.007 0.011 0.015 0.011 0.015 3 0.058 0.042 0.041 0.061 0.076 0.064
4 0.013 0.007 0.010 0.015 0.017 0.008 4 0.054 0.056 0.037 0.062 0.073 0.075
5 0.012 0.013 0.013 0.016 0.014 0.017 5 0.043 0.040 0.051 0.073 0.064 0.062
6 0.012 0.015 0.011 0.006 0.011 0.010 6 0.057 0.046 0.056 0.076 0.067 0.064
7 0.016 0.009 0.006 0.008 0.011 0.007 7 0.049 0.038 0.044 0.075 0.069 0.070
8 0.009 0.008 0.008 0.010 0.011 0.008 8 0.040 0.054 0.047 0.069 0.063 0.057
9 0.016 0.015 0.011 0.008 0.010 0.016 9 0.053 0.049 0.042 0.056 0.058 0.072
10 0.015 0.012 0.014 0.017 0.010 0.011 10 0.050 0.039 0.056 0.072 0.076 0.066
11 0.014 0.014 0.008 0.009 0.016 0.014 11 0.048 0.041 0.040 0.060 0.077 0.073
12 0.017 0.013 0.010 0.010 0.013 12 0.047 0.056 0.063 0.075 0.059
13 0.007 0.011 0.015 0.009 0.012 13 0.056 0.042 0.070 0.072 0.065
14 0.009 0.015 0.017 0.014 0.009 14 0.039 0.060 0.069 0.056 0.067
15 0.008 0.017 0.013 0.009 0.014 15 0.053 0.053 0.075 0.078 0.076
16 0.011 0.013 0.007 0.016 0.010 16 0.036 0.055 0.068 0.075 0.071




Adjusted Faecal IgA OD values
WPI SH5 SH6 SH7 SH8 SH9 SH10
-2 0.067 0.110 0.171 0.108 0.107 0.126
-1 0.152 0.087 0.113 0.109 0.115 0.103
0 0.129 0.102 0.110 0.111 0.170 0.141
1 0.147 0.162 0.119 0.162 0.189 0.159
2 0.247 0.412 0.176 0.170 0.339 0.173
3 0.169 0.423 0.182 0.130 0.350 0.146
4 0.108 0.369 0.121 0.167 0.495 0.219
5 0.197 0.457 0.110 0.127 0.384 0.243
6 0.125 0.377 0.138 0.125 0.304 0.125
7 0.258 0.487 0.104 0.104 0.414 0.158
8 0.124 0.450 0.108 0.145 0.377 0.104
9 0.138 0.305 0.197 0.102 0.232 0.145
10 0.152 0.221 0.125 0.107 0.148 0.162
11 0.250 0.108 0.148 0.107 0.135 0.170
12 0.196 0.214 0.109 0.109 0.141 0.168
13 0.185 0.263 0.110 0.312 0.207
'
14 0.308 0.302 0.109 0.307 0.176
15 0.340 0.237 0.102 0.370 0.277
16 0.314 0.333 0.124 0.241 0.315
17 0.115 0.148 0.138 0.142 0.252
Appendix Table 4.167
Experiment three (3): Adjusted values for F. gigantica (Kenyan strain)
infected and uninfected sheep
Adjusted total Faecal Ig OD values
WPI SH.ll SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 MEAN(-) SEM
-2 0.113 0.092 0.120 0.142 0.117 0.117 0.008 0.110 0.110 0.121 0.120 0.115 0.003
0 0.130 0.109 0.117 0.137 0.118 0.122 0.005 0.116 0.124 0.112 0.128 0.120 0.004
2 0.096 0.075 0.118 0.168 0.119 0.115 0.016 0.127 0.116 0.090 0.117 0.113 0.008
4 0.135 0.114 0.355 0.131 0.230 0.193 0.045 0.109 0.121 0.127 0.110 0.117 0.004
6 0.136 0.115 0.287 0.236 0.246 0.204 0.033 0.119 0.129 0.127 0.108 0.121 0.005
8 0.277 0.223 0.232 0.194 0.204 0.226 0.014 0.112 0.112 0.101 0.124 0.112 0.005
9 0.222 0.240 0.140 0.205 0.215 0.204 0.017 0.122 0.116 0.120 0.118 0.119 0.001
10 0.242 0.206 0.142 0.207 0.217 0.203 0.017 0.114 0.125 0.080 0.119 0.110 0.010
11 0.102 0.245 0.137 0.202 0.212 0.180 0.026 0.110 0.118 0.118 0.127 0.118 0.003
12 0.133 0.112 0.168 0.233 0.243 0.178 0.026 0.127 0.142 0.119 0.121 0.127 0.005
13 0.096 0.750 0.131 0.196 0.206 0.276 0.050 0.102 0.125 0.070 0.117 0.104 0.012
14 0.160 0.039 0.295 0.360 0.870 0.345 0.060 0.111 0.110 0.118 0.126 0.116 0.004
15 0.120 0.199 0.155 0.120 0.230 0.165 0.026 0.112 0.112 0.116 0.112 0.113 0.001
16 0.106 0.085 0.141 0.206 0.216 0.151 0.026 0.108 0.060 0.108 0.112 0.097 0.012
17 0.200 0.179 0.235 0.300 0.310 0.245 0.026 0.107 0.123 0.107 0.120 0.114 0.004
18 0.341 0.320 0.376 0.441 0.451 0.386 0.026 0.109 0.071 0.109 0.060 0.087 0.013
19 0.245 0.224 0.280 0.345 0.355 0.290 0.026 0.120 0.115 0.114 0.116 0.116 0.001
20 0.177 0.156 0.212 0.277 0.287 0.222 0.026 0.120 0.117 0.129 0.107 0.118 0.005
21 0.122 0.101 0.157 0.222 0.232 0.167 0.026 0.114 0.119 0.108 0.112 0.113 0.002




Adjusted Faecal IgGl OD values
WPI SH.11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 MEAN(-) SEM
-2 0.121 0.112 0.121 0.139 0.150 0.129 0.007 0.126 0.124 0.145 0.151 0.137 0.007
0 0.122 0.123 0.143 0.145 0.147 0.136 0.006 0.150 0.128 0.115 0.139 0.133 0.007
2 0.123 0.130 0.136 0.124 0.137 0.130 0.003 0.112 0.135 0.117 0.118 0.121 0.005
4 0.124 0.113 0.119 0.136 0.145 0.127 0.006 0.127 0.150 0.133 0.129 0.135 0.005
6 0.143 0.135 0.135 0.142 0.123 0.136 0.004 0.130 0.145 0.121 0.139 0.134 0.005
8 0.121 0.144 0.131 0.145 0.116 0.131 0.006 0.147 0.136 0.120 0.120 0.131 0.007
10 0.118 0.134 0.149 0.118 0.116 0.127 0.006 0.119 0.142 0.126 0.131 0.130 0.005
12 0.148 0.143 0.132 0.129 0.136 0.138 0.004 0.140 0.130 0.118 0.114 0.126 0.006
14 0.140 0.126 0.145 0.117 0.146 0.135 0.006 0.136 0.132 0.143 0.129 0.135 0.003
16 0.121 0.130 0.119 0.135 0.141 0.129 0.004 0.133 0.144 0.116 0.116 0.127 0.007
18 0.125 0.117 0.136 0.124 0.145 0.129 0.005 0.132 0.146 0.132 0.140 0.138 0.003
19 0.113 0.131 0.150 0.127 0.147 0.134 0.007 0.115 0.150 0.122 0.144 0.133 0.008
20 0.135 0.136 0.139 0.139 0.120 0.134 0.004 0.128 0.128 0.122 0.140 0.130 0.004
21 0.124 0.113 0.130 0.122 0.139 0.126 0.004 0.147 0.120 0.133 0.127 0.132 0.006
22 0.137 0.149 0.144 0.129 0.127 0.137 0.004 0.115 0.123 0.144 0.122 0.126 0.006
23 0.130 0.149 0.141 0.120 0.119 0.132 0.006 0.131 0.134 0.139 0.130 0.134 0.002
24 0.126 0.120 0.122 0.129 0.112 0.122 0.003 0.113 0.128 0.120 0.129 0.123 0.004
25 0.150 0.150 0.116 0.146 0.146 0.142 0.006 0.102 0.135 0.146 0.105 0.122 0.011
26 0.133 0.136 0.138 0.134 0.130 0.134 0.001 0.113 0.070 0.123 0.115 0.105 0.012
27 0.135 0.116 0.101 0.130 0.102 0.117 0.007 0.113 0.129 0.140 0.146 0.132 0.007
Appendix Table 4.169
Adjusted Faecal IgM OD values
WPI SH.11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 MEAN(-) SEM
-2 0.060 0.064 0.088 0.072 0.026 0.062 0.010 0.047 0.044 0.088 0.072 0.063 0.011
0 0.046 0.047 0.059 0.068 0.044 0.053 0.005 0.031 0.025 0.059 0.068 0.046 0.011
2 0.038 0.032 0.069 0.063 0.033 0.047 0.008 0.032 0.041 0.069 0.063 0.051 0.009
4 0.040 0.046 0.081 0.088 0.040 0.059 0.011 0.035 0.025 0.081 0.088 0.057 0.016
6 0.043 0.051 0.056 0.074 0.044 0.054 0.006 0.043 0.042 0.056 0.074 0.054 0.007
8 0.054 0.059 0.094 0.089 0.031 0.065 0.012 0.026 0.037 0.094 0.089 0.062 0.018
10 0.032 0.032 0.088 0.054 0.028 0.047 0.011 0.029 0.032 0.088 0.054 0.051 0.014
12 0.047 0.052 0.055 0.085 0.031 0.054 0.009 0.038 0.036 0.055 0.085 0.054 0.011
14 0.051 0.048 0.056 0.058 0.042 0.051 0.003 0.026 0.023 0.056 0.058 0.041 0.009
16 0.063 0.043 0.066 0.095 0.047 0.063 0.009 0.027 0.037 0.066 0.095 0.056 0.015
18 0.045 0.033 0.060 0.054 0.046 0.048 0.C05 0.042 0.045 0.060 0.054 0.050 0.004
19 0.060 0.047 0.094 0.087 0.027 0.063 0.012 0.045 0.017 0.094 0.087 0.061 0.018
20 0.060 0.064 0.060 0.062 0.035 0.056 0.005 0.037 0.039 0.060 0.062 0.050 0.007
21 0.040 0.056 0.076 0.089 0.041 0.060 0.010 0.034 0.030 0.076 0.089 0.057 0.015
22 0.058 0.060 0.090 0.055 0.044 0.061 0.008 0.046 0.039 0.090 0.055 0.058 0.011
23 0.049 0.055 0.094 0.060 0.032 0.058 0.010 0.036 0.023 0.094 0.060 0.053 0.016
24 0.050 0.046 0.061 0.094 0.034 0.057 0.010 0.034 0.045 0.061 0.094 0.059 0.013
25 0.034 0.036 0.060 0.074 0.043 0.049 0.008 0.040 0.028 0.060 0.074 0.051 0.010
26 0.033 0.038 0.095 0.093 0.033 0.058 0.015 0.036 0.021 0.095 0.093 0.061 0.019























































































Adjusted Faecal IgG2 OD values
SH.11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 MEAN(-)
0.025 0.031 0.032 0.039 0.025 0.030 0.003 0.025 0.032 0.030 0.038 0.031
0.031 0.026 0.027 0.036 0.026 0.029 0.002 0.027 0.036 0.037 0.028 0.032
0.033 0.038 0.033 0.024 0.035 0.033 0.002 0.024 0.040 0.024 0.037 0.031
0.042 0.035 0.029 0.036 0.028 0.034 0.003 0.042 0.027 0.025 0.035 0.032
0.034 0.040 0.033 0.042 0.036 0.037 0.002 0.041 0.026 0.041 0.035 0.036
0.037 0.032 0.040 0.027 0.028 0.033 0.003 0.027 0.041 0.041 0.030 0.035
0.037 0.026 0.039 0.027 0.039 0.034 0.003 0.038 0.041 0.031 0.026 0.034
0.025 0.033 0.040 0.036 0.036 0.034 0.003 0.042 0.027 0.030 0.034 0.033
0.035 0.033 0.029 0.022 0.036 0.031 0.003 0.040 0.024 0.039 0.030 0.033
0.032 0.028 0.040 0.023 0.025 0.030 0.003 0.023 0.032 0.024 0.025 0.026
0.042 0.029 0.042 0.031 0.038 0.036 0.003 0.032 0.027 0.025 0.024 0.027
0.026 0.034 0.031 0.040 0.027 0.032 0.003 0.042 0.038 0.037 0.032 0.037
0.025 0.024 0.041 0.041 0.030 0.032 0.004 0.026 0.026 0.034 0.028 0.029
0.026 0.042 0.039 0.026 0.026 0.032 0.004 0.028 0.038 0.035 0.023 0.031
0.035 0.022 0.027 0.038 0.027 0.030 0.003 0.038 0.023 0.026 0.025 0.028
0.036 0.035 0.042 0.029 0.036 0.036 0.002 0.030 0.028 0.031 0.026 0.029
0.029 0.036 0.027 0.027 0.028 0.029 0.002 0.023 0.030 0.041 0.032 0.032
0.039 0.035 0.032 0.039 0.030 0.035 0.002 0.031 0.026 0.031 0.035 0.031
0.040 0.029 0.041 0.035 0.037 0.036 0.002 0.031 0.027 0.034 0.024 0.029
0.024 0.024 0.041 0.030 0.033 0.030 0.003 0.038 0.027 0.036 0.030 0.033
Appendix Table 4.171
Adjusted Faecal IgA OD values
SH. 11 SH. 12 SH. 13 SH. 14 SH. 15 Mean (+) SEM SH. 16 SH. 17 SH. 18 SH. 19 MEAN(-)
0.076 0.022 0.015 0.060 0.047 0.044 0.011 0.040
0.058 0.022 0.023 0.073 0.023 0.040 0.011 0.022
0.007 0.047 0.008 0.079 0.015 0.031 0.014 0.047
0.062 0.063 0.105 0.168 0.090 0.098 0.019 0.021
0.208 0.177 0.120 0.226 -0.004 0.145 0.042 0.055
0.077 0.206 0.127 0.007 0.036 0.091 0.035 0.007
0.309 0.275 0.106 0.339 0.055 0.217 0.057 0.070
0.032 0.036 0.085 0.295 0.107 0.111 0.048 0.040
0.167 -0.004 0.256 0.208 0.103 0.146 0.045 0.022
0.447 0.036 0.313 0.353 0.168 0.263 0.073 0.040
0.218 0.085 0.134 0.226 0.166 0.034 0.022
0.149 0.724 0.112 0.167 0.288 0.085 0.047
0.252 0.474 0.158 0.002 0.222 0.099 0.023
0.351 0.137 0.206 0.023 0.179 0.069 0.051
0.218 0.339 0.137 0.010 0.176 0.069 0.089
0.112 0.295 0.137 0.120 0.166 0.043 0.027
0.158 0.208 0.090 0.040 0.124 0.037 0.086
0.206 0.353 -0.003 0.022 0.145 0.084 0.005
0.090 0.134 0.015 0.047 0.072 0.026 0.016












































Experiment 5 : Calves infected with F.hepatica and A. gigantica respectively,
Adjusted faecal total Ig OD values: PoiltTest
Fh-E/S Fh-Cathepsin Fh-GST
WPI 14c 15c 23 c 26c 14c 15c 23 c 26c 14c 15c 23 c 26c
-26 0.046 0.058 0.049 0.069 0.059 0.003 0.040 0.024 0.038 0.036 0.055 0.085
-25 0.041 0.052 0.057 0.068 0.059 0.003 0.023 0.032 0.026 0.023 0.056 0.058
-24 0.058 0.042 0.041 0.061 0.048 0.003 0.032 0.027 0.027 0.037 0.066 0.095
-23 0.054 0.056 0.037 0.062 0.052 0.003 0.042 0.038 0.042 0.045 0.060 0.054
-15 0.043 0.040 0.051 0.073 0.055 0.004 0.026 0.026 0.045 0.017 0.094 0.087
-12 0.057 0.046 0.056 0.076 0.059 0.004 0.028 0.038 0.037 0.039 0.060 0.062
-9 0.049 0.038 0.044 0.075 0.052 0.003 0.038 0.023 0.034 0.030 0.076 0.089
-6 0.040 0.054 0.047 0.069 0.057 0.002 0.030 0.028 0.046 0.039 0.090 0.055
-3 0.053 0.049 0.042 0.056 0.049 0.002 0.023 0.030 0.026 0.002 0.031 0.027
0 0.067 0.063 0.073 0.072 0.069 0.002 0.031 0.026 0.069 0.058 0.064 0.077
1 0.050 0.051 0.045 0.070 0.062 0.073 0.064 0.062 0.043 0.040 0.051 0.073
3 0.045 0.056 0.053 0.058 0.072 0.059 0.067 0.064 0.057 0.046 0.056 0.076
4 0.046 0.058 0.049 0.069 0.072 0.060 0.069 0.070 0.049 0.038 0.044 0.075
6 0.041 0.052 0.057 0.068 0.077 0.073 0.063 0.057 0.040 0.054 0.047 0.069
9 0.058 0.042 0.041 0 061 0.076 0.064 0.058 0.072 0.053 0.049 0.042 0.056
12 0.054 0.056 0.037 0.062 0.073 0.075 0.076 0.066 0.050 0.039 0.056 0.072
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